UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

 

FORM 20-F

 

¨   REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

x   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2011

OR

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

OR

¨   SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 

 

Commission file number 000-50790

 

 

 

VUANCE LTD.

(Exact name of Registrant as specified in its charter)

 

Not Applicable

(Translation of Registrant’s Name into English)

 

Israel

(Jurisdiction of incorporation or organization)

 

Nolton House, 14 Shenkar Street, P.O.B 12190, Hertzliya Pituach 46725, Israel

(Address of principal executive offices)

 

Mickey Ben Harush, CFO, +972-9-889-0800, mickeyb@vuance.com,

Nolton House, 14 Shenkar Street, P.O.B 12190, Hertzliya Pituach 46725, Israel

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

 

 

Securities registered or to be registered pursuant to Section 12(b) of the Act.

None

 

Securities registered or to be registered pursuant to Section 12(g) of the Act.

Ordinary Shares, par value NIS 0.0588235 per share

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

None

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 12,035,272 Ordinary Shares, nominal value NIS 0.0588235 per share .

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  ¨   Yes     x     No 

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934.     ¨  Yes     x  No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such reporting requirements for the past 90 days.

 

x Yes   ¨   No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). x Yes   ¨   No  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ¨              Accelerated filer ¨              Non-accelerated filer x

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP x

International Financial Reporting Standards as issued by the International Accounting Standards Board ¨

Other ¨ If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow: Item 17 ¨   Item 18 ¨

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes   ¨     No   x

 

 
 

 

TABLE OF CONTENTS

 

PART I  
   
NOTE REGARDING FORWARD-LOOKING STATEMENTS 4
   
ITEM 1.  Identity of Directors, Senior Management and Advisers. 5
   
ITEM 2.  Offer Statistics and Expected Timetables. 5
   
ITEM 3.  Key Information. 5
   
Selected Financial Data 5
Capitalization and Indebtedness 7
Reasons for the Offer and Use of Proceeds 7
Risk Factors 7
   
ITEM 4.  Information on the company. 24
   
History and Development of the Company 24
Business Overview 27
Organizational Structure 35
Property, Plants and Equipment 36
   
ITEM 4A.  Unresolved Staff Comments. 36
   
ITEM 5.  Operating and Financial Review and Prospects. 37
   
Operating results 37
Liquidity and Capital Resources 44
Research and Development, patents and licenses, etc. 49
Trend Information 49
Off Balance Sheet Arrangements 50
Tabular Disclosure of Contractual Obligations 50
   
ITEM 6.  Directors, Senior Management and Employees. 51
   
Directors and Senior Management 51
Compensation 52
Board Practices 53
Employees 55
Share Ownership 56
   
ITEM 7.  Major Shareholders and Related Party Transactions. 59
   
Major shareholders 59
Related Party Transactions 62
Interests of Experts and Counsel 63
   
ITEM 8.  Financial Information. 64
   
Consolidated Statements and Other Financial Information (Audited) 64
Significant Changes 67
   
ITEM 9.  The Offer And Listing. 67
   
Offer and Listing Details 67
Plan of Distribution 69
Markets 69
Selling Shareholders 69
Dilution 69
Expenses of the Issue 69
   
ITEM 10.  Additional Information. 69

 

2
 

 

Share Capital 69
Memorandum and Articles of Association 69
Material Contracts 74
Exchange Controls 74
Taxation 74
Dividends and Paying Agent 81
Statement by Experts 81
Documents on Display 81
Subsidiary Information 81
   
ITEM 11.  Quantitative and Qualitative Disclosures About Market Risk. 81
   
Quantitative and Qualitative Information about Market Risk 81
   
ITEM 12.  Description of Securities Other than Equity Securities. 82
   
PART II  
   
ITEM 13.  Defaults, Dividend Arrearages and Delinquencies. 82
   
ITEM 14.  Material Modifications to the Rights of Security Holders and Use of Proceeds. 83
   
ITEM 15.  Controls and Procedures. 83
   
ITEM 16A. Audit Committee Financial Expert 84
   
ITEM 16B.  Code of Ethics 84
   
ITEM 16C.  Principal Accountant Fees and Services 84
   
ITEM 16D.  Exemptions from the Listing Standards for Audit Committees 85
   
ITEM 16E.  Purchases of Equity Securities by the Issuer and Affiliated Purchasers 85
   
ITEM 16F.  Change in Registrant’s Certifying Accountant 85
   
ITEM 16G.  corporate governance 85
   
ITEM 16H.  mine safety disclosure 85
   
PART III  
   
ITEM 17.  Financial Statements. 85
   
ITEM 18.  Financial Statements. 85
   
ITEM 19.  Exhibits. 86

 

3
 

 

NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Annual Report on Form 20-F (“Annual Report”) contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 that are not historical facts but rather reflect our present expectations concerning future results and events. Words such as “anticipate,” “estimate,” “expects,” “may,” “projects,” “intends,” “plans,” “believes,” “would,” “could” and words and terms of similar substance used in connection with any discussion of future operating or financial performance may identify forward-looking statements. These forward looking statements include, but are not limited to, statements regarding: (i) our belief about our competitive position in the tracking, asset management and monitoring, active radio frequency identification (“RFID"), e-ID, and our ability to become a key technological player in such markets; (ii) our belief about the commercial possibilities for our products in such markets; (iii) our expectation to be able to leverage our current products and technologies for the development of new applications and penetration to additional markets; (iv) our expectation to be able to continue to participate in the government market; (v) our belief about our ability to leverage our public sector experience into the commercial sector; (vi) our belief regarding the effects of competitive pricing on our margins, sales and market share; (vii) our expectations regarding the effects of the legal proceedings we are involved in on our sales and operating performance (See “Legal Proceedings” in Item 8.A); (viii) our belief regarding the fluctuations of our operating results, including our belief about the effects of inflation and the fluctuation of the NIS/dollar exchange rate on our operating results; (ix) our expectations about our future revenues (or absence of revenues); (x) our expectations about the effects of seasonality on our revenues and operating results; (xi) our expectations regarding development and introduction of future products; (xii) our expectations regarding revenues from our existing customer contracts and purchase orders, including, without limitation, the value of our agreement for our end-to-end system for a national multi-ID issuing and control system with the government of a European country and our expectations for increased revenues from sales of additional technology and raw materials to such government; (xiii) our expectations regarding the success of our active RFID technology; (xiv) our expectations regarding the effectiveness of our marketing programs and generation of business from those programs, including our ability to continue to sell products through strategic alliances and our belief about the role customer service plays in our sales and marketing programs; (xv) our anticipation that sales to a relatively small number of customers will continue to account for a significant portion of our net sales; and (xvi) the anticipated timing of our product introductions. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those stated in such statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below under the captions “Risk Factors” in Item 3.D and “Operating and Financial Review and Prospects” in Item 5 and elsewhere in this Annual Report, as well as in our reports on Form 6-K submitted to the Securities and Exchange Commission, or the SEC. We are not under any obligation, and expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section, and you are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date of this Annual Report.

 

In this Annual Report, all references to "Vuance," the “Company,” "we," "us" or "our" are to Vuance Ltd., a company organized under the laws of the State of Israel, and its subsidiaries.

 

In this Annual Report, unless otherwise specified or unless the context otherwise requires, all references to "$" or "dollars" are to U.S. dollars and all references to "NIS" are to New Israeli Shekels. Except as otherwise indicated, the financial statements of and information regarding Vuance are presented in U.S. dollars.

 

Note: Unless otherwise indicated herein, the prices and quantities of our ordinary shares provided in this Annual Report reflect the 1 to 5.88235 share consolidation (reverse share split) that we completed on April 29, 2007 and which became effective for trading purposes as of May 14, 2007.

 

4
 

 

PART I

 

ITEM 1.     Identity of Directors, Senior Management and Advisers.

 

Not applicable.

 

ITEM 2.     Offer Statistics and Expected Timetables.

 

Not applicable.

 

ITEM 3.     Key Information.

 

A.    Selected Financial Data

 

The following selected consolidated financial data as of December 31, 2011, 2010, 2009, 2008 and 2007 and for the years then ended have been derived from our audited consolidated financial statements. These financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and audited by Fahn Kanne & Co., a member of Grant Thornton International. The selected consolidated financial data set forth below should be read in conjunction with and are qualified by reference to Item 5, "Operating and Financial Review and Prospects" and the consolidated financial statements and notes thereto and other financial information included elsewhere in this Annual Report. Historical results are not necessarily indicative of future results.

 

5
 

 

    (IN THOUSANDS OF U.S. DOLLARS, EXCEPT PER SHARE DATA)  
    2011     2010     2009     2008(**)     2007(**)  
SUMMARY OF STATEMENT OF OPERATIONS:                                        
Revenues     7,922       7,389       9,304       18,112       12,236 (*)
Cost of Revenues     3,306       2,057       3,365       6,945       4,992  
                                         
Gross Profit     4,616       5,332       5,939       11,167       7,244  
                                         
Operating Expenses:                                        
Research and Development     462       386       898       1,738       1,411  
Selling and Marketing     3,505       4,405       5,131       9,905       7,144  
General and Administrative     732       1,985       1,648       2,611       2,728  
Other (income) expenses     (137 )     (396 )     130       8       134  
                                         
Total Operating Expenses     4,562       6,380       7,807       14,262       11,417  
                                         
Operating (Loss) Income     54       (1,048 )     (1,868 )     (3,095 )     (4,173 )
Financial (Expenses) Income, Net     990       (678 )     (620 )     (3,087 )     (4,646 )
                                         
Income (Loss) before Income Tax     1,044       (1,726 )     (2,488 )     (6,182 )     (8,819 )
                                         
Income Tax     (25 )     (50 )     (71 )     (137 )     (390 )(*)
                                         
Net Income (Loss) from continuing operations     1,019       (1,776 )     (2,559 )     (6,319 )     (9,209 )
                                         
Loss from discontinued operations     -       (189 )     (2,526 )     (6,039 )     (2,102 )
                                         
Net income (loss)   $ 1,019     $ (1,965 )   $ (5,085 )   $ (12,358 )   $ (11,311 )
                                         
PER SHARE DATA:                                        
Basic earnings (loss) from continuing operations   $ 0.11     $ (0.29 )   $ (0.46 )   $ (1.22 )   $ (2.09 )
Diluted earnings (loss) from continuing operations   $ 0.09     $ (0.29 )   $ (0.46 )   $ (1.22 )   $ (2.09 )
Basic and Diluted loss from discontinued operations     -     $ (0.03 )   $ (0.46 )   $ (1.17 )   $ (0.48 )
Basic earnings (loss) per share   $ 0.11     $ (0.32 )   $ (0.92 )   $ (2.39 )   $ (2.57 )
Diluted earnings (loss) per share   $ 0.09     $ (0.92 )   $ (0.92 )   $ (2.39 )   $ (2.57 )
                                         
SUMMARY OF BALANCE SHEET DATA:                                        
Cash and Cash Equivalents     215       197       656       812       2,114  
Marketable debt securities                             4,054  
Trade receivables (net of allowance for doubtful accounts of $ 134 and $ 1,553 as of December 31, 2011 and 2010, respectively)     1,542       752       857       840       2,463  
Inventories, net     269       197       82       1,307       56  
Total Current Assets     2,131       1,664       4,236       6,443       14,769  
TOTAL ASSETS     2,455       2,008       4,682       8,935       20,952  
Total Current Liabilities     7,829       4,500       6,332       10,424       8,916  
Accrued Severance Pay     227       254       304       378       362  
SHAREHOLDERS' EQUITY (DEFICIT)     (5,601 )     (7,871 )     (6,271 )     (1,867 )     9,233  

 

 

(*) Certain comparative figures have been reclassified to conform to the current period presentation. The changes did not affect net income, cash flow or stockholders equity.

(**) Due to the sale of certain business activities in January 2010, as described in Item 4 below, those business activities are presented as discontinued operations in accordance with U.S. GAAP.

 

6
 

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

You should carefully consider the following risks together with the other information in this Annual Report in evaluating our business, financial condition and prospects. The risks and uncertainties described below are not the only ones that we face. Additional risks and uncertainties not presently known to us or that we consider immaterial may also impair our business operations, financial results and prospects. If any of the following risks actually occur, our business, financial results and prospects could be harmed. In that case, the trading price of our ordinary shares could decline. You should also refer to the other information set forth in this Annual Report, including our financial statements and related notes and the Section captioned “Note Regarding Forward-Looking Statements.”

 

Risks Related to Our Business

 

We have a history of annual losses and negative operating cash flows and may not be profitable in the future.

 

We have incurred substantial losses and negative cash flows since our inception. We had an operating cash flow deficit in each of 2011, 2010 and 2009. As of December 31, 2011, we had an accumulated deficit of approximately $48,325,000. We incurred net losses of approximately $1,965,000 and $5,085,000 in the years ended December 31, 2010 and 2009, respectively. We incurred net income of approximately $1,019,000 in the year ended December 31, 2011 (which includes a capital gain of $2,149,000 as a result of the Creditor Arrangement). We expect to spend significant amounts of capital to enhance our products and services, develop further sales and operations and fund expansion; and therefore, we may have net losses and negative operating cash flows in the near future. As a result, we will need to generate significant revenue to maintain and/or to increase profitability. Even if we do achieve annual profitability, we may not be able to sustain or increase profitability on an annual basis.

 

The Creditor Arrangement has not been completed, and there is no certainty that it will be completed in a timely manner or at all. A substantial delay in its completion could materially harm our business and financial condition.

 

At the annual general meeting of our shareholders held on September 12, 2010, our shareholders resolved to afford certain of our major creditors with the opportunity to convert the amounts owed to them into our ordinary shares, by means of a set off against the then total outstanding debt to such creditor, at a price of $0.09 per ordinary share, subject to forgiveness of 60% of our total outstanding debt to such creditor. Our board of directors was authorized to set all other terms of the Creditor Arrangement, including, inter alia, its timetable.

 

On November 3, 2010 we petitioned the Petach Tikva District Court of the Central District in Israel, for the court approval of a creditor arrangement (the "Creditor Arrangement") in accordance with Section 350 of the Israeli Companies Law, 5759-1999 (the “Israeli Companies Law”). We requested that the court apply the arrangement approved by our shareholders to all of our creditors as of August 10, 2010, or the Determining Date, and who were still creditors as of December 17, 2010 and who had submitted a claim of debt no later than January 6, 2011. In May 2011, our shareholders subsequently approved the inclusion of additional creditors to be included under the Creditor Arrangement. Although the Creditor Arrangement is supported by a resolution of our shareholders and was presented at the meeting of our creditors, on July 18, 2011 the court decided not to approve our application, mainly due to an objection to the proposed arrangement which was filed by one of our secured creditors, Special Situations Funds ("SSF"). On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi all of its rights under the Convertible Bonds and warrants.

 

In February 2012, our Board of Directors determined to proceed with the Creditor Arrangement without the involvement of the court. As of April 15, 2012, following the forgiveness or conversion of debt pursuant to the Creditor Arrangement in the aggregate amount of $3,640,000 since December 31, 2010, additional debt of approximately $3,286,000 (computed as of December 31, 2011) remains to be forgiven or converted pursuant thereto. However, the completion of the Creditor Arrangement has been delayed, which we believe is, as a result of a dispute over the ownership of approximately $1,022,000 (computed as of December 31, 2011) of our convertible bonds held by Sigma Wave Ltd. (“Sigma”). There is no certainty that the Creditor Arrangement will be completed in a timely manner or at all. A substantial delay in its completion could materially harm our business and financial condition. For more information on the Creditor Arrangement, see below in Item 4A. History and Development of the Company under "Recent Developments."

 

7
 

 

We require capital to fund our operations and may need to curtail or cease our operations if it is not available.

 

As of December 31, 2011, we had a negative working capital in the amount of $2,723,000 (excluding the Convertible Bonds which total debt is approximately $2,975,000 as of December 31, 2011). Since September 2011, we have been financing part of our day-to-day operations with interest-free, short-term loans from Mrs. Tsviya Trabelsi, our former chairman of the Board and the wife of our current chairman of the Board, which amounted to approximately $69,000 as of March 31, 2012. In the past, we have partially funded our operations through the issuance of equity securities and convertible bonds to investors and may not be able to generate a positive cash flow from operations in the future. Continuation of our current operations after utilizing our current cash reserves is dependent upon the generation of additional financial resources either through the issuance of additional equity or debt securities or other sources of financing, generating cash flow from operations or the sale of certain of our assets. Any additional financings will likely cause substantial dilution to existing shareholders. If we are unable to obtain necessary additional financing or generate cash from operations, we may be required to reduce the scope of, or cease, our operations. Even if we raise such additional capital, we may be required to reduce the scope of our operations and may need to implement certain operational changes in order to decrease our expenditure level. Our need for additional capital to finance our operations and growth will be greater should, among other things, our revenue or expense estimates prove to be incorrect. These matters raise substantial doubt about our ability to continue as a going concern. Our financial statements have been prepared assuming that we will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.

 

Servicing our debt obligations requires a significant amount of cash, and our ability to obtain or generate cash depends on many factors beyond our control.

 

Should we not complete the Creditor Arrangement, and if we are unable to otherwise restructure our debt obligations, our ability to satisfy our debt service obligations, including making the payments under the convertible bonds we issued in November 2006, to Brevan Howard Master Fund Limited ("BH") (which were assigned to Sigma on August 24, 2010; see Item 4A) and to Special Situation Funds (which were assigned to Mr. Eliyahu Trabelsi on November 8, 2011; see Item4A) (together, the “Convertible Bonds”), will depend, among other things, upon our future operating performance and our ability to refinance indebtedness when necessary. Each of these factors is to a large extent dependent on economic, financial, competitive, legislative, regulatory and other factors that are beyond our control.

 

Restrictions imposed by our debt instruments may limit our ability to finance our future operations or capital needs or engage in other business activities that may be in our interest. Our failure to comply with our obligations under these instruments could lead to an acceleration of our indebtedness.

 

Our amended Convertible Bonds agreements contain certain covenants that will, among other things, limit our ability and the ability of our subsidiaries to: (i) create liens; (ii) sell or otherwise dispose of assets; (iii) engage in transactions with our affiliates; and (iv) merge or consolidate with another entity or transfer all or substantially all of our assets. These restrictions could limit our ability to obtain future financing, make acquisitions or capital expenditures, withstand economic downturns in our business, the industry or the economy in general, conduct operations or otherwise take advantage of business opportunities that arise.

 

Our failure to make payments due under our debt instruments, or to otherwise comply with the restrictions or our obligations thereunder, could result in an event of default under such instruments and lead to an acceleration of our related indebtedness. In the event of such a default, we are not certain whether we would have, or would be able to obtain, sufficient funds to make the accelerated payments, and as a result certain lenders would be able to proceed against certain of our assets that secure the debt. As of December 31, 2011 and the filing date of this Annual Report, we were in default with the amended Convertible Bonds agreements. For more information on the Creditor Arrangement, see Item 4A. History and Development of the Company under "Recent Developments". For more information on the Convertible Bonds, see Item 5.B, “Liquidity and Capital Resources,” regarding the amendments to the Convertible Bonds.

 

The current economic and financial crisis may have a material adverse effect on our results.         

 

The crisis of the financial and credit markets worldwide in the second half of 2008 has led to an economic slowdown worldwide, and the outlook for 2012 is uncertain. A continuation or worsening of unfavorable economic conditions, including the on-going credit and capital markets disruptions, could have an adverse impact on our business, operating results or financial condition in a number of ways. We may experience declines in revenues, profitability and cash flows as a result of reduced orders, delays in receiving orders or in the completion of projects, delays or defaults in payment or other factors caused by the economic problems of our customers and prospective customers. We may experience supply chain delays, disruptions or other problems associated with financial constraints faced by our suppliers and subcontractors. In addition, changes and volatility in the equity, credit and foreign exchange markets and in the competitive landscape make it increasingly difficult for us to predict our revenues and earnings into the future.

 

8
 

 

Adverse capital and credit market conditions may impact our ability to access liquidity and capital .

 

The capital and credit markets have been experiencing extreme volatility and disruption in recent years. We need liquidity in our day-to-day business activities to pay our operating expenses and interest on our debt.

 

We must raise financing to fund our operations. The availability of financing will depend on a variety of factors such as market conditions, the general availability of credit, the volume of trading activities, the overall availability of credit to the financial services industry, our credit ratings and credit capacity, as well as the possibility that customers or lenders could develop a negative perception of our long- or short-term financial prospects. If our internal sources of liquidity prove to be insufficient, there is a risk that external funding sources might not be available or available at unfavorable terms.

 

Disruptions, uncertainty or volatility in the capital and credit markets may also limit our access to capital required to operate our business. Such market conditions may limit our ability to raise additional capital to support business growth.

 

This would have the potential to decrease both our ability to attain profitability and our financial flexibility. Our results of operations, financial condition, cash flows and regulatory capital position could be materially adversely affected by disruptions in the financial markets.

 

Depending on the impact on our business of the current economic and financial crisis, we may face problems in managing any decline in our business .         

 

If the current economic and financial crisis continues to have an adverse impact on the demand for products or their profitability, we may face difficulties in managing a decline in our business. Our success in handling a contraction of our business will depend on our ability, among other things, to:

 

  develop efficient forecast methods for evaluating the prospective quantity of products that will be ordered by our customers;
  control inventories of components ordered by our contract manufacturers required to meet actual demand, including but not limited to handling the effects of excess inventories accumulated by such manufacturers;
  reduce the costs of manufacturing our products;
  continue to collect receivables from our customers in full and in a timely manner; and
  properly balance the size and capabilities of our workforce.

 

If we are unable to manage a decline in business, we could fail to manage the costs associated with all aspects of our business, which would have a material adverse effect on our business and results of operations.

 

We derive a substantial portion of our revenue from one customer, and the reduction of sales to this customer could adversely impact our operating results by causing a drop in revenues.

 

We depend on one customer for a substantial portion of our revenue. In 2011 and 2010, we derived 95% and 92%, respectively, of our consolidated net revenue from one customer. In 2009, we derived 88% of our consolidated net revenue from two customers. A substantial reduction in sales to, or loss of, our significant customer would adversely affect our business unless we were able to replace the revenue we received from the customer, which replacement we may not be able to find. Specifically, changes that may negatively impact the political or economic stability and environment of the European country from which we derive most of our consolidated net revenues, could adversely affect our business and future operations in such country.

 

As a result of this concentration of revenue from a limited number of customers and our increased reliance on active RFID technology resulting from our sale of certain assets and liabilities related to our electronic access control market and our Government Services Division including our CSMS and RAPTOR suites, our revenue has experienced wide fluctuations, and we expect our revenue to continue to experience wide fluctuations in the future. Part of our sales is not recurring sales; therefore, quarterly and annual sales levels could fluctuate. Sales in any period may not be indicative of sales in future periods.

 

9
 

 

We are relying on On Track Innovations Ltd. as a subcontractor in our E-ID project.

 

On December 31, 2006, we sold our E-ID Division to On Track Innovations Ltd. (“OTI”), an Israeli company listed on the NASDAQ Global Market. Simultaneously, we entered into a service and supply agreement with OTI under which OTI agreed to act as our subcontractor and provide services, products and materials necessary to carry out and complete our obligations with regard to certain projects that were not transferred to OTI, which only one of them is currently active (the “Project”) (see description of this transaction in Item 4.A). We will be dependent on OTI to adequately provide such services, products, and materials in order for us to be in good standing under this Project. If OTI fails to fulfill its obligations and provide such services and products as necessary for the Project arising from any reason, and if we are unable to find other suppliers, it could delay our receipt of revenues for this Project, subject us to certain remedies available to our customer, and damage our business reputation, and therefore could have a material adverse effect on our business, operating results and financial condition.

 

Our reliance on third party technologies, raw materials and components for the development of some of our products and our reliance on third parties for manufacturing may delay product launches, impair our ability to develop and deliver products or hurt our ability to compete in the market.

 

Most of our products integrate third-party technology that we license and/or raw materials and components that we purchase or otherwise obtain the right to use, including: operating systems, microchips, security and cryptography technology for card operating systems, which prevents unauthorized parties from tampering with our cards, and dual interface technology, which enables cards to operate in both contact and contactless mode. Our ability to purchase and license new technologies and components from third parties is and will continue to be critical to our ability to offer a complete line of products that meets customer needs and technological requirements. We may not be able to renew our existing licenses or to purchase components and raw materials on favorable terms, if at all. If we lose the rights to a patented technology, we may need to stop selling or may need to redesign our products that incorporate that technology, and we may lose the potential competitive advantage such technology gave us. In addition, competitors could obtain licenses for technologies for which we are unable to obtain licenses, and third parties may develop or enable others to develop a similar solution to security issues, either of which could adversely affect our results of operations. Also, dependence on the patent protection of third parties may not afford us any control over the protection of the technologies upon which we rely. If the patent protection of any of these third parties were compromised, our ability to compete in the market could also be impaired.

 

We usually do not have minimum supply commitments from our vendors for our raw materials or components and generally purchase raw materials and components on a purchase order basis. Although we generally use standard raw materials and components for our systems, some of the key raw materials or components are available only from a single source or from limited sources. Many of our products are only available from limited sources. Even where multiple sources are available, we typically obtain components and raw materials from only one vendor to ensure high quality, prompt delivery and low cost. If one of our suppliers were unable to meet our supply demands and we could not quickly replace the source of supply, it could have a material adverse effect on our business, operating results and financial condition, for reasons including a delay of receipt of revenues and damage to our business reputation.

 

Delays in deliveries from our suppliers, defects in goods or components supplied by our vendors, or delays in projects that are performed by our subcontractors could cause our revenues and gross margins to decline.

 

We rely on a limited number of vendors and subcontractors for certain components of the products we are supplying and projects we perform. In some cases, we rely on a single source vendor or subcontractor. Any undetected flaws in components or other materials to be supplied by our vendors could lead to unanticipated costs to repair or replace these parts or materials. Even though there are multiple suppliers, we purchase some of our components from single suppliers to take advantage of volume discounts, which presents a risk that the components may not be available in the future on commercially reasonable terms, or at all. Although we believe that there are additional suppliers for the equipment and supplies that we require, we may not be able to make such alternative arrangements promptly. If one of our suppliers were unable to meet our supply demands and we could not quickly replace the source of supply, it could cause a delay of receipt of revenues and damage our business reputation. We depend on subcontractors to adequately perform a substantial part of our projects. If a subcontractor fails to fulfill its obligations under a certain project, it could delay our receipt of revenues for such project and damage our business reputation, and therefore could have a material adverse effect on our business, operating results and financial condition.

 

We acquired all of the issued and outstanding stock capital of Security Holding Corporation in 2007 and completed the sale of this activity in 2010. Certain unexpected outcomes of this acquisition and sale are not yet known.

 

In July 2007, we acquired all of the issued and outstanding stock capital of Security Holding Corp. (“SHC”).

Prior to completion of the acquisition, we conducted a due diligence review of SHC; however, we cannot guarantee that all contingent liabilities were brought to our knowledge. A material liability that had not been discovered in the due diligence process, or since, might affect our business.

 

10
 

 

In January 2010 we completed the sale of certain of the assets (including certain accounts receivable and inventory) and certain of the liabilities (including certain accounts payable) of Vuance Inc. acquired in the acquisition of SHC (see a description of this transaction under the caption “History of the Company” in Item 4.A). In connection with the sale, we recognized an impairment of goodwill and intangible assets. Additionally, the sales agreement included an indemnification provision pursuant to which, Vuance Inc. agreed to indemnify the purchaser from and against any claim or liability of Vuance Inc. or of ours, which may be asserted against the purchaser, with the exception of certain business debts and other liabilities agreed to by the purchaser. Should we be required to indemnify the purchaser our financial results could be materially adversely affected.

 

We acquired substantially all of the assets and liabilities of Intelli-Site, Inc. in 2009 and completed the sale of this activity in 2010. Certain unexpected outcomes of this acquisition and sale are not yet known.

 

In March 2009, we acquired substantially all of the assets and liabilities of Intelli-Site, Inc. (“Intelli-Site”). Prior to completion of the acquisition, we conducted a due diligence review of Intelli-Site; however, we cannot guarantee that all contingent liabilities were brought to our knowledge. A material liability that had not been discovered in the due diligence process might affect our business.

 

In January 2010 we completed the sale of certain of the assets (including certain accounts receivable and inventory) and certain of the liabilities (including certain accounts payable) of Vuance Inc. acquired in the acquisition of Intelli-Site (see a description of this transaction under the caption “History of the Company” in Item 4.A). In connection with the sale, we recognized an impairment of intangible assets. Also, the sales agreement included an indemnification clause pursuant to which, each of the parties shall indemnify the other upon the occurrence of certain agreed upon events. Should we be required to indemnify the purchaser our financial results could be materially adversely affected.

 

We may pursue acquisitions or investments in complementary technologies and businesses. We may be unsuccessful in integrating the acquired businesses and/or complementary technologies and businesses, the acquisition of which we may pursue in the future, and such integrations could divert our resources and adversely affect our financial results.

 

Other than Intelli-Site and SHC, we have not made any other acquisitions. Integrating newly acquired business or technologies into our business could divert our management’s attention from other business concerns and could be expensive and time-consuming. Acquisitions could expose our business to unforeseen liabilities or risks associated with entering new markets. Consequently, we might not be successful in integrating the acquired businesses, technologies or products into our existing business and products, and might not achieve anticipated revenue or cost benefits. In the future, we may pursue acquisitions of, or investments in, complementary technologies and businesses. We may be unable to identify suitable acquisition candidates in the future or to make these acquisitions on a commercially reasonable basis, or at all. Such acquisitions present a number of potential risks and challenges that could, if not met, disrupt our business operations, increase our operating costs and reduce the value to us of the acquired company. For example, if we identify an acquisition candidate, we may not be able to successfully negotiate or finance the acquisition on favorable terms. In addition, future acquisitions could result in customer dissatisfaction and performance problems with an acquired company, which could adversely affect our business.

 

Costs arising from our future acquisitions and dispositions could adversely affect our financial condition.

 

Any acquisition or disposition that we make could result in the use of our cash or equity securities, incurrence and assumption of debt, contingent liabilities, significant acquisition-related expenses, amortization of certain identifiable intangible assets, and research and development write-offs, and could require us to record goodwill and other intangible assets that could result in future impairments that could harm our financial results. We will likely incur significant transaction costs pursuing acquisitions or dispositions, including acquisitions or dispositions that may not be consummated. We may not be able to generate sufficient revenues from our acquisitions or dispositions to offset their costs, which could materially adversely affect our financial condition. The recognition of impairments of tangible, intangible and financial assets results in a non-cash charge on the income statement, which could adversely affect our results of operations

 

Our dependence on third-party distributors, sales agents and value-added resellers could result in marketing and distribution delays, which would prevent us from generating sales revenues.

 

We market and sell some of our products using a network of distributors covering the United States and parts of Europe. We establish relationships with distributors and resellers through agreements that provide prices, discounts and other material terms and conditions under which the reseller is eligible to purchase our systems and products for resale. These agreements generally do not grant exclusivity to the distributors and resellers and, as a general matter, are not long-term contracts, do not have commitments for minimum sales, and could be terminated by the distributor. We do not have agreements with all of our distributors. We are currently engaged in discussions with other potential distributors, sales agents, and value-added resellers. Such arrangements may never be finalized and, if finalized, such arrangements may not increase our revenues or enable us to achieve profitability.

 

11
 

 

Our ability to terminate a distributor who is not performing satisfactorily may be limited. Inadequate performance by a distributor could adversely affect our ability to develop markets in the regions for which the distributor is responsible and could result in substantially greater expenditures by us in order to develop such markets. Our operating results will be highly dependent upon: (i) our ability to maintain our existing distributor arrangements; (ii) our ability to establish and maintain coverage of major geographic areas and establish access to customers and markets; and (iii) the ability of our distributors, sales agents, and value-added resellers to successfully market our products. A failure to achieve these objectives could result in lower revenues.

 

Third parties could obtain access to our proprietary information or could independently develop similar technologies.

 

Despite the precautions we take, third parties may copy or obtain and use our technologies, ideas, know-how and other proprietary information without authorization or may independently develop technologies similar or superior to our technologies. In addition, the confidentiality and non-competition agreements between us and most of our employees, distributors and clients may not provide meaningful protection of our proprietary technologies or other intellectual property in the event of unauthorized use or disclosure. If we are not able to successfully defend our industrial or intellectual property rights, we may lose rights to technologies that we need to develop our business, which may cause us to lose potential revenues, or we may be required to pay significant license fees for the use of such technologies. To date, we have relied primarily on a combination of trade secret and copyright laws, as well as nondisclosure and other contractual restrictions on copying, reverse engineering and distribution to protect our proprietary technology.

 

We have no patents or patent applications, and any patents that we may register in the future may provide only limited protection for our technology and may not be sufficient to provide competitive advantages to us. For example, competitors could be successful in challenging any issued patents or, alternatively, could develop similar or more advantageous technologies on their own or design around our patents. Any inability to protect intellectual property rights in our technology could enable third parties to compete more effectively with us and/or could reduce our ability to compete. In addition, these efforts to protect our intellectual property rights could require us to incur substantial costs even when our efforts are successful.

 

In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as do the laws of Israel or the United States. Our means of protecting our intellectual property rights in Israel, the United States or any other country in which we operate may not be adequate to fully protect our intellectual property rights.

 

Third parties may assert that we are infringing their intellectual property rights.

 

We may face intellectual property litigation, which could be costly, harm our reputation, limit our ability to sell our products, force us to modify our products or obtain appropriate licenses, and divert the attention of management and technical personnel.

 

Our products employ technology that may infringe on the proprietary rights of others, and, as a result, we could become liable for significant damages and suffer other harm to our business. Other than the litigation with Secu-Systems Ltd., as described in Item 8 below under the caption “Legal Proceedings,” we have not been subject to intellectual property litigation to date. We have received demand letters in the past alleging that products or processes of ours are in breach of patents, which we have denied, but no lawsuits have been filed in respect of such claims.

 

Litigation may be necessary in the future to enforce any patents we may obtain and/or any other intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others, or to defend against claims of infringement or invalidity, and we may not prevail in any such future litigation. Litigation, whether or not determined in our favor or settled, could be costly, could harm our reputation and could divert the efforts and attention of our management and technical personnel from normal business operations. In addition, adverse determinations in litigation could result in the loss of our proprietary rights, subject us to significant liabilities, require us to seek licenses from third parties, prevent us from licensing our technology or selling or manufacturing our products, or require us to expend significant resources to modify our products or attempt to develop non-infringing technology, any of which could seriously harm our business.

 

Our products may contain technology provided to us by third parties. Because we did not develop such technology ourselves, we may have little or no ability to determine in advance whether such technology infringes the intellectual property rights of any other party. Our suppliers and licensors may not be required to indemnify us in the event that a claim of infringement is asserted against us, or they may be required to indemnify us only with respect to intellectual property infringement claims in certain jurisdictions, and/or only up to a maximum amount, above which we would be responsible for any further costs or damages. In addition, we have indemnification obligations to certain parties, as well as to OTI, with respect to any infringement of third-party patents and intellectual property rights by our products. If litigation were to be filed against these parties in connection with our technology, we would be required to defend and indemnify such parties.

 

12
 

 

We may be plaintiff or defendant in various legal actions from time to time.

 

From time to time, we are the defendant or plaintiff in various legal actions, which arise in the normal course of business. We are required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of probable losses. A determination of the amount of reserves required for these contingencies, if any, which would be charged to earnings, is made after careful and considered analysis of each individual action with our legal advisors. The required reserves may change in the future due to new developments in each matter or changes in circumstances, such as a change in settlement strategy. A change in the required reserves would affect our earnings in the period the change is made. For more information on the above and our ongoing litigation see under the caption “Legal Proceedings” in Item 8.

 

A security breach of our internal systems or those of our customers could harm our business by adversely affecting the market's perception of our products and services, thereby causing our revenues to decline.

 

For us to further penetrate the marketplace, the marketplace must be confident that we provide effective security protection for national and other secured identification documents and cards. Although we have not experienced any act of sabotage or unauthorized access by a third party of our software or technology to date, if an actual or perceived breach of security occurs in our internal systems or those of our customers, regardless of whether we caused the breach, it could adversely affect the market's perception of our products and services. This could cause us to lose customers, resellers, alliance partners or other business partners, thereby causing our revenues to decline. If we or our customers were to experience a breach of our internal systems, our business could be severely harmed by adversely affecting the market's perception of our products and services.

 

We may be exposed to significant liability for actual or perceived failure to provide required products or services, which could damage our reputation and adversely affect our business by causing our revenues to decline and our costs to rise.

 

Products as complex as those we offer may contain undetected errors or may fail when first introduced or when new versions are released. Despite our product testing efforts and testing by current and potential customers, it is possible that errors will be found in new products or enhancements after commencement of commercial shipments. The occurrence of product defects or errors could result in adverse publicity, delay in product introduction, diversion of resources to remedy defects, loss of or a delay in market acceptance, or claims by customers against us, or could cause us to incur additional costs or lose revenues, any of which could adversely affect our business.

 

Our failure or inability to meet a customer's expectations in the performance of our services, or to do so in the time frame required by the customer, regardless of our responsibility for the failure, could result in a claim for substantial damages against us by the customer, discourage other customers from engaging us for these services, and damage our business reputation. We carry product liability insurance, but existing coverage may not be adequate to cover potential claims.

 

We carry a combined products liability and professional liability insurance. We believe that this insurance coverage is comparable to that of other similar companies in our industry. However, that insurance may not continue to be available to us on reasonable terms or in sufficient amounts to cover one or more large claims, or the insurer may disclaim coverage as to any future claim. We do not maintain insurance coverage for theft by employees, nor do we maintain specific insurance coverage for any interruptions in our business operations. The successful assertion of one or more large claims against us that exceed available insurance coverage, or changes in our insurance policies, including premium increases or the imposition of large deductibles or co-insurance requirements, could adversely affect our business by significantly increasing our costs.

 

Our efforts to expand our international operations are subject to a number of risks, any of which could adversely reduce our future international sales and increase our losses.

 

Most of our revenues to date have been generated in jurisdictions other than the United States. Our inability to obtain or maintain federal or foreign regulatory approvals relating to the import or export of our products on a timely basis could adversely affect our ability to expand our international business. Additionally, our international operations could be subject to a number of risks, any of which could adversely affect our future international sales and operating results, including:

 

· increased collection risks;
· trade restrictions;
· export duties and tariffs;
· uncertain political, regulatory and economic developments;
· inability to protect our intellectual property rights;
· highly aggressive competitors; and

 

13
 

 

· currency issues.

 

In addition, in many countries the national security organizations require our employees to obtain clearance before such employees can work on a particular transaction. Failure to receive or delays in the receipt of, relevant foreign qualifications could also have a material adverse effect on our ability to obtain sales at all or on a timely basis. Additionally, as foreign government regulators have become increasingly stringent, we may be subject to more rigorous regulation by governmental authorities in the future. If we fail to adequately address any of these regulations, our business will be harmed.

 

We have sought in the past and may seek in the future to enter into contracts with governments, as well as state and local governmental agencies and municipalities, which subjects us to certain risks associated with such types of contracts.

 

Most contracts with governments, or with state or local agencies or municipalities (“Governmental Contracts”) are awarded through a competitive bidding process, and some of the business that we expect to seek in the future will likely be subject to a competitive bidding process. Competitive bidding presents a number of risks, including:

 

· the frequent need to compete against companies or teams of companies with more financial and marketing resources and more experience than we have in bidding on and performing major contracts;
· the need to compete against companies or teams of companies that may be long-term, entrenched incumbents for a particular contract we are competing for and which have, as a result, greater domain expertise and established customer relations;
· the substantial cost and managerial time and effort necessary to prepare bids and proposals for contracts that may not be awarded to us;
· the need to accurately estimate the resources and cost structure that will be required to service any fixed-price contract that we are awarded; and
· the expense and delay that may arise if our competitors protest or challenge new contract awards made to us pursuant to competitive bidding or subsequent contract modifications, and the risk that any of these protests or challenges could result in the resubmission of bids on modified specifications, or in termination, reduction or modification of the awarded contract.

 

We may not be afforded the opportunity in the future to bid on contracts that are held by other companies, and are scheduled to expire, if the governments, or the applicable state or local agency or municipality determines to extend the existing contract. If we are unable to win particular contracts that are awarded through the competitive bidding process, we may not be able to operate in the market for the products and services that are provided under those contracts for a number of years. If we are unable to win new contract awards or retain those contracts, if any, that we are awarded over any extended period, our business, prospects, financial condition and results of operations will be adversely affected.

 

In addition, Governmental Contracts subject us to risks associated with public budgetary restrictions and uncertainties, actual contracts that are less than awarded contract amounts, and cancellation at any time at the option of the governmental agency. Any failure to comply with the terms of any Governmental Contracts could result in substantial civil and criminal fines and penalties, as well as suspension from future contracts for a significant period of time, any of which could adversely affect our business by requiring us to pay significant fines and penalties or prevent us from earning revenues from Governmental Contracts during the suspension period. Cancellation of any one of our major Governmental Contracts could have a material adverse effect on our financial condition.

 

Governments, may be in a position to obtain greater rights with respect to our intellectual property than we would grant to other entities. Governmental agencies also have the power, based on financial difficulties or investigations of their contractors, to deem contractors unsuitable for new contract awards. Because we will engage in the government contracting business, we will be subject to audits, and may be subject to investigation, by governmental entities. Failure to comply with the terms of any Governmental Contracts could result in substantial civil and criminal fines and penalties, as well as suspension from future contracts for a significant period of time, any of which could adversely affect our business by requiring us to pay the fines and penalties and prohibiting us from earning revenues from Governmental Contracts during the suspension period.

 

Furthermore, governmental programs can experience delays or cancellation of funding, which can be unpredictable. For example, the U.S. military’s involvement in Iraq has caused the diversion of some Department of Defense funding away from certain projects in which we participated in the past, thereby delaying orders under certain of our governmental contracts. This may make it difficult to forecast our revenues on a quarter-by-quarter basis.

 

14
 

 

Some of the markets that we target for a substantial part of our future growth are in very early stages of development, and if they do not develop, our business may not grow as much or as profitably as we hope.

 

Many of the markets that we target for our future growth are small or non-existent and need to develop if we are to achieve our growth objectives. If some or all of these markets do not develop, or if they develop more slowly than we anticipate, then we will not grow as quickly or as profitably as we hope. In February 2006, we announced the introduction of a new technology and solution for actively tracking people, objects and assets, Active RFID Tracking Systems (“PureRF”). This technology was developed in response to growing market demand for asset tracking solutions in the homeland security and commercial markets.

 

Although we believe the government market is critical to our success in the short term, we believe that both the government and commercial markets will be critical to our long-term success. The development of these markets will depend on many factors that are beyond our control, including the following factors (and other factors discussed elsewhere in the Risk Factors): (i) there can be no assurances that we will be able to continue to apply our expertise and solutions developed for the government market to the commercial market; (ii) the ability of the commercial markets to adopt and implement the active RFID solutions; and (iii) the ability of our management to successfully market our technologies to such government and/or commercial entities.

 

The success of our active RFID business line is dependent on several factors.

 

The success of our active RFID business line is dependent on several factors, including proper new product definitions, product costs, timely completion and introduction of the new product, differentiation of the new product from those of our competitors, and market acceptance of the product, as well as our existing and potential customers’ varying budgets for capital expenditures and new product introduction. We have addressed the need to develop new products through our internal development efforts and joint development efforts with other companies. In light of the OTI Transaction and the sale of certain assets and liabilities related to our electronic access control market and our Government Services Division including our CSMS and RAPTOR suites, the active RFID product line is anticipated to be our main revenue growth generator in the future. There can be no assurance that we will successfully identify new product opportunities and/or develop and bring new products to market in a timely manner, or that the products and technologies developed by others will not render our products or technologies obsolete or noncompetitive. The failure of our new product development efforts could have a material adverse effect on our business, results of operations and future growth.

 

If our technology and solutions ceases to be adopted and used by government and commercial organizations, we may lose some of our existing customers and increase our losses.

 

Our ability to grow depends significantly on whether governmental and commercial organizations adopt our technology and solutions as part of their new standards and whether we will be able to leverage our expertise with government products into commercial products. If these organizations do not adopt our technology, we might not be able to penetrate some of the new markets we are targeting, or we might lose some of our existing customer base. There also can be no assurances that we will be able to continue to apply our expertise and solutions developed for the public sector to the commercial market.

 

In order for us to achieve our growth objectives, our RFID technology must be adapted to and adopted in a variety of areas, including, but not limited to:

 

· public safety and emergency;
· asset management;
· patient and critical equipment tracking in the health care sector;
· building automation;
· patient wandering in the homecare market;
· transportation applications using active RFID as method of monitoring and control; and
· access control in such fields as education and health care.

 

Any or all of these areas may not adopt our RFID technology.

 

We cannot accurately predict the future growth rate, if any, or the ultimate size of the RFID technology markets. The expansion of the market for our products and services depends on a number of factors such as:

 

· the cost, performance and reliability of our products and services compared to the products and services of our competitors;
· customer perception of the benefits of our RFID based solutions;

 

15
 

 

· public perception of the intrusiveness of these solutions and the manner in which organizations use the information collected;
· public perception of the confidentiality of private information;
· customer satisfaction with our products and services; and
· marketing efforts and publicity for our products and services.

 

Even if our RFID solutions gain wide market acceptance, our products and services may not adequately address market requirements and may not gain wide market acceptance. If our solutions or our products and services do not gain wide market acceptance, our business and our financial results will suffer.

 

We need to develop our position as a provider of RFID enabled security solutions and services to earn high margins from our technology, and if we are unable to develop such position, our business will not be as profitable as we hope, if at all.

 

The increasing sophistication of our RFID technology places a premium on providing innovative software systems and services to customers, in addition to manufacturing and supplying RFID technology. While we have had some early success positioning ourselves as a provider of such services and systems, we may not continue to be successful with this strategy and we may not be able to capture a significant share of the market for the sophisticated services and systems that we believe are likely to produce attractive margins in the future. A significant portion of the value of our RFID technology lies in the development of software and applications that will permit the use of RFID technology in new markets. In contrast, the margins involved in manufacturing and selling RFID technology can be relatively small, and may not be sufficient to permit us to earn an attractive return on our development investments.

 

The time from our initial contact with a customer to a sale may be long and subject to delays, which could result in the postponement of our receipt of revenues from one accounting period to the next, increasing the variability of our results of operations and causing significant fluctuations in our revenue from quarter to quarter.

 

The period between our initial contact with a potential customer and the purchase of our products and services is often long and subject to delays associated with the budgeting, approval and competitive evaluation processes that frequently accompany significant capital expenditures, particularly by governmental agencies. The typical sales cycle for our government customers has, to date, ranged from three to 24 months and the typical sales cycle for our commercial customers has ranged from one to six months. A lengthy sales cycle may have an impact on the timing of our revenue, which may cause our quarterly operating results to fall below investor expectations. We believe that a customer's decision to purchase our products and services is discretionary, involves a significant commitment of resources, and is influenced by customer budgetary cycles. To successfully sell our products and services, we generally must educate our potential customers regarding their use and benefits, which can require significant time and resources. This significant expenditure of time and resources may not result in actual sales of our products and services.

 

Due to the nature of our business, our financial and operating results could fluctuate.

 

Our financial and operating results have fluctuated in the past and could fluctuate in the future from quarter to quarter and from year to year for the following reasons:

 

· long customer sales cycles;
· reduced demand for our products and services;
· price reductions;
· new competitors, or the introduction of enhanced products or services from new or existing competitors;
· changes in the mix of products and services we or our customers and distributors sell;
· contract cancellations, delays or amendments by customers;
· the lack of government demand for our products and services or the lack of government funds appropriated to purchasing our products and services;
· unforeseen legal expenses, including litigation costs;
· expenses related to acquisitions;
· other non-recurring financial charges;
· the lack of availability, or increased cost, of key components and subassemblies;
· the inability to successfully manufacture in volume, and reduce the price of, certain of our products; and
· impairment loss of goodwill and intangible assets.

 

16
 

 

The lead time for ordering parts for and manufacturing our products can be significantly long and therefore based on forecasted demands rather than actual orders received.

 

The lead time for ordering parts and materials and building many of our products can be many months. As a result, we must order parts and materials and build our products based on forecasted demand. If demand for our products lags significantly behind our forecasts, we may produce more products than we can sell, which can result in cash flow problems and write-offs or write-downs of obsolete inventory. If demand for our products exceeds our forecasts, our business may be harmed as a result of delays to perform contracts.

 

Our markets are highly competitive and competition could harm our ability to sell products and services and could reduce our market share.

 

The market for RFID enabled products is intensely competitive. We expect competition to increase as the industry grows and as RFID technology begins to converge with the access control and information technology industry. We may not be able to compete successfully against current or future competitors. We face competition from technologically sophisticated companies, many of which have substantially greater technical, financial, and marketing resources than we do. In some cases, we compete with entities that have pre-existing relationships with potential customers. As the active RFID enabled solutions market expands, we expect additional competitors to enter the market.

 

Some of our competitors and potential competitors have larger technical staffs, larger customer bases, more established distribution channels, greater brand recognition and greater financial, marketing and other resources than we do. Our competitors may be able to develop products and services that (i) are superior to our products and services, (ii) achieve greater customer acceptance or (iii) have significantly improved functionality as compared to our existing and future products and services. In addition, our competitors may be able to negotiate strategic relationships on more favorable terms than we are able to negotiate. Many of our competitors may also have well-established relationships with our existing and prospective customers. Increased competition may result in our experiencing reduced margins, loss of sales or decreased market share.

 

The average selling prices for our products may decline as a result of competitive pricing pressures, promotional programs and customers who negotiate price reductions in exchange for longer-term purchase commitments. The pricing of products depends on the specific features and functions of the products, purchase volumes and the level of sales and service support required. As we experience pricing pressure, the average selling prices and gross margins for our products may decrease over product lifecycles. These same competitive pressures may require us to write down the carrying value of any inventory on hand, which could adversely affect our operating results and earnings per share.

 

We rely on the services of certain executive officers and key personnel, the loss of which could adversely affect our business.

 

Our future success depends largely on the efforts and abilities of our executive officers and senior management and other key employees, including technical and sales personnel. The loss of the services of any of these persons could adversely affect our business. We do not maintain any "key-person" life insurance with respect to any of our employees.

 

Our ability to remain competitive depends in part on attracting, hiring and retaining qualified technical personnel; if we are not successful in such hiring and retention, our business could be disrupted.

 

Our future success depends in part on the availability of qualified technical personnel, including personnel trained in software and hardware applications within specialized fields. As a result, we may not be able to successfully attract or retain skilled technical employees, which may impede our ability to develop, install, implement and otherwise service our software and hardware systems and to efficiently conduct our operations.

 

The information technology and network security industries are characterized by a high level of employee mobility and the market for technical personnel remains extremely competitive in certain regions, including Israel. This competition means that (i) there are fewer highly qualified employees available for hire, (ii) the costs of hiring and retaining such personnel are high, and (iii) highly qualified employees may not remain with us once hired. Furthermore, there may be pressure to provide technical employees with stock options and other equity interests in us, which may dilute our shareholders and increase our expenses.

 

The additions of new personnel and the departure of existing personnel, particularly in key positions, can be disruptive, might lead to additional departures of existing personnel and could have a material adverse effect on our business, operating results and financial condition.

 

17
 

 

Our planned growth will place significant strain on our financial and managerial resources and may negatively affect our results of operations and ability to grow more.

 

Our ability to manage our growth effectively will require us:

 

· to continue to improve our operations, financial and management controls, reporting systems and procedures;
· to train, motivate and manage our employees; and
· as required, to install new management information systems.

 

Our existing management and any new members of management may not be able to augment or improve existing systems and controls, or implement new systems and controls, in response to anticipated future growth. If we are successful in achieving our growth plans, such growth is likely to place a significant burden on the operating and financial systems, resulting in increased responsibility for our senior management and other personnel.

 

Some of our products are subject to government regulation of radio frequency technology, which could cause a delay in introducing, or an inability to introduce, such products in the United States and other markets.

 

The rules and regulations of the United States Federal Communications Commission (the "FCC") limit the radio frequency used by and level of power emitting from electronic equipment. Our readers, controllers and other radio frequency technology scanning equipment are required to comply with these FCC rules which may require certification, verification or registration of the equipment with the FCC. Certification and verification of new equipment requires testing to ensure the equipment's compliance with the FCC's rules. The equipment must be labeled according to the FCC's rules to show compliance with these rules. Testing, processing of the FCC's equipment certificate or FCC registration and labeling may increase development and production costs and could delay introduction of our verification scanning device and next generation radio frequency technology scanning equipment into the U.S. market. Electronic equipment permitted or authorized to be used by us through FCC certification or verification procedures must not cause harmful interference to licensed FCC users, and may be subject to radio frequency interference from licensed FCC users. Selling, leasing or importing non-compliant equipment is considered a violation of FCC rules and federal law, and violators may be subject to an enforcement action by the FCC. Any failure to comply with the applicable rules and regulations of the FCC could have a material adverse effect on our business, operating results and financial condition by increasing our compliance costs and/or limiting our sales in the United States.

 

We are exposed to special risks in foreign markets which may make operating in those markets difficult and thereby force us to curtail our business operations.

 

In conducting our business in foreign countries, we are subject to political, economic, legal, operational and other risks that are inherent in operating in other countries. Risks inherent to operating in other countries range from difficulties in settling transactions in emerging markets to possible nationalization, expropriation, price control and other restrictive governmental actions. We also face the risk that exchange controls or similar restrictions imposed by foreign governmental authorities may restrict our ability to convert local currency received or held by it in their countries into U.S. dollars or other currencies, or to take those dollars or other currencies out of those countries.

 

We may fail to maintain effective internal control in accordance with Section 404 of the Sarbanes-Oxley Act of 2002.

 

The Sarbanes-Oxley Act of 2002 imposed certain duties on us and our executive officers and directors. Our efforts to comply with the requirements of the Sarbanes-Oxley Act of 2002, and in particular with Section 404 under it, resulted in increased general and administrative expenses and a diversion of management time and attention, and we expect these efforts to require the continued commitment of resources. If we fail to maintain the adequacy of our internal controls, we may not be able to conclude that we have effective internal control over financial reporting. We cannot assure you that we will able to conclude in future years that we have effective internal control over financial reporting.   Controls that are considered adequate at one time may become inadequate in the future because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Failure to maintain effective internal control over financial reporting could result in investigations or sanctions by regulatory authorities, and could have a material adverse effect on our operating results, investor confidence in our reported financial information, and the market price of our ordinary shares. As discussed in Item 15. Controls and Procedures, as of December 31, 2011, we did not maintain effective internal control over financial reporting.

 

18
 

 

Risks Related to our Location and Incorporation in Israel

 

Conditions in Israel affect our operations in Israel and may limit our ability to sell our products and services.

 

We are incorporated under Israeli law and we also operate offices located in Israel. Political, economic and military conditions in Israel may directly affect our operations and business. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its Arab neighbors and a state of hostility, varying from time to time in degree and intensity, has led to security and economic problems for Israel. In addition, recent civil unrest and political turbulence in various countries in the Middle East and Northern Africa have shaken the stability of those countries. This instability may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries. In addition, Iran has threatened to attack Israel and is widely believed to be developing nuclear weapons. Iran is also believed to have a strong influence among extremist groups in the region, such as Hamas in Gaza and Hezbollah in Lebanon. These situations may potentially escalate in the future to more violent events which may affect Israel and us. Furthermore, several countries still restrict trade with Israeli companies and additional countries may impose such restrictions as a result of changes in the military and/or political conditions in Israel and/or the surrounding countries, which may limit our ability to make sales in, or purchase components from, those countries. Any future armed conflict, political instability, continued violence in the region or restrictions could have a material adverse effect on our business, operating results and financial condition.

 

Our operations could be disrupted as a result of the obligation of management or key personnel to perform military service in Israel.

 

Generally, all nonexempt male adult citizens and permanent residents of Israel under the age of 40, or older for reserves officers or citizens with certain occupations, as well as certain female adult citizens and permanent residents of Israel, are obligated to perform annual military reserve duty and are subject to being called for active duty at any time under emergency circumstances. While we have operated effectively under these requirements since our incorporation, we cannot predict the full impact of such conditions on us in the future, particularly if emergency circumstances occur. If many of our employees are called for active duty, our operations in Israel and our business, operating results and financial condition may be adversely affected.

 

Your rights and responsibilities as a shareholder will be governed by Israeli law and differ in some respects from the rights and responsibilities of shareholders under U.S. law.

 

We are incorporated under Israeli law. The rights and responsibilities of holders of our ordinary shares are governed by our Memorandum of Association and Articles of Association, and by Israeli law. These rights and responsibilities differ in some respects from the rights and responsibilities of shareholders in typical U.S. corporations. In particular, a shareholder of an Israeli company has a duty to act in good faith and customary manner in exercising his or her rights and fulfilling his or her obligations toward the company and other shareholders, and to refrain from misusing his power, including, among other things, when voting at the general meeting of shareholders on certain matters. Israeli law provides that these duties are applicable to shareholder votes on, among other things, amendments to a company’s articles of association, increases in a company’s authorized share capital and mergers and interested party transactions requiring shareholder approval. A shareholder also has a general duty to refrain from exploiting any other shareholder of his or her rights as a shareholder. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine the outcome of a shareholder vote or who, under our Articles of Association, has the power to appoint or prevent the appointment of a director or executive officer in the company, has a duty of fairness toward the company. Israeli law does not define the substance of this duty of fairness, but provides that remedies generally available upon a breach of contract will apply also in the event of a breach of the duty to act with fairness. Because Israeli corporate law has undergone extensive revision in recent years, there is little case law available to assist in understanding the implications of these provisions that govern shareholder behavior.

 

Provisions of Israeli law may delay, prevent or otherwise encumber a merger with or an acquisition of our company, which could prevent a change of control, even when the terms of such transaction are favorable to us and our shareholders.

 

Israeli corporate law regulates mergers, requires tender offers for acquisitions of shares above specified thresholds, requires special approvals for transactions involving directors, officers or significant shareholders and regulates other matters that may be relevant to these types of transactions. Furthermore, Israeli tax considerations may make potential transactions unappealing to us or to some of our shareholders whose country of residence does not have a tax treaty with Israel exempting such shareholders from Israeli tax . These provisions of Israeli law could delay, prevent or impede a merger with or an acquisition of our company, which could prevent a change of control, even when the terms of such transaction are favorable to us and our shareholders and therefore potentially depress the price of our shares.

 

19
 

 

Our shareholders may face difficulties in the enforcement of civil liabilities against Vuance Ltd. and its officers and directors and Israeli auditors or in asserting U.S. securities law claims in Israel.

 

Most of our officers and directors and our Israeli auditors are residents of Israel or otherwise reside outside of the United States. Vuance Ltd. is incorporated under Israeli law and its principal office and facilities are located in Israel. All or a substantial portion of the assets of such persons are or may be located outside of the United States. Therefore, service of process upon Vuance Ltd., such directors and officers and our Israeli auditors may be difficult to effect in the United States. It also may be difficult to enforce a U.S. judgment against Vuance Ltd., such officers and directors and our Israeli auditors as any judgment obtained in the United States against such parties may not be collectible in the United States.

 

In addition, it may be difficult to assert U.S. securities law claims in original actions instituted in Israel. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws because Israel is not the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing these matters.

 

However, subject to time limitations, Israeli courts may enforce a U.S. judgment in a civil matter, if:

 

adequate service of process has been effected and the defendant has had a reasonable opportunity to be heard;

 

the judgment and its enforcement are not contrary to the law, public policy, security or sovereignty of the State of Israel;

 

the judgment was rendered by a court of competent jurisdiction, in compliance with due process and the rules of private international law prevailing in Israel;

 

the judgment was not obtained by fraudulent means and does not conflict with any other valid judgment in the same matter between the same parties;

 

no action between the same parties in the same matter is pending in any Israeli court at the time the lawsuit is instituted in a U.S. court; and

 

the U.S. courts are not prohibited from enforcing judgments of the Israeli courts.

 

Fluctuations in the exchange rate between the U.S. dollar and foreign currencies may affect our operating results.

 

We incur expenses for our operations in Israel in New Israeli Shekels ("NIS") and translate these amounts into U.S. dollars for purposes of reporting consolidated results. As a result, fluctuations in foreign currency exchange rates may adversely affect our expenses and results of operations, as well as the value of our assets and liabilities. Fluctuations may adversely affect the comparability of period-to-period results. In addition, we hold foreign currency balances, primarily NIS, that will create foreign exchange gains or losses, depending upon the relative values of the foreign currency, at the beginning and end of the reporting period, affecting our net income and earnings per share. During 2009 and 2010, the dollar depreciated in relation to the NIS, which raised the dollar cost of our Israeli based operations and adversely affected our financial results, while during 2011 the dollar increased in relation to the NIS, which reduced the dollar cost of our Israeli based operations costs. Although we may use hedging techniques in the future (which we currently do not use), we will not be able to eliminate the effects of currency fluctuations. Thus, exchange rate fluctuations could have a material adverse impact on our operating results and stock price. (See also Item 5, "Impact of Inflation and Currency Fluctuations".)

 

We are unlikely to pay dividends in the foreseeable future and any return on investment may be limited to the value of our ordinary shares.

 

We distributed a cash dividend to our shareholders on one occasion on August 26, 1997 in the aggregate amount of NIS 1.0 million (approximately $266,000 based on the exchange rate between the U.S. dollar and the NIS published by the Bank of Israel on April 22, 2012) and prior to that dividends in the form of bonus shares were distributed on two other occasions. Under the Israeli Companies Law, dividends may only be paid out of profits legally available for distribution and provided that there is no reasonable concern that such payment will prevent us from satisfying our existing and foreseeable obligations as they become due. In addition, a competent court may approve, as per a motion to be filed by a company in accordance with the Israeli Companies Law requirements, a payment which does not meet the profits test, provided that the court was convinced that there is no reasonable concern that such payment will prevent the company from satisfying its existing and foreseeable obligations as they become due. We do not expect to declare or pay cash dividends in the foreseeable future and intend to retain future earnings, if any, to finance the growth and development of our business. If we do not pay dividends, our ordinary shares may be less valuable because a return on your investment will only occur if our share price appreciates.

 

20
 

 

Risks Pertaining to Ownership of Our Ordinary Shares

 

The number of ordinary shares that are available for sale upon exercise of our outstanding warrants, options and convertible bonds is significant in relation to our currently outstanding ordinary shares. Sales of a significant number of our ordinary shares in the public market, or the perception that they may occur, may depress the market price for our ordinary shares.

 

The number of ordinary shares available for sale upon the exercise of our outstanding warrants, options and convertible bonds is significant in relation to the number of ordinary shares currently outstanding. As of December 31, 2011, 12,035,272 of our ordinary shares were outstanding. In addition, we had a total of 2,163,857 ordinary shares issuable upon the exercise of outstanding options, which we have issued to our employees and certain other persons at various prices, some of which have exercise prices below the current market price for our ordinary shares. As of December 31, 2011 , we had a total of 3,002,859 ordinary shares issuable upon the exercise of outstanding warrants issued to investors and consultants, at various prices, which expire between 2012 and 2016. As of December 31, 2011, we had a total of 840,459 ordinary shares issuable upon the conversion of convertible bonds. As of December 31, 2011, our authorized share capital permitted us to issue up to additional 33,957,553 ordinary shares in connection with future grants of options, warrants, shares and other financial instruments.

 

On April 2, 2012 we issued 9,094,400 ordinary shares in respect of the Creditor Arrangement (see Item 4A. History and Development of the Company under "Recent Developments"). As of that date, there were 21,129,672 of our ordinary shares outstanding.

 

In order to complete the Creditor Arrangement we will be required to issue a significant amount of ordinary shares and/or warrants convertible into our ordinary shares.

 

If our warrant or option holders exercise their warrants or options, or holders of convertible bonds covert their bonds into ordinary shares, and determine to sell a substantial number of shares into the market at any given time, there may not be sufficient demand in the market to purchase the shares without a decline in the market price for our ordinary shares. Moreover, continuous sales into the market of a number of shares in excess of the typical trading volume for our ordinary shares, or even the availability of such a large number of shares or the perception that these sales could occur, could cause substantial dilution to existing shareholders, decrease the market price of our ordinary shares, and impair our ability to raise capital in the future.

 

The trading market for our ordinary shares has low liquidity, which could make it difficult for our shareholders to sell their shares at desired prices and amounts.

 

Our ordinary shares currently are traded on the Pink Sheets Electronic Quotation Service. Currently, we do not meet the initial listing conditions of the Nasdaq Stock Market. The market for shares quoted on the Pink Sheets is typically less liquid than that for shares listed on the Nasdaq Stock Market. This could make it more difficult for our shareholders to sell their shares at desired prices and amounts.

 

Our ordinary shares may become subject to the “penny stock” rules of the SEC which will make transactions in our ordinary shares cumbersome and may reduce the value of our shares.

 

Trading in our ordinary shares may become subject to the "penny stock" regulations adopted by the SEC . These regulations generally define a "penny stock" to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions, such as if the issuer of the security has net tangible assets in excess of $2,000,000. The market price of our ordinary shares is currently less than $5.00 per share and our net tangible assets as of December 31, 2011 were approximately $2,455,000. While we believe that our ordinary shares are currently exempt from the definition of penny stock, there is no assurance that they will continue to be exempt from such definition. If our ordinary shares become subject to the “penny stock” rules of the SEC, it will make transactions in our ordinary shares cumbersome and may reduce the value of our shares. This is because for any transaction involving a penny stock, unless exempt, Rule 15g-9 generally requires:

 

21
 

 

· that a broker or dealer approve a person's account for transactions in penny stocks; and
· the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person's account for transactions in penny stocks, the broker or dealer must:

· obtain financial information and investment experience objectives of the person; and
· make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:

· sets forth the basis on which the broker or dealer made the suitability determination; and
· that the broker or dealer received a signed, written statement from the investor prior to the transaction.

 

Disclosure also has to be made by the broker or dealer about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

Generally, brokers may be less willing to execute transactions in securities subject to the "penny stock" rules. This may make it more difficult for investors to dispose of our ordinary shares and cause a decline in our market value if we were to become subject to the said "penny stock" rules.

 

Our default under certain registration rights agreements may result in liquidated damages.

 

In connection with private placements completed in September 2004 and December 2005, in which we issued to the investors ordinary shares and warrants to purchase our ordinary shares, we entered into registration rights agreements pursuant to which we undertook to register such ordinary shares in accordance with the Securities Act of 1933. Accordingly, we filed Forms F-1 on November 2004 and January 5, 2006. Our failure to properly update the Forms (and to make subsequent registrations) in accordance with the registration rights agreements could result in an event of default under such agreements and subject us to liquidated damages.

 

We have shareholders that are able to exercise substantial influence over us and all matters submitted to our shareholders.

 

Sigma is the beneficial owner of approximately 41.81% of our outstanding shares. See Item 7A for more information. Such ownership interest gives Sigma the ability to influence and direct our activities, subject to approvals that may be required for related-party transactions pursuant to Israeli law. Sigma will have influence over the outcome of most matters submitted to our shareholders, including the election of directors and the adoption of a merger agreement, and such influence could make us a less attractive acquisition or investment target. Because the interests of Sigma may differ from the interests of our other shareholders, actions taken by Sigma with respect to us may not be favorable to our other shareholders.

 

If persons engage in short sales of our ordinary shares, including sales of shares to be issued upon the exercise of our outstanding warrants, options and convertible bonds, the price of our ordinary shares may decline.

 

Selling short is a technique used by a shareholder to take advantage of an anticipated decline in the price of a security. In addition, holders of options, warrants and convertible bonds will sometimes sell short knowing they can, in effect, cover the sale through the exercise of an option, warrant or convertible bond, thus locking in a profit. A significant number of short sales or a large volume of other sales within a relatively short period of time can create downward pressure on the market price of a security. Further sales of ordinary shares issued upon exercise of our outstanding warrants, options or convertible bonds could cause even greater declines in the price of our ordinary shares due to the number of additional shares available in the market upon such exercise or conversion, which could encourage short sales that could further undermine the value of our ordinary shares. You could, therefore, experience a decline in the value of your investment as a result of short sales of our ordinary shares.

 

22
 

 

A change in tax laws of any country in which we operate could result in a higher tax expense or a higher effective tax rate on our worldwide earnings.

 

We conduct our operations in various countries throughout the world. Tax laws and regulations are highly complex and subject to interpretation. Consequently, we are subject to changing tax laws, treaties and regulations in and between countries in which we operate, including treaties between nations. Our income tax expense is based upon our interpretation of the tax laws in effect in various countries at the time that the expense was incurred. A change in these tax laws, treaties or regulations, or in the interpretation thereof, or in the valuation of our deferred tax assets, which is beyond our control could result in a materially higher tax expense or a higher effective tax rate on our worldwide earnings.

 

A loss of a major tax dispute or a successful tax challenge to our operating structure, intercompany pricing policies or the taxable presence of our subsidiaries in certain countries could result in a higher tax rate on our worldwide earnings, which could result in a significant negative impact on our earnings and cash flows from operations.

 

Our income tax returns are subject to review and examination. We do not recognize the benefit of income tax positions we believe are more likely than not to be disallowed upon challenge by a tax authority. If any tax authority successfully challenges our operational structure or the taxable presence of our subsidiaries in certain countries; or if the terms of certain income tax treaties are interpreted in a manner that is adverse to our structure; or if we lose a material tax dispute in any country, our effective tax rate on our worldwide earnings could increase substantially and our earnings and cash flows from operations could be materially adversely affected.

 

While we believe that we are not currently a PFIC and do not anticipate becoming a PFIC, United States tax authorities could treat us as a "passive foreign investment company," which could have adverse United States federal income tax consequences to United States holders.

 

Generally, if for any taxable year, 75% or more of our gross income is passive income, or at least 50% of the value of our assets, averaged quarterly, are held for the production of, or produce, passive income, we will be characterized as a passive foreign investment company ("PFIC") for U.S. federal income tax purposes. A determination that we are a PFIC could cause our U.S. shareholders to suffer adverse tax consequences, including having gains realized on the sale of our shares taxed at ordinary income rates, rather than capital gains rates, and being subject to an interest charge on such gain. Similar rules apply to certain "excess distributions" made with respect to our ordinary shares. A determination that we are a PFIC could also have an adverse effect on the price and marketability of our shares. If we are a PFIC for U.S. federal income tax purposes, highly complex rules would apply to U.S. holders owning our ordinary shares. Accordingly, you are urged to consult your tax advisors regarding the application of such rules. See "Item 10.E. Taxation - Passive Foreign Investment Company" below.

 

Being a foreign private issuer exempts us from certain SEC requirements.

 

We are a foreign private issuer within the meaning of rules promulgated under the U.S. Securities and Exchange Act of 1934, as amended (the “Exchange Act”). As such, we are exempt from certain provisions applicable to U.S. public companies including:

 

· the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q and current reports on Form 8-K;
· the sections of the Exchange Act regulating the solicitation of proxies in connection with shareholder meetings;
· the provisions of Regulation FD aimed at preventing issuers from making selective disclosures of material information; and
· the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and establishing insider liability for profits realized from any “short-swing” trading transaction (i.e., a purchase and sale, or sale and purchase, of the issuer’s equity securities within less than six months).

 

Because of these exemptions, investors are not afforded the same protections or information generally available to investors holding shares in public companies organized in the U.S.

 

23
 

 

ITEM 4.     Information on the Company.

 

A. History and Development of the Company

 

History of the Company

 

Vuance Ltd. was incorporated in Israel, as a company limited by shares, on July 4, 1988, under the provisions of the then-current Israeli Companies Ordinance. We now operate under the Israeli Companies Law, which became effective on February 1, 2000, and the Israeli Companies Ordinance (New Version) 1983, as amended.

 

From our incorporation in 1988 until 1999, we were a development-stage company primarily engaged in research and development, establishing relationships with suppliers and potential customers and recruiting personnel with a focus on the governmental market. In 2001, we implemented a reorganization plan, which we completed in 2002. As a result of the reorganization, we expanded our marketing and sales efforts to include the commercial market with a new line of advanced smart card and identification technologies products, while maintaining our governmental market business.

 

During 2002, we sold, in three separate transactions with third party purchasers, our entire equity interest in a U.S. subsidiary, InkSure Technologies, Inc., for which we received aggregate proceeds of approximately $6,600,000. In December 2002, we discontinued the operations, disposed of all of the assets and terminated the employees of two U.S. subsidiaries, Genodus Inc. and Kromotek, Inc.

 

We became a publicly-traded company on NASDAQ Europe stock market (formerly EASDAQ) on April 19, 1999. On October 23, 2003, following the closing of the NASDAQ Europe stock market, we transferred the listing of our ordinary shares to the Euronext Brussels stock market under the symbol “SUP,” which became “VUNC” after our corporate name change on May 14, 2007. We applied for delisting of our shares from the Euronext Brussels stock market, and our application was approved on May 6, 2008, effective August 4, 2008.

 

On July 29, 2004, we filed a Registration Statement on Form 20-F under the Exchange Act. When the Registration Statement became effective on September 29, 2004, we became a foreign private issuer reporting company under the Exchange Act. On November 5, 2004, our ordinary shares began trading in the U.S. on the OTC Bulletin Board under the symbol “SPCBF.OB," which following our name change on May 14, 2007 became “VUNCF.OB.” On August 23, 2007, our ordinary shares were approved for trading on The NASDAQ Capital Market under the symbol “VUNC” and the trading of our shares on the OTC Bulletin Board ceased. On October 1, 2009 our shares were delisted from The NASDAQ Capital Market and beginning on the same date, our shares were quoted under the ticker symbol “VUNCF” in the Pink Sheets. For more information and details on the history of the listing of our ordinary shares see under Item 9.A "Offer and Listing Details".

 

During the fourth quarter of 2005, we established a new Delaware subsidiary (of which we initially owned 80%), Vuance-RFID Inc. (formerly, Pure RF Inc.), which began operations during the first quarter of 2006. During the first quarter of 2006, Vuance-RFID Inc. established a wholly-owned Israeli subsidiary, Vuance RFID Ltd. (formerly, Pure RF Ltd.). Vuance-RFID Inc. and Vuance RFID Ltd. focused on new technologies and solutions for active tracking of people and objects. In February 2007, we purchased the remaining 20% of the stock of Vuance - RFID Inc. from its minority stockholders for an amount of $100,000, whereupon it became our wholly-owned subsidiary. In August 2007, all the employees of Vuance RFID Ltd. were transferred to us, and on December 31, 2007 we purchased all the assets and liabilities of Vuance RFID Ltd. During the year 2008, Vuance-RFID Inc. engaged in an activity to distribute complementary locks and electronic locks. This activity was terminated and it is presented in the financial reports, as discontinued operations.

 

During the fourth quarter of 2006, we established a new wholly-owned subsidiary, S.B.C. Aviation Ltd., (incorporated in Israel) which began operations in 2007 and until 2009 focused on executing information technology and security projects.

 

In 2006 we decided to sell our E-ID Division in order to focus on opportunities in the U.S. for our CSMS business, which we later sold in 2010, and current active RFID tracking businesses, and on December 31, 2006, we sold the E-ID Division to On Track Innovations Ltd., or OTI for 2,827,200 restricted ordinary shares of OTI (of which 212,040 shares were related to consultants, as part of the direct expenses of this transaction). Under the terms of our agreement with OTI, OTI committed to file with the SEC a registration statement covering these ordinary shares and made such filing on April 24, 2007. As of December 31, 2008, we sold all the OTI shares received in the OTI Transaction.

 

Simultaneously, we entered into a service and supply agreement with OTI under which (i) OTI agreed to act as our subcontractor and provide services, products and materials necessary to carry out and complete certain projects that were not transferred to OTI (the “Existing Projects”), and (ii) OTI granted us an irrevocable, worldwide, non-exclusive, non-assignable and non-transferable license to use in connection with our Existing Projects, certain intellectual property rights transferred to OTI as part of the OTI Transaction, for the duration of such projects. The sale of our E-ID division and the services and supply agreement are collectively referred to herein as the “OTI Transaction”.

 

24
 

 

On July 3, 2007, we entered, through our wholly-owned subsidiary, Vuance, Inc., into an agreement (the “SHC Purchase Agreement”) to acquire all of the issued and outstanding stock capital of Security Holding Corp. (“SHC”) from Homeland Security Capital Corporation (OTCBB: HOMS.OB (“HMSC”)) and other minority shareholders (collectively, “Sellers”) for approximately $4,335,000 in our ordinary shares and direct expenses of approximately $600,000 in our ordinary shares. The closing date of this transaction was August 28, 2007 (“SHC Closing Date”). SHC was a Delaware corporation engaged in the business of manufacturing and distributing RFID-enabled solutions, access control and security management systems. As consideration for the acquisition of the stock capital of SHC, 1,097,426 of our ordinary shares ,which were subject to certain lock up mechanism, were issued to the Sellers. HMSC further agreed that at the SHC Closing Date it will grant an irrevocable power of attorney to our Chairman of the Board of Directors to exercise all voting rights related to its Vuance shares until the sale or transfer of such Vuance shares by HMSC to an unaffiliated third party in an arm’s-length transaction. We guaranteed all of the obligations of Vuance Inc. under the SHC Purchase Agreement. During the fourth quarter of 2007, SHC and its subsidiaries were merged into Vuance Inc.

 

In September 2007, we announced that we had entered into a definitive agreement to acquire, through our U.S. subsidiary, Vuance Inc., the credentialing division of Disaster Management Solutions Inc., ("DMS") for approximately $100,000 in cash and up to $650,000 in royalties that will be paid upon sales of the advanced first responder credentialing system (named “RAPTOR”) during the first twelve months following the acquisition (the closing was in August 2007). This acquisition complemented our former incident management solutions business and added the RAPTOR to our former CSMS business (both of which were sold in 2010).

 

On March 25, 2009 we and our subsidiary, Vuance, Inc., completed the acquisition of certain of the assets and certain of the liabilities of Intelli-Site, pursuant to an asset purchase agreement dated March 6, 2009 with Intelli-Site and Integrated Security Systems, Inc (“ISSI”). On the date of closing, Vuance, Inc. agreed to pay Intelli-Site $262,000 payable in cash and in our shares (which were subject to a certain lock up mechanism) and included a contingent consideration of up to $600,000 based upon certain conditions.

 

In January 2010, Vuance, Inc., our wholly-owned subsidiary, completed the sale to OLTIS Security Systems International, LLC (“OSSI”) of certain of its assets (including certain accounts receivable and inventory) and certain of its liabilities (including certain accounts payable) related to our electronic access control market. OSSI paid Vuance, Inc. $146,822 in cash.  In addition, OSSI paid off a loan that Vuance, Inc. took from Bridge Bank, National Association.  We and Vuance, Inc. no longer have any liabilities associated with such loan.

 

In January 2010, we and our subsidiary, Vuance, Inc., completed the sale of certain of the assets and certain of the liabilities of Vuance, Inc. related to our Government Services Division (the “Vuance CSMS Business”), pursuant to a certain asset purchase agreement between us, Vuance, Inc., WidePoint Corporation (“WidePoint”) and Advance Response Concepts Corporation. WidePoint paid Vuance, Inc. $250,000.  In addition, WidePoint agreed to pay Vuance, Inc. a maximum earnout of $1,500,000 over the course of calendar years 2010, 2011, and 2012, subject to the performance of certain financial requirements of the Vuance CSMS Business during each of those years.

 

On January 21, 2010, we incorporated a new wholly-owned subsidiary in the state of Delaware, PureRFid, Inc., to focus on marketing and sales for our active RFID solutions.

 

On March 22, 2010, we entered into a Subscription Agreement with a private investor, Mr. Yitzchak Babayov, pursuant to which at a March 23, 2010 closing we issued 1,538,461 ordinary shares of the Company at a par value of  NIS 0.0588235 (the “Transaction Shares”) in consideration of a one-time cash payment in the amount of $200,000.  

 

Simultaneously with execution of the Subscription Agreement, we entered into a Warrant Agreement with Mr. Babayov, pursuant to which he received a warrant (the “Warrant”) to purchase up to 553,846 of our ordinary shares for an exercise price of $0.15 per share. The Warrant has a term of five (5) years and contains standard adjustments for stock dividends, stock splits, reclassification and similar events. Our shareholders approved and ratified at our annual general meeting held on September 12, 2010, that the purpose of the private placement of the Transaction Shares and Warrant was to provide Mr. Babayov with more than twenty five percent (25%) of our issued and outstanding shares in accordance with Israeli law, which exempts such an acquisition from Israeli tender offer requirements.

 

In March 2010, as part of a significant restructuring of our business operations, our former chief executive officer Eyal Tuchman resigned and we appointed Ron Peer, our former President, as our new chief executive officer.

 

In July 2010, Mrs. Tsviya Trabelsi and Messrs. David Mimon and Menachem Mirski were appointed to our board of directors. Ms. Trabelsi was appointed as chairman of our board of directors in place of Mr. Eli Rozen who also resigned from our board of directors.

 

In September 2010, Mr. Arie Trabelsi was appointed on behalf of Sigma to serve on our board of directors. In October 2010, Mr. Trabelsi resigned as our director and was appointed as our chief executive officer in place of Ron Peer.

 

25
 

 

In October 2010, we entered into an agreement for the sale of our entire equity interest in SuperCom Asia Pacific Ltd., for no consideration. As part of this sale, we assigned to the purchaser certain outstanding loans due to us by SuperCom Asia Pacific in the amount of $1.4 million.

 

Recent Developments

 

On February 10, 2011 we received a credit line in an aggregate amount of $100,000 from an Israeli bank. The credit line is secured by a personal guarantee provided by Mr. Arie Trabelsi and Mrs. Tsviya Trabelsi, which in turn is expected to be secured by an unlimited floating lien on our assets. In addition, on May 6, 2012 we received a bridge loan from the said Israeli bank amounted to NIS100,000 (approximately $26,000, based on the exchange rate between the U.S. dollar and the NIS published by the Bank of Israel on December 31, 2011) which is secured by a personal guarantee provided by Mrs. Tsviya Trabelsi.

 

On October 30, 2011, our board of directors appointed Mr. Arie Trabelsi as a director and to serve as the Vice Chairman of our board of directors, together with Mrs. Tsviya Trabelsi. Mr. Arie Trabelsi resigned from his position as CEO effective November 1, 2011. Our board of directors appointed Mr. Doron Levy as our new CEO, effective November 1, 2011.

 

On December 8, 2011 our shareholders appointed Mr. Avi Ayash as an external director, replacing Mr. Shimon Cohen, who resigned from our board of directors on October 5, 2011.

 

On December 12, 2011, Mrs. Tsviya Trabelsi resigned from our board of directors, and our board of directors approved the appointment of Mr. Arie Trabelsi as its new Chairman.

 

Creditor Arrangement

 

At the annual general meeting of our shareholders held on September 12, 2010, our shareholders resolved to afford certain of our major creditors with the opportunity to convert the amounts owed to them into our ordinary shares, by means of a set off against the then total outstanding debt to such creditor, at a price of $0.09 per ordinary share, subject to forgiveness of 60% of our total outstanding debt to such creditor. Our board of directors was authorized to set all other terms of the Creditor Arrangement, including, inter alia, its timetable.

 

On November 3, 2010, we petitioned the court, for the court approval of a Creditor Arrangement in accordance with Section 350 of the Israeli Companies Law. We requested that the court apply the Creditor Arrangement approved by our shareholders to all of our creditors as of August 10, 2010, or the Determining Date, and who were still creditors as of December 17, 2010 and who had submitted a claim of debt no later than January 6, 2011. We requested that pursuant to the proposed arrangement all such creditors (whether secured, preferential (by statute) and unsecured) shall be considered to have released us from our debt obligations towards them as of such date in exchange for the allotment to all such creditors of our ordinary shares or warrants to purchase our ordinary shares (that are immediately exercisable in a cashless transaction and with an expiration date of December 31, 2012) at a price of $0.09 per ordinary share, valued at 40% of our total outstanding debt to our creditors and in consideration for which the creditors would forgive the remaining 60% of the outstanding debt. In May 2011, our shareholders subsequently approved the inclusion of additional creditors to be included under the Creditor Arrangement.

 

During 2010, as a part of the Creditor Arrangement, certain creditors agreed to convert $271,000 (the total aggregate amounts owed to them) into warrants to purchase an aggregate of 1,206,142 of our ordinary shares.

 

Although the Creditor Arrangement is supported by a resolution of our shareholders and was presented at the meeting of our creditors, on July 18, 2011 the court decided not to approve our application, mainly due to an objection to the proposed arrangement which was filed by one of our secured creditors, Special Situations Funds ("SSF"). On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi all of its rights under the Convertible Bonds and warrants. For more information on the Convertible Bonds see Item 5 – Liquidity and Capital Resources. In February 2012, our Board of Directors determined to proceed with the Creditor Arrangement without the involvement of the court. On December 5, 2011 we received from the Execution Office in Israel a foreclosure order in accordance with Section 44 to the Execution Law Records, vol. 1967, in respect of convertible bonds held by Sigma, up to an amount of NIS 3,903,866 (approximately $1,022,000, based on the exchange rate between the U.S. dollar and the NIS published by the Bank of Israel on December 31, 2011) in favor of a third party. We followed the order’s instructions and recorded the said foreclosure. As of April 15, 2012, following the forgiveness or conversion of debt pursuant to the Creditor Arrangement in the aggregate amount of $3,640,000 since December 31, 2010, additional debt of approximately $3,286,000 (computed as of December 31, 2011) remains to be forgiven or converted pursuant thereto. However, the completion of the Creditor Arrangement has been delayed, which we believe is, as a result of a dispute over the ownership of approximately $1,022,000 (computed as of December 31, 2011) of our convertible bonds held by Sigma. There is no certainty that the Creditor Arrangement will be completed in a timely manner or at all.

 

26
 

 

On March 30, 2011, we entered into a financing agreement with Sigma that entitles us to refinance the short-term obligations under certain convertible bonds held by Sigma on a long-term basis. Pursuant to the agreement, and subject to certain conditions and covenants, Sigma postponed all of our requirements to pay our debts under Sigma's Convertible Bond, relating to principal and interest, as of December 31, 2010, to January 1, 2012. In addition, the agreement requires that interest amounts with respect to fiscal 2011 will become due during July 2011 and thereafter. For more information on the convertible bonds see Item 5 – Liquidity and Capital Resources.

 

As a part of the Creditor Arrangement process, on August 4, 2011, Sigma agreed to convert $400,000 of the amounts owed to it into 4,444,444 of our ordinary shares (which number was determined on June 30, 2011) and to forgive $600,000 of our outstanding debt to Sigma. The ordinary shares were issued on August 11, 2011.

 

On December 31, 2011, as a part of the Creditor Arrangement process, Sigma agreed to convert $722,250 of the amounts owed to them into 8,025,000 of our ordinary shares (which were granted to a trustee, according to Sigma’s request) and to forgive $1,083,375 of our outstanding debt to Sigma. The ordinary shares were issued to Sigma on April 2, 2012. As a result of the conversion of the debt pursuant to the Creditor Arrangement, Sigma has become our controlling shareholder. On December 31, 2011, as a part of the Creditor Arrangement process, Mr. Eliyahu Trabelsi agreed to convert $96,246 of the amounts owed to him into our 1,069,400 ordinary shares and to forgive $144,369 of our outstanding debt to him. The ordinary shares were issued on April 2, 2012.

 

During 2011, as a part of the Creditor Arrangement, certain creditors agreed to convert $322,000 (the total aggregate amounts owed to them) into warrants to purchase 1,081,871 of our ordinary shares and options to purchase 300,000 of our ordinary shares.

 

Principal capital expenditures and divestitures

 

From January 1, 2011 to December 31, 2011, our capital expenditures totaled approximately $23,000 (compared to $4,000 during 2010 and $100,000 during 2009), of which approximately $23,000 (compared to $4,000 during 2010 and $7,000 during 2009) can be attributed to our facilities in Israel, and approximately $0 (compared to $0 during 2010 and $93,000 during 2009) can be attributed to various facilities of our subsidiaries outside of Israel. During the first financial quarter of 2012, our capital expenditures totaled approximately $6,000.

 

See Item 4 - History of the Company for information on our sale of SuperCom Asia; the sale of certain assets and liabilities of Vuance Inc., related to our Government Services Division; and the sale by Vuance, Inc., of certain of its assets and liabilities related to our electronic access control market.

 

Corporate information

 

Our headquarters are located in Israel at Nolton House 14 Shenkar Street, Hertzliya Pituach 46725, Israel and our telephone number is +972-9-889-0800. Our U.S. office is located at Oak Creek, Wisconsin. Our Internet website address is http://www.vuance.com. The information contained on our corporate websites is not a part of this Annual Report.

 

Our agent for SEC matters in the U.S. only is our subsidiary, PureRFid Inc., whose address is 9817 S. 13 th Street, Oak Creek WI 53154, telephone number (414)301-9435.

 

B. Business Overview

 

From 1988 through 2006, our principal business was the design, development and marketing of advanced smart card and identification technologies and products for governmental and commercial customers in Europe, Asia and Africa. As described in Item 4.A (“History and Development of the Company”) above, we decided to sell our E-ID Division in 2006 to focus on opportunities for our RFID and former CSMS businesses (sold in 2010).

 

On July 3, 2007, we entered, through our wholly-owned subsidiary, Vuance, Inc., into an agreement to acquire all of the issued and outstanding capital stock of Security Holdings Corp. (“SHC”), a Delaware corporation engaged in the business of manufacturing and distributing RFID-enabled solutions, access control and security management systems. Following the acquisition of SHC, in March 2009, we completed the acquisition of certain of the assets and certain of the liabilities of Intelli-Site, Inc. to further position ourselves in the offering of competitive RFID security solutions to existing and prospective customers.

 

27
 

 

Prior to January 2010, we offered three principal product suites to our customers: an Active RFID solution under the AAID brand (currently the PureRFid Suite), Electronic Access Control Suite and Credentialing & Incident Management Suite. On January 28, 2010, our wholly-owned subsidiary, Vuance, Inc., completed the sale of certain of its assets and certain of its liabilities related to our electronic access control market, and on January 29, 2010, we and Vuance, Inc. completed the sale of certain of the assets and certain of the liabilities of Vuance, Inc. related to our Government Services Division including our Critical Situation Management System and Credentialing suites (see a description of this transaction under the caption “History of the Company” in Item 4.A). Following the divestitures indicated above, from 2010, we are focusing our sales and marketing efforts on our core competencies, active RFID technology, our PureRFid Suite and existing e-ID projects.

 

Our Products

 

Consequently, since 2010, we currently offer the following principal product suite to our customers:

 

Active RFID

 

Active RFID is long, active radio frequency identification equipment that utilizes active radio frequency communications to track assets, people and objects for potential governmental agency and commercial customers. Our solutions are programmable, small, sensitive and relatively cost effective, providing significant competitive advantages.

 

Prior to January 2010, we offered an active RFID solution under the AAID brand, which we acquired in the acquisition of SHC. The AAID brand was established and well known in the market for tracking vehicles. Since January 2010, we have been engaged in leveraging the marketing position of the AAID brand to introduce our latest product suite, PureRFid. The PureRFid Suite is superior to the AAID Suite, providing a secure, precise and cost-effective means to positively identify, locate, track, monitor, count and protect people and objects, including inventory and vehicles.

 

Our Strategy

 

In 2006, we sold our E-ID division in order to focus on opportunities mainly in the U.S. for our active RFID enabled solutions and CSMS businesses. The sale was completed on December 31, 2006 (See a description of this transaction in Item 4.A above). In August 2007, we completed the acquisition of SHC, a Delaware corporation engaged in the business of manufacturing and distributing RFID-enabled solutions, access control and security management systems. In January 2010, we completed the sale of certain of the assets acquired in the acquisition of SHC, including our Electronic Access Control Suite and our Credentialing & Incident Management Suite to focus on our core competencies, active RFID technology and solutions and e-ID project and solutions.

 

Our four-pronged sales strategy is to:

 

· Develop strong strategic relationships with our business partners, including our systems integrators and distributors who introduce our solutions into their respective markets.

 

· Employ dedicated sales personnel to work closely with such business partners. Since January 2010, our sales personnel focus on active RFID sales through leading system integrators. Our sales personnel customize and adapt solutions that can then be installed and supported by these business partners.

 

· Expand our active RFID sales into other geographical areas such as Europe, Israel and Far East.

 

· Leverage on our reputation, talented personnel, and project management capabilities in the e-ID market, to secure additional project and solutions In the growing e-ID and e-Government markets

 

We have a multi-pronged approach to growth:

 

· Grow organically:

 

1. Increase existing products’ value (e.g., offer products which are smaller, better and cost effective);

 

28
 

 

2. Identify new vertical markets and applications for our existing products and solutions;
3. Develop new products/solutions that meet clients’ needs; and
4. Build a superior sales force. We are dedicating sales teams, coordinated through our U.S. and Israel corporate offices to sell more products/solutions through our growing number of business partners. Cross-selling products and solutions will increase sales to existing customers and create new opportunities.
· Increase our activities and sales in the e-ID and e-Gov growing markets, by establishing joint ventures with partners worldwide.

 

· Providing our customer in the e-ID markets, advanced technologies and solutions for additional e-ID and e-GOV needs.

 

· Make synergistic acquisitions. Continue to “leapfrog” growth through strategic acquisitions of companies with complementary products and/or relations with business partners.

 

Enhancing Our Presence

 

We currently concentrate our marketing efforts for our wireless solutions and technology in the U.S. and Israel.

 

In order to expand our presence, we may pursue acquisitions of or joint venture with one or more companies that have an existing customer base and proved revenues or that can otherwise offer us business synergies in Europe and in the Far East.

 

Identifying New Applications for Our Technologies

 

Our management and its external advisors are working to identify new vertical markets and applications for our technologies in the security, transportation, healthcare, supply chain, energy and other markets. At a time when both government and the private sector are faced with unprecedented challenges to protect public safety and personal privacy, we expect to extend our forward-looking technologies to the U.S. market and to other geographical regions.

 

Leveraging Knowledge and Experience

 

We believe that our exposure to the governmental market and experience in customizing solutions in our e-ID group will contribute to our ability to develop and market products in our wireless ID market. We intend to leverage such knowledge and experience in order to respond to the needs of existing and potential customers in the security and other markets.

 

We also believe that our exposure to the governmental market and experience in solutions in our e-ID group will contribute to our ability to market additional solutions in the growing e-ID and e-Gov Markets. We intend to leverage such knowledge and experience in order to provide our existing customer with advanced technologies and solutions for additional e-ID and e-GOV needs, and in order to locate and secure additional projects in those markets.

 

Seeking Partnerships With Other Relevant Companies

 

To bolster our sales and marketing efforts:

 

· We may seek to partner with distributors that can offer us new relationships within the commercial sector as well as with government agencies and help us increase our geographic breadth and penetrate other selected vertical markets. In addition, we may seek to partner with system integrators experienced in handling large-scale security projects.
· We may seek to enter into strategic partnerships with companies that offer technologies that complement ours.
· We may seek to enter into joint ventures with other companies in order to secure and operate large projects in different countries, where we have no presence or local advantages,

 

29
 

 

Current Businesses

 

Wireless ID Business

 

In February 2006, we introduced our active RFID technology, which utilizes active radio frequency communications to track people and objects. We developed this new technology to meet the growing market demand for asset and person tracking solutions. The new technology expands our wide range of products aimed at the private, the homeland security and the governmental market through a wireless asset tracking system.

 

Prior to January 2010, we offered an active RFID solution under the AAID brand, which we acquired in the acquisition of SHC. The AAID brand was established and well known in the market for tracking vehicles. Since January 2010, we have been engaged in leveraging the marketing position of the AAID brand to introduce our latest product suite, PureRFid. The PureRFid Suite is superior to the AAID Suite, providing a secure, precise and cost-effective means to positively identify, locate, track, monitor, count and protect people and objects, including inventory and vehicles.

 

Product

 

We expect our PureRFid Suite, a complete location position (LP) system solution based on active RFID tag technology, to offer commercial customers and governmental agencies enhanced asset management capabilities. The system can be deployed in physical security applications. The basic components of our PureRFid Suite include:

 

· an active tag, which contains a microchip equipped transmitter, an antenna, a capacitor and battery attached to the item to be identified, located or tracked;
· a web-based management system, which captures and processes the signal from the active tag, and may be configured to provide an alert upon the occurrence of a trigger event;
· one or more wireless receivers;
· one or more activators; and
· the tag's initializer, which is used to configure the PureRFid tags.

 

The PureRFid Suite provides a secure, precise and cost-effective means to positively identify, locate, track, monitor, count and protect people and objects, including inventory and vehicles. The ability to reliably identify and track the movement of people and objects in real time will enable PureRFid Suite customers to detect unauthorized movement of vehicles, trace packages and containers, control personnel and vehicle access to premises, and protect personnel in hazardous working environments and disaster management situations.

 

Customers

 

Most of our customers are also our business partners, i.e., system integrators and distributors who introduce our solutions into their prospective markets. As part of our decision to provide a complete solutions to customers, we anticipate that in year 2012 and on, the number of direct commercial and governmental customers will increase.

 

Market Opportunity

 

Radio frequency identification, or RFID, is a widely adopted technology in the auto-identification market, which addresses electronic identification and location of objects. Typically, an RFID tag or transponder is attached to or incorporated into a product or person. A handheld or stationary device that receives the radio frequency waves from these tags is used to determine their locations. Prior to the adoption of RFID, users identified and tracked assets manually as well as through the use of bar code technology. These solutions were limited because of the need for ongoing human intervention and the lack of instantaneous location capabilities. RFID technology possesses greater range, accuracy, speed and lower line−of−sight requirements than bar code technology.

 

Our PureRFid Suite can track items simultaneously, providing an alert when a tagged item is removed from a pre-determined area, passes through a marked checkpoint or otherwise moves. We believe that potential customers for our PureRFid Suite include the following:

 

Civil and Military Governments . Our PureRFid Suite can provide secure access control into restricted areas and map and track visitors throughout a facility. Many high security facilities, including governmental and industrial facilities, need access monitoring. For example, nuclear power plants, national research laboratories and correctional facilities need to accurately and securely monitor inbound and outbound activity. Line of sight identifiers, such as identification cards, suffer from problems that our RFID technology readily overcomes, including reliance on human visual identification, forgery and tampering. Our PureRFid Suite also enables identification and location of individuals in restricted areas in real time.

 

30
 

 

Airport and Port Security Infrastructure Providers . Our PureRFid Suite can offer solutions for the transportation sector by enabling common carriers to monitor, track, locate and manage multiple baggage items simultaneously, thereby reducing risk of lost baggage, increasing customer service and improving security.

 

Businesses and Industrial Companies . Our PureRFid Suite can be used by businesses, shippers and warehouse operators to manage and track cartons, pallets, containers and individual items in order to facilitate movement, order picking, inventory verification and reduce delivery time. In addition, industrial companies can manage and track their mobile equipment and tools. We believe that our PureRFid Suite can increase efficiency at every stage of asset, inventory and supply chain management by enabling long-range identification and location of products and removing the need for their human visual identification. Our products also work in conjunction with existing bar coding and warehouse systems to reduce the risk of loss, theft and slow speed of transfer.

 

Hospitals and Care Homes . The healthcare sector has successfully utilized RFID technologies for the purposes of infant protection in maternity wards and wander prevention in care homes similar to our asset and personnel location and identification system targeted at the secure facility and hazardous business sectors. Our PureRFid Suite can provide solutions for the healthcare sector for asset, staff, patient and medical record location and identification. We believe that as hospitals continue to upgrade their security measures, RFID technology will be utilized in real time location systems that are designed to immediately locate persons, equipment and objects within the hospital.

 

Livestock Owners . Our PureRFid Suite can be used as livestock identification, tracking and safeguarding system.

 

e-ID and e-Gov Business

 

From 1988 to 2006, our principal business was the design, development and marketing of advanced smart card and identification technologies and products for governmental and commercial customers in Europe, Asia and Africa. Our applications and solutions included e-passports, visas and other border entry documents, national identification and military, police and commercial access identification. As detailed above, in 2006, we decided to sell our e-ID division in order to focus on opportunities in the U.S. for our active RFID (and CSMS businesses, which we sold in 2010).

 

In our e-ID Division, we developed a fully automated production line for picture identification contactless smart cards, and offered our customers raw materials, maintenance and service agreements. We provided identification solutions and contactless smart card production equipment for governmental and commercial customers. As described above, as of the selling date of the e-ID division to OTI, OTI agreed to act as our subcontractor and provide services, products and materials necessary to carry out and complete certain projects that were not transferred to OTI. The customers and contracts of our e-ID Division in 2011, 2010 and 2009 included the following:

 

· A contract for a national multi-ID with a European country - In 2006, we entered into an agreement with a European country which we estimate will generate approximately $50 million in revenues during the 10-year term of the project. Under the agreement we will provide the end-to-end system for a national multi-ID issuing and control system. There can be no assurance, however, that we will realize the full estimated value of this agreement.

 

The project, which commenced during the third quarter of 2006, involves the implementation of an end-to-end national ID issuing and control system based on our Magna system and includes the supply of digital enrollment and production equipment, software, maintenance and supply of secured raw material for the production of various national ID cards.

 

· Other Projects – including:

 

· Biometric Visa system to a European Government
· Automated Smart Card Production System to a European Government
· E-Passport with a European Country

 

At the beginning of 2012, we have decided to leverage on our experience in the e-ID market and have decided to increase our position in the market; (i) by proposing other new technologies and solutions to our existing e-ID customer, (ii) by securing other e-ID projects and solutions by virtue of setting joint ventures with partners presenting worldwide presentence, and with companies holding complementary theologies and products.

 

31
 

 

Security and Border Control

 

In 2007, we entered into an agreement (the “Airport Agreement”) with an international airport in Europe ("EIA") to provide an integrated perimeter security system and a border control system. The establishment of the security and control system began during the third quarter of 2007. Under the Airport Agreement, once the system has been fully implemented and a transmission and acceptance report is signed by the EIA, we would enter a ten-year maintenance period. During the last few weeks our wholly-owned subsidiary, SBC Aviation Ltd., had negotiated an additional agreement with EIA, pursuant to which EIA confirmed the final acceptance and transmission of the system and committed to make a final payment for the system. Recent change of the management of EIA has lead to a delay in the completion and execution of the agreement. We committed to provide final tuning to the system within three months after the said payment. Also, the parties agreed not to enter into the ten-year maintenance period.

 

Research and Development

 

Our past research and development efforts helped us to achieve the goal of offering our customers a complete line of products and solutions. We spent $0.5 million, $0.4 million, and $0.9 million on research and development in 2011, 2010 and 2009, respectively. These amounts were spent on the development or improvement of our technologies and products, primarily in the areas of wireless ID. We will continue to research and develop new technologies and products for the wireless ID market. There can be no assurance that we can achieve any or all of our research and development goals.

 

Sales and Marketing

 

We sell our systems and products worldwide through distribution channels that include direct sales and traditional distributor or reseller sales. We currently have 2 employees that are directly engaged in the sale, distribution and support of our products through centralized marketing offices in distinct world regions, including the employees of PureRFid, Inc., which sell our products in the U.S. We are also represented by several independent distributors and resellers with which we often have distribution agreements.

 

Our distributors and resellers sell our systems and products to business enterprises and government agencies and act as the initial customer service contact for the systems and products they sell. We establish relationships with distributors and resellers through written agreements that provide prices, discounts and other material terms and conditions under which the reseller is eligible to purchase our systems and products for resale. These agreements generally do not grant exclusivity to the distributors and resellers and, as a general matter, are not long-term contracts, do not have commitments for minimum sales and could be terminated by the distributor. We do not have agreements with all of our distributors.

 

Sales Analysis

 

Sales By Geographic Destination:

 

The following table provides a breakdown of total revenue by geographic market (all amounts in thousands of dollars):

 

    Year ended December 31,  
    2011     2010     2009  
    Total     Total     Total  
    revenues     revenues     revenues  
                   
Europe   $ 7,498     $ 6,770     $ 8,180  
Asia Pacific     -       -       76  
United States     344       536       976  
Israel     80       83       72  
                         
    $ 7,922     $ 7,389     $ 9,304  

 

32
 

 

The following table provides a breakdown of total revenue by product category (all amounts in thousands of dollars):

 

    Year ended December 31,  
    2011     2010     2009  
                   
Raw materials and equipment   $ 5,822     $ 3,822     $ 6,884  
Maintenance, royalties and project management     2,100       3,567       2,420  
                         
    $ 7,922     $ 7,389     $ 9,304  

 

Customer Service

 

We believe that customer support plays a significant role in our sales and marketing efforts and in our ability to maintain customer satisfaction, which is critical to our efforts to build our reputation and grow in our existing markets, as well as to our efforts to penetrate and grow in new markets. In addition, we believe that our interaction with our customers and the customers’ feedback involved in our ongoing support functions provide us with information on customer needs and contribute to our product development efforts. We generally provide maintenance services under separate, tailor made agreements. We provide our service through customer training, local third-party service organizations, our subsidiaries, or our personnel, including appropriate personnel sent from any of our offices in U.S., or Israel. We generally provide our customers with a warranty for our products for 12 months. Costs incurred annually by us for product warranties have to date been insignificant; however, there can be no assurance that these costs will not increase significantly in the future.

 

Manufacturing and Availability of Raw Materials

 

Our manufacturing operations consist primarily of materials planning and procurement, quality control of components, kit assembly and integration, final assembly, and testing of fully-configured systems. A significant portion of our manufacturing operations consists of the integration and testing of off-the-shelf components. All of our products and systems, whether or not manufactured by us, undergo several levels of testing, including configuration to customer orders and testing with current release software, prior to delivery.

 

Our manufacturing consists of a range of RFID products solutions. We outsource the manufacturing for our PCB to a number of different suppliers. We sometimes commit to a long-term relationship with such suppliers in exchange for receiving competitive pricing. All PCBs and enclosures are built to our engineering specifications. All PCBs are received in our manufacturing facilities in Israel and then tested, assembled, and retested. Other products are off-the-shelf products, which we purchase from a number of different suppliers.

 

Some of the activities for e-ID Project, such as purchasing, logistics, making integration, installation and testing, are done by third parties according to our instructions and under our supervision.

 

Competition

 

We assess our competitive position from our experience and market intelligence, and from reviewing third party competitive research materials.

 

We believe that Zebra, RF Code, Axcess, Ekahau, Wave Trend, VT and Aeroscout are potential competitors, in niche areas, to us with respect to our wireless ID tracking products and solutions.

 

Our management expects competition to intensify as the markets in which our products and solutions compete continue to develop. Some of our competitors may be more technologically sophisticated or have substantially greater technical, financial, or marketing resources than we do, or may have more extensive pre-existing relationships with potential customers. Although we believe that our products combine technologies and features that provide customers with complete and comprehensive solutions, we cannot assure that other companies will not offer similar products in the future or develop products and services that are superior to our products and services, achieve greater customer acceptance or have significantly improved functionality as compared to our products and services. Increased competition may result in our experiencing reduced margins, loss of sales or decreased market shares.

 

33
 

 

Due to the developing nature of the markets for our wireless ID products and solutions and the ongoing changes in this market, the above-mentioned list may not constitute a full list of all of our competitors and additional companies may be considered our competitors.

 

Intellectual Property

 

Our ability to compete is dependent on our ability to develop and maintain the proprietary aspects of our technology. We rely on a combination of trademark, copyright, trade secret and other intellectual property laws, employee and third-party nondisclosure agreements, licensing and other contractual arrangements. However, these legal protections afford only limited protection for our proprietary technology and intellectual property.

 

In addition, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as do the laws of Israel or the U.S. Our means of protecting our intellectual property rights in Israel, the U.S. or any other country in which we operate may not be adequate to fully protect such rights.

 

Licenses

 

We license technology and software, such as operating systems and database software, from third parties for incorporation into our systems and products and we expect to continue to enter into these types of agreements for future products. Our licenses are either perpetual or for specific terms.

 

As part of the OTI Transaction, we received an irrevocable, worldwide, non-exclusive, non-assignable and non-transferable license to use, in connection with the Existing Projects, the intellectual property that we transferred to OTI. Generally speaking, the license will be valid for the duration of all Existing Projects.

 

Government Regulation

 

We are subject to certain labor statutes and to certain provisions of collective bargaining agreements between the Histadrut (the General Federation of Labor in Israel) and the Coordinating Bureau of Economic Organizations, including the Industrialists’ Association, with respect to our Israeli employees. In addition, some of our Israeli employees are also subject to minimum mandatory military service requirements. (See the discussion under the caption “Employees” in Section D of Item 6.)

 

Generally, we are subject to the laws, regulations and standards of the countries in which we operate and/or sell our products, which vary substantially from country to country. The difficulty of complying with these laws, regulations and standards may be more or less difficult than complying with applicable U.S. or Israeli regulations, and the requirements may differ.

 

Employees

 

As of December 31, 2011 we had 14 full-time employees, compared to 17 full-time employees as of December 31, 2010. (See the discussion under the caption “Employees” in Item 6.D.)

 

Our ability to succeed depends, among other things, upon our continuing ability to attract and retain highly qualified managerial, technical, accounting, sales and marketing personnel.

 

Seasonality

 

Our financial and operating results have fluctuated in the past and our financial and operating results could fluctuate in the future. The period between our initial contact with a potential customer and the sale of our products and services is often long and subject to delays associated with the budgeting, approval and competitive evaluation processes that frequently accompany significant capital expenditures, particularly by governmental agencies. The typical sales cycle for our government customers has to date ranged from three to 36 months and the typical sales cycle for our commercial customers has ranged from one to six months. A lengthy sales cycle may have an impact on the timing of our revenue, which may cause our quarterly operating results to fall below investor expectations. We believe that a customer's decision to purchase our products and services is discretionary, involves a significant commitment of resources, and is influenced by customer budgetary cycles or federal and state grants. To successfully sell our products and services, we generally must educate our potential customers regarding their use and benefits, which can require significant time and resources. This significant expenditure of time and resources may not result in actual sales of our products and services.

 

34
 

 

The lead-time for ordering parts and materials and building many of our products can be many months. As a result, we must order parts and materials and build our products based on forecasted demand. If demand for our products lags significantly behind our forecasts, we may produce more products than we can sell, which can result in cash flow problems and write-offs or write-downs of obsolete inventory.

 

C. Organizational Structure

 

The diagram below shows Vuance Ltd.'s holdings in its subsidiaries and affiliates as of December 31, 2011 and April 30, 2012:

 

 

Vuance, Inc. (formerly, SuperCom Inc.)

Vuance, Inc., incorporated in Delaware, is our wholly-owned subsidiary, and was responsible for our sales and marketing efforts in the U.S until January 2010.

 

Vuance - RFID Inc.

Vuance - RFID Inc. (formerly, Pure RF Inc.) incorporated in Delaware in November 2005. Upon its incorporation we owned 80% of its shares. During January 2006, Vuance - RFID Inc. established a wholly owned Israeli subsidiary, Vuance RFID Ltd. (formerly, Pure RF Ltd.), which focuses on new technologies and solutions for the tracking of people and assets. During February 2007, we purchased the remaining 20% of Vuance - RFID Inc. for $100,000, whereupon Vuance - RFID Inc. became our wholly-owned subsidiary. In August 2007, all the employees of Vuance RFID Ltd. were transferred to us, and on December 31, 2007 we purchased all of the assets and liabilities of Vuance RFID Ltd. Commencing year 2008, Vuance RFID Inc. engaged in an activity to distribute complementary locks and electronic locks. This activity was terminated in the fourth quarter of 2008 and it is presented in the financial reports as discontinued operations.

 

S.B.C Aviation Ltd.

S.B.C Aviation Ltd., incorporated in Israel in the fourth quarter of 2006, is our wholly-owned subsidiary, which commenced operations in 2007, and focused until 2009 on executing information technology and security projects.

 

SuperCom Slovakia A.S. (“SuperCom Slovakia”)

SuperCom Slovakia, incorporated in Slovakia, was established to implement a national documentation project in the Republic of Slovakia. SuperCom Slovakia is 66% owned by us and 34% owned by EIB Group a.s., a privately held Czech company. Despite our ownership of almost two-thirds of the economic interests of SuperCom Slovakia, our voting power in SuperCom Slovakia is 50%.

 

PureRFid, Inc.

PureRFid, Inc., incorporated in Delaware, is our wholly-owned subsidiary, and as of January 2010 is responsible for our sales and marketing efforts in the U.S.

 

SuperCom Asia Pacific Limited (“SuperCom Asia Pacific”)

SuperCom Asia Pacific, incorporated in Hong Kong, had been our wholly-owned subsidiary since November 2003, and had been responsible for our sales and marketing efforts in Asia Pacific. In the third quarter of 2009, we began to wind down operations of SuperCom Asia Pacific. We sold our entire equity interest in SuperCom Asia Pacific, for no consideration pursuant to a purchase agreement entered into on or about October 21, 2010.

 

35
 

 

D. Property, Plants and Equipment

 

We do not own any real estate.

 

We lease approximately 685 square meters of facilities in Hertzliya Pituach, Israel under a two-year lease contract, currently expiring on September 30, 2013. According to the agreement, the monthly fee (including management fees) is approximately $15,000.

 

Vuance, Inc. leases a facility in Peachtree City, GA of approximately 465 square meters for an average monthly fee of $3,100. The lease commenced on March 1, 2008 and expires on February 28, 2013.

  

In 2009, Vuance, Inc. signed a lease agreement in Oak Creek, Wisconsin, which was amended on February 23, 2011, of approximately 557 square meters for an average monthly fee of $5,200. The lease commenced on April 1, 2010 and expires on March 31, 2015.

 

All such leased properties in the U.S. consist of office space for management, administrative, operation, sales and marketing activities.

 

The total annual rental fees, net of rent income from subleases, for 2011, 2010 and 2009 were $176,000, $121,000 and $331,000, respectively. The total annual lease commitments for 2012 are $280,000.

 

All assets are held in the name of Vuance Ltd. and its subsidiaries.

 

The following table details our fixed assets as of December 31, 2011, 2010 and 2009:

 

    December 31,  
    2011     2010     2009  
    (In thousands of US Dollars)  
Cost:                        
Computers and peripheral equipment   $ 254     $ 262     $ 320  
Office furniture and equipment     194       197       198  
Leasehold improvements     24       45       46  
                         
      472       504       564  
Accumulated depreciation:                        
Computers and peripheral equipment     246       244       270  
Office furniture and equipment     128       120       110  
Leasehold improvements     2       30       27  
                         
      376       394       407  
                         
Depreciated cost:   $ 96     $ 110     $ 157  

 

Depreciation expenses for the years ended December 31, 2011, 2010 and 2009 were $28,000 $47,000 and $77,000, respectively.

 

ITEM 4A.     Unsolved Staff Comments.

 

Not applicable.

 

36
 

 

ITEM 5.     Operating and Financial Review and Prospects.

 

A. Operating results

 

The following section should be read in conjunction with our consolidated financial statements and the related notes thereto, which have been prepared in accordance with U.S. GAAP and which are included in Item 18. Some of the statements contained in this section constitute “forward-looking statements.” These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. (See “Note Regarding Forward Looking Statements” at the beginning of this report, and “Risk Factors” In Item 3.D)

 

Revenues

 

The Company and its subsidiaries generate their revenues from the sale of products, maintenance, royalties and long term contracts (including training and installation). The sale of products involves the sale of active RFID products and existing e-ID project. Following delivery of such products, usually revenues from the sale of such products are recognized.

 

Some of our products are tailored to meet the specific needs of our customers. In order to satisfy these needs, the terms of each agreement, including the duration of the agreement and prices for our products and services differ from agreement to agreement.

 

Operating Expenses

 

Our costs associated with a particular project may vary significantly depending on the specific requirements of the customer, the terms of the agreement, as well as on the extent of the technology licensing. As a result, our gross profits from each project may vary significantly.

 

Our research and development expenses consist of salaries and related, raw material, subcontractors, depreciation costs and overheads allocated to research and development activities.

 

Our selling and marketing expenses consist primarily of salaries and related costs, commissions earned by sales and marketing personnel, trade shows, promotional expenses and overhead costs allocated to selling and marketing activities, as well as depreciation expenses and travel costs.

 

Our general and administrative expenses consist primarily of salaries and related costs, allocated overhead costs, office supplies and administrative costs, fees and expenses of our directors, human resources, information technology, depreciation, and professional service fees, including legal counsel, insurance and audit fees.

 

Net Income (Loss)

 

Our operating results are significantly affected by, among other things, the timing of contract awards and the performance of agreements. As a result, our revenues and income (loss) may fluctuate substantially from quarter to quarter, and comparisons over longer periods of time may be more meaningful. The nature of our certain expenses is mainly fixed or semi-fixed and any fluctuation in revenues will generate a significant variation in gross profit and net income (loss).

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. We evaluate our estimates and judgments on an ongoing basis.

 

We base our estimates and judgments on historical experience and on various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Under different assumptions or conditions, actual results may differ from these estimates.

 

Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the U.S. ("US GAAP"). Our significant accounting principles are presented within Note 2 to our Consolidated Financial Statements. While all the accounting policies impact the financial statements, certain policies may be viewed to be critical. These policies are those that are most important to the portrayal of our financial condition and results of operations. Actual results could differ from those estimates. Our management believes that the accounting policies which affect the more significant judgments and estimates used in the preparation of our consolidated financial statements and which are the most critical to fully understanding and evaluating our reported results include the following:

 

37
 

 

· Revenue recognition;
· Allowance for doubtful accounts;
· Contingencies;
· Goodwill and other intangible assets; and
· Going concern.

 

Revenue Recognition

 

We generate our revenues from the sale of products, maintenance, royalties and long term contracts including training and installation. The sale of products currently involves the sale of active RFID products and existing e-ID project. We sell our products in the U.S. through distributors and our local subsidiary, PureRFid, Inc., and directly throughout the rest of the world.

 

Product sales are recognized in accordance with Staff Accounting Bulletin No. 104, “Revenue Recognition” (“SAB No. 104”), when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, collectability is reasonably assured, and inconsequential or perfunctory performance obligations remain. If the product requires specific customer acceptance, revenue is deferred until customer acceptance occurs or the acceptance provision lapses.

 

We recognized certain long-term contract revenues in accordance with ASC Topic 605-35, "Construction-Type and Production-Type Contracts". Pursuant to ASC Topic 605-35, revenues from these contracts are recognized under the percentage of completion method. We measure the percentage of completion based on output or input criteria, such as contract milestones, percentage of engineering completion or number of units shipped, as applicable in each contract. Provisions for estimated losses on uncompleted contracts are made during the period in which such losses are first identified, in the amount of the estimated loss on the entire contract. As of December 31, 2011, no such estimated losses were identified. As of December 31, 2011, all the long-term contracts were completed and their related revenues were recognized in full. We believe that the use of the percentage of completion method is appropriate, since we have the ability, using also independent subcontractor's evaluation, to make reasonably dependable estimates of the extent of progress made towards completion, contract revenues and contract costs. In addition, contracts executed include provisions that clearly specify the enforceable rights of the parties to the contract, the consideration to be exchanged and the manner and the terms of settlement. In all cases, we expect to perform our contractual obligations and the parties are expected to satisfy their obligations under the contract. In contracts that do not meet all the conditions mentioned above, we utilize zero estimates of profits; equal amounts of revenue and cost are recognized until results can be estimated with sufficient accuracy. Revenues and costs recognized pursuant to ASC Topic 605-35 on contracts in progress are subject to management estimates. Actual results could differ from these estimates.

 

We are not obligated to accept returned products or issue credit for returned products, unless a product return has been approved by us in advance and is according to specific terms and conditions. As of December 31, 2011 we had an allowance for customer's returns in an insignificant amount.

 

Our warranty period is typically 12 months. Based primarily on our historical experience, we do not provide for warranty costs when revenue is recognized, since such costs are not material.

 

Deferred revenues and customer advances include amounts received from customers for which revenues have not been recognized.

 

We are entitled to royalties upon of the issuance of a certificate. Such royalties are recognized when the sales are reported to us (usually on a monthly basis).

 

Allowance for doubtful accounts

 

The allowance for doubtful accounts is determined with respect to specific debts that we have determined to be of doubtful collection.

 

We perform ongoing credit evaluations of our customers' financial conditions and we require collateral as we deem necessary. An allowance for doubtful accounts is determined with respect to those accounts that we have determined to be doubtful of collection. If the financial conditions of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances would be required. The allowance for doubtful accounts was $134,000 and $1,553,000 at December 31, 2011 and 2010, respectively.

 

38
 

 

Contingencies

 

From time to time, we are the defendant or plaintiff in various legal actions, which arise in the normal course of business. We are required to assess the likelihood of any adverse judgments or outcomes to these matters as well as potential ranges of probable losses. A determination of the amount of reserves required for these contingencies, if any, which would be charged to earnings, is made after careful and considered analysis of each individual action with our legal advisors. The required reserves may change in the future due to new developments in each matter or changes in circumstances, such as a change in settlement strategy. A change in the required reserves would affect our earnings in the period the change is made. Other than as described under the heading “Legal Proceedings” in Item 8, there are no material pending legal proceedings in which we are a party or of which our property is subject.

 

Goodwill and other intangible assets

 

Under ASC Topic 350, "Intangibles - Goodwill and Other", goodwill acquired in a business combination is deemed to have indefinite life and is not to be amortized. ASC Topic 350 requires goodwill to be tested for impairment at least annually or between annual tests in certain circumstances, and written down when impaired, rather than being amortized. Goodwill is tested for impairment by comparing the fair value of each reporting unit to its carrying value ("step 1"). If the fair value exceeds the carrying value of the reporting unit net assets, goodwill is considered not impaired, and no further testing is required. If the carrying value exceeds the fair value of the reporting unit, then the implied fair value of goodwill is determined by subtracting the fair value of all the identifiable net assets from the fair value of the reporting unit. An impairment loss is recorded for the excess, if any, of the carrying value of the goodwill allocated to the reporting unit over its implied fair value ("step 2").

 

Due to the sale of activities in January 2010, we recorded in 2009 an impairment loss of the entire remaining balance of the goodwill which was attributed to the components sold in an amount of $685,000 and in addition we recorded an impairment loss of certain other intangible assets in an amount of $434,000. As of December 31, 2011 and 2010, the balance of goodwill and intangible assets is nil.

 

Going concern

 

We incurred substantial losses and negative cash flows from operations since our inception. We had an operating cash flow deficit in each of 2011, 2010, and 2009. As of December 31, 2011, we had an accumulated deficit of approximately $48,325,000 and a working capital deficit of $2,723,000 (excluding the Convertible Bonds which total debt is approximately $2,975,000 as of December 31, 2011). We incurred net losses of approximately $1,965,000 and $5,085,000 in the years ended December 31, 2010 and 2009, respectively. In the year ended December 31, 2011, we incurred net income of approximately $1,019,000 (which includes a capital gain of $2,149,000 as a result of extinguishment of debt in 2011). We may continue to have an annual losses and negative cash flows for the near future, and expect to spend significant amounts of capital to enhance our products and services, develop further sales and operations and fund expansion. As a result, we will need to generate significant revenues to achieve annual profitability. Even if we do achieve annual profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Continuation of our current operations after utilizing our current cash reserves and other current assets is dependent upon the generation of additional financial resources. As described in Item 4.A under the caption “Recent Developments”, we wish to complete the Creditor Arrangement, and also are seeking to raise funds either via issuance of additional equity or through receipt of additional bank credit lines. These matters raise substantial doubt about our ability to continue as a going concern. The financial statements have been prepared assuming that we will continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Results of Operations

 

The following table sets forth selected our consolidated income statement data for each of the three years ended December 31, 2011, 2010 and 2009 expressed as a percentage of total revenues.

 

39
 

 

    2011     2010     2009  
                   
Revenues     100 %     100 %     100 %
Cost of revenues     41.7       27.8       36.2  
Gross profit     58.3       72.2       63.8  
Operating expenses                        
Research and development     5.8       5.2       9.7  
Selling and marketing     44.2       59.6       55.1  
General and administrative     9.2       26.9       17.7  
Other (income) expenses     (1.7 )     (5.4 )     1.3  
Total operating expenses     57.6       86.3       83.8  
Operating (loss) income     0.7       (14.2 )     (20 )
Financial (expenses) income, net     12.5       (9.2 )     (6.7 )
Income (loss) before income tax     13.2       (23.4 )     (26.7 )
Income tax     (0.3 )     (0.7 )     (0.8 )
Loss from discontinued operations     -       (2.6 )     (27.1 )
Net (loss) income     12.9       (26.6 )     (54.6 )

 

Operating Results

 

Year Ended December 31, 2011 Compared to Year Ended December 31, 2010

 

Revenues

 

Our revenues from continuing operations in 2011 were $7,922,000, compared to $7,389,000 in 2010, an increase of 7%. The increase in our revenues from continuing operations is primarily due to an increase in revenues from our E-id project.

 

Gross Profit

 

Our gross profits from continuing operations in 2011 were $4,616,000 compared to $5,332,000 in 2010, a decrease of 13%. The gross profit margin for the year 2011 was 58% compared to 72% in 2010. The decrease in gross profit margin attributed to changes in our mix of revenues from products and services. Revenues from the selling of services have higher gross profit than revenues from selling of products.

 

Expenses

 

Our operating expenses from continuing operations in 2011 were $4,562,000, compared to $6,380,000 in 2010, a decrease of 28%. The decrease in operating expenses from continuing operations was primarily due to a decrease in selling and marketing expenses and a decrease in general and administrative expenses, as discussed below.

 

Research and development from continuing operations expenses consist primarily of salaries and related costs, raw material, subcontractors, depreciation and amortization costs and overheads allocated to research and development activities. Our research and development expenses from continuing operations in 2011 were $462,000, compared to $386,000 in 2010, an increase of 20%. The increase in our research and development expenses from continuing operations was primarily due to an increase in salaries and related costs due to headcount increase.

 

40
 

 

Sales and marketing expenses from continuing operations consist primarily of salaries and related costs, commissions earned by sales and marketing personnel and partners, trade shows and overheads allocated to selling and marketing activities, as well as depreciation and amortization expenses and travel costs. Our sales and marketing expenses from continuing operations in 2011 were $3,505,000, compared to $4,405,000 in 2010, a decrease of 20%. The decrease in the sales and marketing expenses from continuing operations was primarily due to a decrease in promotional expenses, arising from the increase in revenues from the selling of products, which resulted in fewer promotional expenses.

 

General and administrative expenses from continuing operations consist primarily of salaries and related costs, allocated overheads, office supplies and administrative, fees and expenses of our directors, bad debts expenses, human resource, information technology, depreciation and amortization, and professional service fees, including legal counsel, insurance and audit fees. Our general and administrative expenses from continuing operations in 2011 were $732,000, compared to $1,985,000 in 2010, a decrease of 63%. The decrease in general and administrative expenses from continuing operations was primarily due to a decrease in salaries and related costs, a decrease in legal expenses and due to a change in management's estimation with respect to the collectability of certain debt which was considered doubtful in 2010 and as of December 31, 2011, on the basis of communications held with the customer, is not considered as doubtful of collection.

 

Other income from continuing operations in 2011 was $137,000 and consisted primarily of gain from the extinguishment of working capital related liabilities as part of the Creditor Arrangement, compared to $396,000 in 2010, which consisted of capital gain from the sale of our Hong Kong subsidiary and gain from the Creditor Arrangement.

 

Financial (Expenses) Income, net

 

Financial (expenses) income from continuing operations consist primarily of interest related to our Convertible Bonds, bank fees, gain on extinguishment of convertible bonds as part of the Creditor Arrangement and exchange rate expenses. Financial income from continuing operations for the year ended December 31, 2011 was $990,000 compared to financial expenses from continuing operations in 2010 of $678,000. The transfer from financial expenses to financial income is mainly due to a $2,006,000 capital gain on extinguishment of debt related to convertible bonds, recognized in 2011, as part of the Creditor Arrangement, which was maintained by an increase in financial expenses with respect to our Convertible Bonds caused by an increase in the interest rate of the bonds and due to our breach of the covenants under the Convertible Bonds, as amended, which required us to incur additional interest of 3% per month on unpaid amounts. The additional interest expenses amounted to $271,000 during the year ended December 31, 2011.

 

Income Tax

 

Income taxes from continuing operations are mainly expenses related to withholding tax at source related to our project with a European country. Income taxes on income from continuing operations for the year ended December 31, 2011 and 2010 were $25,000 and $50,000, respectively. The decrease is mainly due to a decrease related to withholding tax at its source expenses.

 

Loss from discontinued operations

 

Loss from discontinued operations for the year ended December 31, 2010 was $189,000. The loss from discontinued operations is attributed to the sale of our EAC and CSMS businesses, which were sold in January 2010.

 

Net (Loss)Income

 

As a result of the factors described above, our net income in 2011 was $1,019,000, compared to a net loss of $1,965,000 in 2010.

 

Year Ended December 31, 2010 Compared to Year Ended December 31, 2009

 

Revenues

 

Our revenues from continuing operations in 2010 were $7,389,000, compared to $9,304,000 in 2009, a decrease of 21%. The decrease in our revenues from continuing operations is primarily due to a completion of large airport control system in a European country during 2009.

 

41
 

 

Gross Profit

 

Our gross profits from continuing operations in 2010 were $5,332,000 compared to $5,939,000 in 2009, a decrease of 10%. The gross profit margin for the year 2010 was 72% compared to 64% in 2009. The increase in gross profit margin attributed to changes in our mix of revenues.

 

Expenses

 

Our operating expenses from continuing operations in 2010 were $6,380,000, compared to $7,807,000 in 2009, a decrease of 18%. The decrease in operating expenses from continuing operations was primarily due a decrease in research and development expenses, in selling and marketing expenses and in other expenses (income), which are discussed below.

 

Our research and development expenses from continuing operations in 2010 were $386,000, compared to $898,000 in 2009, a decrease of 57%. The decrease in our research and development expenses from continuing operations was primarily due to a decrease in stock-based compensation accounted for in 2009.

 

Our sales and marketing expenses from continuing operations in 2010 were $4,405,000, compared to $5,131,000 in 2009, a decrease of 14%. The decrease in the sales and marketing expenses from continuing operations was primarily due to the decrease in revenues.

 

Our general and administrative expenses from continuing operations in 2010 were $1,985,000, compared to $1,648,000 in 2009, an increase of 20%. The increase in general and administrative expenses from continuing operations was primarily due to an increase in legal expenses in year 2010.

 

Additionally, other (income) expenses from continuing operations consisted in 2010 of other income associated with the selling of our Hong Kong subsidiary and with the Creditor Arrangement. Other expenses from continuing operations in 2009 consisted of expenses that relate to litigations that were settled during the reported period, as described in "Legal Proceedings" in Item 8, and accruals related to legal proceeding exposures. Our other income from continuing operations in 2010 were $396,000, compared to other expenses of $130,000 in 2009.

 

Financial Expenses, net

 

Financial expenses from continuing operations consist primarily of interest related to our Convertible Bonds, banks fees and exchange rate expenses. Financial expenses from continuing operations for the year ended December 31, 2010 and 2009 were $678,000 and $620,000, respectively. The increase in financial expenses from continuing operations is mainly due to an increase in financial expenses with respect to our Convertible Bonds and due to an increase in exchange rate expenses arise from the decline in the NIS/dollar rate.

 

Income Tax

 

Income taxes from continuing operations are mainly expenses related to withholding tax at source related to our project with a European country. Income taxes on income from continuing operations for the year ended December 31, 2010 and 2009 were $50,000 and $71,000, respectively. The decrease is mainly due to a one-time allowance for income taxes recorded in 2009 in relation to our Israeli subsidiary.

 

Loss from discontinued operations

 

Loss from discontinued operations for the year ended December 31, 2010 and 2009 were $189,000 and $2,526,000, respectively. The loss from discontinued operations is attributed to the sale of our EAC and CSMS businesses, which were sold in January 2010.

 

Net Loss

 

As a result of the factors described above, our net loss in 2010 was $1,965,000, compared to a net loss of $5,085,000 in 2009.

 

Impact of Inflation and Currency Fluctuations

 

Because the majority of our revenue is paid in or linked to the U.S. dollar, we believe that inflation and fluctuation in the NIS/dollar exchange rate has limited effect on our results of operations. However, a portion of the cost of our Israeli operations, mainly personnel, is incurred in NIS. Because some of our costs are in NIS, inflation in NIS/dollar exchange rate fluctuations does have some impact on our expenses and, as a result, on our net income. Our NIS costs, as expressed in dollars, are influenced by the extent to which any increase in the rate of inflation in Israel is not offset, or is offset on a delayed basis, by a devaluation of the NIS in relation to the dollar.

 

42
 

 

Historically, the New Israeli Shekel has been devalued in relation to the U.S. dollar and other major currencies principally to reflect the extent to which inflation in Israel exceeds average inflation rates in Western economies. Such devaluations in any particular fiscal period are never completely synchronized with the rate of inflation and therefore may lag behind or exceed the underlying inflation rate.

 

In 2011, the rate of appreciation of the NIS against the U.S. dollar was 8% and the rate of inflation, in Israel, was 2.2%. It is unclear what the devaluation/evaluation and inflation rates will be in the future, and we may be materially adversely affected if inflation in Israel exceeds the devaluation of the NIS against the U.S. dollar or the evaluation of the NIS against the U.S. Dollar, or if the timing of the devaluation lags behind increases in inflation in Israel.

 

We do not engage in any hedging or other transactions intended to manage risks relating to foreign currency exchange rate or interest rate fluctuations. At December 31, 2011, we did not own any market risk sensitive instruments except for our revolving line of credit. However, we may in the future undertake hedging or other similar transactions or invest in market risk-sensitive instruments if our management determines that it is necessary or advisable to offset these risks.

 

Seasonality

 

Our quarterly operations are subject to fluctuations due to several factors, including the factors discused under the caption “Risk Factors—The time from our initial contact with a customer to a sale is long and subject to delays which could result in the postponement of our receipt of revenues from one accounting period to the next, increasing the variability of our results of operations and causing significant fluctuations in our revenue from quarter to quarter” in Item 3.D. It is our experience that, as a general matter, a majority of our sales are made during the latter half of the calendar year consistent with the budgetary, approval and order processes of our governmental agencies customers. Additionally, the period between our initial contact with a potential customer and the purchase of our products and services is often long and subject to delays associated with the budgeting, approval and competitive evaluation processes that frequently accompany significant expenses, particularly for government and government agencies organizations. A lengthy sales cycle may have an impact on the timing of our revenue, which may cause our quarterly operating results to fall below investor expectations. We believe that a customer's decision to purchase our products and services is discretionary, involves a significant commitment of resources, and is influenced by customer budgetary cycles. To successfully sell our products and services, we generally must educate our potential customers regarding their use and benefits, which can require significant time and resources. This significant expenditure of time and resources may not result in actual sales of our products and services, which could have an adverse effect on our results of operations.

 

New Accounting Pronouncements

 

Accounting pronouncements adopted in 2011

 

ASC Topic 605 - 25 “Revenue Recognition - Multiple-Element Arrangements”

 

In October 2009, the FASB issued Accounting Standards Update (ASU) 2009-13, Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force. The amended guidance modified the criteria for recognizing revenue in multiple element arrangements and requires companies to develop a best estimate of the selling price to separate deliverables and allocate arrangement consideration using the relative selling price method. In addition, the amendments eliminated the residual method for allocating arrangement considerations.

 

The amended guidance became effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (fiscal year 2011 for us). The adoption of the new guidance did not have a material impact on our financial position, results of operations or cash flows.

 

ASC Topic 985 - 605, "Software - Revenue Recognition"

 

In October 2009, the FASB issued Accounting Standards Update (ASU) 2009-14, “Certain Revenue Arrangements That Include Software Elements – a consensus of the FASB Emerging Issues Task Force”, to amend the scope of arrangements under ASC 985, Software, 605, “Revenue Recognition” to exclude tangible products containing software components and non-software components that function together to deliver a product’s essential functionality. Such components will be subject to ASC Topic 605 - 25 “Revenue Recognition - Multiple-Element Arrangements”.

 

43
 

 

The amended guidance became effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (fiscal year 2011 for us). The adoption of the new guidance did not have a material impact on our financial position, results of operations or cash flows.

 

Accounting pronouncements not yet effective:

 

ASC Topic 220, “Comprehensive Income”

 

In June 2011, the FASB issued Accounting Standard Update (ASU) 2011-05, “Comprehensive Income (Topic 220) - Presentation of Comprehensive Income” (ASU 2011-05). ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of equity and requires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements.

 

ASU 2011-05 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 (fiscal year 2012 for us) and should be applied retrospectively.

 

In December 2011, the FASB issued Accounting Standard Update (ASU) 2011-12, which defers certain provisions contained in ASU 2011-05 requiring the requirement to present components of reclassifications of other comprehensive income on the face of the income statement or in the notes to the financial statements. However, this deferral does not impact the other requirements contained in the new standard on comprehensive income as described above. ASU 2011-12 is effective during interim and annual periods beginning after December 15, 2011 (fiscal year 2012 for us).  

 

The adoption of ASU 2011-05 and ASU 2011-12 is not expected to have a material impact on our financial condition, results of operations or cash flows.

 

ASC Topic 210, “Balance Sheet”

 

In December 2011, the FASB issued Accounting Standard Update (ASU) 2011-11, “Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities” (ASU 2011-11). ASU 2011-11, enhance disclosures about financial instruments and derivative instruments that are either offset in accordance with the Accounting Standards Codification or are subject to an enforceable master netting arrangement or similar agreement.

 

The amended guidance will be effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods (fiscal year 2013 for us) and should be applied retrospectively to all comparative periods presented.

 

We are currently evaluating the impact that the adoption of ASU 2011-11 would have on our consolidated financial statements, if any.

 

B. Liquidity and Capital Resources

 

Net cash used in operating activities for the year ended December 31, 2011 was $189,000 compared to $1,212,000 during the period ended December 31, 2010, a decrease of $1,023,000, or 84%. This decrease was primarily due to net income of $1,019,000 in 2011 compared to a net loss of $1,965,000 during 2010, which was maintained by an increase in capital gain from the extinguishment of liabilities in 2011 of $2,149,000 compared to $124,000 in 2010.

 

Net cash provided by investing activities during the year ended December 31, 2011 was $116,000, compared to $639,000 during the period ended December 31, 2010, a decrease of $523,000. This decrease was primarily due to the proceeds from the sale of operations net of cash disposed of in 2010.

 

Net cash provided by financing activities during the year ended December 31, 2011 was $91,000, compared to $114,000 during the year ended December 31, 2010, a decrease of $23,000.

 

As of December 31, 2011, our cash and cash equivalents totaled $215,000, compared to $197,000 as of December 31, 2010. Restricted cash totaled $0 as of December 31, 2011, compared to $130,000 as of December 31, 2010. The restricted cash deposit was related to a bank deposit to secure a documentary credit to a supplier, related to our certain project with a European country.

 

44
 

 

We have accumulated net losses of approximately $48,325,000 from our inception through December 31, 2011.

 

As of December 31, 2011, we had a negative working capital in the amount of $2,723,000 (excluding the Convertible Bonds which total debt is approximately $2,975,000 as of December 31, 2011). We believe that we do not have sufficient working capital to meet our anticipated operating expenditure requirements for 2012. Since September 2011, we have been financing part of our day-to-day operations with interest-free, short-term loans from Mrs. Tsviya Trabelsi, our former chairman of the Board and the wife of our current chairman of the Board, which amounted to approximately $69,000 as of March 31, 2012. In the past, we have partially funded our operations through the issuance of equity securities and convertible bonds to investors and may not be able to generate a positive cash flow from operations in the future. Continuation of our current operations after utilizing our current cash reserves is dependent upon the generation of additional financial resources either through the issuance of additional equity or debt securities or other sources of financing, generating cash flow from operations or the sale of certain assets of the Company. Any additional financings will likely cause substantial dilution to existing shareholders. If we are unable to obtain necessary additional financing or generate cash from operations, we may be required to reduce the scope of, or cease, our operations. Even if we raise such additional capital, we may be required to reduce the scope of our operations and may need to implement certain operational changes in order to decrease our expenditure level. Our need for additional capital to finance our operations and growth will be greater should, among other things, our revenue or expense estimates prove to be incorrect. These matters raise substantial doubt about our ability to continue as a going concern. Our financial statements have been prepared assuming that we will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.

 

Since May 1999, we have funded operations primarily through cash generated from our initial public offering on NASDAQ Europe in April 1999, which resulted in total net proceeds of approximately $23,600,000 (before offering expenses), and, to a lesser extent, from our sale of the shares of our former subsidiary, InkSure Technologies, Inc., from borrowings from financial institutions, from private placements of our ordinary shares and warrants to purchase our ordinary shares, in 2004, 2005 and 2010, from issuance of convertible bonds and warrants, from the sale of certain activities of Vuance Inc. in January 2010, and in 2006, 2007 and 2008 from the sale of OTI shares that were received from the sale of the E-ID Division to OTI. As of December 31, 2011, our principal source of liquidity was $215,000 of cash and cash equivalents. As of December 31, 2011, we had $2,975,000 of debt outstanding relating to obligations under our Convertible Bonds and accrued expenses of $2,164,000.

 

During June and July 2004, we received aggregate gross proceeds of $1,225,000 from the private placement of 265,001 ordinary shares and five-year warrants to purchase 106,001 ordinary shares at an exercise price of $6.47 per share. In connection with the private placement, our placement advisors received warrants to purchase 77,941 ordinary shares at an exercise price of $6.47 per share.

 

In August and September 2004, we received gross proceeds of $2,200,000 from a private placement to accredited investors of 420,000 ordinary shares and five-year warrants to purchase 168,000 ordinary shares at an exercise price of $6.47 per share. In connection with the private placement, our placement agent received warrants to purchase 30,240 ordinary shares at an exercise price of $6.47 per share and 75,601 ordinary shares at an exercise price of $5.00 per share. All of such warrants issued in this private placement, except 75,601 warrants with an exercise price of $5.00, were called by us at a redemption price of $0.0588 per warrant pursuant to our right to do so if the closing price (or closing bid price) of our ordinary shares on an U.S. stock exchange, NASDAQ or the OTC Bulletin Board was equal to or greater than $14.70 per share for 10 out of any 15 consecutive trading days. The investors exercised warrants to purchase an aggregate of 194,627 ordinary shares. During the fourth quarter of 2004, 120,176 warrants were exercised for an aggregate amount of approximately $778,000, and approximately $130,000 was received with respect to shares to be allotted in 2005. During the year 2005, 54,451 warrants were exercised for an aggregate amount of approximately $352,000.

 

In November and December of 2005, we received aggregate gross proceeds of $3,050,000 from a private placement by certain investors of 836,292 ordinary shares (of which 150,807 shares were issued after December 31, 2005) and five-year warrants to purchase 292,701 ordinary shares at an exercise price of $3.53 per share. The private placement was made to accredited investors pursuant to Rule 506 of Regulation D, promulgated under the Securities Act of 1933, as amended (the “Securities Act”) and to foreign private investors in offshore transactions in reliance on Regulation S promulgated under the Securities Act. In connection with the private placement, our placement agent received a cash fee of $150,000 and our placement advisors received five-year warrants to purchase 8,446 ordinary shares at an exercise price of $3.53 per share. The investors that participated in this private placement were granted the right, for one year following the closing of the private placement and subject to certain limitations, to participate in future issuances of our capital stock or securities (a “Subsequent Financing”) up to an amount which would permit each investor to maintain its fully diluted percentage equity ownership at the same level existing prior to the Subsequent Financing (after giving effect to such Subsequent Financing). The warrants are callable, subject to certain limitations, at our option if the closing bid price per ordinary share of our ordinary shares equals or exceeds $7.06 for 20 trading days during the term of the warrants. We may however only call, in any 3-month period, the lesser of (i) 20% of the aggregate amount of the warrants initially issued to a warrant holder, or (ii) the total number of warrants then held by such holder.

 

45
 

 

In November 2006, we raised $3,156,500 through the issuance of units consisting of convertible bonds, or the Convertible Bonds and warrants. Units valued at $2,500,000 were issued to Brevan Howard Master Fund Limited or “BH” and units valued at $656,500 were issued to Special Situation Funds (SSF), based on the participation rights provided in a private placement during 2005, which were existing shareholders of us. According to their original terms the Convertible Bonds matured three years from the date of issuance and bore interest at an annual rate of 8%. The Convertible Bonds provided that any withholding and other taxes payable with respect to the interest will be grossed up and paid by us (approximately 3% of the principal of the bonds); and payment of interest will be net of any tax. Subject to certain redemption provisions, the Convertible Bonds may be converted at any time, at the option of the holders, into our ordinary shares at an original conversion price of $5 per share. The holders were also granted warrants entitling them to acquire a total of 134,154 ordinary shares at an original exercise price of $5 per share during the next five years. In respect of this transaction, we paid approximately $215,000 cash as issuance expenses and granted an option to acquire up to 25,000 of our ordinary shares to a third party, exercisable at an original $5 per share. The fair market value of this grant was $ 40,000.

 

Pursuant to their terms, if we fail to fulfill certain conditions of the Convertible Bonds, the holders may accelerate repayment of the principal amount of $3,156,500 of the Convertible Bonds, in which case all interest payable up to the maturity date will immediately become due and payable.

 

We have determined that the embedded conversion feature should not be separated from the host instrument because it is qualified for equity classification. Therefore the transaction was accounted for in accordance with ASC Topic 470 – 20, “Debt – Debt with Conversion and Other Options”.

 

In November 2007, due to a breach of certain conditions of the Convertible Bonds, the holders had the right to accelerate the repayment of the principal with all the interest payable until the maturity date of the bonds. However, we signed an amendment to the agreement with the holders under which we were required to pay to one of the holders interest in the amount of $276,000 (together with any withholding and other taxes payable with respect to the interest (approximately 3% of the principal of the Convertible Bonds)) and with respect to the other holder we changed the conversion ratio of the Convertible Bonds to $4.25. In a consideration the holders waived their right to accelerate the repayment of the Convertible Bonds. We accounted for the amendment as a modification of the Convertible Bonds.

 

In June 2008, following a breach in the amended terms of the Convertible Bonds, we reached an agreement with BH, pursuant to which, among other things, BH waived the requirement that we comply with certain covenants under its Convertible Bonds, in exchange for:

 

1. Increasing the interest rate to 10% starting March 31, 2008. Any withholding and other taxes payable with respect to the interest will be grossed up and paid by us (approximately 3% of the principal of the bonds).
2. Reducing the exercise price of the bond and the warrants to $3 and $2.8, respectively.
3. Our undertaking to place a fixed charge on all income and/or rights in connection with a certain European Airport Project. This charge shall be senior to any indebtedness and/or other pledge and encumbrance, but shall, however, be subject to certain rights of us to use part of the income.
4. Our granting of certain anti-dilution rights with respect to the warrants held by BH.

 

In addition, it was agreed that under certain circumstances BH may demand an early payment in part or in full of the principal amount of its Convertible Bond. We accounted for the amendment as an extinguishment of the Convertible Bonds.

 

Due to the breach of certain of the covenants under the Convertible Bonds, we had to recognize, in 2008, financial expenses in the amount of $553,000, to accelerate deferred expenses in the amount of $138,000 and to accelerate the remaining discount amounts (attributed to warrants and beneficial conversion feature) in the amount of $724,000. In addition, as of December 31, 2008, the Convertible Bond was classified as a current liability.

 

On August 12, 2009, we entered into an agreement with BH to make additional amendments to certain terms of its Convertible Bond, (the “Amendment Agreement”), pursuant to which, in exchange for security in certain of our assets, including all incomes and/or rights in connection therewith to which we and our Subsidiaries are and shall be entitled to as a result of certain legal proceedings involving our Slovakian subsidiary SuperCom Slovakia, and all amounts in connection with the project related to the legal proceedings, BH agreed to (a) waive the requirement that we comply with and (b) amend certain provisions of, its Convertible Bond including, (i) increasing the applicable rate of interest to 12% and by 0.5% every 180 days afterward, (ii) releasing us from certain payments upon the completion of certain payments of principal and interest due under the Convertible Bond, (iii) making monthly payments of $41,000 against the total amount due under the Convertible Bond over an eight (8) year period, and (iv) increasing the number of warrants granted to 159,375 and amend their exercise price of all the warrants to $0.40 per share. The modification was determined to be a debt extinguishment. For more information on the legal proceedings involving SuperCom Slovakia, see Item 8 – Legal Proceedings.

 

46
 

 

On November 9, 2009, we entered into an amendment agreement with Special Situation Funds or “SSF”, the holder of the Convertible Bond in the amount of $623,565, pursuant to which, in exchange for a security in certain of our assets, SSF agreed to (a) waive its requirement that we comply with and (b) amend certain provisions of, its Convertible Bond including, (i) increasing the applicable rate of interest to 12% and by 0.5% every 180 days afterward, (ii) releasing us from certain payments upon the completion of certain payments of principal and interest due under its Convertible Bond, (iii) making monthly payments of $10,000 against the total amount due under the Convertible Bond over an eight (8) year period, (iv) reducing the exercise price of the Convertible Bond and the warrants to $3 and $0.4, respectively and, (v) increase the number of warrants granted to 31,238. The modification was determined to be a debt extinguishment.

 

As of December 31, 2009, in light of the above amendments, total principal amount of $430,000 is presented in current liabilities and a total principle amount of $2,624,000 is presented in long-term liabilities. In addition, an amount of $1,693,000 which includes interest and penalties that it was agreed to be paid after the principal amount is paid, and therefore is presented among long-term loan and others.

 

As of December 31, 2009 we were in compliance with covenants under the amendment Convertible Bond agreements.

 

In January 2010, we have received the investors’ consent to sell our EAC and CSMS businesses (as described in Item 4). In addition, we created a specific (fixed) charge in favor of the investors on the intellectual property rights belonging to our remaining RFID business.

 

On August 24, 2010, BH entered into an Absolute Assignment and Transfer of Bond and Warrant (“Assignment”) with Sigma, an Israeli company and our controlling shareholder. Pursuant to the Assignment, BH transferred to Sigma all of its rights in the BH Convertible Bonds and warrants. The Assignment had no impact on our assets or liabilities or our financial results.

 

At the annual general meeting of our shareholders held on September 12, 2010, our shareholders resolved to afford certain of our major creditors with the opportunity to convert the amounts owed to them into our ordinary shares, by means of a set off against the then total outstanding debt to such creditor, at a price of $0.09 per ordinary share, subject to forgiveness of 60% of our total outstanding debt to such creditor. Our board of directors was authorized to set all other terms of the Creditor Arrangement, including, inter alia, its timetable.

 

On November 3, 2010, we petitioned the court, for the court approval of a Creditor Arrangement in accordance with Section 350 of the Israeli Companies Law. We requested that the court apply the Creditor Arrangement approved by our shareholders to all of our creditors as of August 10, 2010, or the Determining Date, and who were still creditors as of December 17, 2010 and who had submitted a claim of debt no later than January 6, 2011. We requested that pursuant to the proposed arrangement all such creditors (whether secured, preferential (by statute) and unsecured) shall be considered to have released us from our debt obligations towards them as of such date in exchange for the allotment to all such creditors of our ordinary shares or warrants to purchase our ordinary shares (that are immediately exercisable in a cashless transaction and with an expiration date of December 31, 2012) at a price of $0.09 per ordinary share, valued at 40% of our total outstanding debt to our creditors and in consideration for which the creditors would forgive the remaining 60% of the outstanding debt. In May 2011, our shareholders subsequently approved the inclusion of additional creditors to be included under the Creditor Arrangement.

 

Although the Creditor Arrangement is supported by a resolution of our shareholders and was presented at the meeting of our creditors, on July 18, 2011 the court decided not to approve our application, mainly due to an objection to the proposed arrangement which was filed by one of our secured creditors, Special Situations Funds ("SSF"). On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi all of its rights under the Convertible Bonds and warrants. In February 2012, our Board of Directors determined to proceed with the Creditor Arrangement without the involvement of the court. On December 5, 2011 we received from the Execution Office in Israel a foreclosure order in accordance with Section 44 to the Execution Law Records, vol. 1967, in respect of convertible bonds held by Sigma, up to an amount of NIS 3,903,866 (approximately $1,022,000, based on the exchange rate between the U.S. dollar and the NIS published by the Bank of Israel on December 31, 2011) in favor of a third party. We followed the order’s instructions and recorded the said foreclosure. As of April 15, 2012, following the forgiveness or conversion of debt pursuant to the Creditor Arrangement in the aggregate amount of $3,640,000 since December 31, 2010, additional debt of approximately $3,286,000 (computed as of December 31, 2011) remains to be forgiven or converted pursuant thereto. However, the completion of the Creditor Arrangement has been delayed, which we believe is, as a result of a dispute over the ownership of approximately $1,022,000 (computed as of December 31, 2011) of our convertible bonds held by Sigma. If the Creditor Arrangement is not consummated, our ability to satisfy our debt service obligations will depend, among other things, upon our future operating performance and our ability to refinance indebtedness when necessary.

 

47
 

 

On March 30, 2011, we entered into a financing agreement with Sigma that entitles us to refinance the short-term obligations under the Convertible Bonds held by Sigma on a long-term basis. Pursuant to the agreement, and subject to certain conditions and covenants, Sigma postponed all mature amounts, relating to principal and interest, as of December 31, 2010, to January 1, 2012. In addition, the agreement required that interest amounts with respect to fiscal 2011 will become due during July 2011 and thereafter. As a consequence of the financing agreement, as of December 31, 2010, our total outstanding debt to Sigma under the Convertible Bonds was $4,262,000, of which $2,453,000 was presented on our balance sheet among convertible bonds (long-term balance) and $1,810,000 was presented among long-term loan and others.

 

As of December 31, 2010, we were in compliance with the covenants under the amended Convertible Bonds agreements with respect to bonds held by SSF.

 

As a part of the Creditor Arrangement process, on August 4, 2011, Sigma agreed to convert $400,000 of the amounts owed to it into 4,444,444 of our ordinary shares (which number was determined on June 30, 2011) and to forgive $600,000 of our outstanding debt to Sigma. The ordinary shares were issued on August 11, 2011.

 

On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi all of their rights under the Convertible Bonds and warrants.

 

On December 31, 2011, as a part of the Creditor Arrangement process, Sigma agreed to convert $722,250 of the amounts owed to them into 8,025,000 of our ordinary shares (which were granted to a trustee, according to Sigma’s request) and to forgive $1,083,375 of our outstanding debt to Sigma. The ordinary shares were issued to Sigma on April 2, 2012. On December 31, 2011, as a part of the Creditor Arrangement process, Mr. Eliyahu Trabelsi agreed to convert $96,246 of the amounts owed to him into our 1,069,400 ordinary shares and to forgive $144,369 of our outstanding debt to him. The ordinary shares were issued on April 2, 2012.

 

During 2011, as a part of the Creditor Arrangement, certain creditors agreed to convert $322,000 (the total aggregate amounts owed to them) into warrants to purchase 1,081,871 of our ordinary shares and options to purchase 300,000 of our ordinary shares.

 

As of December 31, 2011 and the filing date of this Annual Report, we were not in compliance with the covenants under the amended Convertible Bonds. In 2011, we experienced an increase in financial expenses with respect to our Convertible Bonds caused by an increase in the interest rate of the bonds and due to our breach of the covenants under the Convertible Bonds, as amended, which required us to incur additional interest of 3% per month on unpaid amounts. The additional interest expenses amounted to $271,000 during the year ended December 31, 2011.

 

On December 31, 2006, we concluded the sale of our E-ID division to On-Track Innovations Ltd., or OTI (the "OTI Transaction") for consideration which consisted of 2,827,200 restricted ordinary shares of OTI.

 

As a result of the OTI Transaction, we recognized $10,536,000 as a capital gain on the sale of the E-ID Division in fiscal year 2006.

 

The capital gain was calculated based on OTI’s share price on the closing date, less a discount due to the lock up restrictions of the shares (based on an independent appraisal), the carrying value of the assets that were transferred to OTI and direct expenses (in an amount of $1,550,000) associated with the sale.

 

The direct expenses included, inter alia, the fair value of 212,040 shares out of the shares received by us from OTI that were transferred to consultants, as a finder and legal fee, in connection with the transaction.

 

In connection with the completion of the sale, during January 2007, a financial institution extended a $2,500,000 loan to us. In order to secure this loan we deposited our OTI shares in favor of the financial institution. This loan was repaid in full during 2007.

 

During 2007 and 2008, we sold 1,414,716 and 1,200,444 shares of OTI for a total consideration of $7,639,000 and $3,192,000, respectively.

 

48
 

 

In January 2010, Vuance, Inc., our wholly-owned subsidiary, completed the sale of certain of its assets and certain of its liabilities related to our electronic access control market as well as our Government Services Division, pursuant to certain agreements signed at that time. For additional information on the sale of these businesses please see Item 4.A under "History of the Company".

 

On March 22, 2010, we entered into a Subscription Agreement with a private investor, Mr. Yitzchak Babayov (the “Investor”), pursuant to which at a March 23, 2010 closing we issued 1,538,461 ordinary shares of the Company (the “Transaction Shares”) in consideration of a one-time cash payment in the amount of $200,000. 

 

Concurrent with the issuance of the Transaction Shares, we entered into a Warrant Agreement with the Investor, pursuant to which the Investor received a warrant (the “Warrant”) to purchase up to 553,846 of our ordinary shares at an exercise price of $0.15 per share. The Warrant has a term of five (5) years and contains standard adjustments for stock dividends, stock splits, reclassification and similar events.

 

During the period from January 1, 2011 to December 31, 2011, our capital expenditures totaled approximately $23,000 (compared to $4,000 during 2010 and $100,000 during 2009), of which approximately $23,000 (compared to $4,000 during 2010 and $7,000 during 2009) was expended at or upon our facilities in Israel, and approximately $0 (compared to $0 during 2010 and $93,000 during 2009) was expended upon the various facilities of our subsidiaries outside of Israel. During the first financial quarter of 2012, our capital expenditures totaled approximately $6,000.

 

C. Research and Development, Patents and Licenses, etc.

 

Our past research and development efforts have helped us to achieve our goal of offering our customers a complete line of products and solutions. As of December 31, 2011 the number of employees in our research and development activities was 4. We focus on the new technology of our wireless ID, and expect to maintain our current research and development efforts. We spent $0.5 million, $0.4 million and $0.9 million on research and development in 2011, 2010 and 2009, respectively. These amounts were spent on the development or improvement of our technologies and products, primarily in the area of wireless ID. We will continue to research and develop our wireless ID technology and products. There can be no assurance that we can achieve any or all of our research and development goals.

 

D. Trend Information

 

See – “Results of operations” in Item 5.A for additional information.

 

Industry Trends

 

The increased demand for better security systems and services has positively affected trends within the industry. Personnel and asset management are now leading security concerns in commercial and governmental enterprises. This has created an increasing demand for secure, precise and cost-effective means to positively identify, locate, track, monitor, count and protect people and objects, including inventory and vehicles. Our wireless ID-enabled security solutions provide an optimal solution to these problems as our solutions reliably identify and track the movement of people and objects in real time enabling our customers to detect unauthorized movement of vehicles, trace packages and containers, control personnel and vehicle access to premises.

 

Market and Operational Trends

 

Our quarterly operations results may be subject to significant fluctuations due to several factors. Some of these factors are based primarily on the timing of large orders, which represent a significant percentage of our revenues, customer budget cycles and impact on the timing for buying decisions, as well as competitive pressures and the ability of our partners, distributors and system integrators to become effective in selling and marketing our products, as well as other factors.

 

We expect to benefit from marketing programs and leads generated by partnerships, distributions and systems integration network, as well as sales opportunities identified by them. We intend to expand our marketing and implementation capacity through these third parties, including vendors of complementary products and providers of service applications. By employing third parties in the marketing and implementation process, we expect to enhance sales by taking advantage of their market presence.

 

A significant portion of our 2011 revenues was derived from our governmental projects and the remainder was derived from commercial customers. Historically, our revenues have been concentrated in a few large orders and in a relatively small number of customers. We expect this trend to change and we expect that future revenues will come from larger number of orders and customers.

 

49
 

 

For more information about our expectations regarding future cost of revenues, future operating expenses and liquidity and capital resources, please refer to the section captioned “Risk Factors” in Item 3.D., the sections captioned “Results of Operations” in Item 5.A and the section captioned “Liquidity and Capital Resources” in Item 5.B.

 

Our development and marketing efforts for the solution and product platforms are aimed at addressing several systems and service trends that we see developing in the industry.

 

In December 2006, we concluded the sale of our E-ID Division to OTI. The sale allowed management to focus primarily on the market opportunities we identified for our former CSMS and active RFID solutions. Following the events of September 11, 2001 and other major disasters it has become increasingly important for agencies to track personnel, assets, and other objects on a local positioning basis. Prior to January 2010, we offered our CSMS and RAPTOR solutions to fulfill critical homeland security requirements for public safety and emergency services agencies and local counter-terrorism task forces. In January 2010, we completed the sale of our Electronic Access Control business and our CSMS business to focus our sales and marketing efforts on our core competencies, active RFID technology and our PureRFid Suite.

 

As of the date of this Annual Report, we expect that our 2012 revenues will be primarily derived from:

 

· e-ID and e-Gov projects; and
· Wireless ID products and solutions.

 

Recent Developments and Outlook

 

We expect revenues to continue to be derived from one-time sales and recurring fees, sales of high-end solutions, sales of products, consumables and technology. Sales are expected to continue through OEM partnerships and continual upgrades, maintenance and support will continue to be provided to customers. For more information see the section captioned “ Recent Developments ” in Item 4.

 

E. Off Balance Sheet Arrangements

 

We do not have any off-balance sheet transactions that have or are reasonably likely to have a material effect on our current or future financial condition, changes in financial condition, revenues, expenses, results of operations, liquidity, capital expenditures or capital resources.

 

F. Tabular Disclosure of Contractual Obligations

 

Contractual Obligations

 

The following table summarizes our material contractual obligations and commitments as of December 31, 2011:

 

Contractual Obligations   Total     Less than 1 year     1-3 years     3-5 years     More than
5 years
 
Long-term debt obligations                              
Capital (finance) lease obligations                              
Operating lease obligations   $ 565,000     $ 280,000     $ 269,000     $ 16,000        
Purchase obligations                              
Convertible bonds*   $ 2,975,000     $ 2,975,000       --              
Total contractual cash obligations   $ 3,540,000     $ 3,255,000     $ 269,000     $ 16,000        

 

Operating lease obligations represent commitments under several lease agreements for our facilities and the facilities of certain subsidiaries. Purchase obligations represent purchase orders to an account payable. Convertible bonds represent the amount due to the investors under the convertible bonds assuming there will no conversion to shares, which is described in Item 18, Note 13 to the financial statements included in this Annual Report. Total contractual cash obligations represent significant outstanding commitments for loans from banks, convertible bonds, purchase obligations and lease agreements for facilities. We are not a party to any capital leases.

 

50
 

 

(*) As of December 31, 2011 and the filing date of this Annual Report, we were not in compliance with the terms and conditions of our Convertible Bonds, as amended. See Item 5.B, “Liquidity and Capital Resources,” regarding amendments to our agreements with the holders of the Convertible Bonds. Despite of the contractual cash obligations related to our Convertible Bonds, if the Creditor Arrangement is consummated (see Item 4.A), 60% of these obligations shall be forgiven and 40% of these obligations shall be converted into equity and thus, in such event no cash outlay will be required with respect to this obligation.

 

ITEM 6.     Directors, Senior Management and Employees.

 

A. Directors and Senior Management

 

Board of Directors

 

We are managed by our Board of Directors. Pursuant to our Articles of Association, the number of directors may be determined from time to time by the Board of Directors, and unless otherwise determined, the number of directors comprising the Board of Directors will be between four and ten. Directors are elected for a one year term ending at the following annual general meeting of shareholders, except for our external directors, who are elected for three year terms in accordance with the Israeli Companies Law. However, if no directors are elected at an annual meeting, then the persons who served as directors immediately prior to the annual meeting shall be deemed re-elected at the same meeting. The General Meeting may resolve that a director be elected for a period longer than the time ending at the next annual meeting but not longer than that ending at the third next annual meeting. The Board of Directors elects one of its members to serve as the Chairman.

 

The Board of Directors is composed as follows (as of the date of this Annual Report):

 

Name   Age   Position
Arie Trabelsi   54   Director, Chairman of the Board
Menachem Mirski   56   Director
Avi Ayash   41   External Director (1)
David Mimon   51   Director
Shlomo Benjamin   61   External Director (1)

 

(1) “External Director” as defined in the Israeli Companies Law.

 

Arie Trabelsi has served as a director since November 1, 2011 and as the Chairman of our Board of Directors since December 12, 2011. From September 15, 2010 until October 28, 2010 Mr. Arie Trabelsi was an appointee, on behalf of Sigma Wave Ltd. ("Sigma"), to our board of directors. Mr. Trabelsi served as our Chief Executive Officer, from October 28, 2010 to November 1, 2011. Mr. Trabelsi has over 28 years of experience in the global wireless, internet and communication industries. Prior to joining us, Mr. Trabelsi led Sigma and Sigma Wave Inc., providers of innovative internet and wireless technologies & solutions. Mr. Trabelsi is the sole director of Sigma. Mr. Trabelsi holds Bsc in Electrical and Computer engineering from the Ben Gurion University, Israel and Msc in Electrical and Computer engineering from Drexel University, USA. Mr. Trabelsi's wife, Mrs. Tsviya Trabelsi, is the sister of Mr. David Mimon.

 

Menachem Mirski has served as a director and as a member of our audit committee since July 25, 2010. Mr. Mirski is the founder and a partner of Raz - El Ltd., a software and system development company in Israel. He has more than 25 years of significant experience and expertise as a software developer and project manager for embedded real time systems, including RF-based systems. Mr. Mirski holds a Bachelor of Science in Computing and Electrical Engineering from Ben-Gurion University.

 

David Mimon has served as a director since July 25, 2010. Mr. Mimon is an Israeli advocate and notary with extensive experience in providing legal representation and consulting services to individuals and companies in various areas of law. He is the owner of a legal practice with offices in Netanya and Haifa, Israel. Mr. Mimon holds a LLM from the University of Tel-Aviv. Mr. Mimon is the brother of Mrs. Tsviya Trabelsi, the wife of Mr. Arie Trabelsi.

 

Shlomo Benjamin has served as an external director and as a member of our audit committee since September 17, 2009. Mr. Benjamin is a shareholder and managing director of 4BEST Consulting and Management Ltd., a company engaged in financial consulting to companies and businesses. From 2004 to 2006, Mr. Benjamin was CFO of Globus Group Ltd. From 2002 to 2003, Mr. Benjamin was CEO of H. Aloni Enterprises Ltd. From 1992 to 2002, Mr. Benjamin was CFO and Deputy CEO of Ytong Industries Ltd. From 1987 to 1992, Mr. Benjamin was Finance and Administration Manager in the Azorim group. From 1981 to 1987, Mr. Benjamin served in several executive positions at the Tadiran Group, including as Deputy CEO of T.F.L Ltd. and Chief Accountant of Tadiran Communications Ltd. From 1977 to 1981, Mr. Benjamin was a “Senior” at Braude & Co. accounting firm. Mr. Benjamin is an authorized accountant in Israel and holds a first degree in economics and accounting from the Tel Aviv University.

 

51
 

 

Avi Ayash has served as an external director and as a member of our audit committee since December 8, 2011. Mr. Ayash is the owner of Inbarim, a consulting firm for corporations and employees in the area of actuarial compensation, pensions and insurance, and serves as a member of the board of directors of the ROM fund, as an external director and as the chairman of its audit committee and a member of its investment committee. Mr Ayash has more than 15 years of extensive experience in financial, pension and insurance consulting. Mr. Ayash holds a BA degree and MA degree in Economics from The Hebrew University, a degree in Actuarial Studies from Haifa University and a pension consultant license.

 

Executive Officers and Key Employees

 

As of the date of this Annual Report, our executive officers and certain key employees who are not also directors are:

 

Name   Age   Position
Doron Levy   54   Chief Executive Officer
Mickey Ben Harush   35   Chief Financial Officer
Brenda Gebhardt   48   President and Chief Operations Officer of PureRFid Inc.

 

Doron Levy , Chief Executive Officer. Mr. Levy joined us in November 2011. Until February 2011, Mr. Levy served for over twenty years managing various international commercial operations for the State of Israel. Mr. Levy has extensive knowledge of global business operations and management and has significant expertise in our core technologies.

 

Brenda Gebhardt , PureRFid, Inc. - President and Chief Operations Officer. With over 15 years of experience in the fire and security industry, Ms. Gehhardt has managed projects at Vuance Inc., ADT and Cintas. She has experience in operations including the integration of RFID technologies and facility management applications to control space and assets. Ms. Gehhardt holds a diploma in nursing.

 

Mickey Ben Harush , Chief Financial Officer. Prior to joining us in 2010, Mr. Ben Harush served for four years as the Finance Controller of Elbit Vision Systems Ltd. (OTCBB:EVSNF.OB). Mr. Ben Harush began his financial career at KPMG Israel in 2003, where he served as a Senior Auditor. Mr. Ben Harush holds a Bachelor of Arts in Economics and Accounting from the Haifa University, Israel and a Master of Business Administration from the Tel Aviv University, Israel and is a Certified Public Accountant in Israel.

 

B. Compensation

 

The aggregate amount of compensation paid by us to our board members and executive officers (collectively, the “Named Executive Officers”) as a group for the year ended December 31, 2011 was approximately $380,000. This sum includes amounts paid for salary and social benefits. In addition, we have provided automobiles to our certain executive officers at our expense. During 2011, we issued an aggregate amount of options to purchase up to 550,000 of our ordinary shares to current and former officers.

 

At the Special General Meeting of our shareholders, held on May 12, 2011, our shareholders adopted the recommendations of our Audit Committee and Board of Directors to offer to our then officers (with the exception of Mr. Arie Trabelsi) and non-external directors (with the exception of Mrs. Tsviya Trabelsi) (the "Participants"), subject to certain terms and conditions, to join a temporary arrangement commencing April 1, 2011 and ending on September 30, 2012, pursuant to which all or part of the remuneration payable to them for such applicable period, may be paid in fully vested options to purchase our ordinary shares in lieu of fees and/or salary amounts (as applicable). As of the date of this Annual Report none of the participants has chosen to accept said offer.

 

As of the date of this Annual Report the monthly fee of a director (other than our Chairman of the Board) is $1,500 and the monthly fee of an external director is approximately $617 plus approximately $471 for every board or audit committee meeting. In December 2011, our audit committee and board of directors approved an agreement with Mr. Arie Trabelsi for his services as our active Chairman of the Board. The agreement provides for a monthly payment equal to 60% of our compensation costs, excluding any bonuses, for our Chief Executive Officer, a company car and reimbursement of business expenses. The agreement is subject to the approval of our shareholders, including a majority of the shares voted by shareholders other than Sigma or other shareholders that have a personal interest in the matter. These compensation terms are substantially similar to those of our previous Chairman of the Board.

 

52
 

 

As of December 31, 2011, we had set aside approximately $10,000 to provide pension, retirement or similar benefits for our certain executive officers.

 

Option/SAR Grants during the Year Ended December 31, 2011

 

On August 9, 2011, we issued fully vested options to purchase up to 150,000 of our ordinary shares to Ron Peer, a former Chief Executive Officer as part of his employment agreement. The options (the fair value of which was estimated to be $6,000 based upon the Black-Scholes option pricing model) have an exercise price of $0.11 per share, and will expire five years from the date of grant. Also, 300,000 ordinary shares were issued as consideration to settle liability to the said former Chief Executive Officer.

 

On August 11, 2011, we issued fully vested options to purchase up to 300,000 of our ordinary shares to a former officer as part of the Creditor Arrangement (see also Item 4.A). The options (the fair value of which was estimated to be $36,000, based upon the market price of our shares on the date when the extinguishment was determined) have an exercise price of $0.00 and will expire on December 31, 2012.

 

On August 24, 2011, we issued options to purchase up to 100,000 of our ordinary shares to an officer. The options (the fair value of which was estimated to be $5,000 based upon the Black-Scholes option pricing model) have an exercise price of $0.20, 40,000 of them vested on January 1, 2012, and the remaining 60,000 will vest on January 1, 2013. The options have a term of ten years from the date of grant.

 

As part of the Creditor Arrangement (see also Item 4.A), certain former officers agreed to a partial forgiveness of the debts due to them, in the aggregate amount of $245,000, and agreed to repayment of the remainder of the debt by the issuance by the Company to them of warrants to purchase 1,083,071 of our ordinary shares, with an exercise price of $0.00, expiring on December 31, 2012.

 

Please refer to the Section captioned “Share Option Plan” under Item 6.E below for a description of our Share Options Plan.

 

C. Board Practices

 

Our Board of Directors and senior management consider good corporate governance to be central to our effective and efficient operations. The following table lists our directors, the positions they hold with us and the dates the directors were first elected or appointed:

 

Name   Position   Period Served in Office   Date of Expiration of
Current Term (if
applicable)
Arie Trabelsi   Director
Chairman of the Board
  November 1, 2011 – present(*)   Next annual general meeting
Avi Ayash   External Director   December 8, 2011 - present   December 8, 2014
Shlomo Benjamin   External Director   September 17, 2009 – present   September 17, 2012
David Mimon   Director   July 25, 2010 – present   Next annual general meeting
Menachem Mirski   Director   July 25, 2010 – present   Next annual general meeting

 

(*) On December 12, 2011, Mrs. Tsviya Trablesi resigned from the Board of Directors.

 

Our Articles of Association provide that the number of directors may be determined from time to time by the Board of Directors, and unless otherwise determined, the number of directors comprising the Board of Directors will be between four and ten. The Board of Directors is presently comprised of five members, two of whom were elected as external directors under the provisions of the Israeli Companies Law (discussed below). Our Articles of Association provide further that the majority of the directors appointed to the Board of Directors will be independent directors. Mr. Benjamin, Mr. Ayash and Mr. Mirski satisfy the applicable requirements for independence under our Articles of Association.

 

53
 

 

All directors hold office until their successors are elected at the next annual general meeting of shareholders, except for our external directors Shlomo Benjamin , who shall hold office until September 2012, and Mr. Ayash, who shall hold office until December 2014.

 

Under the Israeli Companies Law, companies incorporated under the laws of Israel whose shares have been offered to the public in or outside of Israel are required to appoint at least two individuals as external directors. External directors are required to possess professional qualifications as set out in regulations promulgated under the Israeli Companies Law. Any individual who is eligible to be appointed as a director may be appointed as an external director, provided that such person, such person’s relative, partner, employer or any entity under the person’s control does not have at the date of appointment, or has not had during the two years preceding the date of appointment, any affiliation with:

 

· the company;
· a controlling shareholder of the company or a relative thereof; or
· any entity controlled by the company or by its controlling shareholder on the date of the appointment or during the two years preceding such date.

 

The term affiliation means any of:

 

· an employment relationship;
· a business or professional relationship that is not negligible;
· control; and
· service as an office holder.

 

No person may serve as an external director if the person’s position or other business creates or may create a conflict of interest with the person’s responsibilities as an external director, or if it may adversely affect his ability to serve as a director. Until the lapse of two years from termination of office, a company or its controlling shareholder may not employ or give any direct or indirect benefit to the former external director. If, at the time of election of an external director, all other directors are of the same gender, the external director to be elected must be of the other gender.

 

Pursuant to the Israeli Companies Law, at least one of the external directors, as well as a number of the non-external directors to be determined by the Board of Directors, are required to have “accounting and financial expertise” and the other external directors are required to have “professional skills,” as such terms are defined in regulations recently promulgated under the Israeli Companies Law.

 

Each committee of a company’s Board of Directors that has the authority to exercise powers of the Board of Directors is required to include at least one external director and its audit committee must include all external directors.

 

External directors are elected at the general meeting of shareholders by a simple majority, provided that the majority includes at least one-half of the shareholders who are not controlling shareholders or interested parties, who are present and voting, or that the non-controlling shareholders and interested parties who vote against the election hold two percent or less of the voting power of the company.

 

Under the Israeli Companies Law, t he initial term of an external director is three years, and such term may be extended for up to two additional three-year terms. In addition, the service of an external director may be extended for additional terms of up to three years each, if both the audit committee and the board of directors confirm that, in light of the expertise and contribution of the external director, the extension of such external director's term would be in the interest of the company. Reelection of an external director may be effected through one of the following mechanisms: (1) the board of directors proposed the reelection of the nominee and the election was approved by the shareholders by the majority required to appoint external directors for their initial term; or (2) a shareholder holding 1% or more of the voting rights proposed the reelection of the nominee, and the reelection is approved by a majority of the votes cast by the shareholders of the company, excluding the votes of controlling shareholders and those who have a personal interest in the matter as a result of their relations with the controlling shareholders, provided that the aggregate votes cast in favor of the reelection by such non-excluded shareholders constitute more than 2% of the voting rights in the company. External directors may be removed only in a general meeting, by the same percentage of shareholders as is required for their election, or by a court, and in both cases only if the external directors cease to meet the statutory qualifications for their appointment or if they violate their duty of loyalty to us. Each committee of a company’s board of directors that is authorized to exercise powers of the board of directors is required to include at least one external director, and all external directors must be members of the company’s audit committee.

 

54
 

 

Audit Committee

 

The Israeli Companies Law requires public companies to appoint an audit committee. The responsibilities of the audit committee include identifying flaws in the management of the company’s business and approving related party transactions as required by law, approving the terms of compensation of company officers, classifying company transactions as extraordinary transactions or non-extraordinary transactions and as material or non-material actions in which an officer has an interest (which will have the effect of determining the kind of corporate approvals required for such transaction), assessing the proper function of the company’s internal audit regime and determining whether its internal auditor has the requisite tools and resources required to perform his role, reviewing the scope of work of the company’s independent accountants and their fees, and implementing a whistleblower policy with respect to employee complaints of business irregularities. An audit committee must be comprised of at least three directors, including all of the external directors, and a majority of the members of the audit committee must be independent or external directors.

 

The Israeli Companies Law further stipulates that the chairman of the Board of Directors of a public company, any director employed by or providing other services on a regular basis to the company, the controlling shareholder or any relative of the controlling shareholder of such company and any director who derives his salary primarily from a controlling shareholder may not be members of the audit committee of the company.

 

Mr. Benjamin, Mr. Ayash and Mr. Mirski are the members of the Audit Committee.

 

Management Employment Agreements

 

We maintain written employment agreements with substantially all of our key employees. These agreements provide, among other matters, for monthly salaries, our contributions to Managers’ Insurance, an Education Fund and severance benefits. All of our agreements with our key employees are subject to termination by either party upon the delivery of notice of termination as provided therein.

 

 Internal Auditor

 

Under the Israeli Companies Law, the Board of Directors must appoint an internal auditor, proposed by the Audit Committee. The role of the internal auditor is to examine, among other matters, whether the company’s activities comply with the law and orderly business procedure. Under the Israeli Companies Law, the internal auditor may not be an interested party or office holder, or a relative of any interested party or office holder, and may not be a member of the company’s independent accounting firm, or its representative. On January 5, 2012 our Board of Directors appointed Shmuel Naiberg, who is a partner at Shiff Hazenfratz & Co., as our internal auditor.

 

D. Employees

 

As of December 31, 2011, 2010 and 2009, we had 14, 17 and 37 full-time employees, respectively (not including service providers). The following table describes our employees and the employees of our subsidiaries by department.

 

    Dec. 31,
2011
    Dec. 31,
2010
    Dec. 31,
2009
 
                   
Research, Development & Manufacturing     7       9       20  
Marketing and Sales     2       3       11  
Administration     5       5       6  
                         
Total     14       17       37  

 

55
 

 

Over the past three years, the number of our employees by geographic area was as follows:

 

    Dec. 31,
2011
    Dec. 31,
2010
    Dec. 31,
2009
 
                   
Israel     10       11       14  
United states     4       6       23  
Total     14       17       37  

 

From time to time, we have engaged temporary employees to fill open positions. These temporary employees, however, historically have not comprised a material number of our employees.

 

Vuance’s Israeli employees are not part of a collective bargaining agreement and none of them are represented by labor unions. However, in Israel we are subject to certain labor statutes and national labor court precedent rulings, as well as to certain provisions of collective bargaining agreements between the Histadrut , which is the General Federation of Labor in Israel, and the Coordinating Bureau of Economic Organizations, including the Industrialists’ Association. These provisions of collective bargaining agreements are applicable to our employees by virtue of expansion orders issued in accordance with relevant labor laws by the Israeli Ministry of Labor and Welfare and which apply such agreement provisions to our employees even though they are not directly part of a union that has signed a collective bargaining agreement.

 

The labor statutes and labor court rulings that apply to our employees principally concern the minimum wage laws , procedures for dismissing employees, determination of severance pay, leaves of absence (such as annual vacation or maternity leave), sick pay and other conditions for employment. The expansion orders which apply to our employees principally concern the requirement for mandatory pension schemes, transportation allowance, annual recreation allowance, the lengths of the workday and workweek, and periodic automatic adjustment of wages relative to increases in the Consumer Price Index in Israel. We provide our employees with benefits and working conditions that comply with the required minimums. Israeli employees and employers are also required to pay pre-determined sums which include a contribution to national health insurance to the Israel National Insurance Institute, which provides a range of social security benefits.

 

Generally, all nonexempt adult male citizens and permanent residents of Israel, under the age of 40, or older for reserves officers or citizens with certain occupations, as well as certain female adult citizens and permanent residents of Israel, are obligated to perform annual military reserve duty and are subject to being called for active duty at any time under emergency circumstances. Some of our officers and employees are obligated to perform annual reserve duty. While we have operated effectively under these requirements since we began operations, no assessment can be made as to the full impact of such requirements on our workforce or business if conditions should change, and no prediction can be made as to the effect on us of any expansion of such obligations.

 

Most of our employees have entered into confidentiality agreements. We have also granted certain employees options to purchase shares of our ordinary shares under our option plan. We consider our relationship with our employees to be good and we have never experienced a general strike or work stoppage.

 

E. Share Ownership

 

The following table sets forth the ordinary shares beneficially owned by each of our directors who beneficially owned more than 1% of our issued ordinary shares as of April 15, 2012. None of our officers beneficially owned more than 1% of our issued ordinary shares as of that date. As of April 15, 2012 , we had 21,129,672 ordinary shares outstanding.

 

Name   Ordinary
Shares
beneficially
held
    % of
Outstanding
Ordinary
Shares as of
April 15, 2012
    Number of
outstanding
convertible
securities
    Exercise
price
  Expiration date
Arie Trabelsi (1)   9,128,995 (2)   41.81 %   705,114     3.00   Convertible Bond : No later than repayment of the debt under the Sigma Convertible Bond
Menachem Mirski   692,660 (3)   3.28 %   -     -   -
Directors and Named Executive Officers as a Group (8 persons)(4)   9,865,155     45.09 %   748,614 (3)   0.20 – 4.64   

Options: December 2017 – August 2021.

Convertible Bond : no later than repayment of the debt under the Sigma Convertible Bond

 

56
 

 

(1) Consists of securities held by Sigma Wave Ltd., or Sigma. Sigma is controlled by family members of Mr. Arie Trabelsi, our Chairman of the Board. Mr. Trabelsi is the sole director of Sigma. As such, Mr. Trabelsi may be deemed to beneficially own the shares held by Sigma.

 

(2) Includes (i) a convertible bond held by Sigma in the principal amount of approximately $2,115,000, which may be converted into 705,114 ordinary shares as of April 15, 2012, (ii) 398,881 ordinary shares held by Sigma, and (iii) 8,025,000 ordinary shares held by Mr. David Mimon as trustee for Sigma. Mr. Mimon is one of our directors and the brother-in-law of Mr. Arie Trabelsi. Mr. Arie Trabelsi is the brother of Mr. Eliyahu Trabelsi and disclaims beneficial ownership of Mr. Eliyahu Trabelsi’s shares. If Sigma participates in the Creditor Arrangement, its convertible bond would be converted into a significant number of our ordinary shares.

 

(3) Consist of 692,660 ordinary shares held by Homeland Security Capital Corporation (“HSCC”), which granted an irrevocable power of attorney to our Chairman of the Board to exercise all voting rights relating to our ordinary shares until the sale or transfer of such shares by HSCC to an unaffiliated third party in an arm’s-length transaction, which, according to our Board resolution from March 29, 2011, were transferred to Mr. Menachem Mirski.

 

(4) Includes options to purchase 43,500 ordinary shares which are currently exercisable and convertible bonds which may be converted into 705,114 ordinary shares.

 

(5) See notes 1 and 2 for the beneficial ownership of Mr. Arie Trabelsi, our Chairman of the Board and Note 3 for the beneficial ownership of Mr. Menachem Mirski, our director . Each of the directors and executive officers not separately identified in the above table beneficially owns less than 1% of our outstanding ordinary shares (including options held by each such party, and which are exercisable ) and has therefore not been separately disclosed.

 

All of our ordinary shares have identical voting rights.

 

Share Option Plans

 

In 2003, we adopted the Vuance Ltd. 2003 Israeli Share Option Plan, a new stock option plan under which we now issue stock options (the “Option Plan”). The Option Plan is intended to provide incentives to our employees, officers, directors and/or consultants by providing them with the opportunity to purchase our ordinary shares. The Option Plan is subject to the provisions of the Israeli Companies Law, administered by the Audit Committee, and is designed: (i) to comply with Section 102 of the Israeli Tax Ordinance or any provision which may amend or replace it and the rules promulgated thereunder and to enable us and grantees thereunder to benefit from Section 102 of the Israeli Tax Ordinance and the Commissioner’s Rules; and (ii) to enable us to grant options and issue shares outside the context of Section 102 of the Israeli Tax Ordinance. Options granted under the Option Plan will become exercisable ratably over a period of three to five years or immediately in certain circumstances, commencing with the date of grant. The options generally expire no later than 10 years from the date of grant. Any options, which are forfeited or canceled before expiration, become available for future grants. As of December 31, 2011, options exercisable for 2,163,857 ordinary shares were outstanding.

 

As a result of an amendment to Section 102 of the Israeli Tax Ordinance as part of the 2003 Israeli tax reform, and pursuant to an election made by us thereunder, capital gains derived by optionees arising from the sale of shares issued pursuant to the exercise of options granted to them under Section 102 after January 1, 2003 will generally be subject to a flat capital gains tax rate of 25%. However, as a result of this election, we will no longer be allowed to claim as an expense for tax purposes the amounts credited to such employees as a benefit when the related capital gains tax is payable by them, as we had previously been entitled to do under Section 102.

 

On June 27, 2007, our Compensation Committee and the board of directors approved a new option plan under which we may grant stock options to our U.S. employees and our subsidiaries. Under this new option plan, we may grant both qualified (for preferential tax treatment) and non-qualified stock options. On August 15, 2007, the new option plan was approved by our shareholders at the general shareholders meeting. 

 

57
 

 

On August 9, 2011, we issued fully vested options to purchase up to 150,000 of our ordinary shares to Ron Peer, a former Chief Executive Officer as part of his employment agreement. The options (the fair value of which was estimated to be $6,000 based upon the Black-Scholes option pricing model) have an exercise price of $0.11 per share, and will expire five years from the date of grant. Also, 300,000 ordinary shares were issued to Mr. Peer as consideration to settle liability to the said former Chief Executive Officer.

 

On August 11, 2011, we issued fully vested options to purchase up to 300,000 of our ordinary shares to a former officer as part of the Creditor Arrangement (see also Item 4.A). The options (the fair market value of which was estimated to be $36,000, based upon the market price of our shares on the date when the extinguishment was determined) have an exercise price of $0.00 and will expire on December 31, 2012.

 

On August 24, 2011, we issued options to purchase up to 385,000 of our ordinary shares to our certain employees . The options (the fair value of which was estimated to be $18,000 based upon the Black-Scholes option pricing model) have an exercise price of $0.20, 155,000 of them vested on January 1, 2012, and the remaining 230,000 will vest on January 1, 2013. The options have a term of ten years from the date of grant.

 

A summary of our stock option activity and related information is as follows:

 

    Year ended December 31  
    2011     2010     2009  
    Number of
options
    Weighted
average
exercise
price
    Number of
options
    Weighted
average
exercise
price
    Number of
options
    Weighted
average
exercise
price
 
Outstanding at beginning of year     1,404,219     $ 1.23       1,489,176     $ 1.34       981,462     $ 2.55  
Granted     835,000     $ 0.11       -       -       767,205     $ 0.015  
Exercised     (10,007 )   $ 0.02       (11,007 )   $ 0.016       (93,056 )   $ 0.015  
Canceled and forfeited     (65,355 )   $ 1.74       (73,950 )   $ 3.52       (166,435 )   $ 3.30  
Outstanding at end of year     2,163,857     $ 0.79       1,404,219     $ 1.23       1,489,176     $ 1.34  
Exercisable at end of year     1,778,857     $ 0.92       1,404,219     $ 1.23       1,413,027     $ 1.26  

 

The weighted average fair value of options granted during the reported periods (excluding options exercisable for 300,000 of our ordinary shares granted in 2011 as part of the extinguishment of liabilities) was $0.05 and $0.43, per option, for the years ended December 31, 2011, 2009, respectively. No options were granted in 2010.

 

In 2011, the fair value of these options was estimated on the date of grant using the Black-Scholes option pricing model. In 2009, the fair value of 125,142 options was calculated using the Black-Scholes option pricing model. For all other options granted in 2009, the fair value of the options issued (as a partial payment of payroll liability) was based on the fair value of the shares on the date of the related payroll, which equals the related payroll liability, since the exercise price was close to nil. The following weighted average assumptions were used for the 2011 and 2009 grants: risk-free rate of 0.76% and 0.75%, respectively, dividend yield of 0%, expected volatility factor of 176.54% and 193.27%, respectively and expected term of 4.64 and 2.08 years, respectively.

 

The expected volatility was based on the historical volatility of our stock. The expected term was based on the historical experience and based on management estimate.

 

We recognized compensation expenses related to share-based employee compensation awards of $10,000, $14,000 and $483,000 for the years ended December 31, 2011, 2010 and 2009, respectively.

 

58
 

 

The following table summarizes the allocation of the stock-based compensation charge in thousands of US dollars:

 

    Year ended December 31,  
    2011     2010     2009  
                   
Cost of revenues   $ 2     $ 3     $ 7  
Research and development expenses     5       2       226  
Selling and marketing expenses     -       3       43  
General and administrative expenses     3       6       207  
                         
    $ 10     $ 14     $ 483  

 

The options outstanding and exercisable as of December 31, 2011, have been separated into ranges of exercise prices as follows:

 

Range of
exercise price
  Options
outstanding
as of
December 31,
2011
    Weighted
average
remaining
contractual life
(years)
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
    Options
exercisable
as of
December
31, 2011
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
 
                                           
$ 0.00 - $ 0.20     1,520,464       6.46       0.07     $ 30,000       1,135,464       0.02     $ 79,000  
$ 1.10 - $ 1.88     449,817       2.89       1.29       -       449,817       1.29       -  
$ 2.47 - $ 3.38     31,076       1.99       2.99       -       31,076       2.99       -  
$ 4.12 - $ 4.64     79,900       5.07       4.31       -       79,900       4.31       -  
$ 5.00 - $ 5.24     65,600       2.99       5.07       -       65,600       5.07       -  
$ 14.82     17,000       2.85       14.82       -       17,000       14.82       -  
                                                         
      2,163,857             $ 0.79               1,778,857     $ 0.92          

 

The aggregate intrinsic value of the above table represents the total intrinsic value, based on our stock price of $0.09 as of December 31, 2011, less the weighted average exercise price per range. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

 

The total intrinsic value of options exercised during the years ended December 31, 2011, 2010 and 2009 was $1,000, $1,000 and $36,000, respectively, based on our average stock price of $0.10, $0.14 and $0.4, during the years ended on those dates respectively.

 

A summary of the status of our non-vested options granted to employees as of December 31, 2011 and changes during the year ended December 31, 2011 is presented below:

 

    Options     Weighted–
average grant-
date fair value
 
             
Non-vested at January 1, 2011     -       -  
Granted     385,000     $ 0.05  
Vested (including cancelled and exercised)     -       -  
Forfeited     -       -  
Non-vested at December 31, 2011     385,000     $ 0.05  

 

As of December 31, 2011, there was $8,000 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plans.

 

ITEM 7.     Major Shareholders and Related Party Transactions.  

 

A. Major shareholders

 

The following table lists the beneficial ownership of our securities as of April 15, 2012 by each person known by us to be the beneficial owner of 5% or more of the outstanding shares of any class of our securities. As of April 15, 2012, 21,129,672 of our ordinary shares were outstanding.

 

59
 

 

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. All information with respect to the beneficial ownership of any principal shareholder has been furnished by such shareholder or is based on the most recent Schedule 13D or 13G filed with the SEC. We believe that all persons named in the table have sole voting and sole investment power with respect to all shares beneficially owned by them. All figures include ordinary shares issuable upon the exercise of convertible bonds, options and warrants exercisable within 60 days of April 15, 2012, and deemed to be outstanding and beneficially owned by the person holding those bonds, options or warrants for the purpose of computing the percentage ownership of that person, but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person. None of the following major shareholders have different voting rights from the other holders of our ordinary shares.

 

Name of Beneficial Owner   Number of Shares
Beneficially Owned
    Percentage of Shares
Outstanding
 
             
Sigma Wave Ltd. (1)     9,128,995       41.81 %
Yitzchak Babayov (2)     1,773,426       8.15 %
Eliyahu Trabelsi(3)     1,726,967       8.12 %
Eli Rozen (4)     1,458,919       6.58 %
Ori Mimon     1,111,111       5.26 %
Aviad Kamara     1,111,111       5.26 %

 


(1) Sigma is controlled by family members of Mr. Arie Trabelsi, our Chairman of the Board. Mr. Trabelsi is the sole director of Sigma. As such, Mr. Trabelsi may be deemed to beneficially own the shares held by Sigma. Includes (i) a convertible bond held by Sigma in the principal amount of approximately $2,115,000, which may be converted into 705,114 ordinary shares as of April 15, 2012, (ii) 398,881 ordinary shares held by Sigma, and (iii) 8,025,000 ordinary shares held by Mr. David Mimon as trustee for Sigma. Mr. Mimon is one of our directors and the brother-in-law of Mr. Arie Trabelsi. Mr. Arie Trabelsi is the brother of Mr. Eliyahu Trabelsi and disclaims beneficial ownership of Mr. Eliyahu Trabelsi’s shares. If Sigma participates in the Creditor Arrangement, its convertible bond would be converted into a significant number of our ordinary shares.
(2) Includes (a) 1,139,580 ordinary shares held by Yitzchak Babayov, and (b) warrants to purchase 633,846 ordinary shares, which are currently exercisable or exercisable within 60 days of April 15, 2012.
(3) Includes (a) 1,591,622 ordinary shares, and (b) a convertible bond which may be converted into 135,345 ordinary shares, which is immediately exercisable/convertible or exercisable within 60 days of April 15, 2012. Mr. Eliyahu Trabelsi is the brother of Mr. Arie Trabelsi and is disclaiming beneficial ownership of Mr. Arie Trabelsi’s shares. If Mr. Eliyahu Trabelsi participates in the Creditor Arrangement, his convertible bond would be converted into a significant number of our ordinary shares.
(4) Includes (a) 412,312 shares held directly by Eli Rozen, (b) options to purchase 553,273 ordinary shares which are currently exercisable or exercisable within 60 days of April 15, 2012, of which 376,462 options to purchase ordinary shares are held by Finel Architecture & Engineering Ltd., a wholly owned company of Mr. Rozen, and (c) warrants to purchase 493,334 ordinary shares which are currently exercisable or exercisable within 60 days of April 15, 2012 .

 

On April 2, 2012, we issued 8,025,000 ordinary shares to Sigma’s trustee, Mr. David Mimon, and 1,069,400 ordinary shares issued to Mr. Eliyahu Trabelsi as part of the Creditor Arrangement (see Items 4A and 5B). On August 11, 2011 we issued 4,444,444 ordinary shares to Sigma as part of the Creditor Arrangement (see Items 4A and 5B).

 

The conversion of our debt into ordinary shares pursuant to the Creditor Arrangement resulted in the dilution of the ownership percentage of most of our holders of ordinary shares. To our knowledge, this dilution resulted in Messrs. Avi Landman, Jack Hassan and HSCC no longer beneficially holding 5% or more of our outstanding ordinary shares.

 

As of April 15, 2012, based on the information available to us, we had in the United States approximately 23 registered holders of our ordinary shares, representing approximately 64% of our total ordinary shares registered at that date.

 

To the best of our knowledge based on the information currently available to us, there are no existing arrangements that may at a future date result in a change of control of Vuance.

 

60
 

 

B. Related Party Transactions

 

It is our policy to enter into transactions with related parties on terms that, on the whole, are no less favorable than those that would be available from unaffiliated parties. Based on our experience in the business segments in which we operate and the terms of our transactions with unaffiliated third parties, we believe that all of the transactions described below met our policy standards at the time they occurred.

 

On October 1, 2001, we entered into a consulting agreement with a company owned by a former Chairman of our Board of Directors who was one of our co-founders. In consideration of these consulting services, we have undertaken to pay $10,500 per month plus motor vehicle expenses. In addition, we were required to pay $1,500 per month as a director’s fee. (Regarding the partial payment in options during 2009 and regarding debt extinguishment during 2010, see below)

 

On July 8, 2010, the Board of Directors accepted the resignation from the board of directors of the Chairman of the Board of Directors, effective July 25, 2010. We recorded during 2010 an expense of $75,000 related to the former consulting agreement. In addition, on July 8, 2010, we entered into a Services Agreement with the former Chairman of the Board of Directors and as of that date one of our major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide us with ongoing consulting services as may be reasonably required by us, for a consideration of 2% of our gross receipts from a major customer and reimbursement of reasonable costs and expenses incurred by the Service Provider.

 

During 2011 and 2010, we recorded an expense of $130,000 and $83,000, respectively, in accordance with the above noted Services Agreement.

 

On October 1, 2001, we entered into a consulting agreement with a company owned by a former member of our Board of Directors, who was also one of our co-founders and a principal shareholder. On January 13 2005, the General Shareholders Meeting approved the following amendments to the consulting agreement:

 

· As of the date of the approval of the General Shareholders Meeting, the consideration shall be to an amount of $7,000 per month.
· Upon the termination of the car lease agreement, to increase the car lease, to a price of up to NIS 4,200 (approximately $ 1,100 as of December 31, 2011), (excluding tax) per month.

 

In addition, we were required to pay $1,500 per month as a director’s fee. (Regarding the partial payment in options during 2009 and regarding debt extinguishment during 2010 see below)

 

On July 8, 2010, the Board of Directors accepted the resignation from the board of directors of the member of our Board of Directors, effective immediately. We recorded during 2010 an expense of $53,000 related to the former consulting agreement. In addition, on July 8, 2010, we entered into a Services Agreement with the former member of the Board of Directors and as of that date one of our major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide us with management services with respect to our certain project for a consideration of (i) a monthly fee of $3,000, (ii) reimbursement of reasonable costs and expenses incurred by the Service Provider, and (iii) we will provide the Service Provider with a cellular phone and an automobile. We shall also grant the Service Provider options to purchase up to 50,000 of our ordinary shares according to terms to be determined by the Board of Directors, which terms have not been yet determined by the date of filing of this Annual Report.

 

During 2011 and 2010, we recorded an expense of $63,000 and $38,000, respectively, in accordance with the above noted Services Agreement.

 

On October 1, 2001, we entered into a consulting agreement with a company owned by one of our co-founders. In consideration for these services, we were required to pay $4,600 per month plus motor vehicle expenses. (Regarding the partial payment in options during 2009 and regarding debt extinguishment during 2010 see below). We recorded during 2010 an expense of $37,000 related to the former consulting agreement. On July 8, 2010, we entered into a Services Agreement with our co-founder and as of that date one of our major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide us with ongoing consulting services as may be reasonably required by us for a consideration of a monthly fee of $3,000 and reimbursement of reasonable costs and expenses incurred by the Service Provider in connection with the services. We shall also grant the Service Provider options to purchase up to 100,000 of our ordinary shares according to terms that will be determined by the Board of Directors, which terms have not been yet determined by the date of filing of this Annual Report.

 

61
 

 

During 2011 and 2010, we recorded an expense of $39,000 and $21,000, respectively, in accordance with the above noted Services Agreement.

 

On December 21, 2008, the Special General Shareholders Meeting approved that as part of a cost cutting plan, all of our non-external directors will join a temporary arrangement pursuant to which the remuneration payable to them shall be paid in fully vested options to purchase our shares instead of in cash, effective October 1, 2008, for a minimum period of three months, with an option to us to extend it from time to time for additional consecutive periods of up to twelve (12) months in the aggregate.

 

During the year 2009, according to the board resolution on October 27, 2008 and the Special General Meeting dated December 21, 2008, we granted to (a) our Chairman of the Board of Directors, (b) a member of our Board of Directors who is also one of our co-founders, (c) one of the co-founders, and (d) another member of our Board of Directors options to purchase up to 256,456, 179,966, 126,944 and 42,121 shares, respectively. The options have an exercise price of 0.0582235 NIS per share, vesting immediately, and will expire after ten years. The options were granted as a partial payment for certain liabilities with respect to the terms of their appointment with us.

 

As part of our debts extinguishments plan (see also Note 1d to the financial reports) and in accordance with their Services Agreement, the abovementioned Service Providers agreed to a partial forgiveness of the debts due to them under the former consulting agreements accrued from October 1, 2009 until July 8, 2010 which total amount was $245,000 and agreed to repayment in 1,083,071 warrants to purchase our ordinary shares as consideration for the entire debts due. The fair value of the warrants was estimated as $130,000. The difference between the carrying amount of the amounts due and the fair value of the warrants was recognized as a capital gain.

 

On July 25, 2010, our Board of directors elected Mrs. Tsviya Trabelsi to serve as the Chairman of the Board of Directors. Mrs. Trabelsi is a controlling shareholder of Sigma, which is our controlling shareholder and the major holder of a principal amount of convertible bonds; and is also the wife of our current Chairman of the Board and the sister of Mr. David Mimon, one of our directors. On May 12, 2011, the special general meeting approved the Service Agreement of Mrs. Trabelsi whereby, her monthly fee would be calculated at 60% of our chief executive officer’s monthly cost (approximately $8,000). In addition to the above consideration, we agreed to bear all reasonable costs and expenses incurred by Mrs. Trabelsi in connection with her services and provide her with an automobile. On December 12, 2011, Mrs. Trabelsi resigned from the board of directors and our board of directors approved the appointment of her husband, Mr. Arie Trabelsi, as its new Chairman, effective December 12, 2011. Mr. Trabelsi served as our chief executive officer until November 1, 2011, and has served as a member of our board of directors since November 1, 2011. Mr. Arie Trabelsi is a director at Sigma, which is our controlling shareholder and the major holder of a principal amount of Convertible Bonds (see Note 12 to the financial reports), and is the brother of Mr. Eliyahu Trabelsi, who holds the other Convertible Bonds and is our shareholder. Following the recommendation of our Audit Committee, our Board of Directors approved the compensation terms of Mr. Arie Trabelsi, which will be substantially the same as those of Mrs. Trabelsi. These compensation terms are subject to the approval of our shareholders, which we expect to request that they approve at our next general meeting of shareholders.

 

As of December 31, 2011, we accrued $279,000 as expenses arising from related party transactions providing consulting services.

 

As of December 31, 2011, we accrued $135,000 as other liability arising from a short term loan that we received from Mrs. Trabelsi. $90,000 of this loan was repaid during January 2012.

 

On April 29, 2012, our board of directors approved the recording of a floating charge on all of our assets in favor of Mrs. Tsviya Trabelsi and Mr. Arie Trabelsi, unlimited in amount, in order to secure personal guarantees granted by them in favor of us, such as to a bank (see Item 4.A. under the caption “Recent Developments”) and in order to secure short-term loans that are given by them from time to time to us.

 

Regarding transactions with a convertible bond holder, Sigma, see Items 4A and 5B

 

C. Interests of Experts and Counsel

 

Not applicable.

 

62
 

 

ITEM 8.     Financial Information.

 

A. Consolidated Statements and Other Financial Information

 

See Item 18.

 

Export Sales

 

Sales in Israel during each of the years 2011, 2010 and 2009 was $80,000, $83,000 and $72,000, respectively. Export sales during each of the years 2011, 2010 and 2009 was $7,842,000 (99% of the total sales volume), $7,306,000 (99% of the total sales volume) and $9,232,000 (99% of the total sales volume), respectively.

 

Legal Proceedings

 

We are party to legal proceedings in the normal course of our business. Other than as described below, there are no material pending legal proceedings to which we are a party or of which our property is subject. Although the outcome of claims and lawsuits against us cannot be accurately predicted, we do not believe that any of the claims and lawsuits described in this paragraph, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or cash flows for any quarterly or annual period.

 

(A) At the annual general meeting of our shareholders held on September 12, 2010, our shareholders resolved to afford certain of our major creditors with the opportunity to convert the amounts owed to them into our ordinary shares, by means of a set off against the then total outstanding debt to such creditor, at a price of $0.09 per ordinary share, subject to forgiveness of 60% of our total outstanding debt to such creditor. Our board of directors was authorized to set all other terms of the Creditor Arrangement, including, inter alia, its timetable.

 

On November 3, 2010, we petitioned the court, for the court approval of a Creditor Arrangement in accordance with Section 350 of the Israeli Companies Law. We requested that the court apply the Creditor Arrangement approved by our shareholders to all of our creditors as of August 10, 2010, or the Determining Date, and who were still creditors as of December 17, 2010 and who had submitted a claim of debt no later than January 6, 2011. We requested that pursuant to the proposed arrangement all such creditors (whether secured, preferential (by statute) and unsecured) shall be considered to have released us from our debt obligations towards them as of such date in exchange for the allotment to all such creditors of our ordinary shares or warrants to purchase our ordinary shares (that are immediately exercisable in a cashless transaction and with an expiration date of December 31, 2012) at a price of $0.09 per ordinary share, valued at 40% of our total outstanding debt to our creditors and in consideration for which the creditors would forgive the remaining 60% of the outstanding debt. In May 2011, our shareholders subsequently approved the inclusion of additional creditors to be included under the Creditor Arrangement.

 

Although the Creditor Arrangement is supported by a resolution of our shareholders and was presented at the meeting of our creditors, on July 18, 2011 the court decided not to approve our application, mainly due to an objection to the proposed arrangement which was filed by one of our secured creditors, Special Situations Funds ("SSF"). On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi all of its rights under the Convertible Bonds and warrants. For more information on the Convertible Bonds see Item 5 – Liquidity and Capital Resources. In February 2012, our Board of Directors determined to proceed with the Creditor Arrangement without the involvement of the court. On December 5, 2011 we received from the Execution Office in Israel a foreclosure order in accordance with Section 44 to the Execution Law Records, vol. 1967, in respect of convertible bonds held by Sigma, up to an amount of NIS 3,903,866 (approximately $1,022,000, based on the exchange rate between the U.S. dollar and the NIS published by the Bank of Israel on December 31, 2011) in favor of a third party. We followed the order’s instructions and recorded the said foreclosure. As of April 15, 2012, following the forgiveness or conversion of debt pursuant to the Creditor Arrangement in the aggregate amount of $3,640,000 since December 31, 2010, additional debt of approximately $3,286,000 (computed as of December 31, 2011) remains to be forgiven or converted pursuant thereto. However, the completion of the Creditor Arrangement has been delayed, which we believe is, as a result of a dispute over the ownership of approximately $1,022,000 (computed as of December 31, 2011) of our convertible bonds held by Sigma. There is no certainty that the Creditor Arrangement will be completed in a timely manner or at all.

 

63
 

 

For more information on the Creditor Arrangement please see Item 4.A "History of the Company" under "Recent Developments".

 

(B) In April 2004, the Department for Resources Supply of the Ministry of Ukraine (the “Department”) filed with the International Commercial Arbitration Court at the Ukrainian Chamber of Commerce and Industry (the “Arbitration Court”) a claim to declare Contract No. 10/82 (the “Contract”), dated April 9, 2002, between us and the Ministry of Internal Affairs of Ukraine (the “Ministry”) void due to defects in the proceedings by which we were awarded the Contract. In July, 2004, the Arbitration Court declared the Contract void. On April 27, 2005, we appealed the decision in the High Commercial Court of Ukraine. In May, 2005, the Department filed with the Arbitration Court a new statement of claim for restitution of $1,047,740, paid to us by the Department under the Contract. On September 27, 2005, we received a negative award issued by the Arbitration Court in the second claim (the “Award”). On December 12, 2005, we were informed that the Supreme Court of Ukraine had dismissed our appeal regarding the July, 2004 decision. On June 29, 2006, the Supreme Court of Ukraine held that the Arbitration Court award was valid and legal under applicable law.

 

On September 28, 2008, the Department filed a petition (the “Petition”) in the Central District Court of Israel (the “Court”), under which the Department requested the approval of the Award as a valid foreign arbitral award under the laws of the State of Israel.

 

During November 2008, we filed with the Court an objection to the Petition and a petition to declare the Award null and void. Our objection and petition rely on what we believe to be well-based evidence that we have against the manner under which the arbitration proceedings were conducted by the Arbitration Court and against their validness and legality. We believe that the arbitration proceedings were conducted partially and jeopardized our basic rights. Our claims are also corroborated by a contrary legal opinion written in the arbitration decision by one of the arbitrators (“Arbitrator”).

 

On February 16, 2009 the Department filed its response to our claims (the “Response”). The Department raised in its Response procedural and other claims, including a claim that we filed in Ukraine a monetary claim which is based on the Award and the filing of such claim basically affirms our acknowledgment that the Award is valid. On March 25, 2009, we filed a response to the Department’s response and a requisition to order the Arbitrator to testify in the scope of the Petition proceedings.

 

On June 6, 2009, a preliminary court session was held regarding the Petition. During the session, the Department’s counsel claimed that one of the two machines that we previously supplied pursuant to the Contract (which machine is priced higher than the amount of the Department’s claim), was not supplied to the Department and was transferred by us to another Ukrainian governmental authority. It is noted that we have documents that evidence that, contrary to the Department’s claim, we supplied both of the machines directly to the Department.

 

At a hearing held on September 23, 2009, the Court accepted our application to summon the Arbitrator as a witness. At the hearings which took place on November 29 and November 30, 2010, the Arbitrator testified in Court. In his testimony the Arbitrator described procedural flaws which occurred, in his view, during the arbitration and also related to threats which were made against him by the Secretary of the Ukrainian Chamber of Commerce and Industry in the course of the arbitration session.

 

Following the testimony of the Arbitrator, the Department asked the Court to summon the other two Ukrainian arbitrators as witnesses. The Court accepted the request and scheduled hearings for their testimonies in 2011. However, the Department’s witnesses (including the other two Ukrainian arbitrators) did not appear in court at the times scheduled for their testimonies. In light thereof, the Court ordered that summations be submitted in writing without having the witnesses of the Department testify.

 

On December 5, 2011 we submitted a summation in writing. However, the Department has not submitted its summation and its counsel even notified the Court that his appointment as the Department’s counsel had been cancelled. In these circumstances we filed a petition for judgment due to the absence of summations by the Department. On February 26, 2012, the Court ruled that it accepts our petition to give judgment due to the lack of summations on behalf of the Department and that the file will be assigned for writing a judgment on the basis of the evidence that had been presented to the Court in the course of the proceeding.

 

On April 15, 2012, the Court dismissed the Department’s Petition and also declared the Award null and void.

 

(C) On October 30, 2003, SuperCom Slovakia, a subsidiary (66%) of Vuance Ltd., received an award from the International Arbitral Centre of the Austrian Federal Economic Chamber (“IAC”), in a case against the Ministry of Interior of the Slovak Republic relating to the agreement on delivery of Technology, Cooperation and Services signed on March 17, 1998. Upon the Arbitral Award, the Ministry of Interior of the Slovak Republic was ordered to pay SuperCom Slovakia the amount of SKK 80,000,000 (approximately $3,438,000 as of December 31, 2011) plus interest accruing from March, 1999. In addition, the Ministry of Interior of the Slovak Republic was ordered to pay the costs of arbitration in the amount of EUR 42,716 (approximately $55,000 as of December 31, 2011) and SuperCom Slovakia’s legal fees in the amount of EUR 63,611 (approximately $82,000 as of December 31, 2011). We have begun an enforcement proceeding to collect the arbitral award. The Ministry of Interior of the Slovak Republic filed a claim with the Commercial Court in Vienna, Austria on February 10, 2004, whereby it challenged and requested to set aside the arbitral award. During September, 2005, the commercial court of Vienna dismissed the claim. On October 21, 2005, the Ministry of the Interior of the Slovak Republic filed an appeal. On August 25, 2006, the Austrian Appellate Court rejected the appeal and ordered the Ministry to reimburse Supercom Slovakia´s costs of the appellate proceeding in the amount of EUR 6,688 within 14 days. On October 3, 2006, we were informed that the Ministry had decided not to file an extraordinary appeal to the Austrian Supreme Court’s decision rejecting its appeal. To date, our efforts to enforce the Commercial Court’s decision have been unsuccessful.

 

64
 

 

(D) On December 16, 1999, Secu-Systems Ltd. (“Secu-systems”) filed a lawsuit with the District Court in Tel-Aviv-Jaffa jointly and severally against us and InkSure Ltd. (“InkSure”) (our former subsidiary, which became a subsidiary of InkSure Technologies, Inc.) seeking a permanent injunction and damages arising from the printing method applied to certain products developed by Inksure. In its lawsuit, Secu-systems asserted claims of breach of a confidentiality agreement between Secu-systems and us, unjust enrichment by us and InkSure, breach of fiduciary duties owed to Secu-systems by us and InkSure, misappropriation of trade secrets by us and InkSure, and damage to Secu-systems’ property. On March 15, 2006, the Court denied the breach of contract claim, but upheld the claim for misappropriation of trade secrets and ordered InkSure and us to cease all activity involving the use of the confidential knowledge and/or confidential information of Secu-systems. In addition, the Court ordered us and Inksure to provide a report certified by an accountant setting forth in full the income and/or benefit received by InkSure and us as a result of the misappropriation activity through the date of the judgment, and ordered us and Inksure, jointly and severally, to pay to Secu-systems compensation in the sum of NIS 100,000 ($26,000 as of December 31, 2011) and legal expenses as well as attorney’s fees in the sum of NIS 30,000 ($8,000 as of December 31, 2011). Secu-systems has filed an appeal, and we and InkSure filed a counter-appeal, on the ruling above.

 

During the years thereafter several Court sessions were held, judgments were made and appeals were filed by each of the parties.

 

On December 15, 2009, the Court suggested that the parties attempt to resolve this dispute through mediation. All of the parties agreed to mediate the matter.

 

In the course of the mediation process, during 2010, an agreement in principle was reached, according to which the mediator will be authorized to determine the sum, within the range between NIS 750,000 (approximately $196,000 as of December 31, 2011) and NIS 1,000,000 (approximately $262,000 as of December 31, 2011), which we shall pay to Secu-Systems. Pursuant to such agreement in principle, the amount determined by the mediator will be paid by us during 2011 in 10 equal, consecutive monthly installments.

 

Following the said agreement in principle, a binding mediation agreement was signed by the parties, and on September 1, 2010, a mediation session was held. On November 30, 2010, the mediator determined that the sum we will have to pay to Secu-System is NIS 893,000 (approximately $234,000 as of December 31, 2011). On January 30, 2012, the parties submitted to the Court a request to approve the mediation agreement. The mediation agreement was approved by the Court on February 5, 2012. During 2011 we paid NIS 535,800 (approximately $140,000 as of December 31, 2011). As of December 31, 2011 there is an allowance in the amount of $94,000 related to this litigation.

 

(E) On May 7, 2012, a supplier of us filed a lawsuit with the Magistrate Court in Tel Aviv in the amount of NIS 360,199 (approximately $94,000 as of December 31, 2011) claiming mainly for payments of products which were supplied during 2011 and for payments for products which were purchased by the supplier but were refused to be received by us due to our dissatisfaction in respect of the supplied products. We are denying the supplier’s claims and have our own claims against the supplier in respect of the quality of the products supplied by him. We are right now in the process of evaluating the lawsuit with our legal advisor. The balance of accounts payable with respect to the supplier as of December 31, 2011 is approximately $46,000, which represents the value of the supplied products during 2011. No additional provision has been recognized with respect to the supplier's claim.

 

Dividend Policy

 

We have not distributed a cash dividend since August 27, 1997 and we do not anticipate any dividend distribution in the foreseeable future. Under the Israeli Companies Law, d ividends may only be paid out of profits legally available for distribution (the “Profits Criteria”) and provided that there is no reasonable concern that such payment will prevent us from satisfying our existing and foreseeable obligations as they become due. In addition, a competent court may approve, as per a motion to be filed by a company in accordance with the Israeli Companies Law requirements, a payment which does not meet the Profit Criteria, provided that the court was convinced that there is no reasonable concern that such payment will prevent the company from satisfying its existing and foreseeable obligations as they become due.

 

In accordance with our Articles of Association, our Board of Directors may from time to time declare and cause the Company to pay to the shareholders such interim or final dividends as the Board of Directors deems appropriate considering the profits of the Company and in compliance with the provisions of the Israeli Companies Law.

 

65
 

 

Subject to the rights of the holders of shares as to dividends, and to the provisions of our Articles of Association, dividends, whether in cash or in bonus shares, shall be paid or distributed, as the case may be, to shareholders pro rata to the amount paid up or credited as paid up on account of their shares, without taking into consideration any premium paid thereon.

 

B.    Significant Changes

 

There are no significant changes that occurred since December 31, 2011, except as otherwise disclosed in this Annual Report and in the annual consolidated financial statements included in this Annual Report.

   

ITEM 9.     The Offer And Listing.

 

A.      Offer and Listing Details

 

The tables included below set forth information regarding the price history of the ordinary shares on the Euronext Brussels stock market and the OTC Bulletin Board/ NASDAQ/ Pink OTC Market for the periods indicated.

 

We commenced trading on the NASDAQ Europe stock market on April 19, 1999. On October 23, 2003, following the closing of the NASDAQ Europe stock market, we transferred the listing of our shares to Euronext Brussels stock market where we traded under the symbol “VUNC.” We applied for delisting of our shares from the Euronext Brussels stock market, and our application was approved on May 6, 2008, effective August 4, 2008.

 

Our ordinary shares were quoted on the OTC Bulletin Board Market under the symbol “VUNC.OB,” from November 5, 2004 until August 22, 2007.

 

Our ordinary shares were approved for listing on the NASDAQ Capital Market and began trading effective August 23, 2007. The shares were traded on NASDQ Capital Market under the symbol “VUNC.”

 

On September 29, 2009 we received a NASDAQ Staff Determination letter indicating that we failed to comply with the minimum stockholders’ equity requirement of $2.5 million as set forth in Listing Rule 5550(b) (formerly Marketplace Rule 4310(c)(3)). As a result, our securities were delisted from The Nasdaq Stock Market and trading in our shares was suspended effective at the open of business on October 1, 2009.

 

Following the delisting from the NASDAQ, as of the open of business on October 1, 2009, we had been advised by Pink OTC Markets Inc., which operates an electronic quotation service for securities traded over-the-counter, that our securities were immediately eligible for quotation in the Pink Sheets. Our ordinary shares are currently quoted under the ticker symbol “VUNCF”.

 

The following table shows, for the periods indicated, the high and low closing prices of our ordinary shares in U.S. dollars as reported on the NASDAQ Europe stock market or the Euronext Brussels stock market, as applicable until August 4, 2008 (conversion to U.S. dollars is based on the exchange rate published by the Bank of Israel). The following table also shows, for the periods indicated, the high and low closing prices of our ordinary shares on the Pink OTC Market or OTC Bulletin Board Market or NASDAQ, as applicable.

 

The Company has not issued any securities in connection with a pre-emptive issue.

 

66
 

 

Period   European Market     US Market  
    Per share ($)     Per share ($)  
    High     Low     High     Low  
Annual                                
2007     5.28       3.58       6.18       3.82  
2008     3.90 (1)      2.40 (1)      4.69       0.29  
2009     N/A       N/A       0.68       0.20  
2010     N/A       N/A       0.29       0.05  
2011     N/A       N/A       0.14       0.04  
Financial quarters                                
2010                                
First quarter     N/A       N/A       0.29       0.08  
Second quarter     N/A       N/A       0.24       0.10  
Third quarter     N/A       N/A       0.16       0.10  
Fourth quarter     N/A       N/A       0.14       0.05  
2011                                
First quarter     N/A       N/A       0.13       0.06  
Second quarter     N/A       N/A       0.14       0.04  
Third quarter     N/A       N/A       0.12       0.04  
Fourth quarter     N/A       N/A       0.12       0.05  
2012                                
First quarter     N/A       N/A       0.17       0.05  
Most recent six months                                
April 2012     N/A       N/A       0.16       0.04  
March 2012     N/A       N/A       0.16       0.08  
February 2012     N/A       N/A       0.15       0.15  
January 2012     N/A       N/A       0.17       0.05  
December 2011     N/A       N/A       0.09       0.09  
November 2011     N/A       N/A       0.09       0.09  

 

On May 8, 2012, the last reported sale price of our ordinary shares on Pink Sheets was $0.11 per share.

 

Lack of Liquidity

 

The delisting of our ordinary shares from the NASDAQ market, significantly affects the ability of investors to trade our securities and negatively affects the liquidity of our ordinary shares. In addition, trading in our ordinary shares may become subject to the "penny stock" regulations adopted by the SEC . These regulations generally define a "penny stock" to be any equity security that has a market price of less than $5.00 per share, subject to certain exceptions, such as if the issuer of the security has net tangible assets in excess of $2,000,000. The market price of our ordinary shares is currently less than $5.00 per share and our net tangible assets as of December 31, 2011 were approximately $2,455,000 . While we believe that our ordinary shares are currently exempt from the definition of penny stock, there is no assurance that they will continue to be exempt from such definition. If our ordinary shares become subject to the “penny stock” rules of the SEC, it will make transactions in our ordinary shares cumbersome and may reduce the value of our shares. This is because for any transaction involving a penny stock, unless exempt, Rule 15g-9 generally requires:

 

· that a broker or dealer approve a person's account for transactions in penny stocks; and
· the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

 

In order to approve a person's account for transactions in penny stocks, the broker or dealer must:

· obtain financial information and investment experience objectives of the person; and
· make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

 

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form:

 

67
 

 

· sets forth the basis on which the broker or dealer made the suitability determination; and
· that the broker or dealer received a signed, written statement from the investor prior to the transaction.

 

Disclosure also has to be made by the broker or dealer about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

Generally, brokers may be less willing to execute transactions in securities subject to the "penny stock" rules. This may make it more difficult for investors to dispose of our ordinary shares and cause a decline in our market value if we were to become subject to the said "penny stock" rules.

 

B.      Plan of Distribution

 

Not applicable.

 

C.    Markets

 

Our ordinary shares were listed for trade on the Euronext Brussels stock market, from October 23, 2003 under the symbol “SUP,” which became “VUNC” after our corporate name change on May 14, 2007. We applied for delisting of our shares from the Euronext Brussels stock market, and our application was approved on May 6, 2008, effective August 4, 2008.

 

Since November 5, 2004, our ordinary shares have also traded on the OTC Bulletin Board under the symbol "SPCBF.OB," which, following our recent name change became “VUNCF.OB.” Since August 23, 2007, our ordinary shares were approved for trading on NASDAQ under the symbol “VUNC” and the trade on the OTC Bulletin Board ceased. On October 1, 2009 our ordinary shares started being quoted under the ticker symbol “VUNCF” on the Pink OTC Market.

 

D.    Selling Shareholders

 

Not applicable.

 

E.      Dilution

 

Not applicable.

 

F.      Expenses of the Issue

 

Not applicable.

 

ITEM 10.     Additional Information.

 

A.    Share Capital

 

Not applicable.

 

B.    Memorandum and Articles of Association

 

Our Memorandum of Association and Articles of Association are attached hereto as noted in Item 19.

 

We are a public company organized in the State of Israel under the Israeli Companies Law. We are registered with the Registrar of Companies of the State of Israel as a publicly traded corporation and we have been assigned public company number 52-00-4407-4. Set forth below is a summary of certain provisions of our Memorandum of Association (the "Memorandum"), the Articles of Association (the "Articles") and the Israeli Companies Law as it applies to the Company. This description does not purport to be complete and is qualified in its entirety by reference to the full text of the Memorandum and Articles and by Israeli law. The Memorandum and the Articles are filed as exhibits to this Annual Report.

 

68
 

 

OBJECTS OF THE COMPANY

 

Pursuant to Section 2 of the Memorandum, the principal object for which we were established is to engage in the development, manufacture, implementation and marketing of computerized systems in general and computerized systems for producing tags, computerized photograph databases for the purpose of identification and for issuing various certificates in particular; consultation in the above fields; development, manufacture, implementation and marketing of any product based on the knowledge and expertise of the parties; and the purchase, sale, import, export and implementation of any action required to realize the above objectives.

 

We are authorized to issue 52,000,000 ordinary shares par value NIS 0.00588235 per share, of which 21,129,672 ordinary shares were outstanding as of April 15, 2012.

 

DIRECTORS

 

Our Articles provide that the number of directors may be determined from time to time by the Board of Directors, and unless otherwise determined, the number of directors comprising the Board of Directors will be between four and ten. With the exception of our external directors, who are elected for three year terms in accordance with the Israeli Companies Law, our directors are elected for a one year term ending at the following annual general meeting of shareholders. However, if no directors are elected at an annual meeting, then the persons who served as directors immediately prior to the annual meeting shall be deemed reelected at the same meeting. The general meeting may resolve that a director be elected for a period not longer than the third next annual meeting. Directors may resign or in certain circumstances be removed by our general meeting prior to the expiration of his term.

 

The board may appoint additional directors (whether to fill a vacancy or create a new directorship) to serve until the next annual shareholders meeting. In case an office of a director has been vacated, the remaining directors may continue to act in every matter so long as the number of its members is not less than the quorum required at the time for meetings of the board. If the number of members of the board decreases below said quorum, the board will not be entitled to act except in case of emergency or for appointing additional directors in order to fill vacant positions on the board or to call a general meeting of the shareholders. The Board of Directors elects one of its members to serve as the Chairman.

 

The Board of Directors may meet and adjourn its meetings as it deems fit, provided, however, that the board must meet at least once in every three months period. A meeting of the board may be called at the request of each director. The quorum required for a meeting of the board is not less than 30% of the number of directors and in any event not less than two directors. Issues arising at any Board of Directors’ meeting are decided by a majority of votes cast at the meeting. In lieu of a board meeting a resolution may be adopted in writing if signed by all directors or to which all of the directors have agreed in writing or by telephone or facsimile, and a meeting may also be held through telephone conference or other communications means, provided however that all participants may hear each other simultaneously. A resolution in writing signed by all of the Directors, shall be as valid and effective for all purposes as if passed at a meeting of the Board of Directors duly convened and held, and for the purpose of this Article "Director" shall include, if duly appointed therefore, a Substitute Director.

 

FIDUCIARY DUTIES OF OFFICERS

 

The Israeli Companies Law codifies the fiduciary duties that "office holders," including directors and executive officers, owe to a company. An office holder's fiduciary duties consist of a duty of care and a duty of loyalty. The duty of loyalty includes avoiding any conflict of interest between the office holder's position in the company and his personal affairs, avoiding any competition with the company, avoiding exploiting any business opportunity of the company in order to receive personal advantage for himself or others, and revealing to the company any information or documents relating to the company's affairs which the office holder has received due to his position as an office holder.

 

APPROVAL OF CERTAIN TRANSACTIONS

 

Transactions with Office Holders; Extraordinary Transactions

 

Under the Israeli Companies Law, all arrangements as to compensation of office holders who are not directors or controlling parties require approval of the audit committee or a compensation committee to the extent that it complies with the statutory requirements which apply to the audit committee, and the Board of Directors. Arrangements regarding the terms of employment and compensation of directors require approval by the audit committee, the Board of Directors and the shareholders.

 

69
 

 

The Israeli Companies Law requires that an office holder of the company promptly disclose any personal interest that he or she may have and all related material information known to him or her, in connection with any existing or proposed transaction by the company. In addition, if the transaction is an extraordinary transaction as defined under Israeli law, the office holder must also disclose any personal interest held by the office holder's spouse, siblings, parents, grandparents, descendants, spouse's descendants, siblings and parents of the office holder's spouse, and the spouses of any of the foregoing. In addition, the office holder must also disclose any interest held by any corporation in which the office holder is a 5% or greater shareholder, director or general manager or in which he or she has the right to appoint at least one director or the general manager. An extraordinary transaction is defined as a transaction other than in the ordinary course of business, otherwise than on market terms, or that is likely to have a material impact on the company's profitability, assets or liabilities.

 

In the case of a transaction which is not an extraordinary transaction, after the office holder complies with the above disclosure requirement, only board approval is required unless the articles of association of the company provide otherwise. The transaction must not be adverse to the company's interest. Furthermore, if the transaction is an extraordinary transaction, then, in addition to any approval stipulated by the articles of association, it also must be approved by the company's audit committee and then by the Board of Directors, and, under certain circumstances, by a meeting of the shareholders of the company.

 

An individual who has a personal interest in a matter that is considered at a meeting of the Board of Directors or the audit committee may not be present at the deliberations or vote on this matter. However, with respect to an office holder, he/she may be present at the meeting discussions if the chairman determines that the office holder has to present the matter . If a majority of the directors has a personal interest in a transaction with us, such directors may be present at the deliberations and vote in this matter, and shareholder approval of the transaction is required.

 

Under the Israeli Companies Law and as long as our Articles are not amended to determine otherwise, certain resolutions, such as resolutions regarding liquidation, require approval of the holders of 75% of the shares represented at the meeting and voting thereon.

 

Disclosure of Personal Interests of a Controlling Shareholder; Approval of Transactions with Controlling Shareholders

 

The Israeli Companies Law applies the same disclosure requirements to a controlling shareholder of a public company, which includes a shareholder that holds 25% or more of the voting rights if no other shareholder owns more than 50% of the voting rights in the company. Extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal interest, and the terms of compensation of a controlling shareholder who is an office holder (including the provision of services to the company) , require the approval of the audit committee, the Board of Directors and the shareholders of the company by simple majority, provided that either such majority vote must include at least one-half of the shareholders who have no personal interest in the transaction and are present at the meeting (without taking into account the votes of the abstaining shareholders), or that the total shareholdings of those who have no personal interest in the transaction who vote against the transaction represent no more than two percent of the voting rights in the company.

 

Agreements and extraordinary transactions with a term exceeding three years are subject to re-approval once every three years by the audit committee, board of directors and the shareholders of the company. Certain types of extraordinary transactions may be approved in advance for a period exceeding three years if the audit committee determines such approval reasonable under the circumstances.

 

The Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would the control 25% or greater of the company's voting rights. This rule does not apply if there is already another such shareholder which controls 25% or greater of the company's voting rights. Similarly, the Israeli Companies Law provides that an acquisition of shares in a public company must be made by means of a special tender offer if as a result of the acquisition the purchaser would hold greater than a 45% voting rights in the company, unless there is another shareholder holding more than a 45% voting rights in the company. These requirements do not apply to: (i) the acquisition of shares in a private placement, provided that such private placement was approved by the general meeting of the company’s shareholders as a private placement purporting to confer to the offeree the control of 25% or greater of the company's voting rights if the there is no other holder of such a block of shares, or purporting to confer to the offeree 45% of the voting rights in the company if there is no other person holding forty-five percent of the voting rights in the company; (ii) was from a shareholder which controls 25% or greater of the company's voting rights which resulted in the acquirer becoming a a shareholder of the company shareholder which controls 25% or greater of the company's voting rights, or (iii) was from a shareholder holding a 45% of the voting in the company which resulted in the acquirer becoming a holder of a 45% of the voting rights in the company. A special tender offer will only be considered accepted if: (i) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the shares of controlling shareholders of the offeror and excluding the holders of a 25% or more block of the voting rights in the company); and (ii) at least 5% of the voting rights in the company are purchased in the tender offer.

 

70
 

 

If, as a result of an acquisition of shares, the acquirer will hold more than 90% of a public company’s outstanding shares or a class of shares, the acquisition must be made by means of a tender offer for all of the outstanding shares or a class of shares. If less than 5% of the outstanding shares are not tendered in the tender offer, and more than half of the shareholders without a personal interest in accepting the offer tendered their shares, then all the shares that the acquirer offered to purchase will be transferred to the acquirer. The Israeli Companies Law provides for appraisal rights if any shareholder files a request in court within six months following the consummation of a full tender offer, but the acquirer will be entitled to stipulate that tendering shareholders forfeit their appraisal rights . If more than 5% of the outstanding shares are not tendered in the tender offer, then the acquirer may not acquire shares in the tender offer that will cause his shareholding to exceed 90% of the outstanding shares ; provided, however, that if the dissenting shareholders constitute less than 2% of the issued and outstanding share capital of the company then the full tender will be accepted and all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law.

 

DUTIES OF SHAREHOLDERS

 

Under the Israeli Companies Law, a shareholder has a duty to act in good faith and in a customary way towards the company and other shareholders and to refrain from abusing his or her power in the company including, among other things, when voting in a general meeting of shareholders on the following matters:

 

· any amendment to the articles of association;
· an increase of the company's authorized share capital;
· a merger; or
· approval of interested party transactions which require shareholder approval.

 

Furthermore, the Israeli Companies Law requires that a shareholder refrain from acting in a discriminatory manner towards other shareholders.

 

The Israeli Companies Law does not describe the substance of the aforementioned duties of shareholders, but provides that laws applicable to a breach of contract, adjusted according to the circumstances shall apply to a breach of such duties. With respect to the obligation to refrain from acting discriminatorily, a shareholder that is discriminated against can petition the court to instruct the company to remove or prevent the discrimination, as well as provide instructions with respect to future actions.

 

In addition, the Israeli Companies Law dictates that any controlling shareholder, any shareholder who knows that it possesses power to determine the outcome of a shareholder vote and any shareholder who, pursuant to the provisions of a company's articles of association, has the power to appoint or prevent the appointment of an office holder in the company, is under a duty to act with fairness towards the company.

 

The Israeli Companies Law does not describe the substance of the aforementioned duty to act with fairness but provides that laws applicable to a breach of contract, adjusted according to the circumstances and taking into account the status within the company of such shareholder, shall apply to a breach of such duty.

 

EXEMPTION, INSURANCE AND INDEMNIFICATION OF DIRECTORS AND OFFICERS

 

Exemption of Office Holders

 

Under the Israeli Companies Law, an Israeli company may not exempt an office holder from liability for breach of his duty of loyalty, but may exempt in advance an office holder from liability to the company, in whole or in part, for a breach of his duty of care, provided the articles of association of the company allow it to do so. Our Articles allow us to exempt our office holders from liability towards us for breach of duty of care to the maximum extent permitted by law.

 

71
 

 

Office Holder Insurance

 

Our Articles provide that, subject to the provisions of the Israeli Companies Law, we may enter into a contract for the insurance of the liability of any of our office holders for any act done by him or her by virtue of being an office holder, in respect of any of the following:

 

· a breach of duty of care towards us or any other person,
· a breach of fiduciary obligations towards us, provided that the office holder acted in good faith and had reasonable grounds to assume that his or her act would not be to our detriment,
· a financial liability imposed on him or her in favor of another person, or
· any other event for which insurance of an office holder is or may be permitted.

 

Indemnification of Office Holders

 

Our Articles provide that we may indemnify an office holder for the following cases of liability and expenses incurred by him or her as a result of an act done by him or her by virtue of being an office holder:

 

· financial liability imposed upon said office holder in favor of another person by virtue of a decision by a court of law, including a decision by way of settlement or a decision in arbitration which has been confirmed by a court of law;
· reasonable expenses of the proceedings, including lawyers’ fees, expended by the office holder or imposed on him by the court for:

(1) proceedings issued against him by or on behalf of the Company or by a third party;

(2) criminal proceedings in which the office holder was acquitted; or

(3) criminal proceedings in which he was convicted in an offense, which did not require proof of criminal intent; or

· any other liability or expense for which the indemnification of an officer holder is not precluded by law.

 

We have obtained directors and officers liability insurance for the benefit of our office holders. In addition, we have sometimes granted indemnification letters to our office holders.

 

Limitations on Exemption, Insurance and Indemnification

 

The Israeli Companies Law provides that a company may not exempt or indemnify an office holder, or enter into an insurance contract, which would provide coverage for any monetary liability incurred as a result of any of the following:

 

· a breach by the office holder of his or her duty of loyalty towards the company unless, with respect to insurance coverage, the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;
· a breach by the office holder of his or her duty of care if the breach was done intentionally or recklessly;
· any act or omission done with the intent to derive an illegal personal benefit; or
· any fine levied against the office holder.

 

Required Approvals

 

In addition, under the Israeli Companies Law, any exemption of, indemnification of, or procurement of insurance coverage for, our office holders must be approved by our audit committee and our Board of Directors and, if the beneficiary is a director, an additional approval by our shareholders is required.

 

RIGHTS OF ORDINARY SHARES

 

Our ordinary shares confer upon our shareholders the right to receive notices of, and to attend, shareholder meetings, the right to one vote per ordinary share at all shareholders' meetings for all purposes, and to share equally, on a per share basis, in such dividends as may be declared by our Board of Directors; and upon liquidation or dissolution, the right to participate in the distribution of any surplus assets of the Company legally available for distribution to shareholders after payment of all debts and other liabilities of the Company. All ordinary shares rank pari passu in all respects with each other.

 

MEETINGS OF SHAREHOLDERS

 

An annual general meeting of our shareholders will be held at least once in every calendar year, not later than 15 months after the last annual general meeting at such time and at such place either within or without the State of Israel as may be determined by our Board of Directors.

 

72
 

 

Our Board of Directors may, whenever it deems fit, convene a special general meeting. Special general meetings may also be convened upon requisition in accordance with the Israeli Companies Law. Our Board is obligated to convene a special general meeting if it receives a written request from any of (a) two Directors or 25% of the total number of Directors; (b) one or more Shareholders, holding at least 5% of our outstanding share capital and at least 1% of the shareholders’ voting power; or (c) one or more shareholders holding no less than 5% of the our outstanding voting shares.

 

MERGERS

 

A merger of the Company shall require resolution adopted by a simple majority vote cast at a general meeting, not taking into account abstentions provided, however, that if the transaction is an extraordinary transaction with a controlling shareholder or in which a controlling shareholder has an interest, then the approvals required will be the corporate approvals under the Israeli Companies Law for such extraordinary transaction.

 

C.    Material Contracts

 

Except for the material contracts described in Item 4 – Recent Developments, in Item 5 – Liquidity and Capital Resources and in Item 6 - Compensation, we are not a party to any other material contracts outside of the ordinary course of business.

 

D.    Exchange Controls

 

 

Pursuant to a general permit issued in 1998 by the Israeli Controller of Foreign Exchange under the Currency Control Law, 1978 (the "Currency Control Law"), there are virtually no restrictions on foreign exchange in the State of Israel, except for certain reporting obligations.  

 

E.    Taxation

 

To the extent that the following discussion is based on new or existing tax or other legislation that has not been subject to judicial or administrative interpretation, there can be no assurance that the views expressed herein will be accepted by the tax or other authorities in question. This discussion is not intended, nor should it be construed, as legal or professional tax advice and it is not exhaustive of all possible tax considerations.

 

Israeli Taxation

 

The following is a summary of the current material Israeli tax laws applicable to companies in Israel with special reference to its effect on us. This summary does not discuss all the acts of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Some parts of this discussion are based on new tax legislation that has not been subject to judicial or administrative interpretation. Accordingly, we cannot assure you that the views expressed in the discussion will be accepted by the tax authorities in question. The discussion is not intended and should not be construed as legal or professional tax advice and does not cover all possible tax considerations.

 

POTENTIAL INVESTORS AND HOLDERS OF OUR SHARES ARE URGED TO CONSULT THEIR OWN TAX ADVISORS AS TO THE ISRAELI OR OTHER TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP AND DISPOSITION OF OUR ORDINARY SHARES, INCLUDING, IN PARTICULAR, THE EFFECT OF ANY FOREIGN, STATE OR LOCAL TAXES.

 

The following discussion describes the material Israeli tax consequences regarding ownership and disposition of Vuance’s ordinary shares applicable to non-Israeli shareholders, including U.S. shareholders.

 

General Corporate Tax Structure

 

Israeli companies are generally subject corporate tax on their taxable income at the rate of 24% for the 2011 tax year and 25% for the 2012 tax year. Following an amendment to the Israeli Income Tax Ordinance, 1961 (the "Tax Ordinance"), which came into effect on January 1, 2012, the corporate tax rate is scheduled to remain at the rate of 25% for future tax years .

 

73
 

 

Taxation of Capital Gains Applicable to Israeli Shareholders and Non-Israeli Shareholders

General

 

Israeli law generally imposes a capital gains tax on the sale of any capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares in Israeli companies, by both residents and non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the shareholder’s country of residence provides otherwise. The law distinguishes between real gain and inflationary surplus. The inflationary surplus is a portion of the total capital gain which is equivalent to the increase of the relevant asset’s purchase price which is attributable to the increase in the Israeli consumer price index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of sale. The real gain is the excess of the total capital gain over the inflationary surplus.

 

Israeli residents :

 

Individuals:

 

Commencing in January 1, 2012, a real capital gain deriving to an individual will be taxed at a rate of 25%, on condition that the income is not classified as business income from the vantage point of the individual. This will apply to the entire real capital gain accrued since the date of purchase, or since January 1, 2003 if the purchase preceded that date.

Notwithstanding the above, the real capital gain will be taxed at a rate of 30% in the following instances:

 

1. The individual deducts interest expenses and linkage differentials.
2. The seller is a "significant shareholder" at the date of the sale of the securities or at any time during the 12-month period preceding the sale. A "significant shareholder" is defined in general as shareholder who holds, either directly or indirectly, alone or together with another, at least 10% of any form of a means of control in a company. The term "together with another" means together with a relative, or together with someone who is not a relative with which the individual, either directly or indirectly, has a regular cooperative agreement regarding the affairs of the company.

 

Companies:

 

The real capital gain on the sale of securities by a company will be taxed at the corporate tax rate applicable during the year of sale (25% for the 2012 tax year onwards).

 

Non-Israeli residents:

 

In general, Non-residents of Israel will be exempt from capital gain tax in relation to the sale of ordinary shares traded on a recognized stock exchange as long as (a) the capital gain is not in his permanent establishment in Israel, (b) the ordinary shares in relation to which the capital gains are derived were acquired by the nonresident after the initial listing of the ordinary shares and (c) neither the shareholder nor the capital gain is subject to certain sections of the Israeli income tax ordinance.

 

However, non-Israeli corporations will not be entitled to such exemption if Israeli residents (i) have a controlling interest of 25% or more in such non-Israeli corporation, or (ii) are the beneficiaries or are entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.

 

In addition, pursuant to the Income Tax Treaty between Israel and the U.S. (the “Tax Treaty”), gains derived from the sale, exchange or disposition of our ordinary shares by a person who qualifies as a resident of the U.S. within the meaning of the Tax Treaty and who is entitled to claim the benefits afforded to US residents under the Tax Treaty, referred to as a Treaty US Resident, would not be subject to Israeli capital gains tax, unless such US Resident owned, directly or indirectly, shares representing 10% or more of the voting power of our company at any time during the 12-month period preceding such sale, exchange or disposition.

 

In some instances where our shareholders may be liable to Israeli tax on the sale of their ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at the source. However, under the Tax Treaty, such U.S. resident would be permitted to claim a credit for such taxes against the U.S. federal income tax imposed with respect to such sale, exchange or disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The Tax Treaty does not relate to U.S. state or local taxes.

 

74
 

 

Tax on Dividends

 

Non-residents of Israel are subject to income tax on income accrued or derived from sources in Israel. These sources of income include passive income such as dividends. On distributions of dividends other than bonus shares, or stock dividends, income tax is applicable at the rate of 25%, or 30% for a shareholder that is considered a significant shareholder at any time during the 12-month period preceding such distribution. A different rate may be provided in a treaty between Israel and the shareholder’s country of residence. Under the Tax Treaty, the maximum tax on dividends paid to a holder of our ordinary shares who is a US resident is 25%; however if not more than 25% of our gross income consists of interest or dividends, then the maximum tax is 12.5% for a shareholder who is a US corporation holding at least 10% of our issued voting power during the part of the taxable year preceding the date of payment of the dividend and during the whole of the prior taxable year (and additional conditions under the Tax Treaty are met).

 

U.S. Federal Income Taxation

 

General

 

The following is a summary of the material U.S. federal income tax consequences of the ownership and disposition of our ordinary shares and warrants. The following discussion is not exhaustive of all possible tax considerations. This summary is based upon the Internal Revenue Code of 1986, as amended (the “Code”), regulations promulgated under the Code by the U.S. Treasury Department (including proposed and temporary regulations), rulings, current administrative interpretations and official pronouncements of the Internal Revenue Service (the “IRS”), and judicial decisions, all as currently in effect and all of which are subject to differing interpretations or to change, possibly with retroactive effect. Such change could materially and adversely affect the tax consequences described below. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax consequences described below.

 

This discussion does not address state, local, or foreign tax consequences of the ownership and disposition of ordinary shares and warrants (see “Israeli Taxation” above).

 

This summary is for general information only and does not address all aspects of the U.S. federal income taxation that may be important to a particular holder in light of its investment or tax circumstances or to holders subject to special tax rules, such as: banks; financial institutions; insurance companies; dealers in stocks, securities, or currencies; traders in securities that elect to use a mark-to-market method of accounting for their securities holdings; tax-exempt organizations; real estate investment trusts; regulated investment companies; qualified retirement plans, individual retirement accounts, and other tax-deferred accounts; expatriates of the U.S.; persons subject to the alternative minimum tax; persons holding ordinary shares or warrants as part of a straddle, hedge, conversion transaction, or other integrated transaction; persons who acquired ordinary shares or warrants pursuant to the exercise of any employee stock option or otherwise as compensation for services; persons actually or constructively holding 10% or more of our voting stock; and U.S. Holders (as defined below) whose functional currency is other than the U.S. dollar.

 

This discussion is not a comprehensive description of all of the U.S. federal tax consequences that may be relevant with respect to the ownership and disposition of our ordinary shares and warrants. We urge you to consult your own tax advisor regarding your particular circumstances and the U.S. federal income and estate tax consequences to you of owning and disposing of our ordinary shares and warrants, as well as any tax consequences arising under the laws of any state, local, or foreign or other tax jurisdiction and the possible effects of changes in U.S. federal or other tax laws.

 

This summary only addresses ordinary shares and warrants that are held as capital assets within the meaning of Section 1221 of the Code, which generally means as property held for investment, and were acquired upon original issuance at their initial public offering price. For purposes of this discussion, the term “U.S. Holder” means a beneficial owner of our ordinary shares and warrants that is any of the following:

 

· a citizen or resident of the U.S. or someone treated as a U.S. citizen or resident for U.S. federal income tax purposes;
· a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the U.S., any state thereof, or the District of Columbia;
· an estate, the income of which is subject to U.S. federal income taxation regardless of its source;
· a trust if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust; or

  

75
 

 

· a trust in existence on August 20, 1996 that has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person.

 

The term “Non-U.S. Holder” means a beneficial owner of our ordinary shares and warrants that is not a U.S. Holder. As described in “Taxation of Non-U.S. Holders” below, the tax consequences to a Non-U.S. Holder may differ substantially from the tax consequences to a U.S. Holder.

 

If a partnership (including for this purpose any entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of our ordinary shares and warrants, the U.S. federal income tax consequences to a partner in the partnership will generally depend on the status of the partner and the activities of the partnership. A holder of our ordinary shares and warrants that is a partnership and the partners in such partnership should consult their own tax advisors regarding the U.S. federal income tax consequences of the ownership and disposition of our ordinary shares and warrants.

 

Taxation of U.S. Holders

 

The discussion in “Distributions on Ordinary Shares” and “Dispositions of Ordinary Shares or Warrants” below assumes that we will not be treated as a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes. For a discussion of the rules that apply if we are treated as a PFIC, see the discussion in “Passive Foreign Investment Company” below.

 

Distributions on Ordinary Shares

 

General. Subject to the discussion in “Passive Foreign Investment Company” below, if you actually or constructively receive a distribution on ordinary shares, you must include the distribution in gross income as a taxable dividend on the date of your receipt of the distribution, but only to the extent of our current or accumulated earnings and profits, as calculated under U.S. federal income tax principles. Such amount must be included without reduction for any Israeli tax withheld. Dividends paid by us generally will not be eligible for the dividends received deduction allowed to corporations with respect to dividends received from certain U.S. corporations. Dividends paid by us may or may not be eligible for preferential rates applicable to qualified dividend income, as described below.

 

To the extent a distribution exceeds our current and accumulated earnings and profits, it will be treated first as a non-taxable return of capital to the extent of your adjusted tax basis in the ordinary shares, and thereafter as capital gain. Preferential tax rates for long-term capital gain may be applicable to non-corporate U.S. Holders.

 

We do not intend to calculate our earnings and profits under U.S. federal income tax principles. Therefore, you should expect that a distribution will generally be reported as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above.

 

Qualified Dividend Income. With respect to non-corporate U.S. Holders (i.e., individuals, trusts, and estates), for taxable years beginning on or before December 31, 2012, dividends that are treated as qualified dividend income (“QDI”) are taxable at a maximum tax rate of 15%. Among other requirements, dividends generally will be treated as QDI if either (i) our ordinary shares are readily tradable on an established securities market in the U.S., or (ii) we are eligible for the benefits of a comprehensive income tax treaty with the U.S. which includes an information exchange program and which is determined to be satisfactory by the U.S. Treasury. For example, it is expected that our ordinary shares will be “readily tradable” if as a result of being listed on The NASDAQ Capital Market.

 

In addition, for dividends to be treated as QDI, we must not be a PFIC (as discussed below) for either the taxable year in which the dividend was paid or the preceding taxable year. We do not believe that we will be a PFIC for our current taxable year. However, please see the discussion under “Passive Foreign Investment Company” below. Additionally, in order to qualify for QDI treatment, you generally must have held the ordinary shares for more than 60 days during the 121-day period beginning 60 days prior to the ex-dividend date. However, your holding period will be reduced for any period during which the risk of loss is diminished.

 

Moreover, a dividend will not be treated as QDI to the extent you are under an obligation (whether pursuant to a short sale or otherwise) to make related payments with respect to positions in substantially similar or related property. Since the QDI rules are complex, you should consult your own tax advisor regarding the availability of the preferential tax rates for dividends paid on ordinary shares.

 

76
 

 

Exercise or Lapse of Warrants

 

Upon the exercise of our warrants, a U.S. Holder will not recognize gain or loss and will have a tax basis in the ordinary shares received equal to the U.S. Holder’s tax basis in the warrant plus the exercise price of the warrant. The holding period for the shares purchased pursuant to the exercise of a warrant will begin on the day following the date of exercise and will not include the period during which the U.S. Holder held the warrant. If a warrant lapses unexercised, a U.S. Holder will recognize a capital loss in an amount equal to its tax basis in the warrant. Such loss will be long-term if the warrant has been held for more than one year. See “Disposition of Ordinary Shares or Warrants” below for a discussion of capital gains tax rates and limitations on deductions for losses. The loss will generally be from U.S. sources, but the loss may be from a non-U.S. source under some circumstances under the U.S.-Israel Tax Treaty. U.S. Holders should consult their own independent tax advisors regarding the sourcing of any losses due to the lapse of our warrants before exercise.

 

Dispositions of Ordinary Shares or Warrants

 

Subject to the discussion in “Passive Foreign Investment Company” below, you generally will recognize taxable gain or loss realized on the sale or other taxable disposition of ordinary shares or warrants equal to the difference between the U.S. dollar value of (i) the amount realized on the disposition (i.e., the amount of cash plus the fair market value of any property received), and (ii) your adjusted tax basis in the ordinary shares or warrants. Such gain or loss will be capital gain or loss.

 

If you have held the ordinary shares or warrants for more than one year at the time of disposition, such capital gain or loss will be long-term capital gain or loss. Preferential tax rates for long-term capital gain (currently, with a maximum rate of 15% for taxable years beginning before December 31, 2012) will apply to non-corporate U.S. Holders. If you have held the ordinary shares or warrants for one year or less, such capital gain or loss will be short-term capital gain or loss taxable as ordinary income at your marginal income tax rate. The deductibility of capital losses is subject to limitations.

 

Passive Foreign Investment Company

 

We generally will be a PFIC under Section 1297 of the Code if, for a taxable year, either (a) 75% or more of our gross income for such taxable year is passive income (the “income test”) or (b) 50% or more of the average quarterly percentage, generally determined by fair market value, of our assets either produce passive income or are held for the production of “passive income (the “asset test”). Passive income includes, for example, dividends, interest, certain rents and royalties, certain gains from the sale of stock and securities, and certain gains from commodities transactions.

 

Certain “look through” rules apply for purposes of the income and asset tests described above. If we own, directly or indirectly, 25% or more of the total value of the outstanding shares of another foreign corporation, we will be treated as if we (a) held directly a proportionate share of the other corporation’s assets, and (b) received directly a proportionate share of the other corporation’s income. In addition, passive income does not include any interest, dividends, rents, or royalties that are received or accrued by us from a “related person” (as defined in Section 954(d)(3) of the Code), to the extent such items are properly allocable to income of such related person that is not passive income.

 

Under the income and asset tests, whether or not we are a PFIC will be determined annually based upon the composition of our income and the composition and valuation of our assets, all of which are subject to change. In determining that we are not a PFIC, we are relying on our projected revenues and projected capital expenditures. If our actual revenues and capital expenditures do not match our projections, we may become a PFIC. For example, if we do not spend enough of the cash (a passive asset) we raise from any financing transactions we may undertake, the relative percentage of our passive assets will increase. In addition, our determination is based on a current valuation of our assets, including goodwill, if it exists. In calculating goodwill, we should value our total assets based on our market capitalization, determined using the market price of our ordinary shares. Such market price may fluctuate. If our market capitalization is less than anticipated or subsequently declines, this will decrease the value of our goodwill and we may become a PFIC. Furthermore, we may make a number of assumptions regarding the amount of value allocable to goodwill. However, it is possible that the IRS will challenge such valuation of goodwill, which may result in our being a PFIC.

 

We do not believe that we are currently a PFIC. However, because the PFIC determination is highly fact intensive and made at the end of each taxable year, there can be no assurance that we will not be a PFIC for the current or any future taxable year or that the IRS will not challenge our determination concerning our PFIC status. If we determine that we are a PFIC, we will take reasonable steps to notify you.

 

Default PFIC Rules under Section 1291 of the Code. If we are a PFIC, the U.S. federal income tax consequences to a U.S. Holder of the ownership and disposition of ordinary shares and warrants will depend on whether such U.S. Holder makes an election to treat us as a qualified electing fund (“QEF”) under Section 1295 of the Code (a “QEF Election”) or a mark-to-market election under Section 1296 of the Code (a “Mark-to-Market Election”). A U.S. Holder owning ordinary shares and warrants while we were or are a PFIC that has not made either a QEF Election or a Mark-to-Market Election will be referred to in this summary as a “Non-Electing U.S. Holder.”

 

77
 

  

If you are a Non-Electing U.S. Holder, you will be subject to the default tax rules of Section 1291 of the Code with respect to:

 

· any “excess distribution” paid on ordinary shares and warrants, which means any distribution received by you which, together with all other distributions received in the current taxable year, exceeds 125% of the average distributions received by you during the three preceding taxable years (or during your holding period for the ordinary shares and warrants, if shorter); and

· any gain recognized on the sale or other taxable disposition (including a pledge) of ordinary shares and warrants.

 

Under these default tax rules:

 

· any excess distribution or gain will be allocated ratably over your holding period for the ordinary shares and warrants;
· the amount allocated to the current taxable year and any period prior to the first day of the first taxable year in which we were a PFIC will be treated as ordinary income in the current year;
· the amount allocated to each of the other years will be treated as ordinary income and taxed at the highest applicable tax rate in effect for that year; and
· the resulting tax liability from any such prior years will be subject to the interest charge applicable to underpayments of tax.

 

In addition, notwithstanding any election you may make, dividends that you receive from us will not be eligible for the preferential tax rates applicable to QDI (as discussed above in “Distributions on Ordinary Shares”) if we are a PFIC either in the taxable year of the distribution or the preceding taxable year, but will instead be taxable at rates applicable to ordinary income.

 

Special rules for Non-Electing U.S. Holders will apply to determine U.S. foreign tax credits with respect to withholding taxes imposed on distributions on ordinary shares.

 

If we are a PFIC for any taxable year during which you hold ordinary shares or warrants, we will continue to be treated as a PFIC with respect to you for all succeeding years during which you hold ordinary shares or warrants, regardless of whether we actually continue to be a PFIC. You may terminate this deemed PFIC status by electing to recognize gain (which will be taxed under the default tax rules of Section 1291 of the Code discussed above) as if your ordinary shares or warrants had been sold on the last day of the last taxable year for which we were a PFIC.

 

If we are a PFIC in any year with respect to you, you will be required to file an annual return on IRS Form 8621 regarding distributions received on ordinary shares and any gain realized on the disposition of ordinary shares or warrants.

 

QEF Election. If you make a QEF Election, you generally will not be subject to the default rules of Section 1291 of the Code discussed above. Instead, you will be subject to current U.S. federal income tax on your pro rata share of our ordinary earnings and net capital gain, regardless of whether such amounts are actually distributed to you by us. However, you can make a QEF Election only if we agree to furnish you annually with certain tax information, and we currently do not intend to prepare or provide such information.

 

Mark-to-Market Election. U.S. Holders may make a Mark-to-Market Election, but only if the ordinary shares are marketable stock. The ordinary shares will be “marketable stock” as long as they listed on NASDAQ, and are regularly traded. Stock is “regularly traded” for any calendar year during which it is traded (other than in de minimis quantities) on at least fifteen days during each calendar quarter. There can be no assurances, however, that our ordinary shares will be treated, or continue to be treated, as regularly traded.

 

If the ordinary shares are marketable stock and you make a Mark-to-Market Election, you generally will not be subject to the default rules of Section 1291 of the Code discussed above. Rather, you generally will be required to recognize ordinary income for any increase in the fair market value of the ordinary shares and warrants for each taxable year that we are a PFIC. You will also be allowed to deduct as an ordinary loss any decrease in the fair market value to the extent of net marked-to-market gain previously included in prior years. Your adjusted tax basis in the ordinary shares and warrants will be adjusted to reflect the amount included or deducted.

 

78
 

 

The Mark-to-Market Election will be effective for the taxable year for which the election is made and all subsequent taxable years, unless the ordinary shares and warrants cease to be marketable stock or the IRS consents to the revocation of the election. You should consult your own tax advisor regarding the availability of, and procedure for making, a Mark-to-Market Election.

 

Since the PFIC rules are complex, you should consult your own tax advisor regarding them and how they may affect the U.S. federal income tax consequences of the ownership and disposition of ordinary shares and warrants.

 

Information Reporting and Backup Withholding

 

Generally, information reporting requirements will apply to distributions on ordinary shares or proceeds on the disposition of ordinary shares and warrants paid within the U.S. (and, in certain cases, outside the U.S.) to U.S. Holders other than certain exempt recipients, such as corporations. Furthermore, backup withholding (currently at 28%) may apply to such amounts if the U.S. Holder fails to (i) provide a correct taxpayer identification number, (ii) report interest and dividends required to be shown on its U.S. federal income tax return, or (iii) make other appropriate certifications in the required manner. U.S. Holders who are required to establish their exempt status generally must provide such certification on IRS Form W-9.

 

Backup withholding is not an additional tax. Amounts withheld as backup withholding from a payment to you may be credited against your U.S. federal income tax liability and you may obtain a refund of any excess amounts withheld by filing the appropriate claim for refund with the IRS and furnishing any required information in a timely manner.

 

Taxation of Non-U.S. Holders

 

Distributions on Ordinary Shares

 

Subject to the discussion in “Information Reporting and Backup Withholding” below, as a Non-U.S. Holder, you generally will not be subject to U.S. federal income tax, including withholding tax, on distributions received on ordinary shares, unless the distributions are effectively connected with a trade or business that you conduct in the U.S. and (if an applicable income tax treaty so requires) attributable to a permanent establishment that you maintain in the U.S.

 

If distributions are effectively connected with a U.S. trade or business and (if applicable) attributable to a U.S. permanent establishment, you generally will be subject to tax on such distributions in the same manner as a U.S. Holder, as described in “Taxation of U.S. Holders – Distributions on Ordinary Shares” above. In addition, any such distributions received by a corporate Non-U.S. Holder may also, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.

 

Dispositions of Ordinary Shares and Warrants

 

Subject to the discussion in “Information Reporting and Backup Withholding” below, as a Non-U.S. Holder, you generally will not be subject to U.S. federal income tax, including withholding tax, on any gain recognized on a sale or other taxable disposition of ordinary shares and warrants, unless (i) the gain is effectively connected with a trade or business that you conduct in the U.S. and (if an applicable income tax treaty so requires) attributable to a permanent establishment that you maintain in the U.S., or (ii) you are an individual and are present in the U.S. for at least 183 days in the taxable year of the disposition, and certain other conditions are present.

 

If you meet the test in clause (i) above, you generally will be subject to tax on any gain that is effectively connected with your conduct of a trade or business in the U.S. in the same manner as a U.S. Holder, as described in “Taxation of U.S. Holders – Dispositions of Ordinary Shares and Warrants” above. Effectively connected gain realized by a corporate Non-U.S. Holder may also, under certain circumstances, be subject to an additional “branch profits tax” at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.

 

If you meet the test in clause (ii) above, you generally will be subject to tax at a 30% rate on the amount by which your U.S. source capital gain exceeds your U.S. source capital loss.

 

Information Reporting and Backup Withholding

 

Payments to Non-U.S. Holders of distributions on, or proceeds from the disposition of, ordinary shares and warrants are generally exempt from information reporting and backup withholding. However, a Non-U.S. Holder may be required to establish that exemption by providing certification of non-U.S. status on an appropriate IRS Form W-8.

 

79
 

 

Backup withholding is not an additional tax. Amounts withheld as backup withholding from a payment to you may be credited against your U.S. federal income tax liability and you may obtain a refund of any excess amounts withheld by filing the appropriate claim for refund with the IRS and furnishing any required information in a timely manner.

 

Medicare Tax

 

In addition to the taxes on dividends and dispositions of our shares or warrants described above, recently enacted legislation requires certain U.S. Holders that are individuals, estates or trusts to pay up to an additional 3.8% tax on net investment income, which may include dividends and capital gains, for taxable years beginning after December 31, 2012.

  

F.    Dividends and Paying Agent

 

Not applicable.

 

G.    Statements by Experts

 

Not applicable.

 

H.    Documents on Display

 

We are subject to the informational requirements of the Exchange Act, applicable to foreign private issuers. We, as a “foreign private issuer,” are exempt from the rules under the Exchange Act prescribing certain disclosure and procedural requirements for proxy solicitations, and our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act, with respect to their purchases and sales of shares. In addition, we are not required to file annual, quarterly and current reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we will file with the SEC, commencing with the fiscal year ending December 31, 2011 within four months after the end of each fiscal year, an annual report on Form 20-F containing financial statements audited by an independent accounting firm. We also expect to furnish quarterly reports on Form 6-K containing unaudited interim financial information for the first three quarters of each fiscal year, within 90 days after the end of such quarter.

 

You may read and copy any document we file or furnish with the SEC at reference facilities at 450 Fifth Street, NW, Washington, DC 20549. You may also obtain copies of the documents at prescribed rates by writing to the Public Reference Section of the SEC at 450 Fifth Street, NW, Washington, DC 20549. Please call the SEC at 1-800-SEC-0330 for further information on the operation of the public reference facilities. You can review our SEC filings and the registration statement by accessing the SEC’s internet site at http://www.sec.gov.

 

I.      Subsidiary Information

 

Not applicable.

 

ITEM 11.     Quantitative and Qualitative Disclosures About Market Risk.

 

Quantitative and Qualitative Information about Market Risk

 

The primary objective of our investment activities, if any, is to preserve principal while at the same time maximizing the income we receive from investments without significantly increasing risk. Some of the securities in which we may invest may be subject to market risk. This means that a change in prevailing interest rates and foreign currency rates against the NIS may cause the value of the investment to fluctuate. For example, if we purchase a security that was issued with a fixed interest rate and the prevailing interest rate later rises, the value of our investment will probably decline. To minimize this risk, we may maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including U.S. dollars, NIS bank deposits, money market funds and government and non-government debt securities. In general, money market funds are not subject to market risk because the interest paid on such funds fluctuates with the prevailing interest rate.

 

Our financial market risk includes risks related to international operations and related foreign currencies. We anticipate that sales outside of North America will continue to account for a significant portion of our consolidated revenue in 2012. To date, most of our sales have been valued in dollars. In future periods, we expect our sales to continue to be principally valued in dollars, narrowing foreign currency exchange risk.

 

80
 

 

We value part of our expenses in some of our international operations, such as Israel, in each country's local currency, and therefore are subject to foreign currency exchange risk. However, through December 31, 2011, we have not experienced any significant negative impact on our operations as a result of fluctuations in foreign currency exchange rates; we have incurred an income of $5,000 in the year ended December 31, 2011 due to fluctuations in foreign exchange rates. We do not use financial instruments to hedge operating expenses in Israel that are valued in local currency. We intend to continue to assess the need to utilize financial instruments to hedge currency exposures on an ongoing basis.

 

We do not use derivative financial instruments for speculative trading purposes, nor do we hedge our foreign currency exposure to offset the effects of changes in foreign exchange rates.

 

Our exposure to market risks for changes in interest rates relates primarily to our credit facility. At December 31, 2011, our financial market risk related to this debt was immaterial. Our general policy is to limit the risk of principal loss and ensure the safety of invested funds by limiting market and credit risk.

 

Foreign currency risk

 

Most of our sales are denominated in U.S. dollars, and we incur most of our expenses in U.S. dollars and Israeli Shekels. According to the salient economic factors indicated in ASC Topic 830, “Foreign Currency Matters,” our cash flow, sale price, sales market, expense, financing and inter-company transactions and arrangement indicators are predominantly denominated in U.S. dollars. In addition, the U.S. dollar is the primary currency of the economic environment in which we operate, and thus the U.S. dollar is our functional and reporting currency.

 

In our balance sheet, we remeasure into U.S. dollars all monetary accounts (principally cash and cash equivalents and liabilities) that are maintained in other currencies. For this remeasurement we use the foreign exchange rate at the balance sheet date. Any gain or loss that results from this remeasurement is reflected in the statement of income as financial income or financial expense, as appropriate.

 

We measure and record non-monetary accounts in our balance sheet (principally fixed assets, prepaid expenses and share capital) in U.S. dollars. For this measurement we use the U.S. dollar value in effect at the date that the asset or liability was initially recorded in our balance sheet (the date of the transaction).    

 

Interest Rate Risk

 

Our cash borrowing from Israeli bank is subject to interest rate changes, and therefore our interest expenses are sensitive to changes in interest rates. The interest rate on our borrowing is linked to LIBOR, which fluctuates. However, the amount of borrowings that we have that is linked to LIBOR is not material to us as a whole, and therefore our exposure to fluctuations in LIBOR rate is not material as well.

 

ITEM 12 . Description of Securities Other than Equity Securities.

 

Not applicable.

 

PART II

 

ITEM 13 . Defaults, Dividend Arrearages and Delinquencies.

 

A. As of the filing date of this Annual Report, we were not in compliance with the covenants under the amended Convertible Bonds (see also Item 4.A under the caption “Recent Developments” and Item 5.B under the caption “Liquidity and Capital Resources”). In 2011, we experienced an increase in financial expenses with respect to our Convertible Bonds caused by an increase in the interest rate of the bonds and due to our breach of the covenants under the Convertible Bonds, as amended, which required us to incur additional interest of 3% per month on unpaid amounts. The additional interest expenses amounted to $271,000 during the year ended December 31, 2011.

 

B. None.

 

81
 

 

ITEM 14. Material Modifications to the Rights of Security Holders and Use of Proceeds .

 

None.

 

ITEM 15. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Our management has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of December 31, 2011. Our disclosure controls and procedures include components of our internal control over financial reporting. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures, as of December 31, 2011, were not effective due solely to the material weakness in our internal control over financial reporting as described below in “Management’s Report on Internal Control over Financial Reporting”.

 

Disclosure controls and procedures are our controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

 

In light of this material weakness, we performed additional analysis as deemed necessary to ensure that the consolidated financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the consolidated financial statements included in this report present fairly, in all material respects, our financial position, results of operations and cash flows for the period presented.

 

Management's Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over our financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP, and includes policies and procedures that:

 

· pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and asset dispositions;
· provide reasonable assurance that transactions are recorded as necessary to permit the preparation of our financial statements in accordance with generally accepted accounting principles;
· provide reasonable assurance that receipts and expenditures are made only in accordance with authorizations of our management and Board of Directors (as appropriate); and
· provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.

 

Our management assessed the effectiveness of internal control over financial reporting as of December 31, 2011, the end of our fiscal year. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in the report entitled “Internal Control – Integrated Framework.”

 

Based on that assessment, our Chief Executive Officer and Chief Financial Officer have concluded that we did not maintain effective internal control over financial reporting as a result of insufficient resources and personnel to properly segregate duties in our finance department, resulting in a material weakness in the financial statement closing process.

 

Inherent limitations on effectiveness of controls.

 

Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

82
 

 

Attestation Report of Registered Public Accounting Firm

 

Not applicable.

 

Changes in Internal Controls over Financial Reporting

 

During the period covered by this Annual Report, no changes in our internal control over financial reporting have occurred that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 16A.     Audit Committee Financial Expert

 

Our Board of Directors has determined that Messrs. Avi Ayash and Shlomo Benjamin, both members of our audit committee, are audit committee financial experts, as defined under the Exchange Act Rules, and are independent in accordance with applicable Exchange Act rules. The relevant experience of each of them is summarized in Item 6A-"Directors and Senior Management".

 

ITEM 16B.     Code of Ethics

 

Our Board of Directors adopted a code of ethics that applies to our chief executive officer, chief financial officer (if any), director of finance, controller, and other persons performing similar functions a copy of which is previously filed and incorporated by reference to this Annual Report. A copy of our code of ethics will be provided, without charge, upon written request of any person delivered as follows: Nolton House, 14 Shenkar Street P.O.B 12190, Hertzliya Pituach 46725 Israel.

 

ITEM 16C.     Principal Accountant Fees and Services

 

Fahn, Kanne & Co., a member of Grant Thornton, serves as our principal independent registered public accounting firm. The following table presents the fees to our external auditors for professional services rendered in the years ended December 31, 2011 and 2010:

 

    2011     2010  
Audit Fees     61,000       75,000  
Audit-Related Fees     -       -  
Tax Fees     5,000       3,000  
Total     66,000       78,000  

 

“Audit Fees” are the aggregate fees billed for the audit of our annual financial statements. This category also includes services that generally the independent registered public accounting firm provides, such as statutory audits including audits required by Israeli government institutes, consents and assistance with and review of documents filed with the SEC.

 

“Tax Fees” are the aggregate fees billed for professional services rendered for tax compliance and tax advice, other than in connection with the audit. Tax compliance involves preparation of original and amended tax returns, tax planning and tax advice.

 

Pre-Approval Policies for Non-Audit Services

 

The audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent auditors. These policies generally provide that we will not engage our independent auditors to render audit or non-audit services unless the service is specifically approved in advance by the Audit Committee or the engagement is entered into pursuant to the pre-approval procedure described below.

 

From time to time, the audit committee may pre-approve specified types of services that are expected to be provided to us by our independent auditors during the next 12 months. Any such pre-approval is detailed as to the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.

 

83
 

 

ITEM 16D. Exemptions from the Listing Standards for Audit Committees

 

None.

 

ITEM 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

ITEM 16F. Change in Registrant’s Certifying Accountant

 

Not applicable.

 

ITEM 16G. Corporate Governance

 

Not applicable.

 

ITEM 16H. Mine Safety Disclosure

 

Not applicable.

 

PART III

ITEM 17. Financial Statements.

 

Not applicable.

 

ITEM 18. Financial Statements.

 

VUANCE LTD.

2011 ANNUAL REPORT

 

INDEX TO THE FINANCIAL STATEMENTS

 

    Page
     
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM   F- 2
CONSOLIDATED FINANCIAL STATEMENTS:    
Consolidated balance sheets   F-3 - F-4
Consolidated statements of operations   F-5
Consolidated s tatements of changes in shareholders’ deficit   F-6
Consolidated statements of cash flows   F-7 - F-8
Notes to consolidated financial statements   F-9 - F-46

 

The amounts in the Financial Statements are stated in U.S. dollars ($) in thousands.

 

84
 

 

VUANCE LTD. AND SUBSIDIARIES

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF DECEMBER 31, 2011

 

IN U.S. DOLLARS

 

INDEX

 

    Page
     
Report of Independent Registered Public Accounting Firm   F-2
     
Consolidated Balance Sheets   F-3 – F-4
     
Consolidated Statements of Operations   F-5
     
Statements of Changes in Shareholders' Deficit   F-6
     
Consolidated Statements of Cash Flows   F-7 – F-8
     
Notes to Consolidated Financial Statements   F-9 – F-46

 

 

  

F- 1
 

 

 

REPORT OF INDEPENDENT Fahn Kanne & Co.
REGISTERED PUBLIC ACCOUNTING FIRM Head Office
TO THE SHAREHOLDERS OF Levinstein Tower
VUANCE LTD. 23 Menachem Begin Road
  Tel-Aviv 66184, ISRAEL
  P.O.B. 36172, 61361
   
  T +972 3 7106666
  F +972 3 7106660
  www.gtfk.co.il

  

We have audited the accompanying consolidated balance sheets of Vuance Ltd. and subsidiaries (the "Company") as of December 31, 2011 and 2010, and the related consolidated statements of operations, changes in shareholders’ deficit and cash flows for each of the three years in the period ended December 31, 2011. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, based on our audits, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of Vuance Ltd. and subsidiaries as of December 31, 2011 and 2010, and the results of their operations, and their cash flows for each of the three years in the period ended December 31, 2011, in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 1f to the financial statements, the Company has incurred substantial recurring losses and negative cash flows from operations and, as of December 31, 2011, the Company had a working capital deficit and total shareholders' deficit. These conditions, along with other matters as set forth in Note 1f, raise substantial doubt about the Company's ability to continue as a going concern. Management’s plans in regards to these matters are also described in Note 1f. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/ Fahn Kanne & Co. Grant Thornton Israel

May 9, 2012

 

Certified Public Accountants

Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd

 

F- 2
 

 

VUANCE LTD. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

U.S. dollars in thousands

 

    December 31,  
    2011     2010  
ASSETS                
                 
CURRENT ASSETS:                
Cash and cash equivalents   $ 215     $ 197  
Restricted cash deposits     -       130  
Trade receivables (net of allowance for doubtful accounts of $ 134 and $ 1,553 as of December 31, 2011 and 2010, respectively)     1,542       752  
Other accounts receivable and prepaid expenses     105       388  
Inventories, net     269       197  
                 
Total current assets     2,131       1,664  
                 
SEVERANCE PAY FUND     228       234  
                 
PROPERTY AND EQUIPMENT, NET     96       110  
                 
Total assets   $ 2,455     $ 2,008  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 3
 

 

VUANCE LTD. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

U.S. dollars in thousands, except share data

 

    December 31,  
    2011     2010  
LIABILITIES AND SHAREHOLDERS' DEFICIT                
                 
CURRENT LIABILITIES:                
Short-term bank credit   $ 112     $ -  
Trade payables     2,439       973  
Employees and payroll accruals     139       151  
Advances from customer     -       1,010  
Accrued expenses and other liabilities     2,164       2,244  
Convertible bonds     2,519       122  
Short-term loan and others     456       -  
                 
Total current liabilities     7,829       4,500  
                 
LONG-TERM LIABILITIES:                
Convertible bonds     -       2,866  
Long-term loan and others     -       2,259  
Accrued severance pay     227       254  
                 
Total long-term liabilities     227       5,379  
                 
COMMITMENTS AND CONTINGENT LIABILITIES                
                 
SHAREHOLDERS' DEFICIT:                
Share capital:                
Ordinary shares of NIS 0.0588235 par value -                
Authorized 52,000,000 shares as of December 31, 2011 and 2010;                
Issued and outstanding: 12,035,272 and 7,280,821 shares as of December 31, 2011 and 2010, respectively     192       113  
Additional paid-in capital     41,713       41,360  
Amount of liability extinguished on account of shares     819       -  
Accumulated deficit     (48,325 )     (49,344 )
                 
Total shareholders' deficit     (5,601 )     (7,871 )
                 
Total liabilities and shareholders' deficit   $ 2,455     $ 2,008  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 4
 

 

VUANCE LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

  U.S. dollars in thousands, except per share data

 

    Year ended
December 31,
 
    2011     2010     2009  
                   
Revenues   $ 7,922     $ 7,389     $ 9,304  
Cost of revenues     3,306       2,057       3,365  
Gross profit     4,616       5,332       5,939  
                         
Operating expenses:                        
Research and development     462       386       898  
Selling and marketing     3,505       4,405       5,131  
General and administrative     732       1,985       1,648  
Other (income) expenses     (137 )     (396 )     130  
Total operating expenses     4,562       6,380       7,807  
                         
Operating (loss) income     54       (1,048 )     (1,868 )
Financial (expenses) income, net     990       (678 )     (620 )
                         
Income (loss) before income tax     1,044       (1,726 )     (2,488 )
Income tax     (25 )     (50 )     (71 )
                         
Net income (loss) from continuing operations     1,019       (1,776 )     (2,559 )
Loss from discontinued operations     -       (189 )     (2,526 )
                         
Net income (loss)   $ 1,019     $ (1,965 )   $ (5,085 )
                         
Earnings (loss) per share from continuing operations:                        
Basic   $ 0.11     $ (0.29 )   $ (0.46 )
Diluted   $ 0.09     $ (0.29 )   $ (0.46 )
                         
Loss per share from discontinued operations basic and diluted:     -     $ (0.03 )   $ (0.46 )
                         
Net earnings (loss) per share:                        
Basic   $ 0.11     $ (0.32 )   $ (0.92 )
Diluted   $ 0.09     $ (0.32 )   $ (0.92 )
                         
Weighted average number of ordinary shares used in computing basic  earnings (loss) per share     9,126,327       6,177,862       5,511,948  
                         
Weighted average number of ordinary shares used in computing diluted earnings (loss) per share     11,710,254       6,177,862       5,511,948  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 5
 

 

VUANCE LTD. AND SUBSIDIARIES

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT

 

U.S. dollars in thousands, except share data

 

    Ordinary shares                                
    Number
of Shares
    Share
capital
    Additional
paid-in
capital
    Amount of
liability
extinguished
on account of
shares
    Accumulated
deficit
    Total
comprehensive
income (loss)
    Total
shareholders'
deficit
 
                                           
Balance as of January 1, 2009     5,259,874     $ 82     $ 40,345     $ -     $ (42,294 )           $ (1,867 )
Issuance of shares in connection with acquisition of Intelli-Site (see Note 1a)     202,626       3       68       -       -       -       71  
Issuance of shares (see Note 13c)     168,865       3       60       -       -       -       63  
                                                         
Exercise of options     93,056       1       -       -       -       -       1  
                                                         
Beneficial conversion feature on convertible bond terms     -       -       24       -       -       -       24  
Stock- based compensation     -       -       522       -       -       -       522  
Net loss     -       -       -       -       (5,085 )   $ (5,085 )     (5,085 )
Total comprehensive loss                                           $ (5,085 )        
Balance as of December 31, 2009     5,724,421     $ 89     $ 41,019     $ -     $ (47,379 )           $ (6,271 )
Issuance of shares in connection with acquisition of Intelli-Site (see Note 1a)     6,932       - *     -       -       -       -       - *
Issuance of shares (see Note 13f)     1,538,461       24       176       -       -       -       200  
Exercise of options     11,007       - *     -       -       -       -       - *
Warrants issued in connection with extinguishments of liabilities (see Note 1d)     -       -       147       -       -       -       147  
Stock- based compensation     -       -       18       -       -       -       18  
Net loss     -       -       -       -       (1,965 )   $ (1,965 )     (1,965 )
Total comprehensive loss                                           $ (1,965 )        
Balance as of December 31, 2010     7,280,821     $ 113     $ 41,360     $ -     $ (49,344 )           $ (7,871 )
Exercise of options     10,007       - *     -       -       -       -       - *
Shares, options and warrants issued in connection with extinguishments of liabilities (see Notes 1d and 13d)     4,744,444       79       343       819       -       -       1,241  
Stock- based compensation     -       -       10       -       -       -       10  
Net income     -       -       -       -       1,019     $ 1,019       1,019  
Total comprehensive income                                           $ 1,019          
Balance as of December 31, 2011     12,035,272     $ 192     $ 41,713     $ 819     $ (48,325 )           $ (5,601 )

 

*Less than $1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 6
 

 

VUANCE LTD. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

U.S. dollars in thousands

 

    Year ended December 31,  
    2011     2010     2009  
Cash flows from operating activities :                        
Net income (loss)   $ 1,019     $ (1,965 )   $ (5,085 )
                         
Adjustments to reconcile net income (loss) to net cash used in operating activities:                        
Depreciation and amortization     28       53       708  
Impairment loss     -       -       1,119  
Accrued severance pay     (27 )     (47 )     (74 )
Stock-based compensation     10       18       522  
Amortization of discount on convertible bonds     -       20       -  
Capital loss on disposal of property and equipment     6       -       -  
Capital gain on sale of subsidiary (Appendix C)     -       (272 )     -  
Capital gain on extinguishments of liabilities     (2,149 )     (124 )     -  
Decrease (increase) in trade receivables     (790 )     105       (667 )
Decrease (increase) in other accounts receivable and prepaid expenses     283       (105 )     644  
Decrease (increase) in inventories, net     (72 )     (132 )     1,008  
Increase (decrease) in trade payables     1,466       (2 )     163  
Increase (decrease) in employees and payroll accruals     3       (311 )     215  
Increase (decrease) in advances from customer     (1,010 )     973       (1,484 )
Increase in accrued expenses and other liabilities     1,044       577       1,270  
                         
Net cash used in operating activities     (189 )     (1,212 )     (1,661 )
                         
Cash flows from investing activities :                        
Purchase of property and equipment     (23 )     (4 )     (100 )
Proceeds from sale of property and equipment     3       -       -  
Acquisition of operation net of cash acquired (Appendix A)     -       -       -  
Proceeds from sale of operations net of cash sold (Appendix B)     -       397       -  
Sale of subsidiary net of cash sold (Appendix C)     -       (3 )     -  
Decrease in severance pay fund     6       49       31  
Restricted cash deposits, net     130       200       1,745  
                         
Net cash provided by investing activities     116       639       1,676  
                         
Cash flows from financing activities :                        
Short-term bank credit, net     112       -       (9 )
Principle repayment of convertible bonds     (21 )     (86 )     (79 )
Issuance of share capital, net of issuance costs     -       200       3  
Proceeds from exercise of options and warrants, net     - *     - *     1  
Payment of liability to a former owner of an acquiree     -       -       (87 )
                         
Net cash (used in) provided by financing activities     91       114       (171 )
                         
Increase (decrease) in cash and cash equivalents     18       (459 )     (156 )
Cash and cash equivalents at the beginning of the year     197       656       812  
                         
Cash and cash equivalents at the end of the year   $ 215     $ 197     $ 656  

 *Less than $1.

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 7
 

 

VUANCE LTD. AND SUBSIDIARIES

  CONSOLIDATED STATEMENTS OF CASH FLOWS (Cont.)

 

U.S. dollars in thousands

 

    Year ended
December 31,
 
    2011     2010     2009  
Supplemental disclosure of cash flows information:                        
                         
Appendix A:                        
Acquisition of operation net of cash acquired:                        
                         
Assets and liabilities of the operation, as of date of purchase:                        
Working capital (excluding cash and cash equivalents)     -       -     $ (62 )
Property and equipment     -       -       (4 )
Intangible assets     -       -       (313 )
Shares issued     -       -       68  
Liabilities to former owner of the acquiree (*)     -       -       311  
                         
    $ -     $ -     $ -  

 

(*) Including $68 which represents the acquisition date fair value of contingent consideration to the former owners.

 

Appendix B:                        
Sale of operations net of cash sold:                        
                         
Assets and liabilities of the operations, as of date of sale:                        
Working capital (excluding cash and cash equivalents)     -     $ (208 )     -  
Property and equipment, net     -       88       -  
Intangible assets, net     -       517       -  
                         
    $ -     $ 397     $ -  

 

Appendix C:                        
Sale of subsidiary net of cash sold:                        
                         
Assets and liabilities of the subsidiary, as of date of sale:                        
Working capital (excluding cash and cash equivalents)     -     $ (276 )     -  
Property and equipment, net     -       4       -  
Long-term liability     -       (3 )     -  
Capital gain on sale of subsidiary     -       272       -  
                         
    $ -     $ (3 )   $ -  

Cash paid during the year for :                        
Interest   $ 6     $ -     $ 109  
Income taxes, net   $ 25     $ 50     $ 31  

 

Supplemental disclosure of non-cash investing and financing activities:                        
                       
Extinguishments of liabilities credited to shareholder’s deficit (see Note 1d)   $ 1,220     $ 147       -  
Issuance of shares to service providers and officer   $ 21     $ -     $ 63  

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F- 8
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

U.S. dollars in thousands (except per share data)

 

NOTE 1:- GENERAL

 

a. Vuance Ltd. (the “Company") was incorporated in 1988 in Israel. The Company’s ordinary shares have been listed for trade on the Pink OTC Markets Inc ., which operates an electronic quotation service for securities traded over-the-counter, since October 1, 2009, under the ticker symbol “VUNCF”..

 

Until January 2010 (the date of the sale of the activities as described below in Note 1b), the Company developed and marketed security solutions for viewing, tracking, locating, credentialing, and managing essential assets and personnel, which encompassed electronic access control, urban security, and critical situation management systems as well as long-range Active RFID for public safety, commercial, and government sectors. Following the sale of certain activities in January 2010, the Company is focusing on its wireless ID products and solutions, e-ID projects and solutions.

 

The Company is headquartered in Israel.

 

The Company sells its products through centralized marketing office in U.S and Israel.

 

The Company's subsidiaries includes: Vuance Inc. incorporated in the United States (see b2 below regarding the presentation of certain activity of Vuance Inc as discontinued operations), Vuance RFID Inc., (incorporated in Delaware) (see b1 below regarding the presentation of certain activity of Vuance RFID as discontinued operations), S.B.C. Aviation Ltd., (incorporated in Israel) which began operations in 2007, and focused until 2009 on executing perimeter security and a border control project at a European International Airport, PureRFid, Inc. (incorporated in Delaware) which focuses on the marketing and selling of the Company’s active RFID solutions and until October 21, 2010 SuperCom Asia Pacific Limited incorporated in Hong Kong which focused on marketing (see c below). As of December 31, 2011, all the Company’s activities were concentrated mainly through Vuance Ltd. and PureRFid, Inc.

 

Regarding the sale of certain assets and liabilities of Vuance Inc in January 2010, see b2 below.

 

On March 25, 2009, the Company, through its subsidiary, Vuance Inc., completed the acquisition of certain assets and liabilities of Intelli-Site, Inc. (“Intelli-Site”). The purchase price was $262 payable in cash and in shares of the Company (which were subject to a certain lock up mechanism) and included a contingent consideration of up to $600 based upon certain conditions.

 

The results of operations of Intelli-Site were included in the consolidated financial statements of the Company commencing April, 2009. However, during the first quarter of 2010, this activity (including the contingent consideration related to it) was sold, see b2 below.

 

F- 9
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 1:- GENERAL (Cont.)

 

b. Discontinued operations
     
1. During the fourth quarter of 2008, the Company ceased the operations of distribution of locks (which commenced during 2008). The assets attributed to this discontinued operations, mainly inventory, were sold during 2009.

 

The results of the discontinued operation for the year ended December 31, 2009, is presented below:

 

    Year ended
December 31, 2009
 
       
Revenues   $ 156  
Cost of revenues   $ (196 )
Selling and marketing   $ (25 )
Net loss   $ (65 )

 

2. On January 28, 2010 (the “Closing Date”), the Company and its subsidiary Vuance, Inc. completed the sale of certain of the assets (including certain accounts receivable and inventory) and certain of the liabilities (including certain accounts payable) of Vuance Inc. (the “Sale”) related to the Company's electronic access control market (the “Vuance EAC Business”), pursuant to a certain Agreement for Purchase and Sale of Business Assets (the “Purchase Agreement”), dated as of January 9, 2010 between Vuance Inc. and OLTIS Security Systems International, LLC (“OSSI”). On the Closing Date, as consideration for the Sale of the Vuance EAC Business, OSSI paid Vuance Inc. $147 in cash. In addition, OSSI paid off (the “Bridge Bank Payment”) a certain Business Financing Agreement (the “Loan”) between Vuance Inc. and Bridge Bank, National Association in an amount of $290. Further to the Bridge Bank Payment, the Loan was released, and the Company and Vuance Inc. no longer have any liabilities associated with the Loan. The Purchase Agreement includes an indemnification clause pursuant to which, Vuance Inc. agrees to indemnify and hold OSSI harmless from and against any claim or liability of Vuance Inc. or the Company, which may be asserted against OSSI, excepting only to the extent of any business debts and other liabilities which OSSI expressly agrees to pay or assume at the closing date.

F- 10
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 1:- GENERAL (Cont.)

 

b. Discontinued operations (cont.)

 

2. (cont.)

 

On January 29, 2010 (the “Closing Date”), the Company and its subsidiary, Vuance, Inc., completed the sale of certain of the assets and certain of the liabilities of Vuance Inc. (the “Sale”) related to the Company's Government Services Division (the “Vuance CSMS Business”), pursuant to a certain asset purchase agreement (the “Purchase Agreement”) dated January 29, 2010 between the Company, Vuance Inc., WidePoint Corporation (“WidePoint”) and Advance Response Concepts Corporation.

 

On the Closing Date, as consideration for the Sale, WidePoint paid Vuance Inc. $250. In addition, WidePoint agreed to pay Vuance Inc. a maximum earn out of $1,500 over the course of the calendar years 2010, 2011, and 2012, subject to the performance of certain financial requirements of the Vuance CSMS Business during each of those years. The Purchase Agreement includes an indemnification clause pursuant to which, each of the parties shall indemnify and hold harmless the other party in the event of the existence of certain circumstances stipulated in the Purchase Agreement.

 

Each of the activities sold meets the definition of a component under ASC Topic 205-20 - “ Discontinued Operation” , and accordingly, the results of operations of these components were presented as discontinued operations.

 

Following the sale of the activities, the Company does not have any involvement with respect to the activities sold.

 

The results of the discontinued operations are as follows:

 

    Year ended December 31,  
    2010     2009  
Revenues   $ 541     $ 4,944  
Cost of revenues     (497 )     (2,521 )
Research and development     (96 )     (930 )
Selling and marketing     (105 )     (1,950 )
General and administrative     (28 )     (761 )
Financial expenses     (4 )     (124 )
Impairment of goodwill and other intangible assets     -       (1,119 )
Net loss   $ (189 )   $ (2,461 )

  

c.       Sale of subsidiary:

 

During October 2010, the Company sold its entire equity interest in its wholly owned Hong Kong subsidiary, SuperCom Asia Pacific Limited (the “Subsidiary”), for no consideration. As part of this sale, the Company assigned to the purchaser certain outstanding loans due to the Company by the Subsidiary in the amount of $1,400. As result of the sale of the Subsidiary, the Company realized a capital gain of $272 in the fourth quarter of 2010.

 

F- 11
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 1:- GENERAL (Cont.)

 

d.       Extinguishment of liabilities

 

On November 3, 2010, the Company submitted to the District Court in Petach-Tikva, Israel, a request to summon meetings of creditors of the Company, in order to approve a proposed arrangement between the Company and its creditors (including convertible bond holders) in accordance with Section 350 of the Israeli Companies Law 5759-1999. The proposed arrangement involved an allotment of ordinary shares or warrants to purchase ordinary shares of the Company to certain of its creditors, at a price of $0.09 per ordinary share against 40% of the total outstanding debt to the creditors, to the effect of total satisfaction of the entire debt owed to the Company’s creditors (thus forgiving and waiving 60% of the total outstanding debt of the Company). The proposed arrangement was based on the one which was approved by the general meeting of the shareholders dated September 12, 2010. The Company convened the meetings of its creditors to approve the proposed debt arrangement during February and March 2011. On March 15, 2011, the Company filed an application with the Petach-Tikva District Court, in Israel, for the approval of the creditor arrangement.

 

On July 18, 2011, the Discrict Court decided not to approve the Company’s application, mainly due to an objection to the proposed arrangement filed by one of the Company’s secured creditors, Special Situations Funds ("SSF"), which later assigned its bond on November 8, 2011 to Mr. Eliyahu Trabelsi (see also Notes 12 and 14f). In February 2012, following the approval of the board of directors, the Company decided to proceed with the arrangement which was approved by its general meeting without further proceeding in the District Court subject to its creditors agreements.

 

As of December 31, 2010, certain creditors with a total outstanding debt of $271 had accepted the Company's debt arrangement proposal. The Company allotted for those certain creditors a total of 1,206,142 warrants to purchase ordinary shares of the Company (see also Note 13f2). In accordance with ASC Topic 470-50-40, the Company recorded an amount of $124 as a gain from extinguishment of debts based on the difference between the carrying amount of the liabilities extinguished ($271) and the fair value of the warrants allotted ($147), which was credited directly to additional paid-in capital.

 

In June, 2011 certain creditors with a total outstanding debt of $322 had accepted the Company's debt arrangement proposal. The Company allotted for those certain creditors a total of 1,081,871 warrants and 300,000 options (with exercise price of nil) to purchase ordinary shares of the Company. In accordance with ASC Topic 470-50-40, the Company recorded an amount of $143 as a gain on extinguishment of debtsbased on the difference between the carrying amount of the liabilities extinguished ($322) and the fair value of the warrants and options allotted ($179), which was credited directly to additional paid-in capital (see also Note 13).

 

In a certain arrangement that was subject to the approval of the board of directors, following such approval, on August 4, 2011, Sigma Wave Ltd (“Sigma”), a convertible bond holder, had accepted the Company's debt arrangement proposal for an amount of $1,000 of its outstanding debt. The Company allotted to Sigma a total of 4,444,444 ordinary shares of the Company (see also Note 12). In accordance with ASC Topic 470-50-40, the Company recorded an amount of $778 as a gain on extinguishment of debts based on the difference between the carrying amount of the liability extinguished ($1,000) and the fair value of the ordinary shares granted ($222), which was credited directly to share capital ($74) and additional paid-in capital ($148).

 

F- 12
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 1:- GENERAL (Cont.)

 

d.       Extinguishment of liabilities (cont.)

 

  On December 31, 2011 Sigma and Mr. Eliyahu Trabelsi had accepted the Company's debt arrangement proposal for an amount of $2,047 of the outstanding convertible debt amount. The arrangement was not subject to any further approvals or other conditions. The Company committed to issue Sigma and Mr. Eliyahu Trabelsi an aggregated number of 9,094,400 of its ordinary shares as full repayment of such amount. In accordance with ASC Topic 470-50-40, the Company recorded an amount of $1,228 as a gain on extinguishment of debt based on the difference between the carrying amounts of the liabilities extinguished ($2,047) and the fair value of the ordinary shares that the Company was committed to issue ($819). In addition an amount of $819 was credited directly to equity as “amount of liability extinguished on account of shares”. The actual allotment of 8,025,000 ordinary shares to a trustee of Sigma and 1,069,400 ordinary shares to Mr. Eliyahu Trabelsi was completed in April, 2012 (see Note 12).

 

The fair value of the equity instruments (shares, warrants and options with exercise price of nil) that were issued in connection with the extinguishment of debts and liabilities, were measured based on a quotation of the Company’s ordinary shares, on the date that the agreement with the respective creditor became effective.

 

The Company proposed the same arrangement to a certain other creditor in an amount of $311 and in respect of the Convertible Bonds which total debt amount is approximately $2,975 as of December 31, 2011.

 

e.       Concentration of risk that may have a significant impact on the Company:

 

Throughout the reporting periods the Company derived most of its revenues from one major customer. See also Note 15c.

 

The Company purchases certain services and products used by it to generate revenues in its projects and sales from several sole suppliers. Although there are only a limited number of manufacturers of those particular services and products, management believe that other suppliers could provide similar services and products on comparable terms without affecting operating results.

 

f. The Company has incurred substantial losses and negative cash flows from operations since its inception. The Company had an operating cash flow deficit in each of the years in the three year period ended December 31, 2011. As of December 31, 2011, the Company had an accumulated deficit of approximately $48,325, working capital deficit of $2,723 (excluding the Convertible Bonds which total debt is approximately $2,975 as of December 31, 2011) and the total shareholders' deficit amounted to $5,601. The Company incurred net income of approximately $1,019 in the year ended December 31, 2011 (which includes a capital gain of $2,149 as a result of extinguishment of debt in 2011) and incurred net losses of approximately $1,965 and $5,085 in the years ended December 31, 2010 and 2009, respectively. The Company may continue to have an annual losses and operating negative cash flows for the near future, and expects to spend significant amounts of capital to enhance its products and services, develop further sales and operations and fund expansion. As a result, the Company will need to generate significant revenues to sustain profitability. The Company may not be able to sustain or increase profitability on a quarterly or annual basis. Continuation of the Company's current operations after utilizing its current cash reserves and other current assets is dependent upon the generation of additional financial resources. As described in Note 1d, the Company wishes to complete the creditors’ arrangement and also is seeking to raise funds either by equity issuances or by receiving banking credit lines. These matters raise substantial doubt about the Company's ability to continue as a going concern. The financial statements have been prepared assuming the Company will continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

F- 13
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("US GAAP").

 

a. Use of estimates:

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to allowance for doubtful account, contingencies and going concern assumptions.

 

b. Financial statements in U.S. dollars:

 

Most of the revenues of the Company and its subsidiaries are received in U.S. dollars. In addition, a substantial portion of the costs of the Company and its subsidiaries are incurred in U.S. dollars. Therefore, management believes that the dollar is the currency of the primary economic environment in which the Company and its subsidiaries operate. Thus, the functional and reporting currency of the Company and its subsidiaries is the U.S. dollar.

 

Monetary accounts maintained in currencies other than the U.S. dollar are re-measured into U.S. dollars in accordance with the standards of the Financial Accounting Standards Board ("FASB"). All transaction gains and losses from the re-measurement of monetary balance sheet items are reflected in the statements of operations as financial income or financial expenses as appropriate.

 

c. Principles of consolidation:

 

The consolidated financial statements include the accounts of the Company and its subsidiaries (unless the non-controlling shareholders have certain approval or veto rights) in Israel, the United States and Hong-Kong (see Note 1c). Material intercompany transactions and balances were eliminated upon consolidation. Material profits from intercompany sales, not yet realized outside the group, were also eliminated.

 

d. Cash and cash equivalents:

 

The Company considers unrestricted short-term highly liquid investments originally purchased with maturities of three months or less to be cash and cash equivalents.

 

e. Restricted cash deposits:

 

Restricted cash includes a deposit which is used to secure agreement with account payable.

 

f.       Allowance for doubtful accounts:

 

The allowance for doubtful accounts is determined with respect to specific amounts the Company has determined to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past experience with such customers and the information available regarding such customers.

 

g.       Inventories:

 

Inventories are stated at the lower of cost or market value. Inventory write-offs are mainly provided to cover risks arising from slow-moving items or technological obsolescence. Cost is determined as follows:

  

F- 14
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

g.       Inventories (cont.):

 

Raw materials, parts and supplies - using the “moving average cost" method or the “first in first out” method.

 

Finished products - on the basis of direct manufacturing costs.

 

h.       Investment in a majority-owned company:

 

The investment in a majority-owned company is presented using the equity method of accounting in accordance with ASC Topic 323 - "Investments - Equity Method and Joint Ventures" , due to substantive participation rights held by the non-controlling shareholders, which impact the Company’s ability to exert control over the investee. See Note 5.

 

i. Property and equipment:

 

Property and equipment are stated at cost, net of accumulated depreciation.

 

Depreciation is computed using the straight-line method, over the estimated useful lives, at the following annual rates:

 

    %
     
Computers and peripheral equipment   33
Office furniture and equipment   6 - 20
Leasehold improvements   Over the shorter of the term of
the lease or the life of the asset

 

j. Impairment of long-lived assets and intangible assets:

 

The Company's long-lived assets and certain identifiable intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such asset is considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds the fair value of the asset. Assets to be disposed of by sale are reported at the lower of the carrying amount or fair value, less costs to sell.

 

k. Convertible Bonds :

 

1. Beneficial conversion feature:

 

The Company has considered the provisions of ASC Topic 815-40, "Derivatives and Hedging - Contracts in Entity's Own Equity" , and determined that the embedded conversion feature of the convertible bonds should not be separated from the host instrument because it qualifies for equity classification. Furthermore, the Company applied ASC Topic 470-20, "Debt - Debt with Conversion and Other Options " which clarifies the accounting for instruments with beneficial conversion features or contingency adjustable conversion ratios.

 

The beneficial conversion feature has been calculated by allocating the proceeds received in financing transactions to the convertible instrument and to any detachable warrants included in the transaction, and by measuring the intrinsic value of the convertible instrument based on the effective conversion price as a result of the allocated proceeds.

 

F- 15
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

k. Convertible Bonds (cont.):

 

1. Beneficial conversion feature (cont.):

 

The amount of the beneficial conversion feature with respect to convertible bonds was recorded as a discount on the convertible bonds with a corresponding amount credited directly to equity as additional paid-in capital. After the initial recognition, the discount on the convertible bonds is amortized as interest expenses over the term of the bonds.

 

2. Issuance costs of convertible bonds – deferred charges:

 

Costs incurred in respect of obtaining financing through issuance of convertible bonds were deferred and expensed as financing expenses over the contractual term of the bonds.

 

3. Modification (or exchange) of a convertible bonds

 

The Company applied the provisions of ASC Topic 470 - 50, "Debt - Modifications and Extinguishments", with respect to the modification of terms of convertible debt instruments. According to ASC Topic 470-50, the Company concluded that the modification that occurred in June 2008, August 2009 and November 2009 was determined to be a debt extinguishment. See Note 12.

 

4. Refinance on a long-term basis

 

The Company applied the provisions of ASC Topic 470 – 10 – 45 “Debt – Other Presentation Matters” with respect to a financing agreement signed after December 31, 2010 but before the issuance of the 2010 financial statements and accordingly, presented as of December 31, 2010, certain convertible bonds in a total amount of $4,262, as a long term liability.

 

l. Accrued severance pay and severance pay fund:

 

The liabilities of the Company for severance pay of its Israeli employees are calculated pursuant to Israel's Severance Pay Law. Employees are entitled to one month's salary for each year of employment, or portion thereof. The Company's liability for all its employees is presented under "accrued severance pay". The Company deposits on a monthly basis to severance pay funds and insurance policies. The value of these policies is presented as an asset on the Company's balance sheet.

 

The deposited funds include accrued income up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the Company’s obligation pursuant to Israel's Severance Pay Law or labor agreements.

 

Severance expenses for the years ended December 31, 2011, 2010 and 2009 amounted to $15, $57 and $22, respectively.

 

m. Goodwill and Intangible assets:

 

Intangible assets are amortized over their useful lives using the straight line method of amortization that reflects the pattern in which the economic benefits of the intangible assets are consumed or otherwise used up, in accordance with ASC Topic 350, "Intangibles - Goodwill and Other" .

 

F- 16
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

m. Goodwill and Intangible assets (cont.):

 

Goodwill represents the excess of the aggregate purchase price over the fair value of the net assets acquired in a purchase business combination. Goodwill is not amortized, but rather is tested for impairment at least annually or between annual tests, if certain events or indications of impairment occur. Goodwill is tested for impairment at the reporting unit level. As required by ASC Topic 350, the Company compares the fair value of each reporting unit to its carrying value ("step 1"). If the fair value exceeds the carrying value of the reporting unit’s net assets, goodwill is considered not to be impaired, and no further testing is required. If the carrying value exceeds the fair value of the reporting unit, then the implied fair value of goodwill is determined by subtracting the fair value of all the identifiable net assets from the fair value of the reporting unit. An impairment loss is recorded for the excess, if any, of the carrying value of the goodwill allocated to the reporting unit over its implied fair value ("step 2").

 

Due to the sale of activities in January 2010 (see Note 1b2), the Company recorded in 2009 an impairment loss of the entire remaining balance of the goodwill which was attributed to the components sold in an amount of $685 and certain other intangible assets in an amount of $434.

 

n.       Revenue recognition:

 

The Company and its subsidiaries generate their revenues from the sale of products, maintenance, royalties and long term contracts (including training and installation).

 

Product sales are recognized in accordance with Staff Accounting Bulletin No. 104, “Revenue Recognition” (“SAB No. 104”), when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, collectability is reasonably assured, and inconsequential or perfunctory performance obligations remain. If the product requires specific customer acceptance, revenue is deferred until customer acceptance occurs or the acceptance provision lapses.

 

The Company is not obligated to accept returned products or issue credit for returned products, unless a product return has been approved by the Company in advance and according to specific terms and conditions. As of December 31, 2011, the Company had an allowance for customer returns in an amount of $13.

 

The Company recognized certain long-term contract revenues in accordance with ASC Topic 605-35, "Construction-Type and Production-Type Contracts" . Pursuant to ASC Topic 605-35, revenues from these contracts are recognized under the percentage of completion method. The Company measures the percentage of completion based on output or input criteria, such as contract milestones, percentage of engineering completion or number of units shipped, as applicable to each contract. Provisions for estimated losses on uncompleted contracts are made during the period in which such losses are first identified, in the amount of the estimated loss on the entire contract. As of December 31, 2011, no such estimated losses were identified.

 

The Company believes that the use of the percentage of completion method is appropriate, since the Company has the ability, using also an independent subcontractor's evaluation, to make reasonably dependable estimates of the extent of progress made towards completion, contract revenues and contract costs. In addition, contracts executed include provisions that clearly specify the enforceable rights of the parties to the contract, the consideration to be exchanged and the manner and terms of settlement. In all cases, the Company expects to perform its contractual obligations and the parties are expected to satisfy their obligations under the contract.

 

F- 17
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

n.       Revenue recognition (cont.):

 

In contracts that do not meet all the conditions mentioned above, the Company utilized zero estimates of profits; equal amounts of revenue and cost are recognized until results can be estimated with sufficient accuracy.

 

Revenues and costs recognized pursuant to ASC Topic 605-35 on contracts in progress are subject to management estimates. Actual results could differ from these estimates.

 

As of December 31, 2010 and 2011, all the long-term contracts were completed and their related revenues were recognized in full.

 

Revenues for maintenance services are recognized over the term of the contracts.

 

The warranty period is usually 12 months. Based primarily on historical experience, the Company does not provide for warranty costs when revenue is recognized, since such costs are not material.

 

Deferred revenues and customer advances include amounts received from customers for which revenues have not been recognized.

 

The Company is entitled to royalties upon the issuance of certificates. Such royalties are recognized when the sales are reported to the Company (usually on a monthly basis).

 

o.       Shipping and handling costs:

 

Shipping and handling fees billed to customers are reflected as revenues while the related shipping and handling costs are included in cost of revenues. To date, shipping and handling costs have not been material.

 

p.       Research and development costs:

 

Research and development costs (other than software) are expensed as incurred.

 

q.       Income taxes:

 

The Company and its subsidiaries account for income taxes in accordance with ASC Topic 740, "Income Taxes" . This Statement prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

 

The Company accounts for uncertain tax positions in accordance with ASC Topic 740-10, which prescribes detailed guidance for the financial statement recognition, measurement and disclosure of uncertain tax positions recognized in an enterprise’s financial statements. According to ASC Topic 740-10, tax positions must meet a more-likely-than-not recognition and measurement threshold. The Company’s accounting policy is to classify interest and penalties relating to uncertain tax positions under income taxes, however the Company did not recognize such items in its fiscal 2011, 2010 and 2009 financial statements.

 

F- 18
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

r.       Concentrations of credit risk:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash deposits and trade receivables. The Company's trade receivables are derived from sales to limited number of customers located primarily in Eastern Europe, the United States and Israel. The Company performs ongoing credit evaluations of its customers' financial condition. The allowance for doubtful accounts is determined with respect to specific debts that the Company has determined to be doubtful of collection. See Note 2f.

 

Cash and cash equivalents and restricted cash deposits are deposited with major banks in Israel and the United States. Management believes that such financial institutions are financially sound and, accordingly, minimal credit risk exists with respect to these financial instruments.

 

The Company has no significant off-balance-sheet concentration of credit risk, such as foreign exchange contracts, option contracts or other foreign hedging arrangements.

 

s.       Basic and diluted earnings (loss) per share:

 

Basic earnings (loss) per share are computed based on the weighted average number of ordinary shares outstanding during each year. Diluted earnings (loss) per share are computed based on the weighted average number of ordinary shares outstanding during each year, plus the dilutive potential of stock options and warrants outstanding during the year using the treasury stock method and the dilutive potential, if any, of convertible bonds using the “if-converted method”.

 

The net earnings (loss) and the weighted average number of shares used in computing basic and diluted earnings (loss) per share for the reported periods are as follows:

 

    Year ended December 31,  
    2011     2010     2009  
Net income (loss) used for the computation of basic and diluted earnings (loss) per share     1,019       (1,965 )     (5,085 )

 

    Year ended December 31,  
    2011     2010     2009  
Weighted average number of shares used in the computation of basic earnings (loss) per share     9,126,327       6,177,862       5,511,948  
Weighted average number of shares used in the computation of diluted earnings (loss) per share     11,710,254       6,177,862       5,511,948  

  

All outstanding stock options, warrants and convertible bonds have been excluded from the calculation of the diluted net loss per share for the years ended December 2010 and 2009, since the effect of the shares issuable with respect of these instruments was anti-dilutive. The calculation of the diluted net earnings per share for the year ended December 31, 2011 included 3,273,477 options and warrants, the effect of which was dilutive.

 

The number of potential shares from the conversion of convertible bonds, options and warrants that have been excluded from the calculation were 2,733,688, 4,557,840 and 3,189,071 for the years ended December 31, 2011, 2010 and 2009, respectively.

 

The potential shares that would have been issued by the Company as a result of the acceptance of the proposal of the Company to its creditor (as described in Note 1d.) were excluded from the calculations as their effect was anti-dilutive. The weighted average number of such potential shares for the year ended December 31, 2011 was approximately 23,652,296.

  

F- 19
 

  

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

t.       Fair value of financial instruments:

 

The following methods and assumptions were used by the Company and its subsidiaries in determining the fair value disclosures for financial instruments:

 

At December 31, 2011 and 2010, the carrying amounts of cash and cash equivalents, restricted cash deposits, current trade receivables, other accounts receivable, trade payables and other accounts payable (which are not included in the proposed arrangement described in Note 1d) approximate their fair value due to the short-term maturity of such financial instruments.

 

As of December 31, 2011 and 2010, the Company is unable to assess the fair value of the remaining balance of convertible bonds and other liabilities subject to the proposed arrangement due to the uncertainties involved with respect to the completion of the arrangement. The terms of the proposed arrangement are described in Note 1d.

 

u.       Accounting for stock-based compensation:

 

Share-based compensation, including grants of stock options, is recognized in the consolidated statement of operations as an operating expense, based on the fair value of the award on the date of grant. The fair value of stock-based compensation is estimated using an option-pricing model.

 

The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company’s consolidated statement of operations.

 

The Company estimates the fair value of employee stock options using a Black-Scholes valuation model. The Company amortizes compensation costs using the graded vesting attribution method over the vesting period, net of estimated forfeitures.

 

v.       Advertising costs:

 

The Company expenses advertising costs as incurred. Advertising expenses for the years ended December 31, 2011, 2010 and 2009, were approximately $10, $15 and $12, respectively.

 

w.       Comprehensive Income:

 

The Company has no comprehensive income components other than net income (loss) in the reporting periods.

 

x.       Reclassifications:

 

Certain comparative figures have been reclassified to conform to the current period presentation. The changes did not affect net income, cash flow or shareholders' deficit.

 

y.       Fair value measurements:

 

The Company applies ASC Topic 820-10, "Fair Value – Measurement and Disclosure" which defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and requires disclosures for fair value measures.

 

In accordance with ASC Topic 820-10, the Company measures and discloses fair value measurements for certain financial and nonfinancial assets and liabilities. Fair value is an exit price, representing the amount that would be received to sell an asset or the amount that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that is required to be determined based on the assumptions that market participants would use to determine the price of an asset or a liability.

 

F- 20
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

y.       Fair value measurements (cont.):

As a basis for considering such assumptions, the fair value accounting standard establishes the following fair value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

Level 1 - Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

 

Level 2 - Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

 

Level 3 - Unobservable inputs are used when little or no market data is available. Level 3 inputs are considered as the lowest priority under the fair value hierarchy.

 

In determining fair value, companies are required to utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as to consider counterparty credit risk in the assessment of fair value.

 

z.       Discontinued operations:

 

The Company applies ASC Topic 205-20, "Presentation of Financial Statements - Discontinued Operation" . According to ASC Topic 205-20, when a component of an entity, as defined in this standard, has been disposed of or is classified as held for sale, the results of its operations, including the gain or loss on the disposed component, required to be classified as discontinued operations and the assets and liabilities of such component should be classified as assets and liabilities attributed to discontinued operations if both of the following conditions are met: a) the operations and cash flows of the component have been (or will be) eliminated from the ongoing operations of the company as a result of the disposal transaction, and b) the entity will not have any significant continuing involvement in the operations of the component after the disposal transaction. (See also Note 1b).

 

aa.       Recently issued accounting pronouncements:

 

1. Accounting pronouncements adopted in 2011

 

A.      ASC Topic 605 - 25 “Revenue Recognition - Multiple-Element Arrangements”

 

In October 2009, the FASB issued Accounting Standards Update (ASU) 2009-13, Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force . The amended guidance modified the criteria for recognizing revenue in multiple element arrangements and requires companies to develop a best estimate of the selling price to separate deliverables and allocate arrangement consideration using the relative selling price method. In addition, the amendments eliminated the residual method for allocating arrangement considerations.

 

The amended guidance became effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (fiscal year 2011 for the Company). The adoption of the new guidance did not have a material impact on the Company’s financial position, results of operations or cash flows.

 

F- 21
 

  

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

aa.       Recently issued accounting pronouncements (cont.):

 

2. Accounting pronouncements adopted in 2011 (cont.)

 

B. ASC Topic 985 - 605, "Software - Revenue Recognition" (cont.)

 

In October 2009, the FASB issued Accounting Standards Update (ASU) 2009-14, “Certain Revenue Arrangements That Include Software Elements – a consensus of the FASB Emerging Issues Task Force”, to amend the scope of arrangements under ASC 985, Software, 605, “Revenue Recognition” to exclude tangible products containing software components and non-software components that function together to deliver a product’s essential functionality. Such components shall be subject to ASC Topic 605 - 25 “Revenue Recognition - Multiple-Element Arrangements” .

 

The amended guidance became effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 (fiscal year 2011 for the Company). The adoption of the new guidance did not have a material impact on the Company’s financial position, results of operations or cash flows.

 

3. Accounting pronouncements not yet effective:

 

A. ASC Topic 220, “Comprehensive Income”

 

In June 2011, the FASB issued Accounting Standard Update (ASU) 2011-05, “Comprehensive Income (Topic 220) - Presentation of Comprehensive Income” (ASU 2011-05). ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of equity and requires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements.

 

ASU 2011-05 will be effective for fiscal years, and interim periods within those years, beginning after December 15, 2011 (fiscal year 2012 for the Company) and should be applied retrospectively.

 

In December 2011, the FASB issued Accounting Standard Update (ASU) 2011-12, which defers certain provisions contained in ASU 2011-05 requiring the requirement to present components of reclassifications of other comprehensive income on the face of the income statement or in the notes to the financial statements. However, this deferral does not impact the other requirements contained in the new standard on comprehensive income as described above. ASU 2011-12 is effective during interim and annual periods beginning after December 15, 2011 (fiscal year 2012 for the Company).  

 

The adoption of ASU 2011-05 and ASU 2011-12 is not expected to have a material impact on the Company’s financial condition, results of operations or cash flows.

 

F- 22
 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)

 

U.S. dollars in thousands (except per share data)

 

NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (cont.)

 

3. Accounting pronouncements not yet effective (cont.):

 

B. ASC Topic 210, “Balance Sheet”

 

In December 2011, the FASB issued Accounting Standard Update (ASU) 2011-11, “Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities” (ASU 2011-11).  ASU 2011-11, enhance disclosures about financial instruments and derivative instruments that are either offset in accordance with the Accounting Standards Codification or are subject to an enforceable master netting arrangement or similar agreement.

 

The amended guidance will be effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods (fiscal year 2013 for the Company) and should be applied retrospectively to all comparative periods presented.

 

The Company is currently evaluating the impact that the adoption of ASU 2011-11 would have on its consolidated financial statements, if any.

  

NOTE 3:- OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES

 

    December 31,  
    2011     2010  
             
Prepaid expenses   $ 21     $ 8  
Government institutions     56       88  
Advance payment to suppliers     -       193  
Others     28       99  
                 
    $ 105     $ 388  

 

NOTE 4:- INVENTORIES, NET

 

    December 31,  
    2011     2010  
             
Raw materials, parts and supplies   $ 216     $ 145  
Finished products     53       52  
                 
    $ 269     $ 197  

 

As of December 31, 2011 and 2010, the inventory is presented net of allowance for slow inventory in the amount of approximately $74 and $108 respectively.

  

F- 23
 

 

 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 5:- INVESTMENT IN A MAJORITY-OWNED COMPANY

 

In December 1997, the Company set up SuperCom Slovakia, owned equally with another third-party investor, in order to execute a transaction with the Ministry of Interior of the Slovak Republic.

 

In March 2000, the Company purchased an additional 16% of SuperCom Slovakia, at a nominal value of $1, and granted such third-party investor a loan in an amount of $275, bearing interest of 0.7% per month, for any amounts outstanding. Interest is compounded on the outstanding principal balance of the loan and is to be repaid under the same conditions as the outstanding principal balance.

 

The third-party investor has an option to buy back 16% of the shares, for $1, upon repayment of the loan to the Company.

 

The Company currently owns 66% of SuperCom Slovakia's outstanding shares and accounts for the investment using the equity method of accounting, due to the substantive participation rights held by the non-controlling interest holder, which impact the Company’s ability to exert control over the investee.

 

During 2006, the Company wrote down the entire loan balance due to litigation developments regarding this issue and due to low probability of collection of the loan. See Note 10c2. During all the reported periods, the subsidiary had no operating activity.

 

NOTE 6:- PROPERTY AND EQUIPMENT, NET

 

    December 31,  
    2011     2010  
Cost:                
Computers and peripheral equipment   $ 254     $ 262  
Office furniture and equipment     194       197  
Leasehold improvements     24       45  
      472       504  
Accumulated depreciation:                
Computers and peripheral equipment     246       244  
Office furniture and equipment     128       120  
Leasehold improvements     2       30  
      376       394  
Depreciated cost   $ 96     $ 110  

 

Depreciation expenses for the years ended December 31, 2011, 2010 and 2009, were $28, $47 and $77, respectively.

 

NOTE 7:- OTHER ASSETS, NET

 

During 2009, the Company recognized an impairment of the remaining outstanding balance of goodwill and other intangible assets which attributed to the components (as described in ASC 360) that have been classified as of December 31, 2009 as discontinued operations. As a result, the impairment loss was classified in the statements of operations for 2009 within the loss from discontinued operations in an amount of $1,119. See Note 2m.

F- 24
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 8:- BANK CREDIT

 

a. As of December 31, 2010, the Company did not have any credit line from banking institutions.

 

On February 10, 2011 the Company received from an Israeli bank a credit line in an amount of $100. As of December 31, 2011, the entire amount was utilized. The credit line is secured by the personal guarantee of the Company’s current and former chairmen of the board of directors.

 

b. Regarding guarantees and liens - see Note 10b.

 

NOTE 9:- ACCRUED EXPENSES AND OTHER LIABILITIES

 

    December 31,  
    2011     2010  
Accrued marketing expenses   $ 541     $ 402  
Subcontractors of long-term contract     252       368  
Litigation provision     147       352  
Related parties     414       71  
Legal service providers     365       364  
Withholding tax provision in respect of Convertible Bonds held by controlling shareholder     177       -  
Other accrued expenses     268       687  
                 
    $ 2,164     $ 2,244  

 

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES

 

a. Lease commitments:

 

The Company's facilities and those of certain subsidiaries are rented under several operating lease agreements for periods ending in 2013 - 2015.

 

In October, 2011, the Company signed lease agreements for new offices in Hertzliya, (Israel), for a period of two years commencing on October 1, 2011. The monthly lease amount, including management fees of the leased property, is approximately $15.

 

The Company's subsidiary in the USA leases a facility in Peachtree City, GA. The average monthly fee of the facility is approximately $3. The lease commenced on March 1, 2008 and is scheduled to expire onFebruary 28, 2013.Vuance, Inc. also leases a facility in Oak Creek, Wisconsin. The average monthly lease amount for the facilities is approximately $5. The lease commenced on April 1, 2010 and is scheduled to expire on March 31, 2015.

 

Future minimum lease commitments under non-cancelable operating leases for the years ended December 31, are as follows:

 

2012   $ 280  
2013     204  
2014     65  
2015     16  
    $ 565  

 

Rent expenses, net of rent income from subleases, for the years ended December 31, 2011, 2010 and 2009, were approximately $176, $121 and $331, respectively.

 

F- 25
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES (cont.)

 

b. Guarantees, indemnity and liens:

 

1. The Company issued a Letter of Credit, with a balance of $130 as of December 31, 2010 to a supplier, related to a certain project of the Company with a European country. As a condition of this Letter of Credit, as of December 31, 2010, the Company deposited $130, which is presented as restricted cash deposits. The Letter of Credit expired on December 31, 2010 and the remaining restricted deposit of $130 was released during January 2011.

 

2. The Company issued on October 17, 2011 a bank guarantee to the services company of its new offices in Herzliya (see a above), in an amount of up to NIS62,662 ($16 as of December 31, 2011).

 

3. Pursuant to the Amendment Agreements with the convertible bonds holders (see also Note 12), in exchange for security in certain assets of the Company, the Company and the investors agreed to waive compliance and amend certain provisions of the Bond.

 

4. On April 29, 2012, the Company’s board of directors approved the recording of a floating charge on all of the Company’s assets in favor of the Company’s current and former chairmen of the board of directors, unlimited in amount, in order to secure personal guarantees granted by them in favor of the Company, such as to a bank (see Note 8a) and in order to secure short-term loans that are given by them from time to time to the Company (see Note 14h).

 

5. See also Note 1b2.

 

c. Litigation:

 

1. In April 2004, the Department for Resources Supply of the Ministry of Ukraine (the "Department") filed a claim with the International Commercial Arbitration Court at the Ukrainian Chamber of Commerce and Industry (the “Arbitration Court”) to declare Contract No. 10/82 (the “Contract”), dated April 9, 2002, between the Company and the Ministry of Internal Affairs of the Ukraine (the "Ministry"), as void due to defects in the proceedings by which the Company was awarded the Contract. In July, 2004, the Arbitration Court declared the Contract as void. On April 27, 2005, the Company appealed the decision to the High Commercial Court of the Ukraine. In May 2005, the Department filed a new statement of claim with the Arbitration Court for restitution of $1,048 paid to the Company by the Department under the Contract. On September 27, 2005, the Company received a negative award issued by the Arbitration Court in the second claim (the "Award"). On December 12, 2005, the Company was informed that the Ukrainian Supreme Court had dismissed its appeal regarding the July 2004 decision. On June 29, 2006, the Ukrainian Supreme Court held that the Arbitration Court award was valid and legal under applicable law.

 

On September 28, 2008, the Department filed a petition (the "Petition") in the Central District Court of Israel (the "Court"), under which the Department requested the approval of the Award as a valid foreign arbitral award under the laws of the State of Israel.

 

During November 2008, the Company filed with the Court an objection to the Petition and a petition to declare the Award null and void. The Company's objection and petition rely on what the Company believes to be well-based evidence which the Company has against the manner under which the arbitration proceedings were conducted by the Arbitration Court and against their validness and legality. The Company believes that the arbitration proceedings were conducted partially and jeopardized its basic rights. The Company's claims are also corroborated by a contrary legal opinion written in the scope arbitration decision by one of the arbitrators ("Arbitrator").

 

F- 26
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES (cont.)

 

c. Litigation (cont.):

 

1. (cont.)

 

On February 16, 2009, the Department filed its response to the Company's claims (the "Response"). The Department raised procedural and other claims in its Response, including a monetary claim that the Company filed which is based on the Award and the filing of such claim basically affirms the Company’s acknowledgment that the Award is valid. On March 25, 2009, the Company filed a response to the Department's response and a requisition to order the Arbitrator to testify in the scope of the Petition proceedings.

 

On June 6, 2009, a preliminary court session was held regarding the Petition. During the session, the Department's counsel claimed that one of the two machines that the Company previously supplied pursuant to the Contract (which machine was priced higher than the amount of the Department's claim) was not supplied to the Department and was transferred by the Company to another Ukrainian governmental authority. It is noted that the Company has documents that evidence that, contrary to the Department's claim, the Company supplied both of the machines directly to the Department.

 

At a hearing held on September 23, 2009, the Court accepted the Company's application to summon the Arbitrator as a witness. At the hearings which took place on November 29 and November 30, 2010, the Arbitrator testified in Court. In his testimony, the Arbitrator described procedural flaws which occurred, in his view, during the arbitration and also related to threats which were made against him by the Secretary of the Ukrainian Chamber of Commerce and Industry in the course of the arbitration session.

 

Following the testimony of the Arbitrator, the Department asked the Court to summon the other two Ukrainian arbitrators as witnesses. The Court accepted the request and scheduled hearings for their testimonies in 2011. However, the Department’s witnesses (including the other two Ukrainian arbitrators) did not appear in court at the times scheduled for their testimonies. In light thereof, the court ordered that summations be submitted in writing without having the witnesses of the Department testify.

 

On December 5, 2011 the Company submitted a summation in writing. However, the Department has not submitted its summation and its counsel even notified the Court that his appointment as the Department’s counsel had been cancelled. In these circumstances the Company filed a petition for judgment due to the absence of summations by the Department. On February 26, 2012, the Court ruled that it accepts the Company’s petition to give judgment due to the lack of summations on behalf of the Department and that the file will be assigned for writing a judgment on the basis of the evidence that had been presented to the Court in the course of the proceeding.

 

On April 15, 2012, the Court gave its judgment, pursuant to the Court dismissed the Department’s Petition and also declared the Award null and void.

 

F- 27
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES (cont.)

 

c. Litigation (cont.):

 

2. On October 30, 2003, SuperCom Slovakia, a subsidiary (66%) of Vuance Ltd., received an award from the International Arbitral Center of the Austrian Federal Economic Chamber, in a case against the Ministry of Interior of the Slovak Republic (“the Ministry”) relating to the Agreement on Delivery of Technology, Cooperation and Services signed on March 17, 1998. Upon the Arbitral Award, the Ministry of Interior of the Slovak Republic was ordered to pay SuperCom Slovakia the amount of SKK 80,000,000 (approximately $3,438 as of December 31, 2011) plus interest accruing from March 1999. In addition, the Ministry of Interior of the Slovak Republic was ordered to pay the costs of arbitration in the amount of EUR 42,716 (approximately $55 as of December 31, 2011) and SuperCom Slovakia’s legal fees in the amount of EUR 63,611 (approximately $82 as of December 31, 2011). The Company has begun an enforcement proceeding to collect the arbitral awards. The Ministry of Interior of the Slovak Republic filed a claim with the Commercial Court in Vienna, Austria on February 10, 2004, whereby it challenged and requested to set aside the arbitral award. During September 2005, the Commercial Court of Vienna dismissed the claim. On October 21, 2005, the Ministry of the Interior of the Slovak Republic filed an appeal. On August 25, 2006, the Austrian Appellate Court rejected the appeal and ordered the Ministry to reimburse Supercom Slovakia´s costs of the appellate proceeding in the amount of EUR 6,688 within 14 days. On October 3, 2006, the Company was informed that the Ministry had decided not to file an extraordinary appeal to the Austrian Supreme Court’s decision rejecting its appeal. To date, the Company’s efforts to enforce the Commercial Court’s decision have been unsuccessful.

 

3. On December 16, 1999, Secu-Systems Ltd. filed a lawsuit with the District Court in Tel-Aviv-Jaffa jointly and severally against the Company and its former subsidiary, InkSure Ltd. (“InkSure”), seeking a permanent injunction and damages arising from the printing method applied to certain products developed by InkSure. In its lawsuit, Secu-Systems asserted claims of breach of a confidentiality agreement between Secu-Systems and the Company, unjust enrichment of the Company and InkSure, breach of fiduciary duties owed to Secu-Systems by the Company and InkSure and misappropriation of trade secrets and damage to Secu-Systems’ property. On March 15, 2006, the Court denied the breach of contract claim, but upheld the claim for misappropriation of trade secrets and ordered InkSure and the Company to cease all activity involving the use of the confidential knowledge and/or confidential information of Secu-Systems. In addition, the court ordered the Company and Inksure to provide a report certified by an accountant setting forth in full the income and/or benefit received by InkSure and the Company as a result of the infringing activity through the date of the judgment, and ordered the Company and Inksure, jointly and severally, to pay to Secu-Systems compensation in the amount of NIS 100,000 ($26 as of December 31, 2011) and legal expenses as well as attorney’s fees in the amount of NIS 30,000 ($8 as of December 31, 2011) (which was paid during 2006). Secu-Systems has filed an appeal, and the Company and InkSure filed a counter-appeal, on the above ruling.

 

During the years thereafter several court sessions were held, judgments were made and appeals were filed by each of the parties.

 

On December 15, 2009, the court suggested that the parties try a mediation process in order to endeavor to come to an agreement. All the parties agreed to the suggestion.

F- 28
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 10:- COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

 

c. Litigation (cont.):

 

3. (cont.)

 

In the course of the mediation process, during 2010, an agreement in principle was reached, according to which the mediator will be authorized to determine the sum, within the range between NIS 750,000 (approximately $196 as of December 31, 2011) and NIS 1,000,000 (approximately $262 as of December 31, 2011), which the Company shall pay to Secu-Systems. Pursuant to such agreement in principle, the amount determined by the mediator will be paid by the Company during 2011 in 10 equal, consecutive monthly installments.

 

Following the said agreement in principle, a binding mediation agreement was signed by the parties, and on September 1, 2010, a mediation session was held. On November 30, 2010, the mediator determined that the sum the Company will have to pay to Secu-System is NIS 893,000 (approximately $234 as of December 31, 2011). On January 30, 2012, the parties submitted to the court a request to approve the mediation agreement. The mediation agreement was approved by the court on February 5, 2012.

 

During 2011 the Company paid NIS 535,800 (approximately $140 as of December 31, 2011). As of December 31, 2011 there is a liability in the amount of $94 related to this litigation.

 

4. On May 7, 2012, a supplier of the Company filed a lawsuit with the Magistrate Court in Tel Aviv in the amount of NIS360,199 (approximately $94 as of December 31, 2011) claiming mainly for payments of products which were supplied during 2011 and for payments for products which were purchased by the supplier but were refused to be received by the Company due to dissatisfaction of the Company in respect of the supplied products. The Company is denying the supplier’s claims and has its own claims against the supplier in respect of the quality of the products supplied by him. The Company is right now in the process of evaluating the lawsuit with its legal advisor. The balance of accounts payable with respect to the supplier as of December 31, 2011 is approximately $46, which represents the value of the supplied products during 2011. No additional provision has been recognized with respect to the supplier's claim.

 

d. In a certain transactions, the Company is obligated to pay a certain percentage of the revenues to third parties.

 

e. The Company is obligated, under certain contracts with one of its manufacturers, to purchase certain blanket orders from such manufacturer, subject to certain terms and conditions.

 

F- 29
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 11:- INCOME TAX

 

a. Measurement of results of operations for tax purposes under the Israeli Income Tax Law (Inflationary Adjustments), 1985.

 

Until December 31, 2007, the results of operations for tax purposes in Israel were measured in terms of earnings in NIS after adjustments for changes in Israel's Consumer Price Index ("CPI"). Commencing January 1, 2008, this law is void and in its place there are transition provisions, whereby the results of operations for tax purposes are to be measured on a nominal basis. As explained in Note 2b, the financial statements are measured in U.S. dollars. The difference between the annual change in Israel's CPI and in the NIS/dollar exchange rate causes a further difference between taxable income and income before taxes shown in the financial statements. In accordance with paragraph 25-3f of ASC TOPIC 740-10-25, Income Taxes , the Company has not provided for deferred income taxes on the above difference between the functional currency and the tax bases of assets and liabilities.

 

b. Changes in the Israeli corporate tax rates:

 

On July 25, 2005, the Israeli Parliament passed an amendment to the Income Tax Ordinance (No. 147) - 2005, gradually reducing the tax rate applicable to the Company as follows: in 2009 - 26% and in 2010 and thereafter - 25%.

 

On July 23, 2009, as part of the Arrangements Law for the period 2009-2010, article 126 of the Income Tax Ordinance (New Version) – 1961 was amended, whereby the corporate tax rate would be gradually reduced commencing in the 2011 tax year and thereafter, as follows: 2011 – 24%, 2012 – 23%, 2013 – 22%, 2014 – 21%, 2015 – 20% and 2016 and thereafter – 18%.

 

On December 6, 2011, the Law for the Change in the Tax Burden (Legislative Amendments) – 2011 was publicized.  As part of the law, among other things, the Economic Efficiency Law (Legislative Amendments for the Implementation of the Economic Plan for 2009 and 2010) – 2009 and the Income Tax Ordinance (New Version) – 1961 were amended whereby, commencing in 2012, the blueprint for the reduction in the corporate tax rates will be cancelled and the corporate tax rate will be 25%. 

 

c. Non-Israeli subsidiaries:

 

Non-Israeli subsidiaries are taxed according to the tax laws of the countries in which they are located.

 

F- 30
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 11:- INCOME TAX (cont.)

 

d. Deferred income taxes:

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the deferred tax assets of the Company and its subsidiaries are as follows:

 

    December 31,  
    2011     2010  
             
Operating loss carryforward   $ 11,128     $ 9,814  
Reserves and allowances     601       739  
                 
Net deferred tax assets before valuation allowance     11,729       10,553  
Valuation allowance     (11,729 )     (10,553 )
                 
Net deferred tax assets   $ -     $ -  
                 
Deferred income taxes consist of the following:                
Domestic   $ 6,892     $ 5,593  
Valuation allowance     (6,892 )     (5,593 )
                 
Foreign     4,837       4,960  
Valuation allowance     (4,837 )     (4,960 )
                 
    $ -     $ -  

 

As of December 31, 2011, the Company and its subsidiaries have provided a valuation allowance in a total amount of $11,729 in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Management currently believes that since the Company and its subsidiaries have a history of losses, the deferred tax assets are not considered more likely than not to be realized in the foreseeable future.

 

e. Carryforward tax losses:

 

Vuance Ltd. has accumulated losses for tax purposes as of December 31, 2011, in an amount of approximately $25,226, which may be carried forward and offset against taxable income in the future for an indefinite period. Vuance Ltd. also has a capital loss in an amount of approximately $13,906 which may be carried forward and offset against capital gains for an indefinite period. Losses carryforwards in Israel are measured in NIS.

 

As of December 31, 2011, Vuance's subsidiaries in the United States have estimated total available carryforward tax losses of approximately $14,182. In the U.S., tax losses can be carried forward for 20 years. However, utilization of U.S. net operating losses may be subject to a substantial annual limitation due to the "change in ownership" provisions of the Internal Revenue Code of 1986 and similar state provisions. These annual limitations may result in the expiration of net operating losses before utilization. An amount of $3,413 of the carryforward tax losses of the Company's subsidiary in the U.S, is subject to such limitation, due to the Security Holding Corp. acquisition in 2007.

 

F- 31
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 11:- INCOME TAX (cont.)

 

f. Vuance Ltd has assessments which are considered as final until the tax year ended December 31, 2007.

 

Vuance’s subsidiaries in the United States and Israel have not received final assessments since their incorporation.

 

g. Income (loss) before income tax consists of the following:

 

    Year ended December 31,  
    2011     2010     2009  
                   
Domestic   $ 1,359     $ (1,275 )   $ (2,011 )
Foreign     (315 )     (451 )     (477 )
                         
    $ 1,044     $ (1,726 )   $ (2,488 )

 

h. Reconciliation of the theoretical tax benefit to the actual tax benefit:

 

A reconciliation of theoretical tax expense, assuming all income is taxed at the statutory rate applicable to the income of companies in Israel, and the actual tax expense, is as follows:

 

    Year ended December 31,  
    2011     2010     2009  
Income (loss) before income tax, as reported in the consolidated statements of operations   $ 1,044     $ (1,726 )   $ (2,488 )
                         
Statutory tax rate in Israel     24 %     25 %     26 %
                         
Theoretical tax (benefit) expense   $ 251     $ (432 )   $ (647 )
Carryforward losses and other deferred taxes for which a full valuation allowance was recorded     (253 )     486       503  
Tax expenses related to withholding tax at source     22       39       31  
Differences in taxes resulting from rate applicable to foreign subsidiary and others     5       (43 )     184  
Actual income tax   $ 25     $ 50     $ 71  

 

F- 32
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 12:- CONVERTIBLE BONDS

 

In November 2006, the Company raised $3,156.5 through the issuance of Units consisting of Convertible Bonds and Warrants. Units valued at $2,500 were issued to Brevan Howard Master Fund Limited (“BH”), and Units valued at $656.5 were issued to Special Situation Funds (“SSF”), based on the participation rights provided in a private placement during 2005, which were existing shareholders of the Company. According to their original terms, the Convertible Bonds mature three years from the date of issuance and bear interest at an annual rate of 8% (which was updated as described below). Any withholding and other taxes payable with respect to the interest will be grossed up and paid by the Company (approximately 3% of the principal of the bonds), payment of interest will be net of any tax. Subject to certain redemption provisions, as described below, the Convertible Bonds may be converted at any time, at the option of the investors, into the Company's ordinary shares at an original conversion price of $5 per share (see amendment below). The investors were also granted warrants entitling them to acquire a total of 134,154 ordinary shares at an original exercise price of $5 per share during the next five years (see amendments below). In respect of this transaction, the Company paid approximately $215 cash as issuance expenses and granted an option to acquire up to 25,000 shares of the Company to a third party, exercisable at an original $5 per share. The fair market value of this grant option was $40.

 

If the Company fails to fulfill certain conditions, the investors may accelerate repayment of the principal amount of $3,156.5 of the Convertible Bonds, in which case all interest payable until maturity date will immediately become due and payable.

 

The Company has determined that the embedded conversion feature should not be separated from the host instrument because it qualifies for equity classification. Therefore the transaction was accounted for in accordance with ASC Topic 470 - 20, "Debt - Debt with Conversion and Other Options” .

 

In November 2007, due to a breach of certain conditions of the convertible bonds, the investors had the right to accelerate the repayment of the principal amount of the bonds with all the interest payable until the maturity date of the bonds. However, the Company signed an amendment to the agreement with the investors under which the Company was required to pay to one of the investors the abovementioned interest amount ($276) (with any withholding and other taxes payable with respect to the interest (approximately 3% of the principal of the bonds)) and in respect of the other investors, the Company changed the conversion ratio of the bonds to $4.25. In consideration, the investors waived their right to accelerate the repayment of the bonds. The Company accounted for this amendment as a modification of the bonds.

 

In June 2008, following a breach of the amended terms of the convertible bonds, the Company reached an agreement with BH (with a principal amount of $2,500), under which, among other things, the investor waived the Company's compliance with certain covenants under its Convertible Bonds, in exchange for:

 

a. Increasing the interest rate to 10% starting March 31, 2008. Any withholding and other taxes payable with respect to the interest will be grossed up and paid by the Company (approximately 3% of the principal of the bonds).

 

b. Reducing the exercise price of the bond and the warrants to $3 and $2.8, respectively.

 

c. The Company undertook to place a fixed charge on all income and/or rights in connection with a certain European Airport Project. This charge shall be senior to any indebtedness and/or other pledge and encumbrance, but shall, however, be subject to certain rights of the Company to use part of the income.
F- 33
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 12:- CONVERTIBLE BONDS (Cont.)

 

d. Certain anti-dilution rights with respect to the warrants held by the investor.

 

In addition, under certain circumstances, the investor might have the right to demand early payment of partial or full amount of the Convertible Bonds (up to the $2,500 as mentioned above). The Company accounted for the amendment as an extinguishment of the Bonds.

 

Due to the breach of certain convertible bond covenants, the Company had to recognize, in 2008, financial expenses in the amount of $553, to accelerate deferred expenses in the amount of $138 and to accelerate the remaining discount amounts (attributed to warrants and the beneficial conversion feature) in the amount of $724. In addition, as of December 31, 2008, the Convertible Bond was classified as a current liability

 

On August 12, 2009, the Company entered into a bond Amendment Agreement (the “Amendment Agreement”) with BH, with principal amount of $2,500, pursuant to the Amendment Agreement, in exchange for security in certain assets of the Company, inter alia all incomes and/or rights in connection therewith to which the Company and its Subsidiaries are and shall be entitled as a result of the Slovakian Project Arbitral Award, and on all amounts in connection with the project related to the arbitration, the Company and the investor agreed to waive compliance and amend certain provisions of the Bond to, among other things, (i) increase the applicable rate of interest to 12% and by 0.5% every 180 days afterward, (ii) release the Company from certain payments upon the completion of certain payments of principal and interest due under the Bond, (iii) make monthly payments of $41 against the total amount due under the Bond over an eight (8) year period, and (iv) increase the number of warrants granted to 159,375 and amend their exercise price to $0.40 per share . The modification was determined to be a debt extinguishment.

 

On November 9, 2009, the Company entered into an Amendment Agreement (the “Amendment Agreement”) with SSF, the other investor (with a principal amount of $624), pursuant to the Amendment Agreement, in exchange for security in certain assets of the Company, the Company and SSF agreed to waive compliance and amend certain provisions of the Bond to, among other things, (i) increase the applicable rate of interest to 12% and by 0.5% every 180 days afterward, (ii) release the Company from certain payments upon the completion of certain payments of principal and interest due under the Bond, (iii) make monthly payments of $10 against the total amount due under the Bond over an eight (8) year period, (iv) reducing the exercise price of the bond and the warrants to $3 and $0.40, respectively and, (v) increase the number of warrants granted to 31,238. The modification was determined to be a debt extinguishment.

 

As of December 31, 2009, in light of the above amendments, total principal amount of $430 was presented among current liabilities and a total principal amount of $2,624 was presented among long-term liabilities. In addition, an amount of $1,693 (including interest and penalties that it was agreed to be paid after the principal amount is paid), was presented among long-term loan and others.

 

In January 2010, the Company received the investors' consent to sell its EAC and CSMS businesses (as described in Note 1b.). In addition, the Company created a specific (fixed) charge in favor of the investors on the intellectual property rights belonging to the remaining RFID business of the Company.

 

F- 34
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 12:- CONVERTIBLE BONDS (Cont.)

 

On August 24, 2010, BH entered into an Absolute Assignment and Transfer of Bond and Warrant (“Assignment”) with Sigma Wave Ltd. (“Sigma”), an Israeli company and a major shareholder of the Company. Pursuant to the Assignment, BH absolutely transfers, assigns and makes over unto Sigma all of its rights, title, obligations and interest in the Convertible Bonds and warrants accruing or growing due and outstanding as at the Closing Date (which later was determined as September 16, 2010) to BH, and BH effective as of and from the Closing Date further assigns and transfers unto Sigma all of its rights and interests in the Company pledged rights and/or assets, and BH effective as of and from the Closing Date further assigns and transfers unto Sigma all of its rights and interests in deeds, documents, writings, papers, books of account and other books relating to or being records of the Convertible Bonds and warrants or by which the Convertible Bonds and warrants are or may hereafter be secured, evidenced, acknowledged or made payable.

 

The Company gave its consent to the Assignment on July 28, 2010.

 

The Assignment had no impact on the Company’s assets or liabilities or its financial results.

 

On March 30, 2011, the Company entered into a financing agreement with Sigma that entitles the Company to refinance the short-term obligations under the Convertible Bonds held by Sigma on a long-term basis. Pursuant to the agreement, and subject to certain conditions and covenants, Sigma postponed all mature amounts relating to principal and interest as of December 31, 2010, to January 1, 2012. In addition, the agreement required that interest amounts with respect to fiscal 2011 will become due during July 2011 and thereafter. As a consequence of the financing agreement, as of December 31, 2010, the Company’s total outstanding debt to Sigma under the Convertible Bonds was $4,262, of which $2,453 was presented among convertible bonds (long-term balance) and $1,810 was presented among long-term loan and others. As of December 31, 2010, the Company was in compliance with the covenants under the amended Convertible Bonds agreements with respect to bonds held by SSF.

 

With respect to an arrangement that was subject to the approval of the board of directors, following such an approval, on August 4, 2011,Sigma had accepted the Company's debt arrangement proposal for an amount of $1,000 debt under the Convertible Bonds in accordance with the proposed arrangement of the extinguishment of liabilities (see Note 1d). The Company allotted Sigma a total of 4,444,444 ordinary shares of the Company (which number was determined on June 30, 2011) and recorded an amount of $778 as a gain on extinguishment of debts based on the difference between the carrying amount of the liability extinguished ($1,000) and the fair value of the ordinary shares granted ($222), which was credited directly to share capital ($74) and additional paid-in capital ($148).

 

On November 8, 2011, SSF sold, assigned and transferred to Mr. Eliyahu Trabelsi (see Note 14f) all of their rights under the Convertible Bonds and warrants.

 

On December 5, 2011, the Company received from the Head of the Execution Office in Israel a foreclosure order in accordance with section 44 to the Israeli Execution Law Records, vol. 1967, in respect of convertible bonds held by Sigma, up to an amount of NIS3,903,866 (approximately $1,022 as of December 31, 2011). The Company acted in accordance with the order’s instructions and recorded the said foreclosure.

 

On December 31, 2011, Sigma had accepted the Company's debt arrangement proposal for an amount of $1,806 of the outstanding debt amount in accordance to the proposed arrangement of the extinguishment of liabilities (see Note 1d). The Company committed to issue Sigma 8,025,000 of its ordinary shares as full repayment of such amount. In accordance with ASC Topic 470-50-40, the Company recorded an amount of $1,083 as a gain on extinguishment of debts based on the difference between the carrying amounts of the liabilities extinguished ($1,806) and the fair value of the ordinary shares granted ($723), which was credited directly to “amount of liability extinguished on account of shares”. The actual allotment of 8,025,000 ordinary shares to a trustee of Sigma was completed in April 2012.

 

F- 35
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 12:- CONVERTIBLE BONDS (Cont.)

 

On December 31, 2011, Mr. Eliyahu Trabelsi had accepted the Company's debt arrangement proposal for an amount of $241 of the outstanding debt amount in accordance with the proposed arrangement of the extinguishment of liabilities (see Note 1d). The Company committed to issue Mr. Eliyahu Trabelsi 1,069,400 of its ordinary shares as full repayment of such amount. In accordance with ASC Topic 470-50-40, the Company recorded an amount of $145 as a gain on extinguishment of debts based on the difference between the carrying amounts of the liabilities extinguished ($241) and the fair value of the ordinary shares granted ($96), which was credited directly to “amount of liability extinguished on account of shares”. The actual allotment of 1,069,400 ordinary shares to Mr. Eliyahu Trabelsi was completed in April 2012.

 

As of December 31, 2011 and the filing date of these financial statements, the Company was not in compliance with the covenants under the amended Convertible Bonds and as a result the remaining balance of the Convertible Bonds were classified as a current liability. Due to the breach of the covenants under the amended Convertible Bonds, the Company had to recognize additional monthly 3% interest on payments that were not paid according to the amended Convertible Bonds. The additional interest expenses amounted to $271 during the year ended December 31, 2011.

 

NOTE 13:- SHARE CAPITAL

 

a. The Company's common stock is quoted under the ticker symbol “VUNCF” on the Pink OTC Markets Inc., which operates an electronic quotation service for securities traded over-the-counter.

 

On May, 14 2007 a 1 for 5.88235 reverse split of the Company’s ordinary shares became effective for trading purposes. Pursuant to this reverse share split, each 5.88235 ordinary shares of NIS 0.01 par value became 1 ordinary share of NIS 0.0588235 par value.

 

b. During 2010, the Company increased its authorized share capital to 52,000,000 ordinary shares.

 

c. During 2009 and 2011, 168,865 and 300,000 ordinary shares, respectively, were issued as consideration to settle liabilities to an officer and other payables in an aggregate amount of $63 and $51, respectively. Regarding ordinary shares that were issued during 2010 under a private placement, see Note 13f4. Regarding ordinary shares that were issued during 2011 and after the balance sheet date, as a part of an extinguishment of liabilities, see Notes 12 and 18.

 

d. Shareholders' rights:

 

The ordinary shares confer upon the holders the right to receive notice to participate and vote in the general meetings of the Company, and the right to receive dividends, if declared.

 

F- 36
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

e. Stock options:

 

1. In 2003, the Company adopted a stock option plan under which the Company issues stock options (the “Option Plan”). The Option Plan is intended to provide incentives to the Company’s employees, officers, directors and/or consultants by providing them with the opportunity to purchase ordinary shares of the Company. Subject to the provisions of the Israeli Companies Law, the Option Plan is administered by the Compensation Committee, and is designed: (i) to comply with Section 102 of the Israeli Tax Ordinance or any provision which may amend or replace it and the rules promulgated thereunder and to enable the Company and grantees thereunder to benefit from Section 102 of the Israeli Tax Ordinance and the Commissioner’s Rules; and (ii) to enable the Company to grant options and issue shares outside the context of Section 102 of the Israeli Tax Ordinance. Options granted under the Option Plan will become exercisable ratably over a period of three to five years or immediately in certain circumstances, commencing with the date of grant. The options generally expire no later than 10 years from the date of grant. Any options which are forfeited or canceled before expiration become available for future grants.

 

As a result of an amendment to Section 102 of the Israeli Tax Ordinance as part of the 2003 Israeli tax reform, and pursuant to an election made by the Company thereunder, capital gains derived by optionees arising from the sale of shares issued pursuant to the exercise of options granted to them under Section 102 after January 1, 2003, will generally be subject to a flat capital gains tax rate of 25%. However, as a result of this election, the Company will no longer be allowed to claim as an expense for tax purposes the amounts credited to such employees as a benefit when the related capital gains tax is payable by them, as the Company had previously been entitled to do under Section 102.

 

On June 27, 2007, the Compensation Committee and board of directors of the Company approved a new option plan under which the Company may grant stock options to the U.S. employees of the Company and its subsidiaries. Under this new option plan, the Company may grant both qualified (for preferential tax treatment) and non-qualified stock options. On August 15, 2007, the new option plan was approved by the shareholders of the Company at the general shareholders meeting. 

 

2. On January 9, 2009, according to the board resolution on October 27, 2008 and the Special General Meeting dated December 21, 2008, the Company issued to: a) the Chairman of the Board of Directors; b) a member of the Company's Board of Directors who is also one of the co-founders; c) one of the co-founders of the Company and d) another member of the Company's Board of Directors options to purchase up to: 256,456, 179,966, 126,944 and 42,121 shares of the Company, respectively. The options have an exercise price of NIS 0.0582235 per share, vested immediately and will expire after ten years. The options (the fair value of which was estimated to $266) were issued as a partial payment for certain liabilities to the terms of their appointment with the Company.

 

On March 12, 2009, the Company issued options to purchase up to 161,718 shares to several employees and ex-employees as a partial payment of their payroll. The options (the fair value of which was estimated to $67) have an exercise price of NIS 0.0582235, vested immediately and will expire after ten years.

 

During 2010 no options were granted.

F- 37
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

e. Stock options (cont.):

 

2. (cont.)

 

On August 9, 2011, the Company issued options to purchase up to 150,000 shares to a former officer of the Company as part of his employment agreement. The options (the fair value of which was estimated at $6) have an exercise price of $0.11, vested immediately and will expire after five years.

 

On August 11, 2011, the Company issued options to purchase up to 300,000 shares to a former officer of the Company as part of the extinguishment of liabilities (see Note 1d). The options (the fair value of which was estimated at $36, based on the Company’s share market price at the date the extinguishment was determined) have an exercise price of $0.00, vested immediately and will expire on December 31, 2012.

 

On August 24, 2011, the Company issued options to purchase up to 385,000 shares to several employees of the Company. The options (the fair value of which was estimated at $18) have an exercise price of $0.20, 155,000 of them vested on January 1, 2012, and the remaining 230,000 will vest on January 1, 2013. The options will expire after ten years.

 

3. A summary of the Company's stock option activity and related information is as follows:

 

    Year ended December 31  
    2011     2010     2009  
    Number of
options
    Weighted
average
exercise
price
    Number of
options
    Weighted
average
exercise
price
    Number of
options
    Weighted
average
exercise
price
 
Outstanding at beginning of year     1,404,219     $ 1.23       1,489,176     $ 1.34       981,462     $ 2.55  
Granted     835,000     $ 0.11       -       -       767,205     $ 0.015  
Exercised     (10,007 )   $ 0.02       (11,007 )   $ 0.016       (93,056 )   $ 0.015  
Canceled and forfeited     (65,355 )   $ 1.74       (73,950 )   $ 3.52       (166,435 )   $ 3.30  
Outstanding at end of year     2,163,857     $ 0.79       1,404,219     $ 1.23       1,489,176     $ 1.34  
Exercisable at end of year     1,778,857     $ 0.92       1,404,219     $ 1.23       1,413,027     $ 1.26  

 

 

The weighted average fair value of options granted during the reported periods (excluding 300,000 options granted in 2011 as part of the extinguishment of liabilities) was $0.05 and $0.43, per option, for the years ended December 31, 2011 and 2009, respectively. In 2010 no options were granted.

 

The fair value of these options was estimated on the date of grant using the Black & Scholes option pricing model. The following weighted average assumptions were used for the 2011 and 2009 grants: risk-free rate of 0.76% and 0.75%, respectively, dividend yield of 0%, expected volatility factor of 176.54% and 193.27%, respectively and expected term of 4.64 and 2.08 years, respectively. In 2009, the fair value of 125,142 options were calculated using the Black & Scholes option pricing model. For all other options granted in 2009, the fair value of the options issued (as a partial payment of payroll liability) was based on the fair value of the shares on the date of the related payroll, which equals the related payroll liability, since the exercise price was close to nil.

 

The expected volatility was based on the historical volatility of the Company’s stock. The expected term was based on the historical experience and based on Management estimate.

 

F- 38
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

e. Stock options (cont.):

 

3. A summary of the Company's stock option activity and related information is as follows (cont.):

 

Compensation expenses recognized by the Company related to its share-based employee compensation awards were $10, $14 and $483 for the years ended December 31, 2011, 2010 and 2009, respectively.

 

The following table summarizes the allocation of the stock-based compensation charge

 

    Year ended December 31,  
    2011     2010     2009  
                   
Cost of revenues   $ 2     $ 3     $ 7  
Research and development expenses     5       2       226  
Selling and marketing expenses     -       3       43  
General and administrative expenses     3       6       207  
                         
    $ 10     $ 14     $ 483  

 

The options outstanding and exercisable as of December 31, 2011, have been separated into ranges of exercise prices as follows:

 

Range of
exercise price
    Options 
outstanding 
as of
December 31,
2011
    Weighted 
average
remaining
contractual life
(years)
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
    Options
exercisable 
as of
December 31,
2011
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
 
                                             
$ 0.00 - $ 0.20       1,520,464       6.46       0.07     $ 30       1,135,464       0.02     $ 79  
$ 1.10 - $ 1.88       449,817       2.89       1.29       -       449,817       1.29       -  
$ 2.47 - $ 3.38       31,076       1.99       2.99       -       31,076       2.99       -  
$ 4.12 - $ 4.64       79,900       5.07       4.31       -       79,900       4.31       -  
$ 5.00 - $ 5.24       65,600       2.99       5.07       -       65,600       5.07       -  
$ 14.82       17,000       2.85       14.82       -       17,000       14.82       -  
                                                             
                                                             
          2,163,857               0.79               1,778,857       0.92          

 

The aggregate intrinsic value of the above table represents the total intrinsic value, based on the Company’s stock price of $0.09 as of December 31, 2011, less the weighted average exercise price per range. This represents the potential amount received by the option holders had all option holders exercised their options as of that date.

 

The total intrinsic value of options exercised during the years ended December 31, 2011 2010 and 2009 was $1, $1 and $36, respectively, based on the Company’s average stock price of $0.10, $0.14and $0.4, during the years ended on those dates respectively.

F- 39
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

e. Stock options (cont.):

 

3. A summary of the Company's stock option activity and related information is as follows (cont.):

 

A summary of the status of the Entity’s non-vested options granted to employees as of December 31, 2011 and changes during the year ended December 31, 2011 is presented below:

 

    Options     Weighted–
average grant-
date fair value
 
             
Non-vested at January 1, 2011     -       -  
Granted     385,000     $ 0.05  
Vested (including cancelled and exercised)     -       -  
Forfeited     -       -  
Non-vested at December 31, 2011     385,000     $ 0.05  

 

As of December 31, 2011, there was $8 of unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the stock option plans.

 

f. Private placements and warrants:

 

1. During 2009, no warrants were granted.

 

During 2010, warrants to acquire up to 1,759,988 shares were granted, of which 553,846, with an exercise price of $0.15 per share were granted to an investor as a part of private placement (see 4 below) and 1,206,142 of which, with an exercise price of $0.00 per share were granted to certain creditors as part of the extinguishments of liabilities (see Note 1d). The fair market value of the warrants granted under the debt extinguishment is $147, based on the Company’s share market price at the date when the extinguishment was determined.

 

During 2011, warrants to purchase up to 1,081,871 shares with an exercise price of $0.00 per share were granted to certain creditors as part of the extinguishments of liabilities (see Note 1d). The fair market value of the warrants granted is $143, based on the Company’s share market price at the date when the extinguishment was determined.

 

F- 40
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

f. Private placements and warrants (cont.):

 

2. A summary of the Company's warrants activity to consultants and investors (including warrants issued in connection with convertible bonds and extinguishment of liabilities), and related information is as follows:

 

    Year ended December 31,  
    2011     2010     2009  
    Number of
warrants
    Weighted
average
exercise
price
    Number of
warrants
    Weighted
average
exercise
price
(*)
    Number of
warrants
    Weighted
average
exercise
price
 
Outstanding at beginning of year     2,157,002     $ 0.36       658,706     $ 2.70       857,185     $ 3.92  
Granted     1,081,871     $ 0.00       1,759,988     $ 0.05       -       -  
Exercised     -       -       -       -       -       -  
Canceled and forfeited     (236,014 )   $ 1.24       (261,692 )   $ 3.53       (198,479 )   $ 5.91  
Outstanding at end of year     3,002,859     $ 0.16       2,157,002     $ 0.36       658,706     $ 2.70  
Exercisable at end of year     3,002,859     $ 0.16       2,157,002     $ 0.36       652,040     $ 2.69  

 

(*) The Weighted average exercise price is after re-pricing of the exercise price related to the convertible bond holders.

 

The warrants to consultants and investors (including warrants issued in connection with convertible bonds and extinguishment of liabilities), outstanding and exercisable as of December 31, 2011, have been separated into ranges of exercise prices as follows:

 

Range of
exercise price
    Warrants
outstanding and
exercisable as of
December 31,
2011
    Weighted
average
remaining
contractual
life (years)
    Weighted
average
exercise
price
    Aggregate
intrinsic
value
 
                           
$ 0.00       2,288,013       1.00     $ 0.00     $ 206  
$ 0.15 - $ 0.65       633,846       3.06     $ 0.21       -  
$ 2.50 - $ 3.53       20,000       1.39     $ 3.38       -  
$ 4.42 - $ 4.85       61,000       2.07     $ 4.72       -  
                                     
          3,002,859             $ 0.16          

 

3. The fair value of all the warrants granted as described above was measured based on the fair value of the instruments issued on the date of grant, since, based on the opinion of Company Management, such measurement is more reliable than the fair value of services.

 

4. On March 22, 2010, the Company entered into a Subscription Agreement with a private investor, Mr. Yitzchak Babayov (the “Investor”), pursuant to which at a March 23, 2010 closing, the Company issued 1,538,461 ordinary shares of the Company at a par value of  NIS 0.0588235 (the “Transaction Shares”) in consideration of a onetime cash payment in the amount of $200.  
F- 41
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 13:- SHARE CAPITAL (Cont.)

 

f. Private placements and warrants (cont.):

 

4. (cont.):

 

Concurrent with the execution of the Subscription Agreement, the Company and the Investor entered into a Warrant Agreement pursuant to which the Investor received a warrant (the “Warrant”) to purchase up to 553,846 ordinary shares of the Company for an exercise price of $0.15 per share. The Warrant has a term of five (5) years and contains standard adjustments for stock dividends, stock splits, reclassification and similar events. The Company’s shareholders approved and ratified at the annual general meeting held on September 12, 2010, that the purpose of the private placement of the Transaction Shares and Warrant was to provide the Investor with more than twenty five percent (25%) of the Company’s issued and outstanding shares as of the date of the agreement in accordance with Israeli law, which exempts such an acquisition from Israeli tender offer requirements

 

The Transaction Shares and the ordinary shares issuable upon the exercise of the Warrant have not been registered under the Securities Act and may not be offered or sold except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act.

 

g. Dividends:

 

No dividends were declared in the reported periods. In the event that cash dividends are declared in the future, such dividends will be paid in NIS. The Company does not intend to distribute cash dividends in the foreseeable future.

 

h. Convertible bonds and warrants issued to the convertible bond holders – see Note 12.

 

NOTE 14:- RELATED PARTY TRANSACTIONS

 

a. On October 1, 2001, the Company entered into a consulting agreement with a company owned by a former Chairman of the Board of Directors, who also was one of the co-founders of the Company.

 

In consideration of these consulting services, the Company has undertaken to pay $10.5 per month plus motor vehicle expenses. In addition the Company was required to pay $1.5 per month as a director’s fee. During 2009 the Company paid in cash $32, pursuant to this agreement. Regarding the partial payment in options during 2009, see Note 14d below and regarding debt extinguishment during 2010, see Note 14e below.

 

On July 8, 2010, the Board of Directors accepted the resignation from the board of directors of the Chairman of the Board of Directors, effective July 25, 2010. The Company recorded during 2010 an expense of $75 related to the former consulting agreement. In addition, on July 8, 2010, the Company entered into a Services Agreement with the former Chairman of the Board of Directors and as of that date one of the Company’s major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide the Company with ongoing consulting services as may be reasonably required by the Company, for a consideration of 2% of the Company’s gross receipts from a major customer and indemnification of reasonable costs and expenses incurred by the Service Provider.

 

During 2011 and 2010, the Company recorded an expense of $130 and $83, respectively, in accordance with the Services Agreement.

 

F- 42
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 14:- RELATED PARTY TRANSACTIONS (Cont.)

 

b. On October 1, 2001, the Company entered into a consulting agreement with a company owned by a former member of the Company's Board of Directors, who was one of the Company's co-founders and a principal shareholder. On January 13 2005, the General Shareholders Meeting approved, inter-alia, the following amendments to the consulting agreement:

 

· As of the date of the approval of the General Shareholders Meeting, the consideration shall be an amount of $7 per month.

 

· Upon the termination of the car lease agreement in March 2005, to increase the car lease, to a price of up to NIS 4,200 (approximately $1.1 as of December 31, 2011), (excluding tax) per month.

 

In addition, the Company was required to pay $1.5 per month as a director’s fee.

 

During 2009 the Company paid in cash $22 pursuant to this agreement. Regarding the partial payment in options during 2009, see below Note 14d and regarding debt extinguishment during 2010 see Note 14e below.

 

On July 8, 2010, the Board of Directors accepted the resignation from the board of directors of the member of the Company's Board of Directors, effective immediately. The Company recorded during 2010 an expense of $53 related to the former consulting agreement. In addition, on July 8, 2010, the Company entered into a Services Agreement with the former member of the Board of Directors and as of that date one of the Company’s major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide the Company with management services with respect to the Company’s certain project for a consideration of (i) a monthly fee of $3, (ii) indemnification of reasonable costs and expenses incurred by the Service Provider, and (iii) the Company will provide the Service Provider with a cellular phone and an automobile. The Company shall also grant the Service Provider options to purchase up to 50,000 ordinary shares of the Company according to terms to be determined by the Board of Directors, which terms have not yet been determined by the date of approval of the financial statements.

 

During 2011 and 2010, the Company recorded an expense of $63 and $38, respectively, in accordance with the Services Agreement.

 

c. On October 1, 2001, the Company entered into a consulting agreement with a company owned by one of the co-founders of the Company.

 

In consideration for these services, the Company was required to pay $4.6 per month plus motor vehicle expenses. During 2009 the Company paid in cash $15 pursuant to this agreement. Regarding the partial payment in options during 2009, see Note 14d below and regarding debt extinguishment during 2010 see Note 14e below.

 

The Company recorded during 2010 an expense of $37 related to the former consulting agreement. On July 8, 2010, the Company entered into a Services Agreement with the co-founder of the Company and as of that date one of the Company’s major shareholders (the “Service Provider”), effective immediately, pursuant to which the parties terminated the former consulting agreement and agreed that the Service Provider will provide the Company with ongoing consulting services as may be reasonably required by the Company for a consideration of a monthly fee of $3 and indemnification of reasonable costs and expenses incurred by the Service Provider in connection with the services. The Company shall also grant the Service Provider options to purchase up to 100,000 ordinary shares of the Company according to terms that will be determined by the Board of Directors, which terms have not yet been determined by the date of approval of the financial statements.

F- 43
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 14:- RELATED PARTY TRANSACTIONS (Cont.)

 

c. (cont.)

 

During 2011 and 2010, the Company recorded an expense of $39 and $21, respectively, in accordance with the Services Agreement.

 

d. On December 21, 2008, the Special General Meeting of Shareholders approved that as part of a cost cutting plan, all of the Company's non-external directors, will join a temporary arrangement pursuant to which the remuneration payable to them shall be paid in fully vested options to purchase shares of the Company instead of in cash, effective October 1, 2008, for a minimum period of three months, with an option to the Company to extend it from time to time for additional consecutive periods of up to twelve (12) months in the aggregate. During 2009, an aggregated number of options to purchase up to 478,543 of the Company’s ordinary shares were granted to the Company’s non-external directors as part of the cost cutting plan. The options have an exercise price of 0.0582235 NIS per share, vesting immediately, and will expire after ten years.

 

e. As part of the debt extinguishment plan of the Company (see also Note 1d) and in accordance with their Services Agreement, the abovementioned Service Providers agreed to a partial forgiveness of the debts due to them under the former consulting agreements accrued from October 1, 2009 until July 8, 2010 which total amount was $245 and agreed to repayment in 1,083,071 warrants to purchase ordinary shares of the Company as consideration for the entire debts due. The fair value of the warrants was estimated as $130. The difference between the carrying amount of the amounts due and the fair value of the warrants was recognized as a capital gain.

 

f. On July 25, 2010, the Board of directors of the Company elected Mrs. Tsviya Trabelsi to serve as the Chairman of the Board of Directors. Mrs. Trabelsi is an officer at Sigma Wave Ltd., which is the controlling shareholder of the Company and the major holder of a principal amount of Convertible Bonds (see Note 12); and is also the wife of the Company’s former chief executive officer and the sister of one of the members of the Company’s board of directors. On May 12, 2011, the special general meeting approved the Service Agreement of the Company’s chairman of the board of directors whereby, her monthly fee will be calculated every month at 60% of the Company’s chief executive officer’s monthly cost (approximately $8). In addition to the above consideration, the Company shall bear all reasonable costs and expenses incurred by the chairman in connection with her services and provide her with an automobile. On December 12, 2011, Mrs. Tsviya Trabelsi resigned from the board effective immediately and the board of directors of the Company approved the appointment of Mr. Arie Trabelsi as its new Chairman, effective December 12, 2011. Mr. Trabelsi served as the chief executive officer of the Company until November 1, 2011, and has served as a member of the Company’s board since November 1, 2011. Mr. Arie Trabelsi is the sole director of Sigma Wave Ltd., which is the controlling shareholder of the Company and the major holder of a principal amount of Convertible Bonds (see Note 12); and is the brother of Mr. Eliyahu Trabelsi who holds the other principal amount of Convertible Bonds and is a shareholder of the Company. His management services fees are subjected to the approval of the next general meeting and are expected to be the same as those paid to Mrs. Tsviya Trabelsi, the former chairman.

 

g. As of December 31, 2011, the Company accrued $279 as expenses arising from related parties providing consulting services.

 

h. As of December 31, 2011, the Company accrued $135 as another liability arising from a short term loan that the Company received from its former Chairman of the Board of Directors. $90 of this loan was repaid by the Company during January, 2012.

 

i. Regarding a convertible bond held by a controlling shareholder see Note 12 and Note 9.
F- 44
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 15:- SEGMENTS, MAJOR CUSTOMERS AND GEOGRAPHIC INFORMATION

 

a. Summary information about geographic areas:

 

The Company manages its business on the basis of one reportable segment (see Note 1 for a brief description of the Company's business) and follows the requirements of ASC Topic 280, "Segment Reporting".

 

The following is a summary of revenues from external customers of the continued operations within geographic areas and data regarding property and equipment, net:

 

    Year ended December 31,  
    2011     2010     2009  
          Property
and
        Property
and
          Property
and
 
    Total
Revenues
    Equipment,
net
    Total
revenues
    Equipment,
net
    Total
revenues
    Equipment,
net
 
                                     
East European country (*)   $ 7,498     $ -     $ 6,770     $ -     $ 8,180     $ -  
Hong Kong     -       -       -       -       76       4  
United States     344       24       536       37       976       52  
Israel     80       72       83       73       72       101  
                                                 
    $ 7,922     $ 96     $ 7,389     $ 110     $ 9,304     $ 157  

 

- Revenues were attributed to countries based on the customer’s location.

 

- Property and equipment were classified based on geographic areas in which such property and equipment items are held.

 

(*) Due to a demand of the customer, the name of the specific country cannot be disclosed.

 

b. Summary of revenues from external customers of the continued operations based on products and services:

 

    Year ended December 31,  
    2011     2010     2009  
                   
Raw materials and equipment   $ 5,822     $ 3,822     $ 6,884  
Maintenance, royalties and project management     2,100       3,567       2,420  
                         
    $ 7,922     $ 7,389     $ 9,304  

 

c. Major customer data as a percentage of total sales from external costumers of the continued operations:

 

    Year ended December 31,  
    2011     2010     2009  
                   
Customer A     95 %     92 %     67 %
                         
Customer B     -       -       21 %

 

F- 45
 

VUANCE LTD. AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Cont.)
U.S. dollars in thousands (except per share data)

 

NOTE 16:- OTHER (INCOME) EXPENSES

 

    Year ended December 31,  
    2011     2010     2009  
                   
Litigation expenses     -       -       130  
Capital loss on disposal of property and equipment     6       -       -  
Gain on extinguishment of debts (*)     (143 )     (124 )     -  
Capital gain on sale of subsidiary     -       (272 )     -  
Net total   $ (137 )   $ (396 )   $ 130  

 

(*) Comprised of the capital gain on extinguishment of working capital related liabilities (employees, service providers etc.). See also Note 1.

 

NOTE 17:- FINANCIAL (EXPENSES) INCOME, NET

 

    Year ended December 31,  
    2011     2010     2009  
Financial expenses:                        
                         
Interest, amortization of discount, bank charges and fees (*)   $ (1,021 )   $ (621 )   $ (592 )
Exchange differences     -       (57 )     (32 )
                         
Total financial expenses     (1,021 )     (678 )     (624 )
Financial income:                        
                         
Gain on extinguishment of convertible bonds (**)     2,006       -       -  
Exchange differences     5       -       -  
Interest     -       -       4  
                         
Total financial income     2,011       -       4  
                         
Net total   $ 990     $ (678 )   $ (620 )

 

(*) In 2011, 2010 and 2009, includes expenses of $968, $586 and $565_related to convertible bonds, respectively. (See Note 12 above).

(**)    See Note 1

 

NOTE 18:- SUBSEQUENT EVENTS

 

a) On March 27, 2012, as required under an agreement between the Company, Sigma and Mr. Eliyahu Trabelsi, entered into in December 2011, the board of directors of the Company approved the issuance of 9,094,400 ordinary shares in respect of extinguishment of liabilities which took place on December 31, 2011 (see Note 12). The actual issuance took place on April 2, 2012 and as of that date the issued and outstanding ordinary shares amounted to 21,129,672 shares.

 

b) See Note 10b.4.

 

 

 

F- 46
 

 

ITEM 19.    Exhibits.

 

Exhibit
Number
  Description
     
1.1 1   Memorandum of Association of the Company. 
     
1.2   Articles of Association of the Company.
     
2.1 1   Forms of Stock Certificates Representing ordinary shares.
     
4.1 1   The Vuance Ltd. 1999 Employee Stock Option Plan (as Amended and Restated in 2002).
     
4.2(a)   The Vuance Ltd. 2003 Israeli Share Option Plan.
     
4.2(b)   The Vuance Ltd. 2007 U.S. Stock Option Plan
     
4.3 3   Asset Purchase Agreement by and among Intelli-Site, Inc., Integrated Security Systems, Inc., Vuance, Inc. and Vuance Ltd. dated as of March 6, 2009.
     
4.4 5   Agreement for Purchase and Sale of Business Assets between Vuance, Inc. and OLTIS Security Systems International, LLC, dated as of January 9, 2010.
     
4.5 5   Asset Purchase Agreement between Vuance Ltd., Vuance, Inc., WidePoint Corporation and Advance Response Concepts Corporation, dated as of January 29, 2010.
     
4.6 4   Subscription Agreement and Warrant Agreement between Vuance Ltd. and Mr. Yitzchak Babayov, dated as of March 22, 2010.
     
4.7 6   Share Purchase Agreement for the sale of SuperCom Asia Pacific Ltd. between Vuance Ltd. and Mr. Steven Slom, Adv. as trustee for an undisclosed purchaser, dated October 21, 2010.
     
4.8 6   Financing Agreement between Vuance Ltd. and Sigma Wave Ltd., dated March 30, 2011.
     
8   List of Subsidiaries of Vuance Ltd.
     
11.1 2   Code of Ethics.
     
12.1   Certification pursuant to Section 302 of the Sarbanes-Oxley Act.
     
12.2   Certification pursuant to Section 302 of the Sarbanes-Oxley Act.
     
13.1   Certification pursuant to Section 906 of the Sarbanes-Oxley Act.
     
13.2   Certification pursuant to Section 906 of the Sarbanes-Oxley Act.
     
15.1   Consent of Fahn, Kanne & Co., a member of Grant Thornton, dated May 9, 2012.
     
101   The following materials from our Annual Report on Form 20-F for the year ended December 31, 2011 formatted in XBRL (eXtensible Business Reporting Language) are furnished herewith: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, and (iii) the Statements of Changes in Shareholders' Deficit, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Consolidated Financial Statements.

 


1      Previously filed as an exhibit to, and incorporated herein by reference from, the Company’s Annual Report on Form 20-F filed on September 14, 2004.

 

86
 

 

2      Previously filed as an exhibit to, and incorporated herein by reference from, the Company’s Annual Report on Form 20-F filed on June 30, 2008.

3 Previously filed as exhibits to, and incorporated herein by reference from, the Company’s Annual Report on Form 20-F filed on June 30, 2009.

4 Previously filed as exhibits to, and incorporated herein by reference from, Exhibit 10.1 and 10.2 to the Company’s report on Form 6-K submitted on April 7, 2010.

5 Previously filed as an exhibit to, and incorporated herein by reference from, the Company’s Annual Report on Form 20-F filed on July 23, 2010.

6 Previously filed as exhibits to, and incorporated herein by reference from, the Company’s Annual Report on Form 20-F filed on June 13, 2011.

 

87
 

 

SIGNATURE

 

Vuance Ltd. hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.

 

  VUANCE LTD.
       
   By:        /s/ Doron Levy
  Name:   Doron Levy
  Title:   Chief Executive Officer

 

Date: May 9, 2012

 

88

 

Exhibit 1.2

 

THE COMPANIES LAW

 

ARTICLES OF ASSOCIATION

 

OF VUANCE LTD.

 

Interpretation

 

1. In these Articles of Association the following terms will have the meanings described below, unless the context requires otherwise:

 

“Articles” These Articles of Association, as may be amended from time to time.
   
“Audit Committee” The audit committee of the Board of Directors, established according to these Articles and the Law.
   
“Board of Directors” The Company’s board of directors.
   
“Company” VUANCE LTD.
   
“Director” A member of the Company’s Board of Directors.
   
“General Meeting” A meeting of the company’s Shareholders convened according to these Articles and the Law.
   
“Independent Director” A Director that qualifies as independent in accordance with the rules of the U.S. Securities and Exchange Commission and of any securities exchange in which the Company has registered its shares on and in accordance with any applicable law or regulation.
   
“Law” The Companies Law - 1999, including any regulations and regulatory orders relating thereto and to the Company, as will be in effect from time to time.
   
“Officer” A Director, General Manager, President, Chief Executive Officer (“CEO”), Deputy General Manager, Assistant

 

 
 

 

  General Manager, and any person holding such office in the Company, even if bearing a different title, and any other manager being directly subordinated to the CEO.
   
“Ordinary Majority” An ordinary majority of all votes properly cast at a General Meeting, without taking into account abstentions.
   
“Register” The register of Shareholders, including branch registers the Company may maintain, kept according to the Law.
   
“Secretary” The Company’s corporate secretary, as may be appointed by the Board from time to time.
   
“Share Capital” The Company’s registered share capital, as authorized in these Articles.
   
“Shareholder” Any person or entity that is a holder of shares of the Company according to these Articles and the Law
   
“Special Majority” A majority of at least sixty-six percent (66%) of all votes properly cast at a General Meeting, without taking into account abstentions.
   
“Voting Instrument” A written form for Shareholders to use, according to these Articles and the Law, in voting at General Meetings.
   
“Writing” A handwritten, typewritten, facsimile, print, e-mail or any other legally recognized form of communication that can be read.

 

2. In these Articles, unless the context otherwise requires, terms used herein shall have the meanings ascribed to them in the Law. In addition, words importing the singular will include the plural, and vice versa. Words importing the masculine gender will include the feminine, and words importing persons will include companies, partnerships, associations and all other legal entities. Days, months and years refer to the Gregorian calendar.

 

3. In the event that an Article is revised or a new Article is added to these Articles, which contradicts an original Article, the revised or added Article(s) will prevail.

 

 
 

 

4. Unless the context requires otherwise, wherever it is specified in these Articles that the provisions thereof are according to or subject to the provisions of the Law and/or any other applicable law, rules or regulations, the intention is to mandatory legislation provisions only.

 

Public Company

 

5.      (a) The Company is a public company as defined in the Law.

 

(b) Subject to any limitation or restriction under any law, the transfer of shares in the Company is not restricted.

 

(c) The number of Shareholders is unlimited.

 

(d) The Company may issue any form of its shares or other securities to the public.

 

6. The liability of each of the Shareholders of the Company is limited to the greater amount of the two - the Share's nominal value, or the amount, which the Shareholder is called to pay to the Company for the shares, which have been allocated to him but have not yet been paid for by him.

 

Permissible Objects

 

7. The Objects of the Company may include any activity permitted by law.

 

8. The Company may contribute, from time to time, reasonable amounts to worthwhile causes, even if the contribution is not based on profit-oriented business considerations.

 

Name and Registered Office

 

9. The name of the Company is: Vuance Ltd . and in Hebrew: ויואנס בע"מ .

 

10. The Registered Office of the Company will be at such place as the Board of Directors shall determine from time to time.

 

Share Capital

 

11. The authorized Share Capital of the Company is NIS 305,882.2 divided into 52,000,000 Ordinary Shares of the Company, nominal value NIS 0.0588235 each.

 

 
 

 

Alteration of Share Capital

 

12. The Company may from time to time, by a Resolution of Shareholders at a General Meeting, whether or not all the shares then authorized have been issued, and whether or not all the shares then issued have been called up for payment, increase its authorized Share Capital by the creation of new shares. Such increase shall be in such amount, divided into shares of such nominal amounts, subject to such restrictions and terms and with such rights and preferences, as the Resolution creating the same shall provide.

 

13. Unless otherwise provided in the Resolution authorizing the increase of Share Capital, the new shares shall be subject to the same provisions applicable to the shares included in the existing Share Capital with regard to the payment of calls, lien, forfeiture, transfer, transmission and otherwise.

 

14. The Company may, by a resolution of the Shareholders at a General Meeting:

 

(a) consolidate and re-divide its Share Capital, fully or partly, into shares of larger nominal (par) value than its existing shares;

 

(b) divide, by sub-division of its existing shares or any of them, into shares of smaller nominal (par) value than is fixed by the Memorandum of Association and these Articles; provided, however, that the proportion between the amount paid and the amount unpaid on each share which is not fully paid up shall be retained at such sub-division;

 

(c) cancel any shares of its issued or unissued share capital, and decrease the amount of its authorized share capital by the amount of the shares so canceled, subject to any commitment (including a conditional commitment) given by the Company in respect of such shares and provided that the cancellation of any issued shares shall be equally made on a pro-rata basis with respect to all issued shares of the Company;

 

(d) reduce its Share Capital in any manner, subject to any approval required by law.

 

The Shareholders may delegate to the Company’s Board of Directors, the authority to resolve with respect to execution of actions set forth in Sections 14(a) and 14(b) above, within a time frame and subject guidelines and limitations approved at a General Meeting.

 

15. If, as a result of a consolidation or split of shares authorized under these Articles, fractions of a share will stand to the credit of any Shareholder, the Board is authorized, at its discretion, to act as follows:

 

(a) determine that fractions of shares that do not entitle their owners to a whole share, will be sold by the Company, and that the consideration for such sale be paid to the beneficiaries, on terms the Board may determine;

 

 
 

 

(b) allot to every Shareholder who holds a fraction of a share resulting from a consolidation and/or a split, shares of the class that existed prior to the consolidation and/or split, in a quantity that, when consolidated with the fraction, will constitute a whole share, and such allotment will be considered valid immediately prior to the consolidation or split;

 

(c) determine the manner for paying the amounts to be paid for shares allotted in accordance with Sub-Section (b) above, including on account of bonus shares; and/or

 

(d) determine that the owners of fractions of shares will not be entitled to receive a whole share in respect of a share fraction or that they may receive a whole share with a different par value than that of the fraction of a share.

 

Allotment and Rights of Shares

 

16. Subject to these Articles and to the terms of any General Meeting resolution creating new shares, the allotment and issue of shares will be as determined by the Board of Directors, who may in its sole discretion allot and issue such shares to persons on terms and conditions and at such times as determined by the Board of Directors, including the allotment of bonus shares.

 

17. (a) Each ordinary share will entitle its owner to receive notices of, to attend, and to cast one vote at a General Meeting.

 

(b) All shares of the Company of the same class shall rank pari passu in respect of dividends, allotment of bonus shares, distribution of assets or otherwise.

 

18. (a) The rights granted to Shareholders of any class of shares issued with preferred or other special rights will not, unless specifically provided by the terms of issue of the shares of that class, be deemed to be modified by the creation or issue of shares of a different class.

 

(b) Unless otherwise provided for by the terms of issuance of particular class of shares, the Company may create or change rights, preferences, restrictions and provisions related to one or more of the classes of shares, after receipt of consent in writing of all Shareholders of the affected class, or a Resolution passed at a General Meeting of such class. These Articles will apply, as applicable, to every such separate General Meeting of a class.

 

19. The rights applicable to any shares, whether in the original Share Capital or any increased Share Capital, may be changed according to the provisions of these Articles, provided however, that the Company will not disparately reduce or restrict the existing Shareholders' voting rights through any corporate action or issuance.

 

 
 

 

Repurchase of shares

 

20. The Company may, at any time and from time to time, subject to the Law, purchase back or finance the purchase of any shares or other securities issued by the Company, in such manner and under such terms as the Board of Directors shall determine, whether from any one or more Shareholders. Such purchase shall not be deemed a payment of dividends; and no Shareholder will have the right to require the Company to purchase his shares or to offer to purchase shares from any other Shareholder.

 

Share Register and Share Certificates

 

21. The Company will maintain a Register of Shareholders according to the Law. The Company may maintain the Register of Shareholders or one or two branch Registers of Shareholders, in Israel or another jurisdiction, which will be considered as part of the Register.

 

22. The Company will not be bound by or required to recognize any right or interest in any share other than rights or interests of the Shareholder duly registered in the Register or otherwise proven in accordance with these Articles and the Law.

 

23. Every person whose name duly appears as a shareholder in the Register or who otherwise establishes proof of ownership in accordance with these Articles and the Law, will have the right without payment to receive, within two (2) months after allotment or registration of transfer (unless the conditions of allotment or transfer provide for a longer period), a stamped certificate for all the shares registered in his name. The certificate will specify the number of shares for which it is issued. In case of joint Shareholders the Company will not be required to issue more than one certificate to all the joint Shareholders. Delivery of a certificate to any of the joint Shareholders will be sufficient delivery to all. Every certificate will be signed by two Directors and countersigned by the Secretary or by other persons nominated by the Board of Directors for that purpose. The Company may withhold the issue of share certificates for shares not fully paid up.

 

24. If any share certificate will be defaced, worn out, destroyed or lost, it may be replaced following production of any evidence, provision of any indemnity and payment of any of the Company’s out of pocket expenses as the Board of Directors will require. In case of defacement or wearing out, replacement will require delivery of the old certificate.

 

Share Warrants, Options and Debentures

 

25. The Company may issue from time to time share warrants, options on shares, debentures and similar forms of securities. The price, terms and conditions of any such securities will be determined by the Board of Directors.

 

 
 

 

26. Subject to the applicable provisions of the Law, the Company may issue and redeem redeemable preference shares and redeemable warrants. The terms of redemption of, and the rights and obligations attached to such securities, shall be determined by the Board of Directors, either in general or with respect to a particular issue.

 

Lien on Shares

 

27. The Company will have a lien on every share for all amounts payable by a shareholder in respect of such share, whether or not such payables have matured. However, the Board of Directors may at any time declare any share to be wholly or partly exempt from the provisions of this Article. The Company’s lien, if any, on a share will extend to all dividends payable on that share.

 

28. The Company may sell any shares on which it has a lien at such time and in such manner as will be determined by the Board of Directors. However, no sale will be made prior to the lapse of fourteen (14) days from the date of sending a notice in writing to the registered Shareholders, demanding payment of such sum and giving notice of the Company’s intention to sell in default. To give effect to any such sale, the Board of Directors may authorize transfer of the shares sold to the purchaser who will be registered as the holder of the Shares. The Company will receive the net proceeds of the sale which will be applied in payment of the sum then payable on the lien. The balance of the sale proceeds, if any, will be paid to the person holding the shares immediately prior to the sale, subject to any lien for sums that were not currently payable for the shares prior to the sale.

 

Calls on Shares; Forfeiture of Shares

 

29. The Board of Directors may, at its discretion, from time to time authorize the amount and manner of the consideration to be given to the Company for shares. The Board may also make calls on Shareholders for any moneys unpaid on their shares. Each Shareholder will be liable to pay the amount of every call so made on him to the persons and at the times, places and installments specified by the Board. A call may be revoked or postponed as the Board may determine.

 

30. A call will be considered to have been made, at the time the Board of Directors approves the resolution authorizing such call.

 

31. The joint shareholders of a share will be jointly and severally liable for the payment of all calls and related installments.

 

32. The Board of Directors may, at its discretion, authorize receipt of advances from any shareholder relating to future calls on shares. The Board may authorize interest to be paid as may be agreed with the advancing shareholder.

 

33. Any sum that, by the terms of a share, is payable upon the share’s allotment or at any fixed date, will be considered to be a call duly made and payable on the date fixed for such payment. In case of non-payment of such sum, the relevant provisions of these Articles will apply as if such sum were a call duly made and notified according to these Articles.

 

 
 

 

34. The Board of Directors may, upon the issue of shares, differentiate between the Shareholders as to the amount of calls to be paid and the times of payment.

 

35. If any shareholder fails to pay all or part of any call or installment of a call on or before the day set for such payment, the Board of Directors may serve a notice on such Shareholder. The notice will require payment of the amount remaining unpaid together with interest, at such rate as the Board will determine, and any expenses that may have accrued by reason of such non-payment. The notice will state a date, not less than fourteen (14) days from the date of the notice, on or before which such call or installment, and all interest and expenses that have accrued by reason of such non-payment are to be paid. It will also state the place where payment is to be made, and will state that in the event of non-payment on or before the time and at the place set, the shares for which such call was made will be liable to be forfeited. If the requirements of any such notice are not met, any share for which such notice has been given may, as long as the payment required by the notice has not been made, be forfeited by a resolution of the Board to that effect. A forfeiture of shares will include all dividends applicable to the shares not actually paid before the forfeiture, even if the dividend has already been declared.

 

36. When any shares have been forfeited in accordance with these Articles, notice of forfeiture will be promptly given to the Shareholder or to the person entitled to the shares by transmission, as the case may be. An entry of such notice having been given and of the date of the forfeiture of the applicable shares will be made in the Register. However, a forfeiture will not be invalid solely due to the failure to give such notice or to make such entry in the Register.

 

37. (a) Following a forfeiture, the Board of Directors may, at any time before the forfeited share has been otherwise disposed of, revoke the forfeiture and return the share to the Shareholder on terms determined by the Board.

 

(b) Every forfeited share may be sold or re-allotted or otherwise disposed of, to any other person, on such terms as the Board of Directors may determine.

 

38. A person whose shares have been forfeited will remain liable to pay to the Company all calls made and not paid on such shares at the time of forfeiture, and interest thereon to date of payment, in the same manner as if the shares had not been forfeited. Such person will also remain liable to satisfy any claims and demands which the Company might have enforced regarding the shares at the time of forfeiture, without any deduction or allowance for the value of the shares at the time of forfeiture. However, if the Company chooses to sell the forfeited shares, then the net consideration received by the Company for such shares will be deducted from the amount the person whose shares have been forfeited is liable to pay the Company.

 

 
 

 

39. The forfeiture of a share will cause the extinction at the time of forfeiture of all claims and demands against the Company regarding the share, and all other rights and liabilities relating to the share as between the forfeiting Shareholder and the Company, except as provided by law.

 

40. A written declaration by a Director that a share has been duly forfeited according to these Articles and stating the date of forfeiture, will be conclusive evidence of the facts stated in the declaration against any persons claiming to be entitled to the forfeited shares. Such declaration, together with the Company’s receipt for the consideration, if any, given for the forfeited shares on their sale or disposition, and a duly signed share certificate delivered to the purchaser, will confer good title to the shares. Such purchaser will be registered as the holder of the shares.

 

Conversion of Shares into Stock

 

41. (a) The Company may, by a Resolution of the Shareholders at a General Meeting, convert any paid-up shares into stock, and may reconvert any stock into paid-up shares of any denomination.

 

(b) The holders of stock may transfer the same, or any part thereof, in the same manner, and subject to the same regulations, as the shares from which the stock arose might, prior to conversion, have been transferred, or as near thereto as circumstances admit; but the Board of Directors may from time to time fix the minimum amount of stock transferable, and restrict or forbid the transfer of fractions of that minimum.

 

(c) The holders of stock shall, according to the amount of stock held by them, have the same rights, privileges, and advantages as regards dividends, voting at General Meetings, and other matters as if they held the shares from which the stock arose, but no such privileges or advantage, except participation in the dividends and profits of the Company, shall be conferred by any such aliquot part of stock as would not, if existing in shares, have conferred that privilege or advantage.

 

(d) Such of the Articles of the Company, as are applicable to paid-up shares shall apply to stock, and the words "share" and "Shareholder" therein shall include "stock" and "Stockholder".

 

Transfer of Shares

 

42. Transfer of fully paid up shares in the Company shall not require the approval of the Board of Directors.

 

 
 

 

43. No transfer of shares shall be registered unless a proper instrument of transfer has been submitted to the Company, coupled, to the extent applicable, with the certificate for the shares to be transferred, and any other evidence as the Board of Directors may reasonably require of the title of the transferor. The transferor will be considered to remain the Shareholder until the name of the transferee is entered in the Register for the applicable shares.

 

44. The instrument of transfer of any share shall be in the usual or customary form or as near thereto as possible, and shall be signed by the transferor and transferee.

 

45. The Board of Directors may decline to register any transfer of shares, which have not been fully paid up.

 

46. The transfer books, the Register and registers of debenture-holders may be closed during such time as the Board of Directors deems fit, not exceeding a total of thirty (30) days in each year.

 

47. The Board of Directors may determine a fee to be charged for registration of a transfer.

 

Transmission of Shares upon Death, Bankruptcy or Dissolution

 

48. The executors and administrators of the deceased sole holder of a share or, if there are no executors or administrators, such persons, heirs (as evidenced by a probate or such other evidence as the Board of Directors may reasonably deem sufficient) shall be the only persons recognized by the Company as having any title to the share. In case of a share registered in the name of two or more holders, the Company shall recognize the survivor or survivors as the only persons having any title to or benefit in the share.

 

49. The receiver or liquidator of a Shareholder in winding-up or dissolution, or the trustee in bankruptcy, or any official receiver of any bankrupt Shareholder, upon producing such evidence as the Board of Directors may deem sufficient as to his authority to act in such capacity under this Article, may be registered as a Shareholder in respect of such shares, or may, subject to the regulations as to transfer herein contained, transfer such shares.

 

Borrowing Powers

 

50. The Company may from time to time, at its discretion, borrow or secure the payment of any sum or sums of money for the purposes of the Company.

 

51. The Company may raise the funds for or secure the repayment of such sum or sums in such manner, at such times and upon such terms and conditions as it deems fit and, in particular, by the issue of bonds, perpetual or redeemable debentures, debenture stock, or any mortgages or charges, on the whole or any part of the property of the Company, both present and future, including its uncalled capital at that time and its called but unpaid capital.

 

 
 

 

Convening of General Meetings

 

52. General Meetings will be held at least once in every calendar year at the time and place, and with an agenda, as may be determined by the Board of Directors. Shareholders representing at least ten percent (10%) of the Company’s outstanding share capital and one percent (1%) of the Company’s voting power may request the Chairman of the Board to add appropriate items to a General Meeting agenda.

 

53. Unless otherwise determined by the Board of Directors and subject to the Law and applicable rules and regulations, the business of a General Meeting shall be to receive the financial statements and the Board of Directors report, to elect Directors, to appoint independent certified accountants, and to transact any other business which according to these Articles, the Law or any applicable rules or regulations, is to be addressed at a General Meeting. Each annual General Meeting will be called an “Annual Meeting”, and any other General Meeting will be called a “Special Meeting”.

 

54. Each Annual Meeting will take place no later than fifteen (15) months after the previous Annual Meeting, and no later than the end of the applicable calendar year. The Board may convene a Special Meeting at any time it deems necessary.

 

55. The Board of Directors will convene a Special Meeting on receipt of a written request from any of:

 

(a) two (2) Directors or twenty-five percent (25%) of the total number of Directors;

 

(b) one (1) or more Shareholders, holding at least five percent (5%) of the issued Share Capital and at least one percent (1%) of the Shareholders’ voting power; or

 

(c) one (1) or more Shareholders holding no less that five percent (5%)of the Company’s issued voting shares.

 

56. A Special Meeting requested under Article 55 above will be convened within the period specified in the relevant provisions of the Law. If the Board of Directors fails to convene such meeting within such time, then the required Special Meeting may be convened, in the same manner as for other Special Meetings, by any of the Directors and/or by Shareholders who requested the convening (representing at least one-half of such Shareholders’ voting rights), provided it is convened no later than three (3) months after submission of the written request to the Board.

 

 
 

 

57. The Board of Directors will set a record date in accordance with the requirements of the Law, for Shareholders entitled to receive notice of and vote at a General Meeting. Subject to the terms of the Law, the date to be determined by the Board, shall not precede the date for which a General Meeting was called by more than forty (40) nor by less than four (4) days (or any longer or shorter period permitted by Law). The determination of a record date shall apply to any adjournment of the meeting; provided, however, that the Board of Directors may set a new record date for the adjourned meeting.

 

58. A written notice of the convening of a General Meeting will be given, at least twenty-one (21) days in advance, or a longer period as may be required under the Law or any other applicable rules and regulations. The notice will specify the place, date and time of the Meeting, the record date, and other items as specified in the Law. The place of the meeting will be in Israel unless otherwise specified by the Board.

 

59.   (a)      The accidental omission to give notice of a General Meeting to, or the non receipt of notice by, any Shareholder entitled thereto, shall not invalidate the proceedings at such meetings.

 

(b)      No shareholder present, in person or by proxy, at the commencement of a General Meeting shall be entitled to seek the revocation of any proceedings or resolutions adopted at such General Meeting on account of any defect in the notice of such meeting relating to the time or the place thereof.

 

Proceedings at General Meetings

 

60. No business will be transacted at any General Meeting or at any adjourned meeting unless a quorum is present. The quorum at any General Meeting or at any adjourned meeting, will be at least two (2) Shareholders present in person, by Proxy or by a Voting Instrument and holding or representing at least thirty three and one third percent (33 1/3%) of the issued voting ordinary shares.

 

61. If within one-half (1/2) hour from the time set for the holding of a General Meeting a quorum is not present, the meeting will be adjourned to the same day, time and place in the next week or as will be determined in the notice to the Shareholders, or another date and place as shall be determined by the Board of Directors.

 

62. Except as provided in these Articles, the Law and any other applicable rules and regulations, all business transacted at a General Meeting will be decided by a resolution adopted by a simple majority of the votes cast at the General Meeting, not taking into account abstentions.

 

63. The Chairman of the Board of Directors will preside at any General Meeting as the chairman of the General Meeting, but if there will be no such Chairman, or if at any General Meeting he will not be present or is unwilling to act as Chairman of the General Meeting, the Shareholders present will choose any Director to act as Chairman of the meeting. If no Director is present, or if all the Directors present decline to take the chair, the Shareholders present will choose a Shareholder present to be chairman of the meeting. The chairman of any General Meeting shall not be entitled to a second or tie-breaking vote.

 

 
 

 

64. The chairman of a General Meeting may, with the consent of any General Meeting at which a quorum is present (and will if so directed by the meeting) adjourn the meeting from time to time and from place to place. No Shareholder will have the right to any other notice of adjournment. However, whenever a General Meeting is adjourned for twenty one (21) days or more, notice of the adjourned General Meeting will be given in the same manner as for the original General Meeting. No business shall be transacted at any adjourned meeting other than the business which might have been transacted at the meeting as originally called.

 

Voting at General Meetings; Voting Instruments

 

65. Shareholders in the Company who are registered in the Register on the date determined by the Board of Directors in its resolution to convene a General Meeting and who are present at the meeting, in person or by proxy, or deemed to be present by a Voting Instrument, shall be entitled to participate in and vote at the General Meeting.

 

66. The vote may be by show of hands, by secret ballot, by Voting Instrument or by any other manner authorized by the Board of Directors consistent with the Law. A Shareholder will have one (1) vote for each share held by him. However, unless otherwise determined by the Board, no Shareholder will be permitted to vote at a General Meeting or to appoint a Proxy to so vote unless he has paid all calls for payment and all moneys due to the Company from him with respect to his shares.

 

67. A Proxy present at a General Meeting will have the same rights as a Shareholder with respect to voting at a General Meeting. A Proxy may be granted to any person, whether or not such person is a Shareholder.

 

68. The vote of the senior of any joint Shareholders, whether in person, by Voting Instrument or by Proxy, will be accepted to the exclusion of the votes of other joint Shareholders. For the purpose of these Articles, seniority will be determined by the order in which the names appear in the Register.

 

69. An objection to a Shareholder’s or a Proxy’s right to vote in a General Meeting must be raised at the applicable meeting or adjourned meeting in which that person was supposed to vote. The chairman of the meeting will decide whether to accept or reject any objection raised at the proper time regarding the vote of a Shareholder or Proxy, and the chairman of the General Meeting’s decision will be final. Every vote not disqualified as provided above will be valid for all matters at the General Meeting.

 

 
 

 

70. A Shareholder that is a corporation or other form of legal entity will have the right to appoint a person to be its representative at any General Meeting. The representative so appointed will have the right to exercise on behalf of the entity he represents all the powers that the entity itself might exercise in connection with the General Meeting.

 

71. A Shareholder who has been declared legally incompetent or has otherwise been appointed a legal guardian, may, following proof of appointment of a legal guardian or similar representative, vote at a General Meeting through such guardian or similar representative, whether in person, by Voting Instrument or by Proxy.

 

72. A vote by Proxy or by Voting Instrument will be considered valid even in the event of the death or declaration of incompetence of the appointee/signatory or the cancellation of the Proxy appointment or Voting Instrument or expiration of a Proxy appointment or Voting Instrument in accordance with the Law and any other applicable rules and regulations, or the transfer of the shares for which the Proxy appointment or Voting Instrument was given, unless the Company receives at the Registered Office, prior to a General Meeting, a written notice as specified below. For a Voting Instrument or Proxy appointment that has been provided to the Company for a specific General Meeting to be considered invalid, a written notice of cancellation of a Voting Instrument or a Proxy appointment must be duly signed by the applicable Shareholder specifying the applicable shares, the name of the Shareholder, legal representative or successor in interest and nature of the event invalidating the Proxy appointment or Voting Instrument. In the event of voting by a secret ballot or by Voting Instrument, a notice canceling the appointment of a Proxy will be valid if it is signed by the appointee/signatory or its legal representative or successor in interest and received at the Registered Office no later than one (1) hour before the beginning of the vote.

 

73. A Shareholder will have the right, to vote by a Voting Instrument as an alternative to voting in person or by Proxy. In all applicable cases, the Company will send the Voting Instrument to the Shareholders before the applicable General Meeting, no later than the time set for that purpose in the Law.

 

74. A Shareholder has the right to vote by a separate Proxy with respect to each share held by him, provided that each Proxy will have a separate letter of appointment containing the serial number of the shares for which the Proxy is entitled to vote. If a specific share is included in more than one (1) letter of appointment, then no Proxy will have the right to vote such share.

 

75. An instrument appointing a Proxy, which is not limited in time, will expire twelve (12) months after the date of its execution. If the appointment is for a limited time period, even exceeding twelve (12) months, the instrument will be valid for such period as specified in the instrument.

 

76.     (a)   A Voting Instrument, instrument of appointment of a Proxy, power of attorney or other instrument relating to voting at a General Meeting, must be in writing.

 

 
 

 

(b) Any instrument of appointment a of proxy, whether for any specified meeting or otherwise shall, as far as circumstances permit, be in the following form or in any other acceptable form approved by the Board of Directors:

 

“I, , of , being the holder of shares of NIS each, hereby appoint Mr. of to vote for me and on my behalf at the General Meeting of the Company to be held on the day of in the year and at any adjourned meeting of such meeting.”

 

IN WITNESS WHEREOF I have set my hand this ___ day of the month of _____________ in the year _____."

 

(c) The original or a copy of such confirmed instrument will be delivered to the Registered Office, or to such other place in Israel or abroad as the Board may from time to time designate, at least twenty-four (24) hours before the time set for the applicable original or adjourned General Meeting. Otherwise, that person will not be entitled to vote that share through the instrument. At the request of the chairman of a General Meeting, written evidence of such authorization, in a reasonably acceptable form and content, satisfactory to the chairman of the General Meeting, shall be furnished to the chairman of the General Meeting.

 

Role and Composition of The Board of Directors

 

77. The Board of Directors will set the policies of the Company and oversee the execution by the General Manager of his tasks and acts. The Board will have all residual powers not granted under these Articles or by law to any other Company body.

 

78. The General Meeting may assume powers granted under these Articles or by Law to the Board of Directors. However, any decision to assume such powers must be adopted by a Special Majority and must specify the matters and time period for which such powers are assumed.

 

79. The number of Directors may be determined from time to time by the Board. Unless otherwise determined by the Board, the number of Directors comprising the Board will be at least four (4) and not more than ten (10). The majority of the Directors will be Independent Directors, and at least two (2) of the Directors shall be External Directors in accordance with the requirements of the Law. A Director is not required to be a Shareholder.

 

80. The Directors will be entitled to be reimbursed for reasonable expenses incurred by them in performing their services as Directors. The External Directors shall be paid for their services, as prescribed under the Law and as resolved by the General Meeting.

 

 
 

 

81. Subject to the provisions of the Law, a Director (or any other Officer) shall not be disqualified by his holding of such office with the Company from holding any other office or function with the Company (other than the office of an Internal Auditor or Independent Certified Accountant) or from giving services for consideration to the Company, save that the additional employment of a Director and the terms thereof must be approved, as required by the Law; nor will a Director (or any other Officer) be disqualified by the holding of such office with the Company from holding any other office or function or from giving services for consideration to a company in which the Company holds any shares or in which it is interested in any other way.

 

Election, Appointment and Removal of Directors

 

82. Directors will be elected annually by the Shareholders at the Annual Meeting. Directors may be nominated in accordance with rules and regulations that may apply to the Company. Directors will hold office until the conclusion of the next Annual Meeting or until their earlier removal or resignation. However, if no Directors are elected at an Annual Meeting, then the persons who served as Directors immediately prior to the Annual Meeting shall be deemed reelected at the same meeting, and will continue to serve as Directors unless otherwise determined by the Annual Meeting. Directors will be eligible for re-election.

 

83. Notwithstanding Article 82 above:

 

(a) the General Meeting may resolve that a director be elected for a period longer than by the next Annual Meeting but not longer than the third next Annual Meeting.

 

(b) Shareholders holding a majority of the outstanding share capital of the Company may remove or elect directors by a written notice to the Company.

 

(c) A General Meeting may, remove any Director from his office before the end of his term and can, by a resolution adopted by a simple majority, elect another person in his place.

 

84. The Chairman of the Board of Directors will be appointed by the Board from the Directors elected to their office. Such Director will serve as Chairman of the Board of Directors until he ceases to hold the office of Director or until the General Meeting replaces him.

 

85. The Board of Directors will have the power, from time to time, to appoint additional Directors if the current number of Directors is less than ten (10) or such other maximum number approved by the Board of Directors. Any Director so appointed will hold office until the conclusion of the next Annual Meeting, unless he is removed or resigns earlier.

 

 
 

 

86. Where the office of a Director has been vacated, the remaining Directors may continue to act, but if their number is reduced below the minimum number specified in these Articles, or if the number of the Directors elected by a General Meeting is lower than the minimum number specified in these Articles, then the Director or Directors continuing to hold office shall not act except in case of an emergency, or for the purpose of increasing the number of Directors, by way of appointment of additional Directors, or for the purpose of convening a General Meeting of the Company, but not for any other purpose.

 

87. Subject to the terms of the Law, a Director will be removed if he:

 

(a) becomes bankrupt or enters into similar status (and if the Director is a company, upon its winding-up);

 

(b) dies or is declared legally incompetent;

 

(c) resigns his office by notice in writing given to the Company;

 

(d) is removed by a resolution of a General Meeting; or

 

(e) upon the occurrence of any of the applicable events set forth in the Law.

 

Substitute Director

 

88.      (a)   A Director may, by notice in writing to the Company and subject to Sub-Section (b), appoint for a specific meeting a substitute (hereinafter referred to as "Substitute Director" ), revoke the appointment of such Substitute Director and appoint another in his place. Any appointment, or revocation of appointment of a Substitute Director shall become effective on the date set in the respective notice of appointment or revocation, as the case may be, but not before delivery thereof to the Company.

 

(b) A person may not act as a Substitute Director if he is not qualified to be appointed a Director or if he currently serves as a Director or Substitute Director.

 

(c) A Substitute Director shall be entitled to receive notices of the meeting of the Board of Directors for which he has been appointed and to attend and vote at such meeting as if he were a Director, and he shall have all the rights and be subject to all obligations of the Director for whom he acts as Substitute Director.

 

(d) The office of a Substitute Director shall ipso facto be vacated at the end of the meeting of the Board of Directors for which he has been so appointed; if he is removed from office in accordance with Sub-Section (a) hereof; if the office of the Director by whom he has been appointed Substitute Director is vacated for any reason whatsoever or upon the death of the Substitute Director or upon the occurrence of any of the events referred to in Article 88.

 

 
 

 

External Directors

 

89. The Board of Directors will include at least two (2) External Directors or such other number, all as required in order to comply with the qualifications described in the Law.

 

90. An External Director will be nominated by a majority vote at a General Meeting, provided that:

 

(a) The majority vote at the General Meeting will include at least one- third (1/3) of the total number of the votes of the non-controlling Shareholders voting at the meeting. For the purposes of this Article, abstentions will not be counted towards the total number of the non-controlling Shareholders; and

 

(b) The total number of non-controlling Shareholders voting against the resolution appointing the External Director, is not more than one percent (1%) of the total voting rights in the Company.

 

91. The compensation and indemnification of expenses of External Directors will be determined in accordance with the applicable provisions of the Law.

 

92. An External Director will be appointed for a period of three (3) years. The term of his office may be extended by a resolution of the General Meeting for an additional three (3) years. An External Director may be removed from his office only in accordance with the applicable provisions of the Law.

 

Board of Directors Meetings

 

93. The Board of Directors may convene, adjourn and otherwise regulate its meetings, as it deems fit; provided, however, that the Board will meet at least once in every three (3) months period. Unless otherwise determined by the Board, the quorum for a Board meeting will be not less than thirty percent (30%) of the then number of Directors but in any event not less then two directors.

 

94. No business shall be transacted at a meeting of the Board of Directors unless the requisite quorum is present at the commencement of the meeting, and no resolution shall be adopted unless the requisite quorum is present when the resolution is voted upon.

 

95. Issues arising at any Board of Directors’ meeting will be decided by a majority of votes cast at the meeting. In case of a tie, the Chairman will not have a second or casting vote.

 

 
 

 

96. Each Director will receive at least 3 (three) days prior notice of a Board meeting. Such notice may be given by any means of communication as determined by the Chairmen or the Secretary, including, among others, telephone, facsimile or e-mail. Such notice will include the time and location of the meeting and a reasonable description of the meeting’s agenda. Notwithstanding anything to the contrary herein, failure to deliver notice to a Director of any such meeting in the manner required hereby may be waived (in advance or retroactively) by such Director, and a meeting shall be deemed to have been duly convened notwithstanding such defective notice of such failure or defect. Without derogating from the foregoing, no Director present at the commencement of a meeting of the Board of Directors shall be entitled to seek the revocation of any proceedings or resolutions adopted at such meeting on account of any defect in the notice of such meeting relating to the time or the place thereof.

 

97. At the request of any Director, the Secretary will summon a meeting of the Board of Directors.

 

98. The Chairman of the Board of Directors shall take the chair at all meetings of the Board of Directors, but if there is no Chairman, or if at any meeting he is not present within fifteen (15) minutes of the time appointed for the meeting, or if he is unwilling to take the chair at the meeting, the Directors present shall choose on Director to serve as the Chairman of such meeting.

 

99. A meeting of the Board of Directors at which a quorum is present shall be competent to exercise all the authorities, powers and discretions by or under the Law and the Articles of the Company at that time vested in or exercisable by the Board of Directors.

 

100. Directors may participate in a Board meeting or Board committee meeting by means of a telephone conference or other communications media, provided that all participating Directors can hear each other simultaneously. Participation by such means will be considered as presence in person at a meeting.

 

101. All acts done at any meeting of the Board of Directors, or of a Committee of the Board of Directors, or by any person acting as a Director shall, notwithstanding that it may afterwards be discovered that there was some defect in the appointment of such Directors or members of a Committee of the Board of Directors or persons acting as aforesaid or any of them, or that they or any of them were disqualified, be as valid as if every such person had been duly appointed and was qualified to be Director or a member of such Committee of the Board of Directors.

 

102. A resolution in writing signed by all of the Directors or to which all of the Directors have agreed in writing or by telephone or facsimile, shall be as valid and effective for all purposes as if passed at a meeting of the Board of Directors duly convened and held, and for the purpose of this Article "Director" shall include, if duly appointed therefore, a Substitute Director.

 

 
 

 

103. Minutes in writing signed by the Chairman will serve as evidence of a resolution passed at a duly convened meeting of the Board of Directors.

 

Committees of the Board of Directors

 

104. Subject to the applicable provisions of the Law regarding matters that the Board may not delegate to a committee, the Board of Directors may delegate any of its powers to committees consisting of at least three (3) Directors, provided that each such committee shall include at least one (1) External Director. The Board of Directors may from time to time revoke such delegation or alter the composition of any such committee. Any committee so formed will exercise its powers in accordance with any directions given to it by the Board.

 

105. A Board committee may elect a chairman. If no such chairman is elected, or if at any meeting the chairman is not present within fifteen (15) minutes after the time appointed for holding the meeting, the committee members present may choose a committee member to be chairman of the meeting. Unless otherwise specifically directed by the Board of Directors, the meetings and proceedings of any committee will be governed by the applicable provisions in these Articles regulating the meetings and proceedings of the Board.

 

106. A committee may meet and adjourn as its members may determine. Issues arising at any meeting will be determined by a majority of votes of the members present. In case of a tie the chairman of the committee will not have a second or tie breaking vote.

 

107. The Board of Directors will appoint an Audit Committee. The composition, responsibilities and authorities of the Audit committee shall be in accordance with the Law and with the applicable rules and regulations the Company is subject to.

 

Local Management

 

108. The Board of Directors may from time to time, provide for the management and transaction of the affairs of the Company in any specified locality, whether in Israel or abroad, in such manner as it deems fit, and the provisions contained in the next following Article shall be without prejudice to the general powers vested by these Articles on the Board of Directors.

 

109. The Board of Directors may from time to time, and at any time, establish any local board or agency for managing any of the affairs of the Company in any such specified locality, and may appoint any person to be a member of such local board, or any manager or agent, and may fix their remuneration. Subject to the provisions of the Law, the Board of Directors may from time to time, and at any time, delegate to any person so appointed any of the powers, authorities and discretions at that time vested in the Board of Directors, on such terms and subject to such conditions as the Board of Directors deems fit, and the Board of Directors may at any time remove any person so appointed and may revoke or vary any such delegation.

 

 
 

 

General Manager

 

110. The Board of Directors shall from time to time appoint one or more persons, whether or not Directors as Chief Executive Officer or Officers, General Manager or Managers, or President of the Company, either for a fixed or an unlimited term, and from time to time (subject to any provisions of the Law and of any contract between any such person and the Company) remove or dismiss him or them from office and appoint another or others in his or their stead.

 

111. The remuneration of a General Manager, Chief Executive Officer and President, shall from time to time (subject to the provisions of the Law and any contract between him and the Company) be determined by the Board of Directors, and may be subject to a recommendation of the majority of the Independent Directors, or of a compensation committee comprised solely of Independent Directors.

 

112. The General Manager shall be responsible for the day-to-day management of the Company’s affairs within the framework of the Company’s policy set by the Board of Directors and subject to its directions; he shall have all management and execution powers not vested by the Law or these Articles in any other Organ, and he will be subject to the supervision of the Board of Directors. Subject to the provisions of the Law, the Board of Directors may from time to time, and at any time, entrust to and confer upon the General Manager such powers exercisable under the Articles by the Board of Directors as it may deem fit, and may confer such powers for such time, and to be exercised for such objects and purposes, and upon such terms and conditions, and with such restrictions, as it deems expedient; and it may confer such powers, either collaterally with, or to the exclusion of, and in substitution for, all or any of the powers of the Board of Directors in that behalf; and may from time to time revoke, withdraw, alter, or vary all or any of such powers.

 

Dividends and Reserves

 

113. The Board of Directors may from time to time declare and cause the Company to pay to the Shareholders such interim or final dividend as the Board of Directors deems appropriate considering the profits of the Company and in compliance with the provisions of the Law. The Board may set the dividend record date (which date may be on or after the date of declaration) and the time for payment.

 

114. No dividend shall be paid otherwise than out of the profits of the Company.

 

115. No dividend shall be paid other than in compliance with the provisions of the Law; and no dividend shall carry interest as against the Company.

 

 
 

 

116. The Board of Directors may, before declaring any dividend, set aside, out of the profits of the Company, such sums as it deems appropriate, as a reserve fund to meet contingencies, or for equalization of dividends, or for special dividends, or for repairing, improving and maintaining any of the property of the Company, or for such other purposes as the Board of Directors shall in its absolute discretion deem conducive to the interests of the Company; and may invest such sum(s) so set aside in such investments as it may deem fit, and from time to time vary such investments, and dispose of all or any part thereof for the benefit of the Company, and may divide the reserve fund into such special funds as it deems fit, and use the reserve fund or any part thereof in the business of the Company, and that without being bound to keep the same separate from the other asset of the Company.

 

117. Subject to special rights of Shareholders and subject to the provisions of these Articles, dividends, whether in cash or in bonus shares, shall be paid or distributed, as the case may be, to Shareholders pro rata to the amount paid up or credited as paid up on account of the of their shares, without taking into consideration any premium paid thereon; but the amount paid up on account of a share prior to call being made thereon or prior to the due date for payment thereof, and on which the Company is paying interest, shall not, for purposes of this Article, be deemed to be an amount paid up on account of a share. Notwithstanding the above, and to the extent that the rights attached to the shares or the terms of issue thereof otherwise provide, the Board of Directors may determine that any amount paid on a share during the period in respect of which the dividend has been declared shall entitle the holder of such share only to a proportionate amount of the dividend having regard to the date of the payment of the said amount of capital.

 

118. Unless otherwise directed by the Board of Directors or by a General Meeting, any dividend may be paid by check or bank transfer to the registered address of the Shareholder; or in case of joint Shareholders, to the one of them first named in the Register regarding the joint holding. The receipt of the person whose name on the record date appears on the Register as the owner of any share, or in the case of joint Shareholders, of any one of such joint Shareholders, will be sufficient evidence of all payments made for such share. All dividends unclaimed after having been declared may be invested or otherwise used as directed by the Board for the benefit of the Company until claimed. Upon the lapse of seven (7) years from the declaration of such dividends, the Company will have no obligation to pay the unclaimed dividend. No unclaimed dividend or interest will bear interest from the Company.

 

 
 

 

119. Without derogation from the provisions of Section 113, upon the recommendation of the Board of Directors approved by a resolution at a General Meeting, any General Meeting may resolve that any moneys, investments, or other assets forming part of the undivided profits of the Company standing to the credit of the reserve fund, or to the credit of the reserve fund for the redemption of capital or in the hands of the Company and available for distribution of dividends, or representing premiums received on the issue of shares and standing to the credit of the share premium account, be capitalized and distributed among such of the Shareholders as would be entitled to receive the same if distributed by way of dividend and in the same proportion and on the same basis ; and that all or any part of such capitalized fund be applied on behalf of such Shareholders in paying up in full, either at par or at such premiums as the resolution may provide, any unissued shares or debentures of the Company, which shall be distributed accordingly and shall be accepted by such Shareholders in full satisfaction of their rights in the said capitalized sum.

 

120. Without derogation from the provisions of Section 113, a General Meeting may resolve that a dividend be paid, in whole or in part, in cash and/or by the distribution of specific assets and, in particular, by distribution of paid-up shares, paid-up debentures, or debenture stock of any other company, or in any one or more combinations of such ways.

 

121. In order to give effect to any resolution regarding the distribution of shares or debentures by way of capitalization of profits as aforesaid, the Board of Directors may:

 

(a) settle, in such manner as it deems fit, any difficulty arising with regard to the distribution and take any steps it deems fit to overcome such difficulty;

 

(b) issue certificates for fractions of shares or resolve that fractions of lesser amount than that decided upon by the Board of Directors will not be taken into account for the purpose of adjusting the rights of the shareholders, or sell fractions of shares and pay the net consideration to the persons entitled thereto;

 

(c) sign on the shareholders' behalf any contract or other document that may be required in order to give effect to the distribution, and in particular it may sign and submit for registration a contract as mentioned in section 291 of the Law;

 

(d) make any arrangement or other settlement required, in the board of directors' opinion, to facilitate the distribution.

 

122. The Board of Directors may deduct from any dividend or other amount to be paid in respect of shares held by any Shareholder, whether alone or together with another Shareholder, any sum or sums due from him and payable by him, alone or together with any other person, to the Company on account of calls or the like.

 

123. If several persons are registered as joint holders of any share, any one of them may give valid receipts for any dividends payable on the share.

 

Minutes

 

124. The Board of Directors shall cause minutes to be duly entered in books provided for that purpose:

 

 
 

 

(a) of the names of the Directors present at each meeting of the Board of Directors and of any Committee of the Board of Directors;

 

(b) of the names of the Shareholders present at each General Meeting;

 

(c) of all directions given by the Board of Directors to any Committee of the Board of Directors;

 

(d) of the proceedings and resolutions of General Meetings and of meetings of the Board of Directors and Committees of the Board of Directors.

 

125. Any minutes, as aforesaid, of a meeting of the Board of Directors, which is confirmed and signed by the chairman of the meeting or by the Chairman of the Board of Directors, and any minutes of a meeting of a Committee of the Board of Directors or of a General Meeting, if signed by the chairman of such meeting, shall be accepted as prima facie evidence of the matters therein recorded.

 

Stamp and rights of signature

 

126. The Company shall have a stamp, and the Board of Directors shall provide for the safe custody of such stamp.

 

127. The Board of Directors shall be entitled to authorize any person(s) (even if such person(s) is/are not Director(s) of the Company) to act and sign on behalf of the Company, and the acts and signatures of such person or persons on behalf of the Company shall bind the Company insofar as such person or persons acted and signed within the scope of his or their authority.

 

The Secretary, officers and Attorneys

 

128. Unless otherwise determined by the Board of Directors, the Chairman of the Board of Directors, the President or any committee or officer authorized by the Board of Directors may from time to time appoint a Secretary for the Company, as well as other officers, personnel, agents and employees, to permanent, temporary or special positions, and the General Manager may determine and/or modify their titles, powers, duties, remuneration, salaries and bonuses. The Chairman of the Board of Directors, the President, or any committee or officer authorized by the Board of Directors may from time to time, in its discretion, revoke such appointments, modify their scope, or suspend the service of any one or more of such persons.

 

129. The Board of Directors may from time to time, and at any time, by power of attorney, appoint any company, firm or person or body of persons, whether nominated directly or indirectly by the Board of Directors, to be the Company’s Attorney or Attorneys for such purposes and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the General Manager under the Law or these Articles), and for such period and subject to such conditions as it deems fit, and any such power of attorney may contain such provisions for the protection and convenience of persons dealing with any such Attorney as the General Manager may deem fit, and may also authorize any such Attorney to delegate all or any of the powers, authorities and discretions vested in him.

 

 
 

 

Accounts

 

130. The Board of Directors will cause the Company’s books of accounts to be kept in accordance with legal requirements. A Shareholder who is not a Director shall not have any right of inspecting any account or book or document of the Company except as conferred upon him by Law or authorized by the Board of Directors or by the General Meeting.

 

131. The Company will issue financial statements as required by the Law and other applicable rules and regulations. The issued financial statements will be available for inspection by the Board of Directors and Shareholders at the Registered Office during regular office hours.

 

Independent Certified Accountants

 

132. The Company will appoint Independent Certified Accountants at a General Meeting. The Independent Certified Accountants will hold office until the end of the next Annual Meeting. However, the Shareholders at a General Meeting may remove the Independent Certified Accountants or extend the term of appointment for up to three (3) years. The independency, certification and registration of the Independent Certified Accountant shall be in accordance with the Law and applicable rules and regulations.

 

133. The fee of the Independent Certified Accountants will be set and approved by the Board of Directors.

 

Internal Auditor

 

134. (a) The Board of Directors, subject to the recommendation of the Audit Committee, will appoint an Internal Auditor for the Company. The Internal Auditor will report to the General Manager.

 

(b) The Internal Auditor may only be removed or replaced in accordance with the applicable provisions of the Law.

 

Mergers

 

135. Notwithstanding Section 327 of the Law, the Company may approve any Merger as defined in the Law, by a resolution adopted by a simple vote cast at a General Meeting, not taking into account abstentions.

 

 
 

 

Notices

 

136. (a) Notices by the Company to a Shareholder shall be given by registered mail to the address, if any, supplied by such Shareholder for the purpose of giving notices, as listed in the Register. In the absence of such address, notice shall be deemed to have been given by posting thereof at the Registered Office of the Company. Notice may also be given by way of transmission of facsimile and/or e-mail, based on details of such Shareholder as listed in the Register.

.

(b) Notice by registered mail or notice sent to any address outside of the State of Israel shall be deemed received three (3) days from the date on which a properly addressed, prepaid enclosure containing the notice was mailed. Notice by facsimile and/or e-mail, shall be deemed to be received one (1) day from their transmission.

 

137. Notice to joint Shareholders may be given by sending it only to the Shareholder first named in the Register for the applicable shares.

 

138. (a) The Board of Directors may authorize other methods of notice to Shareholders that are consistent with the Law and applicable rules and regulations.

 

(b) Notices of General Meetings will contain the information required by the Law and applicable rules and regulations.

 

Exemption, Insurance and Indemnity

 

139. The Company may exempt any Officer from his liability to the Company for breach of duty of care, to the maximum extent permitted by law, before or after the occurrence giving rise to such liability.

 

140. Subject to the provisions of the Law, the Company may exempt and release in advance or retroactively, any Officer from liability resulting from his breach of his duty of care to the Company.

 

141. Subject to the provisions of the Law, the Company may procure, as the Board may from time to time determine, Directors’ and Officers’ liability insurance covering the liabilities of an Officer for any act done by him by virtue of being an Officer, in respect of any of the following:

 

(a) breach of duty of care towards the Company or towards any other person;

  

(b) breach of fiduciary duty towards the Company, provided that such Officer acted in good faith and had a reasonable basis to assume that his action would not harm the interests of the Company;

 

 
 

 

(c) financial liabilities imposed on him in favor of a third party; or

 

(d) any other event for which insurance of an Officer is or may be permitted.

 

142. Subject to the provisions of the Law, the Company may undertake in advance or retroactively to indemnify any past or present Officer in respect of a liability or expense as detailed in Article 143 below, imposed on him as a result of an act carried out in his capacity as an Officer. However, if made in advance, such undertaking will be limited to the kinds of events that, in the Board’s opinion, are foreseeable at the time of the approval of the indemnification undertaking and will be limited to the amount fixed by the Board as reasonable under the circumstances which shall not exceed 25% of the Company’s Shareholders Equity for the time being.

 

143. An indemnity, as provided in Article 142 above, may be issued in respect of a liability or expense as follows:

 

(a) financial liability imposed upon said Officer in favor of another person by virtue of a decision by a court of law, including a decision by way of settlement or a decision in arbitration which has been confirmed by a court of law ;

 

(b) reasonable expenses of the proceedings, including lawyers’ fees, expended by the Officer or imposed on him by the court for:

 

(1) proceedings issued against him by or on behalf of the Company or by a third party;

 

(2) criminal proceedings in which the Officer was acquitted; or

 

(3) criminal proceedings in which he was convicted in an offense, which did not require proof of criminal intent; or

 

(c) any other liability or expense for which the indemnification of an Officer is not precluded by Law.

  

144. Subject to the provisions of the Law, the Company may issue an undertaking in advance or retroactively to indemnity any person, including an Officer, who acts or acted on behalf or at the request of the Company as a director or officer of another company in which the Company, directly or indirectly, is a shareholder, or in which the Company has any other interest. Such indemnity will be in respect of a liability or expense referred to in Article 143 above, imposed on him as a result of an act carried out by him in his capacity as a director or officer of the other company. However, such undertaking, if made in advance, will be limited to the kinds of events that, in the Board’s opinion, are foreseeable at the time of the approval of the indemnification undertaking and will be limited to the amount set by the Board as reasonable under the circumstances which shall not exceed 25% of the Company’s Shareholders Equity for the time being.

 

 
 

 

145. Subject to the provisions of the Law, nothing in these Articles will limit the Company, in any manner, from entering into an agreement of liability insurance, or in granting an exemption or indemnification in respect of:

 

(a) an Officer, or a director or officer of another company as provided in Article 144 above, to the extent that the insurance, exemption or indemnity is not prohibited by law; or

 

(b) any person who is not an officer, or a director of another company as provided in Article 144 above, including but not limited to employees and representatives of the Company.

 

Reorganization and Winding Up

 

146. If the Company will be wound up voluntarily the liquidators may, with the approval of a Special Majority of the Shareholders voting at a General Meeting, divide among the Shareholders any part of the Company’s assets remaining after payment of all of the Company’s outstanding obligations. Such approval may also vest any part of the Company’s assets to trustees under trusts for the benefit of the Shareholders as the liquidators may determine.

 

147 On any sale of the Company or its assets through a liquidation or winding-up, a Special Majority of the Shareholders voting at a General Meeting may authorize the Board of Directors or liquidators to: (a) accept fully or partly paid up Shares, debentures, or other Company securities, whether registered in Israel or in other jurisdictions, whether existing or contingent, for the purchase in whole or in part of Company property and, if the profits of the Company permit, distribute such shares, securities or any other Company property among the Shareholders without requiring their realization, or vest the same in trustees for their benefit; and/or (b) distribute or appropriate the Company’s cash, Shares, other securities, benefits or property as so approved at the General Meeting. In such case, all Shareholders will be bound to accept any valuation on distribution so authorized, and will waive all rights in relation to such valuation, except where otherwise required by law.

  

Amendments to Articles

 

148. These Articles may be amended, in whole or in part, by an Ordinary Majority of the Shareholders voting at a General Meeting.

 

 

 

   

Exhibit 4.2(a)

 

VUANCE LTD.

 

THE 2003 ISRAELI SHARE OPTION PLAN

 

(*In compliance with Amendment No. 132 of the Israeli Tax Ordinance, 2002)

 

1
 

 

TABLE OF CONTENTS

 

1. PURPOSE OF THE ISOP 3
   
2. DEFINITIONS 3
   
3. ADMINISTRATION OF THE ISOP 6
   
4. DESIGNATION OF PARTICIPANTS 7
   
5. DESIGNATION OF OPTIONS PURSUANT TO SECTION 102 7
   
6. TRUSTEE 8
   
7. SHARES RESERVED FOR THE ISOP 9
   
8. PURCHASE PRICE 9
   
9. ADJUSTMENTS 10
   
10. TERM AND EXERCISE OF OPTIONS 11
   
11. VESTING OF OPTIONS 12
   
12. DIVIDENDS 13
   
13. RESTRICTIONS ON ASSIGNABILITY AND SALE OF OPTIONS 13
   
14. EFFECTIVE DATE AND DURATION OF THE ISOP 13
   
15. AMENDMENTS OR TERMINATION 13
   
16. GOVERNMENT REGULATIONS 14
   
17. CONTINUANCE OF EMPLOYMENT 14
   
18. GOVERNING LAW & JURISDICTION 14
   
19. ARBITRATION 14
   
20. TAX CONSEQUENCES 14
   
21. NON-EXCLUSIVITY OF THE ISOP 15
   
22. MULTIPLE AGREEMENTS 15

   

2
 

 

This plan, as amended from time to time, shall be known as Vuance Ltd 2003 Israeli Share Option Plan (the “ ISOP ”).

 

1. PURPOSE OF THE ISOP

 

The ISOP is intended to provide an incentive to retain, in the employ of the Company and its Affiliates (as defined below), persons of training, experience, and ability, to attract new employees, directors, consultants, service providers and any other entity which the Board shall decide their services are considered valuable to the Company, to encourage the sense of proprietorship of such persons, and to stimulate the active interest of such persons in the development and financial success of the Company by providing them with opportunities to purchase shares in the Company, pursuant to the ISOP.

 

2. DEFINITIONS

 

For purposes of the ISOP and related documents, including the Option Agreement, the following definitions shall apply:

 

2.1 Affiliate ” means any “employing company” within the meaning of Section 102(a) of the Ordinance.

 

2.2 Approved 102 Option ” means an Option granted pursuant to Section 102(b) of the Ordinance and held in trust by a Trustee for the benefit of the Optionee.

 

2.3 Board means the Board of Directors of the Company.

 

2.4 Capital Gain Option (CGO) ” as defined in Section 5.4 below.

 

2.5 Cause” means, (i) conviction of any felony involving moral turpitude or affecting the Company; (ii) any refusal to carry out a reasonable directive of the chief executive officer, the Board or the Optionee’s direct supervisor, which involves the business of the Company or its Affiliates and was capable of being lawfully performed; (iii) embezzlement of funds of the Company or its Affiliates; (iv) any breach of the Optionee’s fiduciary duties or duties of care of the Company; including without limitation disclosure of confidential information of the Company; and (v) any conduct (other than conduct in good faith) reasonably determined by the Board to be materially detrimental to the Company.

 

2.6 “Chairman” means the chairman of the Committee.

  

2.7 “Committee” means a share option compensation committee appointed by the Board, which shall consist of no fewer than two members of the Board.

 

2.8 “Company” means Vuance Ltd, an Israeli company.

 

2.9 “Companies Law” means the Israeli Companies Law 5759-1999.

 

2.10 Controlling Shareholder ” shall have the meaning ascribed to it in Section 32(9) of the Ordinance.

 

3
 

 

2.11 “Date of Grant” means, the date of grant of an Option, as determined by the Board and set forth in the Optionee’s Option Agreement.

 

2.12 Employee” means a person who is employed by the Company or its Affiliates, including an individual who is serving as a director or an office holder, but excluding Controlling Shareholder.

  

2.13 “Expiration date” means the date upon which an Option shall expire, as set forth in Section 10.2 of the ISOP.

 

2.14 “Fair Market Value” means as of any date, the value of a Share determined as follows:

 

(i) If the Shares are listed on any established stock exchange or a national market system, including without limitation the Euronext, the NASDAQ National Market system, or the NASDAQ SmallCap Market of the NASDAQ Stock Market, the Fair Market Value shall be the closing sales price for such Shares (or the closing bid, if no sales were reported), as quoted on such exchange or system for the last market trading day prior to time of determination, as reported in the Wall Street Journal, or such other source as the Board deems reliable.

 

Without derogating from the above, solely for the purpose of determining the tax liability pursuant to Section 102(b)(3) of the Ordinance, if at the Date of Grant the Company’s shares are listed on any established stock exchange or a national market system or if the Company’s shares will be registered for trading within ninety (90) days following the Date of Grant, the Fair Market Value of a Share at the Date of Grant shall be determined in accordance with the average value of the Company’s shares on the thirty (30) trading days preceding the Date of Grant or on the thirty (30) trading days following the date of registration for trading, as the case may be ;

 

(ii) If the Shares are regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value shall be the mean between the high bid and low asked prices for the Shares on the last market trading day prior to the day of determination, or;

 

(iii) In the absence of an established market for the Shares, the Fair Market Value thereof shall be determined in good faith by the Board.

 

2.15 “ISOP” means this 2003 Israeli Share Option Plan.

 

2.16 ITA” means the Israeli Tax Authorities.

 

2.17 “Non-Employee” means a consultant, adviser, service provider, Controlling Shareholder or any other person who is not an Employee.

 

2.18 Ordinary Income Option (OIO) ” as defined in Section 5.5 below.

 

2.19 “Option” means an option to purchase one or more Shares of the Company pursuant to the ISOP.

 

4
 

 

2.20 “102 Option” means any Option granted to Employees pursuant to Section 102 of the Ordinance.

 

2.21 “3(i) Option” means an Option granted pursuant to Section 3(i) of the Ordinance to any person who is Non- Employee.

 

2.22 “Optionee” means a person who receives or holds an Option under the ISOP.

 

2.23 “Option Agreement” means the share option agreement between the Company and an Optionee that sets out the terms and conditions of an Option.

 

2.24 Ordinance” means the 1961 Israeli Income Tax Ordinance [New Version] 1961 as now in effect or as hereafter amended.

 

2.25 “Purchase Price” means the price for each Share subject to an Option.

 

2.26 “Section 102” means section 102 of the Ordinance as now in effect or as hereafter amended.

 

2.27 “Share” means the ordinary shares, NIS 0.01 par value each, of the Company.

 

2.28 “Successor Company” means any entity the Company is merged to or is acquired by, in which the Company is not the surviving entity.

 

2.29 “Transaction” means (i) merger, acquisition or reorganization of the Company with one or more other entities in which the Company is not the surviving entity, (ii) a sale of all or substantially all of the assets of the Company.

 

2.30 “Trustee” means any individual appointed by the Company to serve as a trustee and approved by the ITA, all in accordance with the provisions of Section 102(a) of the Ordinance.

 

2.31 Unapproved 102 Option ” means an Option granted pursuant to Section 102(c) of the Ordinance and not held in trust by a Trustee.

 

2.32 “Vested Option” means any Option, which has already been vested according to the Vesting Dates.

 

2.33 “Vesting Dates” means, as determined by the Board or by the Committee, the date as of which the Optionee shall be entitled to exercise the Options or part of the Options, as set forth in section 11 of the ISOP.

 

3. ADMINISTRATION OF THE ISOP

 

3.1 The Board shall have the power to administer the ISOP either directly or upon the recommendation of the Committee, all as provided by applicable law and in the Company’s Articles of Association. Notwithstanding the above, the Board shall automatically have residual authority if no Committee shall be constituted or if such Committee shall cease to operate for any reason.

 

5
 

 

3.2 The Committee shall select one of its members as its Chairman and shall hold its meetings at such times and places as the Chairman shall determine. The Committee shall keep records of its meetings and shall make such rules and regulations for the conduct of its business as it shall deem advisable.

 

3.3 The Committee shall have the power to recommend to the Board and the Board shall have the full power and authority to: (i) designate participants; (ii) determine the terms and provisions of the respective Option Agreements, including, but not limited to, the number of Options to be granted to each Optionee, the number of Shares to be covered by each Option, provisions concerning the time and the extent to which the Options may be exercised and the nature and duration of restrictions as to the transferability or restrictions constituting substantial risk of forfeiture and to cancel or suspend awards, as necessary; (iii) determine the Fair Market Value of the Shares covered by each Option; (iv) make an election as to the type of 102 Approved Option; and (v) designate the type of Options.

 

The Committee shall have full power and authority to :(i) alter any restrictions and conditions of any Options or Shares subject to any Options (ii) interpret the provisions and supervise the administration of the ISOP; (iii) accelerate the right of an Optionee to exercise in whole or in part, any previously granted Option; (iv) determine the Purchase Price of the Option; (v) prescribe, amend and rescind rules and regulations relating to the ISOP; and (vi) make all other determinations deemed necessary or advisable for the administration of the ISOP.

 

3.4 Notwithstanding the above, the Committee shall not be entitled to grant Options to the Optionees, however, it will be authorized to issue Shares underlying Options which have been granted by the Board and duly exercised pursuant to the provisions herein in accordance with section 112(a)(5) of the Companies Law.

 

3.5 The Board shall have the authority to grant, at its discretion, to the holder of an outstanding Option, in exchange for the surrender and cancellation of such Option, a new Option having a purchase price equal to, lower than or higher than the Purchase Price of the original Option so surrendered and canceled and containing such other terms and conditions as the Committee may prescribe in accordance with the provisions of the ISOP.

 

3.6 Subject to the Company’s Articles of Association, all decisions and selections made by the Board or the Committee pursuant to the provisions of the ISOP shall be made by a majority of its members except that no member of the Board or the Committee shall vote on, or be counted for quorum purposes, with respect to any proposed action of the Board or the Committee relating to any Option to be granted to that member. Any decision reduced to writing shall be executed in accordance with the provisions of the Company’s Articles of Association, as the same may be in effect from time to time.

 

3.7 The interpretation and construction by the Committee of any provision of the ISOP or of any Option Agreement thereunder shall be final and conclusive unless otherwise determined by the Board.

 

6
 

 

3.8 Subject to the Company’s Articles of Association and the Company’s decision, and to all approvals legally required, including, but not limited to the provisions of the Companies Law, each member of the Board or the Committee shall be indemnified and held harmless by the Company against any cost or expense (including counsel fees) reasonably incurred by him, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the ISOP unless arising out of such member's own fraud or bad faith, to the extent permitted by applicable law. Such indemnification shall be in addition to any rights of indemnification the member may have as a director or otherwise under the Company's Articles of Association, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise.

 

4. DESIGNATION OF PARTICIPANTS

 

4.1 The persons eligible for participation in the ISOP as Optionees shall include any Employees and/or Non-Employees of the Company or of any Affiliate; provided, however, that (i) Employees may only be granted 102 Options; (ii) Non-Employees may only be granted 3(i) Options; and (iii) Controlling Shareholders may only be granted 3(i) Options.
     
4.2 The grant of an Option hereunder shall neither entitle the Optionee to participate nor disqualify the Optionee from participating in, any other grant of Options pursuant to the ISOP or any other option or share plan of the Company or any of its Affiliates .

 

4.3 Anything in the ISOP to the contrary notwithstanding, all grants of Options to directors and office holders shall be authorized and implemented in accordance with the provisions of the Companies Law or any successor act or regulation, as in effect from time to time.

 

5. DESIGNATION OF OPTIONS PURSUANT TO SECTION 102

 

5.1 The Company may designate Options granted to Employees pursuant to Section 102 as Unapproved 102 Options or Approved 102 Options.

 

5.2 The grant of Approved 102 Options shall be made under this ISOP adopted by the Board as described in Section 15 below, and shall be conditioned upon the approval of this ISOP by the ITA.

 

5.3 Approved 102 Option may either be classified as Capital Gain Option (“ CGO ”) or Ordinary Income Option (“ OIO ”).

 

5.4 Approved 102 Option elected and designated by the Company to qualify under the capital gain tax treatment in accordance with the provisions of Section 102(b)(2) shall be referred to herein as CGO .

 

5.5 Approved 102 Option elected and designated by the Company to qualify under the ordinary income tax treatment in accordance with the provisions of Section 102(b)(1) shall be referred to herein as OIO .

 

5.6 The Company’s election of the type of Approved 102 Options as CGO or OIO granted to Employees (the “ Election ”), shall be appropriately filed with the ITA before the Date of Grant of an Approved 102 Option. Such Election shall become effective beginning the first Date of Grant of an Approved 102 Option under this ISOP and shall remain in effect until the end of the year following the year during which the Company first granted Approved 102 Options. The Election shall obligate the Company to grant only the type of Approved 102 Option it has elected, and shall apply to all Optionees who were granted Approved 102 Options during the period indicated herein, all in accordance with the provisions of Section 102(g) of the Ordinance. For the avoidance of doubt, such Election shall not prevent the Company from granting Unapproved 102 Options simultaneously.

 

7
 

 

5.7 All Approved 102 Options must be held in trust by a Trustee, as described in Section 6 below .

 

5.8 For the avoidance of doubt, the designation of Unapproved 102 Options and Approved 102 Options shall be subject to the terms and conditions set forth in Section 102 of the Ordinance and the regulations promulgated thereunder.

 

5.9 With regards to Approved 102 Options, the provisions of the ISOP and/or the Option Agreement shall be subject to the provisions of Section 102 and the Tax Assessing Officer’s permit, and the said provisions and permit shall be deemed an integral part of the ISOP and of the Option Agreement. Any provision of Section 102 and/or the said permit which is necessary in order to receive and/or to keep any tax benefit pursuant to Section 102, which is not expressly specified in the ISOP or the Option Agreement, shall be considered binding upon the Company and the Optionees.

 

6. TRUSTEE

 

6.1 Approved 102 Options which shall be granted under the ISOP and/or any Shares allocated or issued upon exercise of such Approved 102 Options and/or other shares received subsequently following any realization of rights, including without limitation bonus shares, shall be allocated or issued to the Trustee and held for the benefit of the Optionees for such period of time as required by Section 102 or any regulations, rules or orders or procedures promulgated thereunder (the “ Holding Period ”). In the case the requirements for Approved 102 Options are not met, then the Approved 102 Options shall be treated as Unapproved 102 Options, all in accordance with the provisions of Section 102 and regulations promulgated thereunder.

 

6.2 Notwithstanding anything to the contrary, the Trustee shall not release any Shares allocated or issued upon exercise of Approved 102 Options prior to the full payment of the Optionee’s tax liabilities arising from Approved 102 Options which were granted to him and/or any Shares allocated or issued upon exercise of such Options.
6.3 With respect to any Approved 102 Option, subject to the provisions of Section 102 and any rules or regulation or orders or procedures promulgated thereunder, an Optionee shall not be sell or release from trust any Share received upon the exercise of an Approved 102 Option and/or any share received subsequently following any realization of rights, including without limitation, bonus shares, until the lapse of the Holding Period required under Section 102 of the Ordinance. Notwithstanding the above, if any such sale or release occurs during the Holding Period, the sanctions under Section 102 of the Ordinance and under any rules or regulation or orders or procedures promulgated thereunder shall apply to and shall be borne by such Optionee.

 

8
 

 

6.4 Upon receipt of Approved 102 Option, the Optionee will sign an undertaking to release the Trustee from any liability in respect of any action or decision duly taken and bona fide executed in relation with the ISOP, or any Approved 102 Option or Share granted to him thereunder.

 

7. SHARES RESERVED FOR THE ISOP; RESTRICTION THEREON

 

7.1 The Company has reserved 5,000,000 (Five million) authorized but unissued Shares, for the purposes of the ISOP and for the purposes of any other share option plans which may be adopted by the Company in the future, subject to adjustment as set forth in Section 9 below. Any Shares which remain unissued and which are not subject to the outstanding Options at the termination of the ISOP shall cease to be reserved for the purpose of the ISOP, but until termination of the ISOP the Company shall at all times reserve sufficient number of Shares to meet the requirements of the ISOP. Should any Option for any reason expire or be canceled prior to its exercise or relinquishment in full, the Shares subject to such Option may again be subjected to an Option under the ISOP or under the Company’s other share option plans.

 

7.2 Each Option granted pursuant to the ISOP, shall be evidenced by a written Option Agreement between the Company and the Optionee, in such form as the Board or the Committee shall from time to time approve. Each Option Agreement shall state, among other matters, the number of Shares to which the Option relates, the type of Option granted thereunder (whether a CGO, OIO, Unapproved 102 Option or a 3(i) Option), the Vesting Dates, the Purchase Price per share, the Expiration Date and such other terms and conditions as the Committee or the Board in its discretion may prescribe, provided that they are consistent with this ISOP.

 

8. PURCHASE PRICE

 

8.1 The Purchase Price of each Share subject to an Option shall be determined by the Committee in its sole and absolute discretion in accordance with applicable law, subject to any guidelines as may be determined by the Board from time to time. Each Option Agreement will contain the Purchase Price determined for each Optionee.

 

8.2 The Purchase Price shall be payable upon the exercise of the Option in a form satisfactory to the Committee, including without limitation, by cash or check. The Committee shall have the authority to postpone the date of payment on such terms as it may determine.

 

8.3 The Purchase Price shall be denominated in the currency of the primary economic environment of, either the Company or the Optionee (that is the functional currency of the Company or the currency in which the Optionee is paid) as determined by the Company.

 

9
 

 

9. ADJUSTMENTS

 

Upon the occurrence of any of the following described events, Optionee's rights to purchase Shares under the ISOP shall be adjusted as hereafter provided:

 

9.1 In the event of Transaction, the unexercised Options then outstanding under the ISOP shall be assumed or substituted for an appropriate number of shares of each class of shares or other securities of the Successor Company (or a parent or subsidiary of the Successor Company) as were distributed to the shareholders of the Company in connection and with respect to the Transaction. In the case of such assumption and/or substitution of Options, appropriate adjustments shall be made to the Purchase Price so as to reflect such action and all other terms and conditions of the Option Agreements shall remain unchanged, including but not limited to the vesting schedule, all subject to the determination of the Committee or the Board, which determination shall be in their sole discretion and final. The Company shall notify the Optionee of the Transaction in such form and method as it deems applicable at least ten (10) days prior to the effective date of such Transaction.

 

9.2 Notwithstanding the above and subject to any applicable law, the Board or the Committee shall have full power and authority to determine that in certain Option Agreements there shall be a clause instructing that, if in any such Transaction as described in section 9.1 above, the Successor Company (or parent or subsidiary of the Successor Company) does not agree to assume or substitute for the Options, the Vesting Dates shall be accelerated so that any unvested Option or any portion thereof shall be immediately vested as of the date which is ten (10) days prior to the effective date of the Transaction.

 

9.3 For the purposes of section 9.1 above, an Option shall be considered assumed or substituted if, following the Transaction, the Option confers the right to purchase or receive, for each Share underlying an Option immediately prior to the Transaction, the consideration (whether shares, options, cash, or other securities or property) received in the Transaction by holders of shares held on the effective date of the Transaction (and if such holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the Transaction is not solely ordinary shares (or their equivalent) of the Successor Company or its parent or subsidiary, the Committee may, with the consent of the Successor Company, provide for the consideration to be received upon the exercise of the Option to be solely ordinary shares (or their equivalent) of the Successor Company or its parent or subsidiary equal in Fair Market Value to the per Share consideration received by holders of a majority of the outstanding shares in the Transaction; and provided further that the Committee may determine, in its discretion, that in lieu of such assumption or substitution of Options for options of the Successor Company or its parent or subsidiary, such Options will be substituted for any other type of asset or property including cash which is fair under the circumstances.

 

9.4 If the Company is voluntarily liquidated or dissolved while unexercised Options remain outstanding under the ISOP, the Company shall immediately notify all unexercised Option holders of such liquidation, and the Option holders shall then have ten (10) days to exercise any unexercised Vested Option held by them at that time, in accordance with the exercise procedure set forth herein. Upon the expiration of such ten-days period, all remaining outstanding Options will terminate immediately.

 

9.5 If the outstanding shares of the Company shall at any time be changed or exchanged by declaration of a share dividend (bonus shares), share split, combination or exchange of shares, recapitalization, or any other like event by or of the Company, and as often as the same shall occur, then the number, class and kind of the Shares subject to the ISOP or subject to any Options therefore granted, and the Purchase Prices, shall be appropriately and equitably adjusted so as to maintain the proportionate number of Shares without changing the aggregate Purchase Price, provided, however, that no adjustment shall be made by reason of the distribution of subscription rights (rights offering) on outstanding shares. Upon happening of any of the foregoing, the class and aggregate number of Shares issuable pursuant to the ISOP (as set forth in Section 7 hereof), in respect of which Options have not yet been exercised, shall be appropriately adjusted, all as will be determined by the Board whose determination shall be final .

 

10
 

 

10. TERM AND EXERCISE OF OPTIONS

 

10.1 Options shall be exercised by the Optionee by giving written notice to the Company and/or to any third party designated by the Company (the “ Representative ”), in such form and method as may be determined by the Company and when applicable, by the Trustee in accordance with the requirements of Section 102, which exercise shall be effective upon receipt of such notice by the Company and/or the Representative and the payment of the Purchase Price at the Company’s or the Representative’s principal office. The notice shall specify the number of Shares with respect to which the Option is being exercised.

 

10.2 Options, to the extent not previously exercised, shall terminate forthwith upon the earlier of: (i) the date set forth in the Option Agreement; and (ii) the expiration of any extended period in any of the events set forth in section 10.5 below.

 

10.3 The Options may be exercised by the Optionee in whole at any time or in part from time to time, to the extent that the Options become vested and exercisable, prior to the Expiration Date, and provided that, subject to the provisions of section 10.5 below, the Optionee is employed by or providing services to the Company or any of its Affiliates, at all times during the period beginning with the granting of the Option and ending upon the date of exercise.

 

10.4 Subject to the provisions of section 10.5 below, in the event of termination of Optionee’s employment or services, with the Company or any of its Affiliates, all Options granted to such Optionee will immediately expire. A notice of termination of employment or service shall be deemed to constitute termination of employment or service. For the avoidance of doubt, in case of such termination of employment or service, the unvested portion of the Optionee’s Option shall not vest and shall not become exercisable.

 

10.5 Notwithstanding anything to the contrary hereinabove and unless otherwise determined in the Optionee’s Option Agreement, an Option may be exercised after the date of termination of Optionee's employment or service with the Company or any Affiliates during an additional period of time beyond the date of such termination, but only with respect to the number of Vested Options at the time of such termination according to the Vesting Dates, if :

 

(i) termination is without Cause, in which event any Vested Option still in force and unexpired may be exercised within a period of ninety (90) days after the date of such termination; or-

 

(ii) termination is the result of death or disability of the Optionee, in which event any Vested Option still in force and unexpired may be exercised within a period of three (3) months after the date of such termination; or -

 

11
 

 

(iii) prior to the date of such termination, the Committee shall authorize an extension of the terms of all or part of the Vested Options beyond the date of such termination for a period not to exceed the period during which the Options by their terms would otherwise have been exercisable.

 

For avoidance of any doubt, if termination of employment or service is for Cause, any outstanding unexercised Option (whether vested or non-vested), will immediately expire and terminate, and the Optionee shall not have any right in connection to such outstanding Options.

 

10.6 To avoid doubt, the Optionees shall not have any of the rights or privileges of shareholders of the Company in respect of any Shares purchasable upon the exercise of any Option, nor shall they be deemed to be a class of shareholders or creditors of the Company for purpose of the operation of sections 350 and 351 of the Companies Law or any successor to such section, until registration of the Optionee as holder of such Shares in the Company’s register of shareholders upon exercise of the Option in accordance with the provisions of the ISOP, but in case of Options and Shares held by the Trustee, subject to the provisions of Section 6 of the ISOP.

 

10.7 Any form of Option Agreement authorized by the ISOP may contain such other provisions as the Committee may, from time to time, deem advisable.

 

10.8 With respect to Unapproved 102 Option, if the Optionee ceases to be employed by the Company or any Affiliate, the Optionee shall extend to the Company and/or its Affiliate a security or guarantee for the payment of tax due at the time of sale of Shares, all in accordance with the provisions of Section 102 and the rules, regulation or orders promulgated thereunder.

 

11. VESTING OF OPTIONS

 

11.1 Subject to the provisions of the ISOP, each Option shall vest following the Vesting Dates and for the number of Shares as shall be provided in the Option Agreement. However, no Option shall be exercisable after the Expiration Date.

 

11.2 An Option may be subject to such other terms and conditions on the time or times when it may be exercised, as the Committee may deem appropriate. The vesting provisions of individual Options may vary.

 

12. DIVIDENDS

 

With respect to all Shares (but excluding, for avoidance of any doubt, any unexercised Options) allocated or issued upon the exercise of Options purchased by the Optionee and held by the Optionee or by the Trustee, as the case may be, the Optionee shall be entitled to receive dividends in accordance with the quantity of such Shares, subject to the provisions of the Company’s Articles of Association (and all amendments thereto) and subject to any applicable taxation on distribution of dividends, and when applicable subject to the provisions of Section 102 and the rules, regulations or orders promulgated thereunder.

 

12
 

 

13. RESTRICTIONS ON ASSIGNABILITY AND SALE OF OPTIONS

 

13.1 No Option or any right with respect thereto, purchasable hereunder, whether fully paid or not, shall be assignable, transferable or given as collateral or any right with respect to it given to any third party whatsoever, except as specifically allowed under the ISOP, and during the lifetime of the Optionee each and all of such Optionee's rights to purchase Shares hereunder shall be exercisable only by the Optionee.

 

Any such action made directly or indirectly, for an immediate validation or for a future one, shall be void.

 

13.2 As long as Options and/or Shares are held by the Trustee on behalf of the Optionee, all rights of the Optionee over the Shares are personal, can not be transferred, assigned, pledged or mortgaged, other than by will or pursuant to the laws of descent and distribution.

 

14. EFFECTIVE DATE AND DURATION OF THE ISOP

 

The ISOP shall be effective as of the day it was adopted by the Board and shall terminate at the end of ten (10) years from such day of adoption.

 

The Company shall obtain the approval of the Company’s shareholders for the adoption of this ISOP or for any amendment to this ISOP, if shareholders’ approval is necessary or desirable to comply with any applicable law including without limitation the US securities law or the securities laws of other jurisdiction applicable to Options granted to Optionees under this ISOP, or if shareholders’ approval is required by any authority or by any governmental agencies or national securities exchanges including without limitation the US Securities and Exchange Commission.

 

15. AMENDMENTS OR TERMINATION

 

The Board may at any time, but when applicable, after consultation with the Trustee, amend, alter, suspend or terminate the ISOP. No amendment, alteration, suspension or termination of the ISOP shall impair the rights of any Optionee, unless mutually agreed otherwise between the Optionee and the Company, which agreement must be in writing and signed by the Optionee and the Company. Termination of the ISOP shall not affect the Committee’s ability to exercise the powers granted to it hereunder with respect to Options granted under the ISOP prior to the date of such termination.

 

16. GOVERNMENT REGULATIONS

 

The ISOP, and the granting and exercise of Options hereunder, and the obligation of the Company to sell and deliver Shares under such Options, shall be subject to all applicable laws, rules, and regulations, whether of the State of Israel or of the State of Belgium or of the United States or any other State having jurisdiction over the Company and the Optionee, including the registration of the Shares under the securities act of Belgium and/or the United States Securities Act of 1933, and the Ordinance and to such approvals by any governmental agencies or national securities exchanges as may be required. Nothing herein shall be deemed to require the Company to register the Shares under the securities laws of any jurisdiction.

 

13
 

 

17. CONTINUANCE OF EMPLOYMENT OR HIRED SERVICES

 

Neither the ISOP nor the Option Agreement with the Optionee shall impose any obligation on the Company or an Affiliate thereof, to continue any Optionee in its employ or service, and nothing in the ISOP or in any Option granted pursuant thereto shall confer upon any Optionee any right to continue in the employ or service of the Company or an Affiliate thereof or restrict the right of the Company or an Affiliate thereof to terminate such employment or service at any time.

 

18. GOVERNING LAW & JURISDICTION

 

The ISOP shall be governed by and construed and enforced in accordance with the laws of the State of Israel applicable to contracts made and to be performed therein, without giving effect to the principles of conflict of laws. The competent courts of Tel-Aviv, Israel shall have sole jurisdiction in any matters pertaining to the ISOP.

 

19. ARBITRATION

 

Any dispute in relation with this ISOP and the exercise of rights thereunder, shall be brought to arbitration of the legal counsel to the Company (“ the Arbitrator ”), who shall decide on such dispute in accordance with the provisions of the Arbitration Law - 1968 and its supplement. The decision of the Arbitrator shall be final and shall bind the Company and the Optionee.

 

20. TAX CONSEQUENCES

 

20.1 Any tax consequences arising from the grant or exercise of any Option, from the payment for Shares covered thereby or from any other event or act (of the Company and/or its Affiliates, the Trustee or the Optionee), hereunder, shall be borne solely by the Optionee. The Company and/or its Affiliates and/or the Trustee shall withhold taxes according to the requirements under the applicable laws, rules, and regulations, including withholding taxes at source. Furthermore, the Optionee shall agree to indemnify the Company and/or its Affiliates and/or the Trustee and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Optionee.

 

20.2 The Company and/or, when applicable, the Trustee shall not be required to release any Share certificate to an Optionee until all required payments have been fully made.

 

21. NON-EXCLUSIVITY OF THE ISOP

 

The adoption of the ISOP by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangements or as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of Options otherwise than under the ISOP, and such arrangements may be either applicable generally or only in specific cases.

 

For the avoidance of doubt, prior grant of options to Optionees of the Company under their employment agreements, and not in the framework of any previous option plan, shall not be deemed an approved incentive arrangement for the purpose of this Section.

 

14
 

 

22. MULTIPLE AGREEMENTS

 

The terms of each Option may differ from other Options granted under the ISOP at the same time, or at any other time. The Board may also grant more than one Option to a given Optionee during the term of the ISOP, either in addition to, or in substitution for, one or more Options previously granted to that Optionee.

 

* * *

 

15

 

 

Exhibit 4.2(b)

VUANCE LTD.
2007 U.S. STOCK OPTION PLAN

 

1.            Purpose . The purpose of the Vuance Ltd. 2007 Stock Option Plan (the “Plan”) is to foster the ability of Vuance Ltd. and its affiliates to attract, motivate, reward and retain key personnel through the grant of options to purchase the Company’s ordinary shares. The Plan is intended to apply to key personnel of Vuance Ltd. and its affiliates who are citizens or residents of the United States or earn income from the Company or its Affiliates within the United States.

 

2.            Definitions . For purposes of the Plan and related documents, including the Option Agreement, the following definitions shall apply. As used herein, the masculine includes the feminine and the singular includes the plural, and vice versa,

 

(a)          “Affiliate" means each of the following: (a) any Subsidiary; (b) any Parent; (c) any corporation, trade or business (including, without limitation, a partnership or limited liability company) that is directly or indirectly controlled 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) by the Company or one of its Affiliates; and (d) any other entity in which the Company or any of its Affiliates has a material equity interest and that is designated as an "Affiliate" by resolution of the Committee; provided that the Shares subject to an Option constitute "service recipient" stock for purposes of Section 409A of the Code or otherwise do not subject the Option to Section 409A of the Code.

 

(b)          "Board" means the Board of Directors of the Company.

 

(c)          “Cause” means any of the following: (1) conviction of any felony involving moral turpitude or affecting the Company; (2) any refusal to carry out a reasonable directive of the chief executive officer, the Board or the optionee’s direct supervisor; which involves the business of the Company or its Affiliates and was capable of being lawfully performed; (3) embezzlement of funds of the Company or its Affiliates; (4) any breach of the optionee’s fiduciary duties or duties of care to the Company, including without limitation disclosure of confidential information of the Company; or (5) any conduct (other than conduct in good faith) reasonably determined by the Board to be materially detrimental to the Company.

 

(d)          “Chairman” means the chairman of the Committee.

 

(e)          "Code" means the Internal Revenue Code of 1986, as amended. Any reference to any section of the Code shall also be a reference to any successor provision and any Treasury Regulation promulgated thereunder.

 

(f)          "Committee" means a committee which may be appointed by the Board pursuant to Section 3 of the Plan or if no such committee is appointed and acting, the Board.

 

(g)          “Companies Law” means the Israeli Companies Law 5759-1999.

 

(h)          “Company" means Vuance Ltd, an Israeli company.

 

 
 

 

(i)          "Consultant" means any natural person who provides bona fide consulting or advisory services to the Company or its Affiliates pursuant to a written agreement, which services are not in connection with the offer and sale of securities in a capital raising transaction.

 

(j)          "Disability" means a permanent and total disability as defined in Section 22(e)(3) of the Code. A Disability shall only be deemed to occur at the time of the determination by the Committee of the Disability. Notwithstanding the foregoing, for Options that are subject to Section 409A of the Code, Disability shall mean that a Participant is disabled under Section 409A(a)(2)(C)(i) or (ii) of the Code.

 

(k)          "Eligible Employees" means each employee of the Company or an Affiliate.

 

(l)          "Fair Market Value" means, unless otherwise required by any applicable provision of the Code or any regulations issued thereunder, as of any date and except as provided below, the last sales price reported for the Shares on the applicable date: (a) as reported on the principal national securities exchange in the United States on which it is then traded; or (b) if not traded on any such national securities exchange, as quoted on an automated quotation system in the United States sponsored by the National Association of Securities Dealers, Inc., including, but not limited to, the OTC Bulletin Board, or if the Shares shall not have been reported or quoted on such date, on the first day prior thereto on which the price of the Shares was reported or quoted.

 

(m)          "Incentive Stock Option" or “ISO” means any Stock Option awarded to an Eligible Employee of the Company, its Subsidiaries and its Parent (if any) under the Plan intended to be and designated as an "incentive stock option" within the meaning of Section 422 of the Code.

 

(n)          “Non-Employee Director" means a member of the Board who is not an employee of the Company or a Subsidiary.

 

(o)          "Non-Qualified Stock Option" means any Stock Option awarded under the Plan that is not an Incentive Stock Option.

 

(p)          "Option Agreement" means the agreement between the Company and a Participant that sets out the terms and conditions of an Option.

 

(q)          “Parent" means any parent corporation of the Company within the meaning of Section 424(e) of the Code.

 

(r)          "Participant" means an Eligible Employee, Non-Employee Director or Consultant to whom an Award has been granted pursuant to the Plan..

 

(s)          "Shares" means the Ordinary Shares, NIS (new Israeli sheqels) 0.0588235 par value each, of the Company.

 

(t)          "Stock Option" or "Option" means any option to purchase Shares granted to Eligible Employees, Non-Employee Directors or Consultants pursuant to the Plan.

 

- 2 -
 

 

(u)          "Subsidiary" means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code.

 

(v)         "Successor Company" means any entity the Company is merged into or is acquired by, where the Company is not the surviving entity.

 

(w)          "Ten Percent Stockholder" means a person owning stock possessing more than 10% of the total combined voting power of all classes of stock of the Company, its Subsidiaries or its Parent.

 

(x)          “Termination of Employment” means the termination of a Participant’s employment or other service with the Company or its Affiliates.

 

(y)          “Transaction” means (i) a merger, acquisition, or reorganization of the Company with one or more other entities in which the Company is not the surviving entity, or (ii) a sale of all or substantially all of the assets of the Company.

 

3.            Administration .

 

(a)          The Board may appoint a Committee which will consist of such number of directors of the Company, not less than two, as may be fixed from time to time by the Board. The Board shall have the power to appoint the members of the Committee, to remove members from, or add members to, the Committee and to fill vacancies in the Committee however caused. The Plan will be administered by the Committee, or where no such Committee has been established by the Board.

 

(b)          The Committee shall select one of its members as its Chairman and shall hold its meetings at such times and places as the Chairman shall determine. The Committee shall keep records of its meetings and shall make such rules and regulations for the conduct of its business as it shall deem advisable

 

(c)          The Committee shall have the full power and authority to: (i) designate Participants; (ii) determine the terms and provisions of the respective Option Agreements, including, but not limited to, the number of Options to be granted to each Participant, the number of Shares to be covered by each Option, provisions concerning the time and the extent to which the Options may be exercised and the nature and duration of restrictions as to the transferability and to cancel or suspend awards, as necessary; (iii) determine the Fair Market Value of the Shares covered by each Option and (iv) designate the type of Options, whether Incentive Stock Options or Non-Qualified Options.

 

(d)          The Committee shall have full power and authority to (i) alter any restrictions and conditions of any Options or Shares subject to any Options; (ii) interpret the provisions and supervise the administration of the Plan; (iii) accelerate the right of a Participant to exercise in whole or in part, any previously granted Option; (iv) determine the purchase price of the Option; (v) prescribe, amend and rescind rules and regulations relating to the Plan; and (vi) make all other determinations deemed necessary or advisable for the administration of the Plan.

 

- 3 -
 

 

(e)          The Committee shall have the authority to grant, at its discretion, to the holder of an outstanding Option, in exchange for the surrender and cancellation of such Option, a new Option having a purchase price equal to, lower than or higher than the purchase price of the original Option so surrendered and canceled and containing such other terms and conditions as the Committee may prescribe in accordance with the provisions of the Plan, subject to the provisions of Section 409A of the Code.

 

(f)          Subject to the Company's Articles of Association, all decisions and selections made by the Committee pursuant to the provisions of the Plan shall be made by a majority of its members except that no member of the Committee shall vote on, or be counted for quorum purposes, with respect to any proposed action of the Committee relating to any Option to be granted to that member. Any decision reduced to writing shall be executed in accordance with the provisions of the Company's Articles of Association, as the same may be in effect from time to time.

 

(g)          The interpretation and construction by the Committee of any provision of the Plan or of any Option Agreement thereunder shall be final and conclusive.

 

(h)          No member of the Committee shall be liable for any act or determination made in good faith with respect to the Plan or any Option granted thereunder.

 

4.            Option Pool . All shares issuable under the Plan shall come out of the pool of Shares reserved from time to time in connection with the 2003 Israeli Stock Option Plan of the Company..

 

5.            General Eligibility .

 

(a)          All Eligible Employees and Consultants of the Company and its Affiliates, and Non-Employee Directors of the Company are eligible to be granted Options.

 

(b)          Notwithstanding anything herein to the contrary, only Eligible Employees of the Company, its Subsidiaries and its Parent (if any) are eligible to be granted Incentive Stock Options under the Plan.

 

(c)          Eligibility for the grant of an Option or an Incentive Stock Option and actual participation in the Plan shall be determined by the Committee in its sole discretion.

 

6.            Stock Options . Subject to the terms of the Plan, each Option shall be in such form and contain such terms and conditions as the Committee shall deem appropriate. The Committee may grant Options that do and Options that do not qualify as “incentive stock options” under Section 422 of the Code.

 

(a)           Option Term . No Option granted under the Plan may be exercisable after the expiration of ten years from the date it is granted (five years in the case of an ISO granted to a Ten Percent Stockholder).

 

- 4 -
 

 

(b)           Exercise Price . The exercise price per Share covered by an Option must be at least equal to the Fair Market Value per Share on the grant date (110% of Fair Market Value in the case of an ISO granted to an employee who is a Ten Percent Stockholder).

 

(c)           Exercise of Options . Options granted to a Participant may be exercised by the Participant in whole at any time or in part from time to time, to the extent that the Options have become vested and exercisable, and provided that, subject to the provisions of section 6(f) below, the Participant is employed by or providing services to the Company or any of its Affiliates, at all times during the period beginning with the granting of the Option and ending upon the date of exercise. Notwithstanding the foregoing, no Options may be exercised after the expiration date of the Option.

 

(d)           Manner of Exercise . A vested Option may be exercised by transmitting to the Secretary of the Company (or other person designated by the Committee) a written notice identifying the Option that is being exercised and specifying the number of whole shares to be purchased pursuant to that Option, together with payment in full of the exercise price and the withholding taxes due in connection with the exercise, unless and except to the extent that other arrangements satisfactory to the Company have been made for such payments. The exercise price and applicable tax withholding obligation may be paid (i) in cash or by check in U.S. dollars or other currency permitted by the Committee or (ii) at the sole discretion of the Committee, (1) by withholding of Shares subject to the Options; (2) by the delivery of previously-owned Shares, or (3) any other form of legal consideration that may be acceptable to the Committee, or (iii) by a combination of the foregoing. The Committee may permit payment to be made pursuant to a cashless exercise program established and made available through a registered broker-dealer in accordance with applicable law. Any Shares transferred to the Company (or withheld upon exercise) in connection with the exercise of an Option shall be valued at Fair Market Value for purposes of determining the extent to which the exercise price and/or tax withholding obligation is satisfied by such transfer (or withholding) of Shares.

 

(e)           Termination of Options . Options, to the extent not previously exercised, shall terminate forthwith upon the earlier of: (i) the expiration date set forth in the Option Agreement; and (ii) the expiration of any extended period in any of the events set forth in section 6(f) below.

 

(f)           Effect of Termination of Employment or Other Service . The Committee may establish such exercise and other conditions applicable to an Option following the Termination of Employment of the Participant as the Committee deems appropriate on a grant-by-grant basis. Unless the Committee determines otherwise, either at the time of grant or, subject to applicable law (including, without limitation, the requirements of Section 409A or the Code), subsequent to that time, in the event of the Participant’s Termination of Employment: (1) that portion of the Participant’s Option that is not then vested will expire immediately upon Termination of Employment; (2) that portion of a Participant’s Option that is then vested will expire (a) 90 days following a Termination of Employment for reasons other than death, Disability or Cause, (b) three (3) months following a Termination of Employment due to the Participant’s death, (c) three (3) months following a Termination of Employment due to the Participant’s Disability, or (d) immediately upon a Termination of Employment by the Company or an affiliate for Cause. Prior to the date of such termination, the Committee may authorize an extension of the terms of all or part of the vested Options beyond the date of such termination for a period not to exceed the period during which the Options by their terms would otherwise have been exercisable. For avoidance of any doubt, if the Termination of Employment is for Cause, any outstanding unexercised Option (whether vested or non-vested), will immediately expire and terminate, and the Participant shall not have any right in connection with such outstanding Options.

 

- 5 -
 

 

(g)           Rights of Option Holders . Participants shall not have any of the rights or privileges of shareholders of the Company in respect of any Shares purchasable upon the exercise of any Option, nor shall they be deemed to be a class of shareholders or creditors of the Company for purpose of the operation of sections 350 and 351 of the Companies Law or any successor to such section, until registration of the Participant as a holder of such Shares in the Company's register of shareholders following exercise of the Option in accordance with the provisions of the Plan.

 

(h)           Option Agreements . Each Option granted pursuant to the Plan shall be evidenced by a written Option Agreement between the Company and the Participant in such form as the Committee shall from time to time approve. Each Option Agreement shall state, among other matters, the number of Shares to which the Option relates, the type of Option granted thereunder (whether an Incentive Option or a Non-Qualified Option), the vesting dates, the exercise price per share, the expiration date and such other terms and conditions as the Committee in its discretion may prescribe, provided that they are consistent with this Plan. Any form of Option Agreement authorized by the Plan may contain such other provisions as the Committee may, from time to time, deem advisable.

 

(i)           Vesting of Options . Subject to the provisions of the Plan, each Option shall vest following the vesting dates and for the number of Shares as shall be provided in the Option Agreement. However, no Option shall be exercisable after the expiration date. An Option may be subject to such other terms and conditions on the time or times when it may be exercised, as the Committee may deem appropriate. The vesting provisions of individual Options may vary.

 

(j)           Limitations on ISOs . Notwithstanding anything in the Plan to the contrary, to the extent required from time to time by the Code and/or applicable regulations, the following additional provisions shall apply to the grant of Options that are intended to qualify as ISOs:

 

(a)           Fair Market Value Limitation . The aggregate Fair Market Value (determined as of the date the ISO is granted) of the Shares with respect to which ISOs are exercisable for the first time by any Participant during any calendar year (under all plans of the Company (or any Parent or Subsidiary corporation within the meaning of Code Section 424) shall not exceed one hundred thousand dollars ($100,000) or such other amount as may subsequently be specified by the Code and/or applicable regulations; provided that, to the extent that such limitation is exceeded, any Options on Shares with a Fair Market Value in excess of such amount shall be deemed to be Non-Qualified Stock Options.

 

- 6 -
 

 

(b)           Code Section 422 . ISOs shall contain such other provisions as the Committee shall deem advisable, but shall in all events be consistent with and contain or be deemed to contain all provisions required in order to qualify as incentive stock options under Section 422 of the Code.

 

7.            Non-Transferability . No Option granted under the Plan shall be transferable by a Participant other than upon the Participant’s death to a beneficiary designated by the Participant in a manner acceptable to the Committee, or, if no duly designated beneficiary shall survive the Participant, pursuant to the Participant’s will or by the laws of descent and distribution. All Options shall be exercisable during the Participant’s lifetime only by the Participant. Except as otherwise specifically provided by law, no Option granted under the Plan may be transferred in any manner, and any attempt to transfer any such Option shall be void, and no such Option shall in any manner be liable for or subject to the debts, contracts, liabilities, engagements or torts of any person who shall be entitled to such Option, nor shall it be subject to attachment or legal process for or against such person. Notwithstanding the foregoing, the Committee may determine at the time of grant or thereafter that an Option (other than an ISO) is transferable in whole or part to such persons, under such circumstances, and subject to such conditions as the Committee may prescribe.

 

8.            Capital Changes, Reorganization, Sale . Upon the occurrence of any of the following described events, each Optionee's rights to purchase Shares under the Plan shall be adjusted as hereafter provided:

 

(a)          In the event of a Transaction, the Board or Committee may determine that the unexercised Options then outstanding under the Plan shall be assumed or substituted for an appropriate number of shares of each class of shares or other securities of the Successor Company (or a parent or subsidiary of the Successor Company) as were distributed to the shareholders of the Company in connection and with respect to the Transaction. In the case of such assumption and/or substitution of Options, the Board or Committee may determine that appropriate adjustments shall be made to the number and exercise price of Options so as to reflect such action and that all other terms and conditions of the Option Agreements shall remain unchanged, including but not limited to the vesting schedule and that the Company shall notify each Participant of the Transaction in such form and method as it deems appropriate at least ten (10) days prior to the effective date of such Transaction.

 

(b)          Notwithstanding the above and subject to any applicable law, the Board or Committee shall have full power and authority to determine in any Transaction, if the Successor Company (or parent or subsidiary of the Successor Company) does not agree to assume or substitute for the Options, the vesting dates shall be accelerated so that any unvested Option or any portion thereof shall be immediately vested as of a date selected by the Board or Committee prior to the effective date of the Transaction, or that all unexercised options shall expire as of the date of the Transaction.

 

- 7 -
 

 

(c)          For the purposes of sections 8(a) and (b) above, an Option may be considered assumed or substituted if, following the Transaction, the Option confers the right to purchase or receive, for each Share underlying an Option immediately prior to the Transaction, the consideration (whether shares, options, cash, or other securities or property) received in the Transaction by holders of shares held on the effective date of the Transaction (and if such holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the Transaction is not solely ordinary shares (or their equivalent) of the Successor Company or its parent or subsidiary, the Board or Committee may, with the consent of the Successor Company, provide for the consideration to be received upon the exercise of the Option to be solely ordinary shares (or their equivalent) of the Successor Company or its parent or subsidiary equal in Fair Market Value to the per Share consideration received by holders of a majority of the outstanding shares in the Transaction; and provided further that the Board or Committee may determine, in its discretion, that in lieu of such assumption or substitution of Options for options of the Successor Company or its parent or subsidiary, such Options will be substituted for any other type of asset or property including cash which is fair under the circumstances. Any Option Agreement may provide for specific rights of an optionee upon a Transaction. To extent determined by the Board or the Committee, any outstanding Options that are not exercised before a Transaction shall thereupon terminate.

 

(d)          If the Company is voluntarily liquidated or dissolved while unexercised Options remain outstanding under the Plan, the Company shall immediately notify all unexercised Option holders of such liquidation, and the Option holders shall then have ten (10) days to exercise any unexercised vested Option held by them at that time, in accordance with the exercise procedure set forth herein. Upon the expiration of such ten-days period, all remaining outstanding Options will terminate immediately.

 

(e)          If the outstanding Shares of the Company shall at any time be changed or exchanged by declaration of a share dividend (bonus shares), share split, reverse split, combination or exchange of shares, recapitalization, or any other like event by or of the Company, and as often as the same shall occur, then the number, class and kind of the Shares subject to the Plan or subject to any Options therefore granted, and the exercise prices, shall be appropriately and equitably adjusted so as to maintain the proportionate number of Shares without changing the aggregate exercise price, provided, however, that no adjustment shall be made by reason of the distribution of subscription rights (rights offering) on outstanding Shares. Upon happening of any of the foregoing, the class and aggregate number of Shares issuable pursuant to the Plan (as set forth in section 4 hereof), in respect of which Options have not yet been exercised, shall be appropriately adjusted, all as will be determined by the Board whose determination shall be final.

 

(f)          All determinations and adjustments under this Section shall be made by the Board or Committee, in its sole discretion and its determination as to what adjustments shall be made, and the extent thereof, shall be final, binding and conclusive.

 

9.            Tax Withholding and Tax Consequences .

 

(a)          As a condition to the exercise of any Option or the delivery of any Shares pursuant to any Option, or in connection with any other event that gives rise to a federal or other governmental tax withholding obligation on the part of the Company or an Affiliate relating to an Option, the Company and/or the Affiliate may (i) deduct or withhold (or cause to be deducted or withheld) from any payment or distribution to an optionee whether or not pursuant to the Plan or (ii) require the optionee to remit cash (through payroll deduction or otherwise), in each case in an amount sufficient in the opinion of the Company to satisfy such withholding obligation or (iii) arrange for the optionee to satisfy and tax withholding obligations by any method described in section 6(d) of the Plan and permitted by the Committee.

 

- 8 -
 

 

(b)          Any tax consequences arising from the grant or exercise of any Option, from the payment for Shares covered thereby or from any other event or act (of the Company and/or its Affiliates or the Participant), hereunder, shall be borne solely by the optionee. Furthermore, the optionee shall agree to indemnify the Company and/or its Affiliates and hold them harmless against and from any and all liability for any such tax or interest or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the optionee.

 

10.          Amendment and Termination . The Board may at any time amend, alter, suspend or terminate the Plan. Any amendment that would increase the aggregate number of Shares issuable under the Plan or that would modify the class of persons eligible to receive Options shall be subject to the approval of the Company’s stockholders. No amendment, alteration, suspension or termination of the Plan shall impair the rights of any optionee, unless mutually agreed otherwise between the optionee and the Company, which agreement must be in writing and signed by the optionee and the Company. Termination of the Plan shall not affect the Committee's ability to exercise the powers granted to it hereunder with respect to Options granted under the Plan prior to the date of such termination.

 

11.          General Provisions .

 

(a)           Shares Issued Under Plan . Shares available for issuance under the Plan may be authorized and unissued, held by the Company in its treasury or otherwise acquired for purposes of the Plan. No fractional Shares will be issued under the Plan.

 

(b)           Compliance with Law . The Company will not be obligated to issue or deliver Shares pursuant to the Plan unless the issuance and delivery of such shares complies with applicable law, including, without limitation, the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and the requirements of any stock exchange or market upon which the Shares may then be listed, and any such issuance or delivery of Shares shall be further subject to the approval of counsel for the Company with respect to such compliance.

 

(c)           Transfer Orders; Placement of Legends . All certificates for Shares delivered under the Plan shall be subject to such stock-transfer orders and other restrictions as the Company may deem advisable under the rules, regulations, and other requirements of the Securities and Exchange Commission, any stock exchange or market upon which the Shares may then be listed, and any applicable federal or state securities law. The Company may cause a legend or legends to be placed on any such certificates to make appropriate reference to such restrictions.

 

- 9 -
 

 

12.          No Employment or other Rights . Nothing contained in the Plan or in any Option Agreement shall confer upon any optionee any right with respect to the continuation of his employment or other service with the Company or an Affiliate or interfere in any way with the right of the Company and its Affiliates at any time to terminate such employment or other service or to modify the other terms and conditions of the optionee’s employment or other service.

 

13.          Decisions and Determinations Final . All decisions and determinations made by the Board or Committee pursuant to the provision of the Plan shall be final, binding and conclusive on all persons. In the event of any conflict between the Plan and an Option Agreement, the provisions of the Plan shall govern.

 

14.          Nonexclusivity of the Plan . The adoption of the Plan by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangement or as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options otherwise than under the Plan, and such arrangements may be either applicable generally or only in specific cases.

 

15.          Governing Law . All rights and obligations under the Plan and each Option agreement or instrument shall be governed by and construed in accordance with the laws of the State of Israel, without regard to its principles of conflict of laws, but shall be interpreted, to the extent possible, in order to preserve the tax treatment and tax qualification pursuant to the Code and other applicable Israeli and foreign tax laws and in a manner consistent with applicable laws, rules and regulations referred to in section 16. It is the intention of the Company that Incentive Stock Options granted under the Plan qualify as such under Section 422 of the Code and that all Options granted under the Plan comply with Section 409A of the Code.

 

16.          Beneficiary Designation . Each Participant may, from time to time, name any beneficiary or beneficiaries to whom any benefit under the Plan is to be paid in case of the Participant’s death before the Participant receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant with respect to such benefit, shall be in a form prescribed by the Company, and shall be effective only when filed by the Participant in writing with the Company during the Participant’s lifetime. In the absence of any such designation, any benefits remaining unpaid under the Plan at the Participant’s death shall be paid to the Participant’s estate unless otherwise provided in the Option Agreement.

 

17.          Government Regulations . The Plan, and the granting and exercise of Options hereunder, and the obligation of the Company to sell and deliver shares under such Options, shall be subject to all applicable laws, rules, and regulations, whether of the State of Israel or of the United States or any other State having jurisdiction over the Company and the Participant, including the registration of the Shares under the United States Securities Act of 1933, as amended, and to such approvals by any governmental agencies or national securities exchanges or other markets on which the Shares are traded as may be required.

 

(a)           Compliance with Section 409A of the Code . Except as otherwise specifically provided by the Committee at the time a Stock Option is granted, any Option providing for a deferral of compensation must satisfy the requirements of Section 409A. Toward that end, if any payment or benefit received or to be received by a Participant pursuant to an Option would cause the Participant to incur a penalty tax or interest under Section 409A of the Code or any regulations or United States Treasury Department guidance promulgated thereunder, the Committee may reform the provision(s) of such Option in order to avoid to the maximum extent practicable the incurrence of any such penalty tax or interest.

 

- 10 -
 

 

18.          Arbitration . Any dispute in relation with this Plan and the exercise of rights thereunder shall be subject to arbitration in accordance with the Labor Arbitration Rules of the American Arbitration Association. The decision of the arbitrator shall be final and shall bind the Company and the optionee.

 

19.          Dividends . With respect to all Shares (but excluding, for avoidance of any doubt, any unexercised Options) allocated or issued upon the exercise of Options purchased by the optionee and held by the optionee, the optionee shall be entitled to receive dividends in accordance with the quantity of such Shares, subject to the provisions of the Company's Articles of Association (and all amendments thereto) and subject to any applicable taxation on distribution of dividends.

 

20.          Term of the Plan . The Plan shall be effective as of the date of its adoption by the Board, subject to the approval of the stockholders of the Company within one year from the date of such adoption by the Board. The Plan shall terminate on the tenth anniversary of the date of its adoption by the Board, unless sooner terminated by the Board. The rights of any person with respect to any Option granted under the Plan that is outstanding at the time of the termination of the Plan shall not be affected solely by reason of the termination of the Plan and shall continue in accordance with the terms of the Option and of the Plan.

 

21.          Multiple Agreements . The terms of each Option may differ from other Options granted under the Plan at the same time, or at any other time. The Board may also grant more than one Option to a given Participant during the term of the Plan either in addition to, or in substitution for, one or more Options previously granted to that Participant.

 

- 11 -

 

Exhibit 8

 

SUBSIDIARIES OF VUANCE LTD. AS OF APRIL 30, 2012  

 

Name of Subsidiary

 

Jurisdiction of Organization

 

Percent Owned

 
           
Vuance Inc.   United States   100 %
Vuance RFID Inc.*   United States   100 %
S.B.C. Aviation Ltd.   Israel   100 %
SuperCom Slovakia A.S.   Slovakia   66 %
PureRFid Inc.   United States   100 %

 

* Vuance RFID Inc. has an Israeli wholly-owned subsidiary, Vuance RFID Ltd.

 

 

 Exhibit 12.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Doron Levy, certify that:

 

1. I have reviewed this Annual Report on Form 20-F of Vuance Ltd.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the Company and have:

 

a) Designed such disclosure controls and procedures , or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect the Company’s internal control over the financial reporting; and

 

5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 9, 2012

 

/s/ Doron Levy  
Doron Levy  
Chief Executive Officer  

 

 

Exhibit 12.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002

 

I, Mickey Ben Harush, certify that:

 

1. I have reviewed this Annual Report on Form 20-F of Vuance Ltd.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The Company’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the Company and have:

 

a) Designed such disclosure controls and procedures , or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect the Company’s internal control over the financial reporting; and

 

5. The Company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s Board of Directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 9, 2012 

 

/s/ Mickey Ben Harush  
Chief Financial Officer and Principal Accounting Officer  

 

 

Exhibit 13.1

 

SECTION 906 CERTIFICATION

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Vuance Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

The Annual Report on Form 20-F for the fiscal year ended December 31, 2011 (the “Form 20-F”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act of 1934, and the information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Dated: May 9, 2012 /s/ Doron Levy
  By: Doron Levy
  Title: Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

Exhibit 13.2

 

SECTION 906 CERTIFICATION

 

CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Vuance Ltd. (the “Company”), does hereby certify, to such officer’s knowledge, that:

 

The Annual Report on Form 20-F for the fiscal year ended December 31, 2011 (the “Form 20-F”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act of 1934, and the information contained in the Form 20-F fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 9, 2012 /s/ Mickey Ben Harush
  By: Mickey Ben Harush
  Title: Chief Financial Officer and Principal Accounting Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

Exhibit 15.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We have issued our report dated May 9, 2012 accompanying the consolidated financial statements included in the Annual Report of Vuance Ltd. on Form 20-F for the year ended December 31, 2011. We hereby consent to the incorporation by reference of said report in the Registration Statements of Vuance Ltd. on Form S-8 (File Nos. 333-121231 and 333-175785, effective December 14, 2004).

 

/s/FAHN KANNE & CO. GRANT THORNTON ISRAEL

 

Tel-Aviv, Israel

May 9, 2012